,docId,isValid,passage,passage_id,e1,e2
0,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,T-cell factor,alpha-catenin
1,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,T-cell factor,beta-catenin
2,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,T-cell factor,beta-catenin
3,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,alpha-catenin,beta-catenin
4,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,alpha-catenin,beta-catenin
5,BioInfer.d0,True,alpha-catenin inhibits beta-catenin signaling by preventing formation of a beta-catenin*T-cell factor*DNA complex.,BioInfer.d0.s0,beta-catenin,beta-catenin
6,BioInfer.d1,True,A binary complex of birch profilin and skeletal muscle actin could be isolated by gel chromatography.,BioInfer.d1.s0,profilin,skeletal muscle actin
7,BioInfer.d1,True,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,brain actin,profilin
8,BioInfer.d1,True,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,profilin,muscle actin
9,BioInfer.d1,True,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,profilin,actin
10,BioInfer.d1,False,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,brain actin,muscle actin
11,BioInfer.d1,False,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,brain actin,actin
12,BioInfer.d1,False,"Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.",BioInfer.d1.s1,muscle actin,actin
13,BioInfer.d1,True,Interaction of plant profilin with mammalian actin.,BioInfer.d1.s2,profilin,actin
14,BioInfer.d1,True,"In viscometric assays, the birch protein was seen to modulate actin filament formation analogous to animal profilin.",BioInfer.d1.s3,actin,profilin
15,BioInfer.d1,True,"These data indicate that the actin-binding domains in plant and animal profilins are functionally highly conserved, although the overall sequence similarity is less than 25%.",BioInfer.d1.s4,profilins,actin
16,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,alpha-catenin,gamma-catenin
17,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,alpha-catenin,E-cadherin
18,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,alpha-catenin,beta-catenin
19,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,gamma-catenin,E-cadherin
20,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,gamma-catenin,beta-catenin
21,BioInfer.d2,False,"Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.",BioInfer.d2.s0,E-cadherin,beta-catenin
22,BioInfer.d3,True,Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.,BioInfer.d3.s0,utrophin,alpha-syntrophin
23,BioInfer.d3,True,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,acetylcholine receptor,alpha-syntrophin
24,BioInfer.d3,True,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,acetylcholinesterase,alpha-syntrophin
25,BioInfer.d3,True,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,utrophin,alpha-syntrophin
26,BioInfer.d3,False,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,acetylcholine receptor,acetylcholinesterase
27,BioInfer.d3,False,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,acetylcholine receptor,utrophin
28,BioInfer.d3,False,"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.",BioInfer.d3.s1,acetylcholinesterase,utrophin
29,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,calreticulin
30,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,actin
31,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,alpha 5 integrins
32,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,pp125
33,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,beta 1 integrins
34,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,talin
35,BioInfer.d4,True,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,pp125,focal adhesion kinase
36,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,actin
37,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,alpha 5 integrins
38,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,pp125
39,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,beta 1 integrins
40,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,talin
41,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha-catenin,focal adhesion kinase
42,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,calreticulin,focal adhesion kinase
43,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,actin,alpha 5 integrins
44,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,actin,pp125
45,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,actin,beta 1 integrins
46,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,actin,talin
47,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,actin,focal adhesion kinase
48,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha 5 integrins,pp125
49,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha 5 integrins,beta 1 integrins
50,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha 5 integrins,talin
51,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,alpha 5 integrins,focal adhesion kinase
52,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,pp125,beta 1 integrins
53,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,pp125,talin
54,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,beta 1 integrins,talin
55,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,beta 1 integrins,focal adhesion kinase
56,BioInfer.d4,False,"Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.",BioInfer.d4.s0,talin,focal adhesion kinase
57,BioInfer.d5,True,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,actin,profilin
58,BioInfer.d5,True,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,actin,profilin
59,BioInfer.d5,False,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,actin,actin
60,BioInfer.d5,False,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,actin,profilin
61,BioInfer.d5,False,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,profilin,actin
62,BioInfer.d5,False,Acanthamoeba actin and profilin can be cross-linked between glutamic acid 364 of actin and lysine 115 of profilin.,BioInfer.d5.s0,profilin,profilin
63,BioInfer.d5,True,Acanthamoeba profilin was cross-linked to actin via a zero-length isopeptide bond using carbodiimide.,BioInfer.d5.s1,profilin,actin
64,BioInfer.d5,False,"Since the NH2 terminus of profilin is blocked, Edman degradation gave only the sequence of the conjugated actin CNBr fragment beginning with Trp-356.",BioInfer.d5.s2,profilin,actin
65,BioInfer.d6,True,Acanthamoeba profilin affects the mechanical properties of nonfilamentous actin.,BioInfer.d6.s0,actin,profilin
66,BioInfer.d6,True,"In contrast, profilin had little effect on the rigidity and viscosity of actin filaments.",BioInfer.d6.s1,profilin,actin
67,BioInfer.d6,False,"We speculate that nonfilamentous actin and profilin, both of which form shear-sensitive structures, can be modeled as flocculant materials.",BioInfer.d6.s2,profilin,actin
68,BioInfer.d7,True,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,muscle actin,profilin
69,BioInfer.d7,False,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,profilin,muscle actin
70,BioInfer.d7,False,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,profilin,actin
71,BioInfer.d7,False,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,profilin,profilin
72,BioInfer.d7,False,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,muscle actin,actin
73,BioInfer.d7,False,"Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.",BioInfer.d7.s0,actin,profilin
74,BioInfer.d7,True,Acanthamoeba profilin strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba actin polymerization in 50 mM KCl.,BioInfer.d7.s1,actin,profilin
75,BioInfer.d7,True,"Addition of profilin to polymerized actin causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.",BioInfer.d7.s2,profilin,actin
76,BioInfer.d7,False,"Addition of profilin to polymerized actin causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.",BioInfer.d7.s2,profilin,profilin
77,BioInfer.d7,False,"Addition of profilin to polymerized actin causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.",BioInfer.d7.s2,actin,profilin
78,BioInfer.d7,False,Mechanism of action of Acanthamoeba profilin: demonstration of actin species specificity and regulation by micromolar concentrations of MgCl2.,BioInfer.d7.s3,profilin,actin
79,BioInfer.d7,True,"MgCl2 strongly inhibits these effects of profilin, most likely by binding to the high-affinity divalent cation site on the actin.",BioInfer.d7.s4,actin,profilin
80,BioInfer.d8,False,"Accordingly, beta-catenin is also found in these structures, again in the absence of alpha-catenin.",BioInfer.d8.s0,alpha-catenin,beta-catenin
81,BioInfer.d8,True,"In addition to its presence in cell-cell adhesion sites, we have found beta-catenin, but not alpha-catenin, in the Z-discs of heart and skeletal striated muscles.",BioInfer.d8.s1,beta-catenin,alpha-catenin
82,BioInfer.d9,True,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin 57-264
83,BioInfer.d9,True,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin
84,BioInfer.d9,True,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin
85,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,beta-catenin
86,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin
87,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin 57-264
88,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,beta-catenin,alpha-catenin
89,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,alpha-catenin 57-264,alpha-catenin
90,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,alpha-catenin 57-264,alpha-catenin
91,BioInfer.d9,False,"A chimera consisting of the alpha-catenin-binding region of beta-catenin linked to the amino terminus of alpha-catenin 57-264 behaves as a monomer in solution, as expected, since beta-catenin binding disrupts the alpha-catenin dimer.",BioInfer.d9.s0,alpha-catenin,alpha-catenin
92,BioInfer.d10,True,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,nucleocapsid protein,phosphoprotein
93,BioInfer.d10,True,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,nucleocapsid protein,P
94,BioInfer.d10,True,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,phosphoprotein,N
95,BioInfer.d10,True,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,P,N
96,BioInfer.d10,False,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,nucleocapsid protein,N
97,BioInfer.d10,False,Acidic domain of the phosphoprotein (P) of vesicular stomatitis virus differentially interacts with homologous and heterologous nucleocapsid protein (N).,BioInfer.d10.s0,phosphoprotein,P
98,BioInfer.d11,False,"A common feature of these talin-positive domains is the deep membrane infoldings, where bundles of actin filaments are inserted into the membrane.",BioInfer.d11.s0,actin,talin
99,BioInfer.d12,True,A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.,BioInfer.d12.s0,rad52,RAD51
100,BioInfer.d12,False,A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.,BioInfer.d12.s0,rad52,RAD52
101,BioInfer.d12,False,A core activity associated with the N terminus of the yeast RAD52 protein is revealed by RAD51 overexpression suppression of C-terminal rad52 truncation alleles.,BioInfer.d12.s0,RAD51,RAD52
102,BioInfer.d14,True,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,gelsolin,Actin-binding proteins
103,BioInfer.d14,True,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,actin,Actin-binding proteins
104,BioInfer.d14,True,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,Actin-binding proteins,profilin
105,BioInfer.d14,False,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,gelsolin,actin
106,BioInfer.d14,False,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,gelsolin,profilin
107,BioInfer.d14,False,"Actin-binding proteins such as profilin and gelsolin bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric actin.",BioInfer.d14.s0,actin,profilin
108,BioInfer.d14,False,"These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.",BioInfer.d14.s1,profilin,actin
109,BioInfer.d14,False,"These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.",BioInfer.d14.s1,profilin,gelsolin
110,BioInfer.d14,False,"These studies suggest that profilin and gelsolin may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the actin polymerization.",BioInfer.d14.s1,actin,gelsolin
111,BioInfer.d14,True,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,PI 3-kinase,tau
112,BioInfer.d14,True,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,PI 3-kinase,actin
113,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,profilin,PI 3-kinase
114,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,profilin,tau
115,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,profilin,actin
116,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,profilin,gelsolin
117,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,PI 3-kinase,gelsolin
118,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,tau,actin
119,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,tau,gelsolin
120,BioInfer.d14,False,This effect is specific to profilin and gelsolin because other cytoskeletal proteins such as tau or actin do not affect PI 3-kinase activity.,BioInfer.d14.s2,actin,gelsolin
121,BioInfer.d16,True,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,ADF,actin-binding proteins
122,BioInfer.d16,True,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,Actin-depolymerizing factor,actin-binding proteins
123,BioInfer.d16,True,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,cofilin,actin-binding proteins
124,BioInfer.d16,True,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,actin,actin-binding proteins
125,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,ADF,Actin-depolymerizing factor
126,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,ADF,cofilin
127,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,ADF,actin
128,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,Actin-depolymerizing factor,cofilin
129,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,Actin-depolymerizing factor,actin
130,BioInfer.d16,False,Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.,BioInfer.d16.s0,cofilin,actin
131,BioInfer.d17,False,"Actin expression was reduced by 25-50%, relative to that of myosin heavy chain, in smooth muscle of KO mice, without any change in the relative distribution of the actin isoforms.",BioInfer.d17.s0,Actin,actin
132,BioInfer.d17,False,"Actin expression was reduced by 25-50%, relative to that of myosin heavy chain, in smooth muscle of KO mice, without any change in the relative distribution of the actin isoforms.",BioInfer.d17.s0,Actin,myosin heavy chain
133,BioInfer.d17,False,"Actin expression was reduced by 25-50%, relative to that of myosin heavy chain, in smooth muscle of KO mice, without any change in the relative distribution of the actin isoforms.",BioInfer.d17.s0,actin,myosin heavy chain
134,BioInfer.d18,True,"Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.",BioInfer.d18.s0,actin,profilin
135,BioInfer.d18,False,"Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.",BioInfer.d18.s0,Actin,actin
136,BioInfer.d18,False,"Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.",BioInfer.d18.s0,Actin,profilin
137,BioInfer.d20,True,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB-binding-protein,CREB
138,BioInfer.d20,True,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB-binding-protein,CREB
139,BioInfer.d20,True,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB,CBP
140,BioInfer.d20,True,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB,CBP
141,BioInfer.d20,False,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB-binding-protein,CBP
142,BioInfer.d20,False,"Active, Ser133-phosphorylated CREB effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein CREB-binding-protein, CBP, which bridges the CRE/CREB complex to components of the basal transcriptional apparatus.",BioInfer.d20.s0,CREB,CREB
143,BioInfer.d21,False,Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.,BioInfer.d21.s0,actin,profilin
144,BioInfer.d21,False,Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.,BioInfer.d21.s0,actin,Actophorin
145,BioInfer.d21,False,Actophorin and profilin have opposite effects on the rate of exchange of nucleotide bound to actin monomers.,BioInfer.d21.s0,profilin,Actophorin
146,BioInfer.d24,False,"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).",BioInfer.d24.s0,pp60src,actin-binding protein
147,BioInfer.d24,False,"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).",BioInfer.d24.s0,pp60src,talin
148,BioInfer.d24,False,"Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of actin-binding protein, talin, and pp60src in response to A23187 (1 microM).",BioInfer.d24.s0,actin-binding protein,talin
149,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,E-cadherin
150,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,alpha-catenin
151,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,N-cadherin
152,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,Ki-67
153,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,actin
154,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,plakoglobin,beta-catenin
155,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,E-cadherin,alpha-catenin
156,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,E-cadherin,N-cadherin
157,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,E-cadherin,Ki-67
158,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,E-cadherin,actin
159,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,E-cadherin,beta-catenin
160,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,alpha-catenin,N-cadherin
161,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,alpha-catenin,Ki-67
162,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,alpha-catenin,actin
163,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,alpha-catenin,beta-catenin
164,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,N-cadherin,Ki-67
165,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,N-cadherin,actin
166,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,N-cadherin,beta-catenin
167,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,Ki-67,actin
168,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,Ki-67,beta-catenin
169,BioInfer.d25,False,"Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.",BioInfer.d25.s0,actin,beta-catenin
170,BioInfer.d26,True,A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.,BioInfer.d26.s0,AP-1,glucocorticoid receptor
171,BioInfer.d27,True,ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.,BioInfer.d27.s0,actin,iota toxin
172,BioInfer.d27,True,ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.,BioInfer.d27.s0,iota toxin,profilin
173,BioInfer.d27,False,ADP-ribosylation of actin at Arg 177 by Clostridium perfringens iota toxin increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the profilin-induced stimulation of nucleotide exchange.,BioInfer.d27.s0,actin,profilin
174,BioInfer.d27,True,"In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.",BioInfer.d27.s1,erythrocyte transferase,actin
175,BioInfer.d27,False,"In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.",BioInfer.d27.s1,profilin,erythrocyte transferase
176,BioInfer.d27,False,"In contrast, ADP-ribosylation of actin at Arg95/Arg372 induced by turkey erythrocyte transferase decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the profilin-induced stimulation of nucleotide exchange.",BioInfer.d27.s1,profilin,actin
177,BioInfer.d28,False,"After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of ""dashes"" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.",BioInfer.d28.s0,beta-catenin,VE-cadherin
178,BioInfer.d28,False,"After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of ""dashes"" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.",BioInfer.d28.s0,beta-catenin,alpha-catenin
179,BioInfer.d28,False,"After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of ""dashes"" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.",BioInfer.d28.s0,VE-cadherin,alpha-catenin
180,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,vascular endothelial cadherin,beta-catenin
181,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,vascular endothelial cadherin,alpha-catenin
182,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,vascular endothelial cadherin,plakoglobin
183,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,beta-catenin,alpha-catenin
184,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,beta-catenin,plakoglobin
185,BioInfer.d28,False,"Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.",BioInfer.d28.s1,alpha-catenin,plakoglobin
186,BioInfer.d29,True,"After digestion of the 60 kDa fragment with cyanogen bromide, the N-terminal 21-amino acid sequence of one of the resulting peptides was found to show sequence similarity to a region near the actin-binding site (amino acid residues 260-281) of yeast fimbrin.",BioInfer.d29.s0,fimbrin,actin
187,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,actin,DNase I
188,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,actin,actin-binding proteins
189,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,actin,profilin
190,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,DNase I,actin-binding proteins
191,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,DNase I,profilin
192,BioInfer.d30,False,"After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.",BioInfer.d30.s0,actin-binding proteins,profilin
193,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
194,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
195,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
196,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
197,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
198,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
199,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
200,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
201,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
202,BioInfer.d31,True,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
203,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
204,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
205,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
206,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
207,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
208,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
209,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
210,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
211,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
212,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
213,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
214,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
215,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
216,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
217,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
218,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
219,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
220,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
221,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
222,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
223,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
224,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
225,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
226,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
227,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
228,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
229,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
230,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
231,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
232,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
233,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
234,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
235,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
236,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
237,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
238,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
239,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
240,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
241,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
242,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
243,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
244,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
245,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
246,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
247,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
248,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
249,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
250,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
251,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
252,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
253,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
254,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
255,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
256,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
257,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
258,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
259,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
260,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
261,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
262,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
263,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
264,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
265,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
266,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
267,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
268,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
269,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
270,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
271,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
272,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
273,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
274,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
275,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
276,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
277,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
278,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
279,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
280,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
281,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
282,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
283,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
284,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
285,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
286,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
287,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
288,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
289,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
290,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
291,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
292,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
293,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
294,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
295,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
296,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
297,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
298,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
299,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
300,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
301,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
302,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
303,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
304,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
305,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
306,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
307,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
308,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
309,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
310,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
311,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
312,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
313,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
314,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
315,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
316,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
317,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
318,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
319,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
320,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
321,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
322,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
323,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
324,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
325,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
326,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
327,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H3
328,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2B
329,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H4
330,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histone
331,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
332,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
333,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
334,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
335,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
336,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
337,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
338,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2B
339,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H4
340,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,histone
341,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2A.1
342,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H1
343,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H1(0)
344,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,histones
345,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2A.Z
346,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2A.X
347,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2A.2
348,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H3,H2A.2
349,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H4
350,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,histone
351,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H2A.1
352,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H1
353,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H1(0)
354,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,histones
355,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H2A.Z
356,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H2A.X
357,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H2A.2
358,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2B,H2A.2
359,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,histone
360,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H2A.1
361,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H1
362,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H1(0)
363,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,histones
364,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H2A.Z
365,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H2A.X
366,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H2A.2
367,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H4,H2A.2
368,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.1
369,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1
370,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H1(0)
371,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,histones
372,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.Z
373,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.X
374,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histone,H2A.2
375,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H1
376,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H1(0)
377,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,histones
378,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H2A.Z
379,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H2A.X
380,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H2A.2
381,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.1,H2A.2
382,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,H1(0)
383,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,histones
384,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,H2A.Z
385,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,H2A.X
386,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,H2A.2
387,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1,H2A.2
388,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1(0),histones
389,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1(0),H2A.Z
390,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1(0),H2A.X
391,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1(0),H2A.2
392,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H1(0),H2A.2
393,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histones,H2A.Z
394,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histones,H2A.X
395,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histones,H2A.2
396,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,histones,H2A.2
397,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.Z,H2A.X
398,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.Z,H2A.2
399,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.Z,H2A.2
400,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.X,H2A.2
401,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.X,H2A.2
402,BioInfer.d31,False,"After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.",BioInfer.d31.s0,H2A.2,H2A.2
403,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,myosin I,fimbrin
404,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,myosin I,actin
405,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,myosin I,villin
406,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,fimbrin,actin
407,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,fimbrin,villin
408,BioInfer.d32,False,"A further outcome of this study is that the actin filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either villin, fimbrin or myosin I of the intestinal brush border.",BioInfer.d32.s0,actin,villin
409,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,alpha-catenin,E-cadherin
410,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,alpha-catenin,beta-catenin
411,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,alpha-catenin,gamma-catenin
412,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,E-cadherin,beta-catenin
413,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,E-cadherin,gamma-catenin
414,BioInfer.d33,True,"A highly significant correlation was observed between the loss of expression of E-cadherin, alpha-catenin and gamma-catenin, but not beta-catenin, with increased TNM stage (p <0.05).",BioInfer.d33.s0,beta-catenin,gamma-catenin
415,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,beta-catenin,E-cadherin
416,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,beta-catenin,gamma-catenin
417,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,beta-catenin,alpha-catenin
418,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,E-cadherin,gamma-catenin
419,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,E-cadherin,alpha-catenin
420,BioInfer.d33,False,"Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).",BioInfer.d33.s1,gamma-catenin,alpha-catenin
421,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,avidin,beta-catenin
422,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,avidin,alpha-catenin
423,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,avidin,E-cadherin
424,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,avidin,gamma-catenin
425,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,beta-catenin,alpha-catenin
426,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,beta-catenin,E-cadherin
427,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,beta-catenin,gamma-catenin
428,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,alpha-catenin,E-cadherin
429,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,alpha-catenin,gamma-catenin
430,BioInfer.d33,False,"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.",BioInfer.d33.s2,E-cadherin,gamma-catenin
431,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,alpha-catenin,gamma-catenin
432,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,alpha-catenin,E-cadherin
433,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,alpha-catenin,beta-catenin
434,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,gamma-catenin,E-cadherin
435,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,gamma-catenin,beta-catenin
436,BioInfer.d33,False,"RESULTS: E-cadherin, alpha-catenin, beta-catenin and gamma-catenin were expressed in a normal membranous pattern in all normal bladder epithelium specimens.",BioInfer.d33.s3,E-cadherin,beta-catenin
437,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,E-cadherin,beta-catenin
438,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,E-cadherin,alpha-catenin
439,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,E-cadherin,beta-cat
440,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,E-cadherin,alpha-cat
441,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,E-cadherin,E-cad
442,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-catenin,alpha-catenin
443,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-catenin,beta-cat
444,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-catenin,alpha-cat
445,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-catenin,E-cad
446,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,alpha-catenin,beta-cat
447,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,alpha-catenin,alpha-cat
448,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,alpha-catenin,E-cad
449,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-cat,alpha-cat
450,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,beta-cat,E-cad
451,BioInfer.d34,False,"AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.",BioInfer.d34.s0,alpha-cat,E-cad
452,BioInfer.d35,True,Aip1p interacts with cofilin to disassemble actin filaments.,BioInfer.d35.s0,Aip1p,actin
453,BioInfer.d35,True,Aip1p interacts with cofilin to disassemble actin filaments.,BioInfer.d35.s0,Aip1p,cofilin
454,BioInfer.d35,True,Aip1p interacts with cofilin to disassemble actin filaments.,BioInfer.d35.s0,actin,cofilin
455,BioInfer.d35,True,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,actin,actin
456,BioInfer.d35,True,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,actin,Aip1p
457,BioInfer.d35,True,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,actin,cofilin
458,BioInfer.d35,False,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,actin,Aip1p
459,BioInfer.d35,False,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,actin,cofilin
460,BioInfer.d35,False,"Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.",BioInfer.d35.s1,Aip1p,cofilin
461,BioInfer.d35,True,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,cofilin
462,BioInfer.d35,True,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,Aip1p
463,BioInfer.d35,True,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,cofilin,Aip1p
464,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,cofilin
465,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,actin
466,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,cofilin
467,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,actin,Aip1p
468,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,cofilin,actin
469,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,cofilin,cofilin
470,BioInfer.d35,False,"A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.",BioInfer.d35.s2,cofilin,Aip1p
471,BioInfer.d35,True,"Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.",BioInfer.d35.s3,actin depolymerizing factor,cofilin
472,BioInfer.d35,True,"Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.",BioInfer.d35.s3,cofilin,Aip1p
473,BioInfer.d35,False,"Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.",BioInfer.d35.s3,actin depolymerizing factor,Aip1p
474,BioInfer.d35,True,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,cofilin,Aip1p
475,BioInfer.d35,True,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,actin,Aip1p
476,BioInfer.d35,True,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,actin,cofilin
477,BioInfer.d35,True,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,Aip1p,cofilin
478,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,cofilin,actin
479,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,cofilin,cofilin
480,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,cofilin,cofilin
481,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,actin,cofilin
482,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,Aip1p,cofilin
483,BioInfer.d35,False,We conclude that Aip1p is a cofilin-associated protein that enhances the filament disassembly activity of cofilin and restricts cofilin localization to cortical actin patches.,BioInfer.d35.s4,cofilin,cofilin
484,BioInfer.d36,True,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,protein kinase,LIMK2
485,BioInfer.d36,True,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,cofilin,LIMK2
486,BioInfer.d36,True,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,cofilin,LIMK2
487,BioInfer.d36,True,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,actin
488,BioInfer.d36,True,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,actin,LIMK2
489,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,protein kinase,cofilin
490,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,protein kinase,LIMK2
491,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,protein kinase,actin
492,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,protein kinase,LIMK2
493,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,cofilin
494,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,LIMK2
495,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,actin
496,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,LIMK2
497,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,cofilin,actin
498,BioInfer.d36,False,"A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.",BioInfer.d36.s0,LIMK2,LIMK2
499,BioInfer.d37,True,"All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between profilin and monomeric actin with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.",BioInfer.d37.s0,profilin,actin
500,BioInfer.d37,True,The interaction of Acanthamoeba actin and Acanthamoeba profilin was evaluated as a function of ionic conditions.,BioInfer.d37.s1,actin,profilin
501,BioInfer.d39,True,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,IgG,actin-binding protein
502,BioInfer.d39,True,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,IgG,talin
503,BioInfer.d39,True,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,IgG,vinculin
504,BioInfer.d39,False,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,actin-binding protein,talin
505,BioInfer.d39,False,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,actin-binding protein,vinculin
506,BioInfer.d39,False,"Although binding patterns of different sera were not identical, almost all sera caused IgG binding to platelet components of 87-90 kD, 140 kD (identified as vinculin) and 220-240 kD (tentatively identified as talin and actin-binding protein).",BioInfer.d39.s0,talin,vinculin
507,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
508,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
509,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
510,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
511,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
512,BioInfer.d41,True,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
513,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
514,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
515,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,profilin
516,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
517,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,profilin
518,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
519,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
520,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
521,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
522,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
523,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
524,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
525,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
526,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
527,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
528,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
529,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
530,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,actin
531,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
532,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,actin
533,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,profilin,profilin
534,BioInfer.d41,False,"Although profilin released actin at the appropriate time to stimulate actin assembly during exposure to chemoattractants, the concentration of profilin in PMN was insufficient to explain the high unpolymerized actin content in unstimulated PMN and the quantity of actin released from profilin too small to account for the large shifts from unpolymerized to polymerized actin associated with maximal chemoattractant stimulation.",BioInfer.d41.s0,actin,profilin
535,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,actin,actin
536,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,actin,profilin
537,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,actin,profilin
538,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,actin,profilin
539,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,actin,profilin
540,BioInfer.d41,False,Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.,BioInfer.d41.s1,profilin,profilin
541,BioInfer.d41,True,"We examined the role of the actin monomer sequestering protein, profilin, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.",BioInfer.d41.s2,profilin,actin
542,BioInfer.d41,True,"We examined the role of the actin monomer sequestering protein, profilin, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.",BioInfer.d41.s2,profilin,PMN actin
543,BioInfer.d41,False,"We examined the role of the actin monomer sequestering protein, profilin, in the regulation of PMN actin filament assembly during chemoattractant stimulation using a Triton extraction method.",BioInfer.d41.s2,actin,PMN actin
544,BioInfer.d43,True,"Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.",BioInfer.d43.s0,actin,glucokinase
545,BioInfer.d43,False,"Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.",BioInfer.d43.s0,actin,islet glucokinase
546,BioInfer.d43,False,"Although co-localization of glucokinase with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.",BioInfer.d43.s0,glucokinase,islet glucokinase
547,BioInfer.d43,True,A portion of glucokinase appeared to be co-localized with actin filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.,BioInfer.d43.s1,glucokinase,actin
548,BioInfer.d43,True,Co-localization of glucokinase with actin filaments.,BioInfer.d43.s2,actin,glucokinase
549,BioInfer.d43,True,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,glucokinase,actin
550,BioInfer.d43,False,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,islet-type glucokinase,glucokinase
551,BioInfer.d43,False,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,islet-type glucokinase,liver- type glucokinase
552,BioInfer.d43,False,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,islet-type glucokinase,actin
553,BioInfer.d43,False,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,glucokinase,liver- type glucokinase
554,BioInfer.d43,False,"When liver- or islet-type glucokinase was transiently expressed in COS-7 cells, the expressed glucokinase was also co-localized with actin filaments in the cytoplasm of these transfected cells.",BioInfer.d43.s3,liver- type glucokinase,actin
555,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,BCK1-20
556,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,glc7-10
557,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MEKK
558,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,glc7-10
559,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,MEK
560,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,glc7-10
561,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,glc7-10
562,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,glc7-10
563,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,glc7-10
564,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,glc7-10
565,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,glc7-10
566,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,MAP kinase
567,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,glc7-10
568,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,SLG1
569,BioInfer.d44,True,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,PKC1
570,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MKK1
571,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,HCS77
572,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,Pkc1p
573,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,WSC1
574,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MID2
575,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,RHO2
576,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MPK1
577,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,ROM2
578,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,glc7-10
579,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,PKC1
580,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,SLG1
581,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MEK
582,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1,MAP kinase
583,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,BCK1-20
584,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,HCS77
585,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,Pkc1p
586,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,WSC1
587,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,MID2
588,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,RHO2
589,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,MPK1
590,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,ROM2
591,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,glc7-10
592,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,PKC1
593,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,SLG1
594,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,MEKK
595,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MKK1,MAP kinase
596,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,HCS77
597,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,Pkc1p
598,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,WSC1
599,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,MID2
600,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,RHO2
601,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,MPK1
602,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,ROM2
603,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,glc7-10
604,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,PKC1
605,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,SLG1
606,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,MEKK
607,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,MEK
608,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,BCK1-20,MAP kinase
609,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,Pkc1p
610,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,WSC1
611,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,MID2
612,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,RHO2
613,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,MPK1
614,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,ROM2
615,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,glc7-10
616,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,PKC1
617,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,SLG1
618,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,MEKK
619,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,MEK
620,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,HCS77,MAP kinase
621,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,WSC1
622,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,MID2
623,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,RHO2
624,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,MPK1
625,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,ROM2
626,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,glc7-10
627,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,glc7-10
628,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,PKC1
629,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,SLG1
630,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,MEKK
631,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,MEK
632,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,Pkc1p,MAP kinase
633,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,MID2
634,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,RHO2
635,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,MPK1
636,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,ROM2
637,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,glc7-10
638,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,PKC1
639,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,SLG1
640,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,MEKK
641,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,MEK
642,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,WSC1,MAP kinase
643,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,RHO2
644,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,MPK1
645,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,ROM2
646,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,glc7-10
647,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,PKC1
648,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,SLG1
649,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,MEKK
650,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,MEK
651,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MID2,MAP kinase
652,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,MPK1
653,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,ROM2
654,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,glc7-10
655,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,PKC1
656,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,SLG1
657,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,MEKK
658,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,MEK
659,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,RHO2,MAP kinase
660,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,ROM2
661,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,glc7-10
662,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,PKC1
663,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,SLG1
664,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,MEKK
665,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MPK1,MEK
666,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,glc7-10
667,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,PKC1
668,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,SLG1
669,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,MEKK
670,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,MEK
671,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,ROM2,MAP kinase
672,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,glc7-10
673,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,PKC1
674,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MEKK
675,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MEK
676,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MAP kinase
677,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,SLG1
678,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MEKK
679,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MEK
680,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,glc7-10,MAP kinase
681,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,PKC1,SLG1
682,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,PKC1,MEKK
683,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,PKC1,MEK
684,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,PKC1,MAP kinase
685,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,SLG1,MEKK
686,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,SLG1,MEK
687,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,SLG1,MAP kinase
688,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MEKK,MEK
689,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MEKK,MAP kinase
690,BioInfer.d44,False,"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.",BioInfer.d44.s0,MEK,MAP kinase
691,BioInfer.d48,True,"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.",BioInfer.d48.s0,vinculin,actin
692,BioInfer.d48,True,"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.",BioInfer.d48.s0,actin,talin
693,BioInfer.d48,False,"A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of talin and vinculin on the structure, chain dynamics, elasticity and viscoelasticity of actin filaments with time.",BioInfer.d48.s0,vinculin,talin
694,BioInfer.d48,True,The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.,BioInfer.d48.s1,actin,talin
695,BioInfer.d48,True,The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.,BioInfer.d48.s1,actin,vinculin
696,BioInfer.d48,False,The viscoelasticity of entangled actin networks: the influence of defects and modulation by talin and vinculin.,BioInfer.d48.s1,talin,vinculin
697,BioInfer.d49,True,A model is proposed for the function of profilin in actin-based motility.,BioInfer.d49.s0,actin,profilin
698,BioInfer.d49,True,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,profilin,actin
699,BioInfer.d49,True,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,actin
700,BioInfer.d49,True,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,T beta 4
701,BioInfer.d49,True,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,T beta 4
702,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,profilin,actin
703,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,profilin,thymosin beta 4
704,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,profilin,T beta 4
705,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,profilin,T beta 4
706,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,thymosin beta 4
707,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,T beta 4
708,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,thymosin beta 4
709,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,actin,T beta 4
710,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,thymosin beta 4,T beta 4
711,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,thymosin beta 4,T beta 4
712,BioInfer.d49,False,"As a consequence, in the presence of thymosin beta 4 (T beta 4), low amounts of profilin promote extensive actin assembly off of the pool of actin-T beta 4 complex.",BioInfer.d49.s1,T beta 4,T beta 4
713,BioInfer.d49,True,How profilin promotes actin filament assembly in the presence of thymosin beta 4.,BioInfer.d49.s2,actin,profilin
714,BioInfer.d49,False,How profilin promotes actin filament assembly in the presence of thymosin beta 4.,BioInfer.d49.s2,actin,thymosin beta 4
715,BioInfer.d49,False,How profilin promotes actin filament assembly in the presence of thymosin beta 4.,BioInfer.d49.s2,thymosin beta 4,profilin
716,BioInfer.d49,True,The role of profilin in the regulation of actin assembly has been reexamined.,BioInfer.d49.s3,actin,profilin
717,BioInfer.d49,True,"When barbed ends are capped, profilin simply sequesters globular actin.",BioInfer.d49.s4,profilin,actin
718,BioInfer.d50,True,mDia binds profilin likely to promote actin polymerization.,BioInfer.d50.s0,mDia,profilin
719,BioInfer.d50,True,mDia binds profilin likely to promote actin polymerization.,BioInfer.d50.s0,mDia,actin
720,BioInfer.d50,True,mDia binds profilin likely to promote actin polymerization.,BioInfer.d50.s0,profilin,actin
721,BioInfer.d51,False,MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.,BioInfer.d51.s0,MSH2,MSH6
722,BioInfer.d51,False,MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.,BioInfer.d51.s0,MSH2,MSH3
723,BioInfer.d51,False,MSH2 plays a fundamental role in mispair recognition whereas MSH3 and MSH6 appear to modify the specificity of this recognition.,BioInfer.d51.s0,MSH6,MSH3
724,BioInfer.d52,True,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,t-SNARE,syntaxin 3
725,BioInfer.d52,True,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,Munc18-2,Sec1
726,BioInfer.d52,True,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,Munc18-2,syntaxin 3
727,BioInfer.d52,False,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,t-SNARE,Munc18-2
728,BioInfer.d52,False,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,t-SNARE,Sec1
729,BioInfer.d52,False,"Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.",BioInfer.d52.s0,Sec1,syntaxin 3
730,BioInfer.d52,True,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,syntaxin,Sec1
731,BioInfer.d52,True,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,syntaxin 3,Munc18-2
732,BioInfer.d52,False,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,syntaxin,syntaxin 3
733,BioInfer.d52,False,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,syntaxin,Munc18-2
734,BioInfer.d52,False,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,Sec1,syntaxin 3
735,BioInfer.d52,False,"Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.",BioInfer.d52.s1,Sec1,Munc18-2
736,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,Munc18-2,syntaxin 3
737,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,Munc18-2,SNAP-23
738,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,Munc18-2,syntaxin 3
739,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,syntaxin 3,SNAP-23
740,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,syntaxin 3,syntaxin 3
741,BioInfer.d52,True,"The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.",BioInfer.d52.s2,SNAP-23,syntaxin 3
742,BioInfer.d52,False,This implies that Munc18-2 function in apical membrane trafficking involves aspects independent of the syntaxin 3 interaction.,BioInfer.d52.s3,syntaxin 3,Munc18-2
743,BioInfer.d53,True,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,alpha-catenin
744,BioInfer.d53,True,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,E-cadherin
745,BioInfer.d53,True,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,catenins,E-cadherin
746,BioInfer.d53,True,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,alpha-catenin,E-cadherin
747,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,beta-catenin
748,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,catenins
749,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,E-cadherin
750,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,beta-catenin
751,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,alpha-catenin
752,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,E-cadherin
753,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,catenins
754,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,E-cadherin
755,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,beta-catenin
756,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,catenins,beta-catenin
757,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,catenins,alpha-catenin
758,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,catenins,E-cadherin
759,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,beta-catenin
760,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,alpha-catenin
761,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,E-cadherin,E-cadherin
762,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,alpha-catenin
763,BioInfer.d53,False,"Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.",BioInfer.d53.s0,beta-catenin,E-cadherin
764,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,profilin
765,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
766,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
767,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
768,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
769,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
770,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,profilin,actin
771,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,actin,actin
772,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,actin,actin
773,BioInfer.d55,False,"Analysis of profilin: actin crystals reveals an extensive intermolecular network, rather than a discrete ""monomeric complex"", comprising stacked actin ribbons held in place by columns of profilin molecules, wedged in between neighboring actin subunits and running perpendicular to the ribbons.",BioInfer.d55.s0,actin,actin
774,BioInfer.d55,False,Molecular packing in profilin: actin crystals and its implications.,BioInfer.d55.s1,profilin,actin
775,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR2,SIR4
776,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR2,SIR1
777,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR2,SIR3
778,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR4,SIR1
779,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR4,SIR3
780,BioInfer.d56,False,"Analysis of changes in state suggests that SIR1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas SIR2, SIR3, and SIR4 are required for maintenance.",BioInfer.d56.s0,SIR1,SIR3
781,BioInfer.d57,True,"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.",BioInfer.d57.s0,profilin,spleen actin gamma
782,BioInfer.d57,True,"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.",BioInfer.d57.s0,profilin,spleen actin beta
783,BioInfer.d57,False,"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the spleen actin (beta, gamma) which appears to regulate the interaction with profilin.",BioInfer.d57.s0,spleen actin gamma,spleen actin beta
784,BioInfer.d57,True,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,actin,spleen actin
785,BioInfer.d57,True,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,actin,spleen profilin
786,BioInfer.d57,True,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,spleen actin,spleen profilin
787,BioInfer.d57,False,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,profilin,actin
788,BioInfer.d57,False,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,profilin,spleen actin
789,BioInfer.d57,False,"The interaction between calf spleen profilin and actin depends critically on the status of the C-terminus of the actin, and in the case of profilin, the C-terminus is of great importance for the physiochemical behaviour of the protein.",BioInfer.d57.s1,profilin,spleen profilin
790,BioInfer.d58,False,Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of profilin and actin did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.,BioInfer.d58.s0,profilin,actin
791,BioInfer.d59,True,"Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that cofilin was cross-linked with the N-terminal segment of actin containing residues 1-12.",BioInfer.d59.s0,actin,cofilin
792,BioInfer.d59,True,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,actin,cofilin
793,BioInfer.d59,True,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,actin-binding protein,cofilin
794,BioInfer.d59,False,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,actin,actin-binding protein
795,BioInfer.d59,False,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,actin,cofilin
796,BioInfer.d59,False,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,cofilin,actin-binding protein
797,BioInfer.d59,False,"Purification of cofilin, a 21,000 molecular weight actin-binding protein, from porcine kidney and identification of the cofilin-binding site in the actin sequence.",BioInfer.d59.s1,cofilin,cofilin
798,BioInfer.d60,True,"Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and RAD52 from G0 to G1/S/G2 do not require DNA-PK.",BioInfer.d60.s0,DNA-PK,RAD51
799,BioInfer.d60,True,"Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and RAD52 from G0 to G1/S/G2 do not require DNA-PK.",BioInfer.d60.s0,DNA-PK,RAD52
800,BioInfer.d60,False,"Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of RAD51 and RAD52 from G0 to G1/S/G2 do not require DNA-PK.",BioInfer.d60.s0,RAD51,RAD52
801,BioInfer.d60,False,"In this study, cell cycle-dependent expression of human and rodent RAD51 and RAD52 proteins was monitored using two approaches.",BioInfer.d60.s1,RAD52,RAD51
802,BioInfer.d61,True,Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.,BioInfer.d61.s0,plakoglobin,alpha-catenin
803,BioInfer.d61,True,Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.,BioInfer.d61.s0,beta-catenin,alpha-catenin
804,BioInfer.d61,False,Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.,BioInfer.d61.s0,plakoglobin,beta-catenin
805,BioInfer.d61,True,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,plakoglobin
806,BioInfer.d61,True,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,beta-catenin
807,BioInfer.d61,True,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,beta-catenin
808,BioInfer.d61,True,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,plakoglobin
809,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,alpha-catenin
810,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,beta-catenin
811,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,plakoglobin
812,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,plakoglobin
813,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,alpha-catenin,beta-catenin
814,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,beta-catenin,plakoglobin
815,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,beta-catenin,plakoglobin
816,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,beta-catenin,beta-catenin
817,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,plakoglobin,plakoglobin
818,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,plakoglobin,beta-catenin
819,BioInfer.d61,False,"Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.",BioInfer.d61.s1,plakoglobin,beta-catenin
820,BioInfer.d61,True,"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.",BioInfer.d61.s2,beta-catenin,alpha-catenin
821,BioInfer.d61,True,"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.",BioInfer.d61.s2,plakoglobin,alpha-catenin
822,BioInfer.d61,False,"Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.",BioInfer.d61.s2,beta-catenin,plakoglobin
823,BioInfer.d61,True,"When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.",BioInfer.d61.s3,alpha-catenin,beta-catenin
824,BioInfer.d61,False,"When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.",BioInfer.d61.s3,alpha-catenin,E-cadherin
825,BioInfer.d61,False,"When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.",BioInfer.d61.s3,E-cadherin,beta-catenin
826,BioInfer.d62,True,"An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.",BioInfer.d62.s0,UL52,UL5
827,BioInfer.d62,True,"An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.",BioInfer.d62.s0,UL52,UL8
828,BioInfer.d62,True,"An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.",BioInfer.d62.s0,UL5,UL8
829,BioInfer.d62,True,Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.,BioInfer.d62.s1,UL52,UL8
830,BioInfer.d62,True,Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.,BioInfer.d62.s1,UL5,UL8
831,BioInfer.d62,False,Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.,BioInfer.d62.s1,UL52,UL5
832,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,helicase-primase,UL5
833,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,helicase-primase,UL8
834,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,helicase-primase,UL52
835,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,UL5,UL8
836,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,UL5,UL52
837,BioInfer.d62,True,"The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.",BioInfer.d62.s2,UL8,UL52
838,BioInfer.d63,True,"An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).",BioInfer.d63.s0,alpha-catenin,E-cadherin
839,BioInfer.d63,False,"An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).",BioInfer.d63.s0,beta-catenin,alpha-catenin
840,BioInfer.d63,False,"An association was seen between E-cadherin and alpha-catenin expression, in both effusions and solid tumours, and for beta-catenin in solid tumours (range p<0. 001 to p=0.014).",BioInfer.d63.s0,beta-catenin,E-cadherin
841,BioInfer.d65,True,An oligomeric form of simian virus 40 large T-antigen is immunologically related to the cellular tumor antigen p53.,BioInfer.d65.s0,large T-antigen,p53
842,BioInfer.d65,True,The cellular tumor antigen p53 is bound to the simian virus 40 (SV40) large T-antigen in SV40-infected and -transformed cells.,BioInfer.d65.s1,p53,large T-antigen
843,BioInfer.d66,True,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,cyclin-dependent kinase inhibitor,p27KIP1
844,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,proliferating cell nuclear antigen,cyclin-dependent kinase inhibitor
845,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,proliferating cell nuclear antigen,p130
846,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,proliferating cell nuclear antigen,p27KIP1
847,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,proliferating cell nuclear antigen,cyclin D
848,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,cyclin-dependent kinase inhibitor,p130
849,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,cyclin-dependent kinase inhibitor,cyclin D
850,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,p130,p27KIP1
851,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,p130,cyclin D
852,BioInfer.d66,False,"Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.",BioInfer.d66.s0,p27KIP1,cyclin D
853,BioInfer.d67,True,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,capping protein
854,BioInfer.d67,True,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP1,capping protein
855,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,SAC6
856,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,fimbrin
857,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,tropomyosin
858,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,actin
859,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,CAP1
860,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,Abp1p
861,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,ABP1
862,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,ACT1
863,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP2,TPM1
864,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,fimbrin
865,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,tropomyosin
866,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,actin
867,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,CAP1
868,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,Abp1p
869,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,capping protein
870,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,ABP1
871,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,ACT1
872,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,SAC6,TPM1
873,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,tropomyosin
874,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,actin
875,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,CAP1
876,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,Abp1p
877,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,capping protein
878,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,ABP1
879,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,ACT1
880,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,fimbrin,TPM1
881,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,actin
882,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,CAP1
883,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,Abp1p
884,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,capping protein
885,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,ABP1
886,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,ACT1
887,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,tropomyosin,TPM1
888,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,CAP1
889,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,Abp1p
890,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,capping protein
891,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,ABP1
892,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,ACT1
893,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,actin,TPM1
894,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP1,Abp1p
895,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP1,ABP1
896,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP1,ACT1
897,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,CAP1,TPM1
898,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,Abp1p,capping protein
899,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,Abp1p,ABP1
900,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,Abp1p,ACT1
901,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,Abp1p,TPM1
902,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,capping protein,ABP1
903,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,capping protein,ACT1
904,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,capping protein,TPM1
905,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,ABP1,ACT1
906,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,ABP1,TPM1
907,BioInfer.d67,False,"A null mutation of the actin gene (ACT1) is lethal, but null mutations in the tropomyosin (TPM1), fimbrin (SAC6), Abp1p (ABP1), and capping protein (CAP1 and CAP2) genes have relatively mild or no effects.",BioInfer.d67.s0,ACT1,TPM1
908,BioInfer.d68,True,"ORC1, ORC4 and Cdc6 were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.",BioInfer.d68.s0,ORC4,ORC1
909,BioInfer.d68,True,"ORC1, ORC4 and Cdc6 were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.",BioInfer.d68.s0,ORC4,Cdc6
910,BioInfer.d68,True,"ORC1, ORC4 and Cdc6 were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.",BioInfer.d68.s0,ORC1,Cdc6
911,BioInfer.d68,True,Green fluorescent protein-tagged ORC1 associated with chromatin throughout mitosis in living cells and co-localized with ORC4 in metaphase spreads.,BioInfer.d68.s1,Green fluorescent protein,ORC1
912,BioInfer.d68,True,Green fluorescent protein-tagged ORC1 associated with chromatin throughout mitosis in living cells and co-localized with ORC4 in metaphase spreads.,BioInfer.d68.s1,ORC4,ORC1
913,BioInfer.d68,False,Green fluorescent protein-tagged ORC1 associated with chromatin throughout mitosis in living cells and co-localized with ORC4 in metaphase spreads.,BioInfer.d68.s1,Green fluorescent protein,ORC4
914,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,phosphoprotein,P
915,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,phosphoprotein,nucleocapsid protein
916,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,phosphoprotein,N
917,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,P,nucleocapsid protein
918,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,P,N
919,BioInfer.d69,False,A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral nucleocapsid (N) protein and phosphoprotein (P) in a dose-dependent manner.,BioInfer.d69.s0,nucleocapsid protein,N
920,BioInfer.d70,True,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,myosin heavy chain,Aprotinin
921,BioInfer.d70,True,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,thrombin,Aprotinin
922,BioInfer.d70,True,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,Aprotinin,actin
923,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,myosin heavy chain,thrombin
924,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,myosin heavy chain,thrombin
925,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,myosin heavy chain,actin
926,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,thrombin,thrombin
927,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,thrombin,actin
928,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,Aprotinin,thrombin
929,BioInfer.d70,False,"Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.",BioInfer.d70.s0,thrombin,actin
930,BioInfer.d71,False,"RAD51, RAD52, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.",BioInfer.d71.s0,RAD52,RAD51
931,BioInfer.d71,False,"RAD51, RAD52, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.",BioInfer.d71.s0,RAD52,RAD54
932,BioInfer.d71,False,"RAD51, RAD52, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.",BioInfer.d71.s0,RAD51,RAD54
933,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD59,RAD52
934,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD59,RAD57
935,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD59,RAD51
936,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD52,RAD57
937,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD52,RAD51
938,BioInfer.d72,False,"RAD51, RAD52, RAD57, and RAD59 were required for efficient gap repair using either chromosomal or plasmid donors.",BioInfer.d72.s0,RAD57,RAD51
939,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD51,RAD55
940,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD51,RAD54
941,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD51,RAD57
942,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD55,RAD54
943,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD55,RAD57
944,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.",BioInfer.d73.s0,RAD54,RAD57
945,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD55,RAD51
946,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD55,RAD57
947,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD55,RAD54
948,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD51,RAD57
949,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD51,RAD54
950,BioInfer.d73,False,"RAD51, RAD54, RAD55 and RAD57 are still required when the same transcribed donor is on the chromosome.",BioInfer.d73.s1,RAD57,RAD54
951,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD55,RAD52
952,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD55,RAD57
953,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD55,RAD51
954,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD55,RAD54
955,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD52,RAD57
956,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD52,RAD51
957,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD52,RAD54
958,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD57,RAD51
959,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD57,RAD54
960,BioInfer.d73,False,"Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.",BioInfer.d73.s2,RAD51,RAD54
961,BioInfer.d75,True,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,actin-binding protein,profilin
962,BioInfer.d75,False,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,phospholipase C-gamma 1,actin-binding protein
963,BioInfer.d75,False,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,phospholipase C-gamma 1,profilin
964,BioInfer.d75,False,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,phospholipase C-gamma 1,tyrosine kinase
965,BioInfer.d75,False,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,actin-binding protein,tyrosine kinase
966,BioInfer.d75,False,"A reconstitution is described that requires not only the growth factor, its receptor with tyrosine kinase activity, and the soluble phospholipase C-gamma 1, but also the small soluble actin-binding protein profilin.",BioInfer.d75.s0,profilin,tyrosine kinase
967,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,Arm
968,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,Armadillo
969,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,beta-catenin
970,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Arm,beta-catenin
971,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,beta-catenin,CBP
972,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CREB,CBP
973,BioInfer.d76,True,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Armadillo,beta-catenin
974,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,beta-catenin
975,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,CREB
976,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,CBP
977,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Arm,beta-catenin
978,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Arm,CREB
979,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Arm,Armadillo
980,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Arm,CBP
981,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,beta-catenin,CREB
982,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,beta-catenin,Armadillo
983,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,beta-catenin,beta-catenin
984,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CREB,Armadillo
985,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CREB,beta-catenin
986,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,Armadillo,CBP
987,BioInfer.d76,False,"Armadillo (Arm) repeat 10 to the COOH terminus of beta-catenin is involved in binding to CBP, whereas beta-catenin interacts directly with the CREB-binding domain of CBP.",BioInfer.d76.s0,CBP,beta-catenin
988,BioInfer.d77,True,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,profilin,Arp2
989,BioInfer.d77,True,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,profilin,Arp 3
990,BioInfer.d77,True,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,Arp2,Arp 3
991,BioInfer.d77,True,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,Arp2,actin
992,BioInfer.d77,True,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,Arp 3,actin
993,BioInfer.d77,False,Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.,BioInfer.d77.s0,profilin,actin
994,BioInfer.d77,True,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,profilin
995,BioInfer.d77,True,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,actin
996,BioInfer.d77,True,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,Arp2,profilin
997,BioInfer.d77,True,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,Arp2,Arp 3
998,BioInfer.d77,True,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,Arp 3
999,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,Arp2
1000,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,profilin
1001,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,actin
1002,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,Arp 3
1003,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,Arp2
1004,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,profilin
1005,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,Arp 3
1006,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,Arp2,actin
1007,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,profilin,actin
1008,BioInfer.d77,False,"By analytical ultracentrifugation, rhodamine-labeled profilin binds Arp2/3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of profilin for barbed ends of actin filaments and its high affinity for actin monomers.",BioInfer.d77.s1,actin,Arp 3
1009,BioInfer.d77,True,Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.,BioInfer.d77.s2,actin,profilin
1010,BioInfer.d77,True,Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.,BioInfer.d77.s2,Arp2,profilin
1011,BioInfer.d77,False,Here we show that the Arp2 subunit of the complex can be chemically cross-linked to the actin-binding site of profilin.,BioInfer.d77.s2,actin,Arp2
1012,BioInfer.d78,True,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,actin
1013,BioInfer.d78,True,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,ADF
1014,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,actin
1015,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,cofilin
1016,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,ADF
1017,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,ADF
1018,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,cofilin
1019,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,actin
1020,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,ADF
1021,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,ADF
1022,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,actin
1023,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,ADF
1024,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,cofilin,ADF
1025,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,actin,ADF
1026,BioInfer.d78,False,"As a nuclear transport signal sequence exists in cofilin and ADF but not in actin, ADF and/or cofilin may be responsible for the nuclear import of actin in myogenic cells under certain conditions.",BioInfer.d78.s0,ADF,ADF
1027,BioInfer.d78,True,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,cofilin,actin
1028,BioInfer.d78,True,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,cofilin,actin-binding proteins
1029,BioInfer.d78,True,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,ADF,actin
1030,BioInfer.d78,True,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,ADF,actin-binding proteins
1031,BioInfer.d78,False,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,cofilin,ADF
1032,BioInfer.d78,False,"Immunofluorescence microscopy revealed that two actin-binding proteins of low molecular weight with different functional activity, ADF and cofilin, are transported into nuclei of cultured myogenic cells to form rod structures there together with actin, when the cells were incubated in medium containing dimethylsulfoxide.",BioInfer.d78.s1,actin,actin-binding proteins
1033,BioInfer.d78,True,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,ADF,actin
1034,BioInfer.d78,True,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,ADF,cofilin
1035,BioInfer.d78,True,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,actin,cofilin
1036,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,cofilin,ADF
1037,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,cofilin,ADF
1038,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,cofilin,actin
1039,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,cofilin,cofilin
1040,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,ADF,ADF
1041,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,ADF,actin
1042,BioInfer.d78,False,"In most cases, ADF and cofilin colocalized in the same nuclear actin rods, but ADF appeared to predominate in mononucleated cells, while cofilin was present in multinucleated myotubes.",BioInfer.d78.s2,ADF,cofilin
1043,BioInfer.d79,True,"A series of truncations was carried out at the C terminus of profilin, a region that has been implicated in actin binding.",BioInfer.d79.s0,actin,profilin
1044,BioInfer.d79,True,"Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.",BioInfer.d79.s1,profilin,actin
1045,BioInfer.d79,False,"Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.",BioInfer.d79.s1,profilin,profilins
1046,BioInfer.d79,False,"Since our earlier studies of Acanthamoeba profilins suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and actin binding may be important for profilin function.",BioInfer.d79.s1,actin,profilins
1047,BioInfer.d81,True,"As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.",BioInfer.d81.s0,cofilin,actin
1048,BioInfer.d81,True,"As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.",BioInfer.d81.s0,cofilin,Abp1p
1049,BioInfer.d81,True,"As expected from immunofluorescence experiments, Abp1p, cofilin, and actin colocalized in immuno-EM to the dense patchlike structures but not to the cables.",BioInfer.d81.s0,actin,Abp1p
1050,BioInfer.d81,True,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,cofilin,actin binding proteins
1051,BioInfer.d81,True,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,actin binding proteins,Abp1p
1052,BioInfer.d81,False,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,cofilin,Abp1p
1053,BioInfer.d81,False,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,cofilin,actin
1054,BioInfer.d81,False,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,actin binding proteins,actin
1055,BioInfer.d81,False,Immuno-EM double-labeling experiments were conducted with antibodies to actin together with antibodies to the actin binding proteins Abp1p and cofilin.,BioInfer.d81.s1,Abp1p,actin
1056,BioInfer.d82,True,"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.",BioInfer.d82.s0,actin,cofilin/ADF
1057,BioInfer.d82,True,"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.",BioInfer.d82.s0,cofilin/ADF,twinstar
1058,BioInfer.d82,False,"A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the twinstar locus, a gene that encodes a Drosophila member of the cofilin/ADF family of actin-severing proteins.",BioInfer.d82.s0,actin,twinstar
1059,BioInfer.d83,True,"As previous studies indicated that the RVS161 and RVS167 gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.",BioInfer.d83.s0,RVS161,RVS167
1060,BioInfer.d84,False,"As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of alpha actin or myosin heavy chain mRNA.",BioInfer.d84.s0,myosin heavy chain,alpha actin
1061,BioInfer.d84,False,"In contrast, alpha actin and myosin heavy chain mRNA accumulation was not enhanced in hybrid embryos.",BioInfer.d84.s1,myosin heavy chain,alpha actin
1062,BioInfer.d85,True,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,UBL1,UBE2I
1063,BioInfer.d85,True,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,RAD51,UBE2I
1064,BioInfer.d85,True,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,RAD52,UBE2I
1065,BioInfer.d85,True,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,UBE2I,p53
1066,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,UBL1,RAD51
1067,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,UBL1,RAD52
1068,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,UBL1,p53
1069,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,RAD51,RAD52
1070,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,RAD51,p53
1071,BioInfer.d85,False,"Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system.",BioInfer.d85.s0,RAD52,p53
1072,BioInfer.d87,True,A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.,BioInfer.d87.s0,E-cadherin,beta-catenin
1073,BioInfer.d87,True,A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.,BioInfer.d87.s0,E-cadherin,alpha-catenin
1074,BioInfer.d87,True,A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.,BioInfer.d87.s0,beta-catenin,alpha-catenin
1075,BioInfer.d87,False,"However, the recombinant fusion protein containing wild-type beta-catenin precipitated alpha-catenin from these cells.",BioInfer.d87.s1,beta-catenin,alpha-catenin
1076,BioInfer.d87,True,"These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.",BioInfer.d87.s2,beta-catenin,E-cadherin
1077,BioInfer.d87,True,"These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.",BioInfer.d87.s2,beta-catenin,alpha-catenin
1078,BioInfer.d87,True,"These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.",BioInfer.d87.s2,E-cadherin,alpha-catenin
1079,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,alpha-catenin,E-cadherin
1080,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,alpha-catenin,beta-catenin
1081,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,alpha-catenin,beta-catenin
1082,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,E-cadherin,beta-catenin
1083,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,E-cadherin,beta-catenin
1084,BioInfer.d87,True,"Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.",BioInfer.d87.s3,beta-catenin,beta-catenin
1085,BioInfer.d87,True,"While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.",BioInfer.d87.s4,cadherin,alpha-catenin
1086,BioInfer.d87,False,"While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.",BioInfer.d87.s4,cadherin,beta-catenin
1087,BioInfer.d87,False,"While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.",BioInfer.d87.s4,alpha-catenin,beta-catenin
1088,BioInfer.d88,True,"At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.",BioInfer.d88.s0,villin,actin
1089,BioInfer.d88,True,"At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.",BioInfer.d88.s0,fimbrin,actin
1090,BioInfer.d88,False,"At the light microscope level, brush cells can be identified by antibodies against the actin filament crosslinking proteins villin and fimbrin that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.",BioInfer.d88.s0,villin,fimbrin
1091,BioInfer.d89,True,"BACKGROUND: Although profilin is believed to be an essential regulator of the actin cytoskeleton in most cells, its precise role in mammalian cells remains unknown.",BioInfer.d89.s0,actin,profilin
1092,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,p27,cyclin E
1093,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,p27,cyclin-dependent kinase 2
1094,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,p27,cyclin-dependent kinase inhibitor
1095,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,cyclin E,Kip1
1096,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,cyclin E,cyclin-dependent kinase 2
1097,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,Kip1,cyclin-dependent kinase 2
1098,BioInfer.d91,True,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,Kip1,cyclin-dependent kinase inhibitor
1099,BioInfer.d91,False,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,p27,Kip1
1100,BioInfer.d91,False,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,cyclin E,cyclin-dependent kinase inhibitor
1101,BioInfer.d91,False,"BACKGROUND: p27(Kip1), a cyclin-dependent kinase inhibitor, negatively regulates the G1 phase progression of the cell cycle by binding to the cyclin E/cyclin-dependent kinase 2 complex.",BioInfer.d91.s0,cyclin-dependent kinase 2,cyclin-dependent kinase inhibitor
1102,BioInfer.d92,True,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,beta-catenin,alpha-catenin
1103,BioInfer.d92,True,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,alpha-catenin
1104,BioInfer.d92,True,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,alpha-catenin,E-cadherin
1105,BioInfer.d92,True,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,alpha-catenin
1106,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,beta-catenin,actin
1107,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,beta-catenin,alpha-catenin
1108,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,beta-catenin,actin
1109,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,beta-catenin,E-cadherin
1110,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,actin
1111,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,E-cadherin
1112,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,alpha-catenin
1113,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,alpha-catenin,actin
1114,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,alpha-catenin,alpha-catenin
1115,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,actin,E-cadherin
1116,BioInfer.d92,False,"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.",BioInfer.d92.s0,E-cadherin,alpha-catenin
1117,BioInfer.d94,True,"Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.",BioInfer.d94.s0,profilin,thymosin beta 4
1118,BioInfer.d94,True,"Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.",BioInfer.d94.s0,profilin,actin
1119,BioInfer.d94,True,"Because both proteins exchange rapidly between actin molecules, low concentrations of profilin can overcome the inhibitory effects of high concentrations of thymosin beta 4 on the nucleotide exchange.",BioInfer.d94.s0,thymosin beta 4,actin
1120,BioInfer.d95,True,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD 54
1121,BioInfer.d95,True,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD 57
1122,BioInfer.d95,True,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD 55
1123,BioInfer.d95,True,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,rad52-20
1124,BioInfer.d95,True,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD52
1125,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD51
1126,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,RAD52
1127,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 54,RAD 57
1128,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 54,RAD 55
1129,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 54,RAD51
1130,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 54,RAD52
1131,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 54,rad52-20
1132,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 57,RAD 55
1133,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 57,RAD51
1134,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 57,RAD52
1135,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 57,rad52-20
1136,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 55,RAD51
1137,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 55,RAD52
1138,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD 55,rad52-20
1139,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD51,rad52-20
1140,BioInfer.d95,False,"Because other researchers have shown that the RAD51 and RAD52 proteins interact, RAD51 on a high copy number plasmid was tested and found to suppress the rad52-20 allele, but RAD 54, 55 and 57 did not suppress.",BioInfer.d95.s0,RAD52,rad52-20
1141,BioInfer.d96,False,"Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified myosin heavy chain and actin ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).",BioInfer.d96.s0,myosin heavy chain,actin
1142,BioInfer.d97,True,Binding of talin to actin occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.,BioInfer.d97.s0,actin,talin
1143,BioInfer.d97,True,Platelet talin binds to actin in vitro and hence is an actin binding protein.,BioInfer.d97.s1,Platelet talin,actin
1144,BioInfer.d97,True,Platelet talin binds to actin in vitro and hence is an actin binding protein.,BioInfer.d97.s1,Platelet talin,actin binding protein
1145,BioInfer.d97,False,Platelet talin binds to actin in vitro and hence is an actin binding protein.,BioInfer.d97.s1,actin,actin binding protein
1146,BioInfer.d99,True,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,VEGF-receptor-2,VEGF
1147,BioInfer.d99,True,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,VEGF,KDR
1148,BioInfer.d99,True,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,VEGF,flk-1
1149,BioInfer.d99,False,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,VEGF-receptor-2,KDR
1150,BioInfer.d99,False,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,VEGF-receptor-2,flk-1
1151,BioInfer.d99,False,Biochemical analyses revealed a strong induction of VEGF-receptor-2 (flk-1/KDR) tyrosine-autophosphorylation by VEGF which was maximal after 5 minutes and was followed by receptor downregulation.,BioInfer.d99.s0,KDR,flk-1
1152,BioInfer.d100,True,Biochemical complementation experiments also indicate that the PRP9 and PRP11 proteins interact.,BioInfer.d100.s0,PRP11,PRP9
1153,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP5,U2 snRNP
1154,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP5,PRP21
1155,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP5,PRP9
1156,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP5,PRP11
1157,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,U2 snRNP,PRP21
1158,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,U2 snRNP,PRP9
1159,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,U2 snRNP,PRP11
1160,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP21,PRP9
1161,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP21,PRP11
1162,BioInfer.d100,True,"Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.",BioInfer.d100.s1,PRP9,PRP11
1163,BioInfer.d100,True,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP9,U2 snRNP
1164,BioInfer.d100,True,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP5,U2 snRNP
1165,BioInfer.d100,True,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP5,DEAD box helicase
1166,BioInfer.d100,True,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP11,U2 snRNP
1167,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP9,PRP5
1168,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP9,PRP11
1169,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP9,DEAD box helicase
1170,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP5,PRP11
1171,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,PRP11,DEAD box helicase
1172,BioInfer.d100,False,"Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.",BioInfer.d100.s2,U2 snRNP,DEAD box helicase
1173,BioInfer.d102,True,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,actin,pollen profilin
1174,BioInfer.d102,True,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,pollen actin,profilin
1175,BioInfer.d102,False,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,actin,pollen actin
1176,BioInfer.d102,False,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,actin,profilin
1177,BioInfer.d102,False,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,pollen actin,pollen profilin
1178,BioInfer.d102,False,"Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.",BioInfer.d102.s0,profilin,pollen profilin
1179,BioInfer.d102,True,"In this study, profilin is identified as an actin-binding protein in higher plants which is present in monocot and dicot angiosperms.",BioInfer.d102.s1,profilin,actin-binding protein
1180,BioInfer.d102,True,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,profilin,profilin
1181,BioInfer.d102,True,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,profilin,actins
1182,BioInfer.d102,True,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,profilin,profilin
1183,BioInfer.d102,True,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,actins,profilin
1184,BioInfer.d102,False,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,profilin,actins
1185,BioInfer.d102,False,The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.,BioInfer.d102.s2,profilin,profilin
1186,BioInfer.d103,True,Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.,BioInfer.d103.s0,actin,PKC-delta
1187,BioInfer.d103,True,Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.,BioInfer.d103.s0,talin,PKC-delta
1188,BioInfer.d103,False,Bistratene A causes phosphorylation of talin and redistribution of actin microfilaments in fibroblasts: possible role for PKC-delta.,BioInfer.d103.s0,actin,talin
1189,BioInfer.d104,True,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,Rep-3,MSH3
1190,BioInfer.d104,True,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,mutS,MSH3
1191,BioInfer.d104,True,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,mutS,MSH3
1192,BioInfer.d104,True,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,MSH3,MSH2
1193,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,Rep-3,mutS
1194,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,Rep-3,mutS
1195,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,Rep-3,MSH2
1196,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,mutS,mutS
1197,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,mutS,MSH2
1198,BioInfer.d104,False,MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.,BioInfer.d104.s0,mutS,MSH2
1199,BioInfer.d105,True,"Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis.",BioInfer.d105.s0,VEGF,Neuropilin-1
1200,BioInfer.d105,True,"Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis.",BioInfer.d105.s0,Neuropilin-1,vascular endothelial growth factor
1201,BioInfer.d105,False,"Neuropilin-1 is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (VEGF), a potent regulator for vasculogenesis and angiogenesis.",BioInfer.d105.s0,VEGF,vascular endothelial growth factor
1202,BioInfer.d106,True,Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.,BioInfer.d106.s0,Neuropilin-1,vascular endothelial growth factor
1203,BioInfer.d107,True,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,collapsin-1,Neuropilin-1
1204,BioInfer.d107,True,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,vascular endothelial growth factor-165,collapsin-1
1205,BioInfer.d107,True,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,semaphorin III,Neuropilin-1
1206,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,collapsin-1,vascular endothelial growth factor-165
1207,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,collapsin-1,semaphorin III
1208,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,collapsin-1,collapsin-1
1209,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,vascular endothelial growth factor-165,semaphorin III
1210,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,vascular endothelial growth factor-165,Neuropilin-1
1211,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,semaphorin III,collapsin-1
1212,BioInfer.d107,False,Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.,BioInfer.d107.s0,Neuropilin-1,collapsin-1
1213,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,VEGFR-2
1214,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,vascular endothelial growth factor 165
1215,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,VEGF165
1216,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,VEGF165
1217,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,VEGF receptor 2
1218,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,VEGFR-2
1219,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,vascular endothelial growth factor 165
1220,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,VEGF165
1221,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,VEGF165
1222,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,VEGF receptor 2
1223,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,VEGF165
1224,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,tyrosine kinase
1225,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,VEGF receptor 2
1226,BioInfer.d108,True,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,tyrosine kinase,VEGF receptor 2
1227,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,Neuropilin 1
1228,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,VEGF
1229,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,NP-1,tyrosine kinase
1230,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,VEGF
1231,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,Neuropilin 1,tyrosine kinase
1232,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,vascular endothelial growth factor 165
1233,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,VEGF165
1234,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,VEGF
1235,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGFR-2,VEGF receptor 2
1236,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,vascular endothelial growth factor 165,VEGF165
1237,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,vascular endothelial growth factor 165,VEGF165
1238,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,vascular endothelial growth factor 165,VEGF
1239,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,vascular endothelial growth factor 165,tyrosine kinase
1240,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,vascular endothelial growth factor 165,VEGF receptor 2
1241,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,VEGF165
1242,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,VEGF
1243,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,tyrosine kinase
1244,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,VEGF receptor 2
1245,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,VEGF
1246,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF165,tyrosine kinase
1247,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF,tyrosine kinase
1248,BioInfer.d108,False,Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).,BioInfer.d108.s0,VEGF,VEGF receptor 2
1249,BioInfer.d111,False,Both pathway cells and superior tarsal smooth muscle cells expressed alpha-smooth muscle actin and smooth muscle myosin heavy chain throughout development.,BioInfer.d111.s0,smooth muscle myosin heavy chain,alpha-smooth muscle actin
1250,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,N-cadherin,alpha-catenin
1251,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,N-cadherin,beta-catenin
1252,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,N-cadherin,p120
1253,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,alpha-catenin,beta-catenin
1254,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,alpha-catenin,p120
1255,BioInfer.d112,False,"Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.",BioInfer.d112.s0,beta-catenin,p120
1256,BioInfer.d113,True,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,beta-catenin
1257,BioInfer.d113,True,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,E-cadherin,alpha-catenin
1258,BioInfer.d113,True,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,tyrosine kinase
1259,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,E-cadherin
1260,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,EGFR
1261,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,tyrosine kinase
1262,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,alpha-catenin
1263,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,E-cadherin,EGFR
1264,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,E-cadherin,tyrosine kinase
1265,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,E-cadherin,beta-catenin
1266,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,alpha-catenin
1267,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,EGFR,beta-catenin
1268,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,tyrosine kinase,alpha-catenin
1269,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,tyrosine kinase,beta-catenin
1270,BioInfer.d113,False,"Both tyrosine phosphorylation and association of beta-catenin with EGFR were inhibited by tyrphostin, a specific inhibitor of the EGFR tyrosine kinase, whereas dissociation of alpha-catenin from E-cadherin was not.",BioInfer.d113.s0,alpha-catenin,beta-catenin
1271,BioInfer.d113,True,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,alpha-catenin,beta-catenin
1272,BioInfer.d113,True,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,alpha-catenin,E-cadherin
1273,BioInfer.d113,True,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,beta-catenin,EGFR
1274,BioInfer.d113,True,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,beta-catenin,E-cadherin
1275,BioInfer.d113,False,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,alpha-catenin,EGFR
1276,BioInfer.d113,False,The results suggest that tyrosine phosphorylation of beta-catenin is achieved by EGFR upon tryptic digestion of cells and concurrent with but independent of dissociation of alpha-catenin from E-cadherin.,BioInfer.d113.s1,EGFR,E-cadherin
1277,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,E-cadherin,alpha-catenin
1278,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,EGFR,beta-catenin
1279,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,EGFR,beta-catenin
1280,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,beta-catenin,beta-catenin
1281,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,beta-catenin,EGF receptor
1282,BioInfer.d113,True,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,beta-catenin,EGF receptor
1283,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,E-cadherin,EGFR
1284,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,E-cadherin,beta-catenin
1285,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,E-cadherin,beta-catenin
1286,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,E-cadherin,EGF receptor
1287,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,EGFR,EGF receptor
1288,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,EGFR,alpha-catenin
1289,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,beta-catenin,alpha-catenin
1290,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,beta-catenin,alpha-catenin
1291,BioInfer.d113,False,"Tyrosine phosphorylation of beta-catenin was concomitantly induced with association of beta-catenin with EGF receptor (EGFR) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of alpha-catenin from E-cadherin.",BioInfer.d113.s2,EGF receptor,alpha-catenin
1292,BioInfer.d114,False,"RAD52 or RAD51 recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).",BioInfer.d114.s0,RAD52,RAD51
1293,BioInfer.d115,True,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF11,SNF
1294,BioInfer.d115,True,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF11,SNF2
1295,BioInfer.d115,True,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF11,SWI
1296,BioInfer.d115,True,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF,SWI
1297,BioInfer.d115,False,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF,SNF2
1298,BioInfer.d115,False,"SNF11, a new component of the yeast SNF-SWI complex that interacts with a conserved region of SNF2.",BioInfer.d115.s0,SNF2,SWI
1299,BioInfer.d115,True,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SWI,SNF11
1300,BioInfer.d115,True,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SWI,SNF
1301,BioInfer.d115,True,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SNF2,SNF11
1302,BioInfer.d115,True,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SNF11,SNF
1303,BioInfer.d115,False,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SWI,SNF2
1304,BioInfer.d115,False,SNF11 interacts with SNF2 in vitro and copurifies with the SNF-SWI complex from yeast cells.,BioInfer.d115.s1,SNF2,SNF
1305,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD1,BUD3
1306,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD1,BUD2
1307,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD1,BUD5
1308,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD1,BUD4
1309,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD1,RSR1
1310,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD3,BUD2
1311,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD3,BUD5
1312,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD3,BUD4
1313,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD3,RSR1
1314,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD2,BUD5
1315,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD2,BUD4
1316,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD2,RSR1
1317,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD5,BUD4
1318,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD5,RSR1
1319,BioInfer.d116,False,"Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: BUD1/RSR1, BUD2, BUD3, BUD4 and BUD5.",BioInfer.d116.s0,BUD4,RSR1
1320,BioInfer.d117,True,By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.,BioInfer.d117.s0,talin,vinculin
1321,BioInfer.d117,False,By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.,BioInfer.d117.s0,talin,actin
1322,BioInfer.d117,False,By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing vinculin and talin; thus the cells assemble typical stress fibers but do not appear to polarize.,BioInfer.d117.s0,actin,vinculin
1323,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,actin,filamin
1324,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,actin,vinculin
1325,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,actin,vasodilator-stimulated phosphoprotein
1326,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,actin,profilin
1327,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,filamin,vinculin
1328,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,filamin,vasodilator-stimulated phosphoprotein
1329,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,filamin,profilin
1330,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,vinculin,vasodilator-stimulated phosphoprotein
1331,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,vinculin,profilin
1332,BioInfer.d118,False,"By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes actin tails were shown to contain the cytoskeletal proteins vasodilator-stimulated phosphoprotein profilin, vinculin, and filamin.",BioInfer.d118.s0,vasodilator-stimulated phosphoprotein,profilin
1333,BioInfer.d119,True,By site-directed mutagenesis of profilin II from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing actin and poly-(L)-proline-binding activity respectively.,BioInfer.d119.s0,profilin II,actin
1334,BioInfer.d119,True,"The K114E profilin exhibited a profound decrease in its ability to interact with actin, whereas binding to poly-(L)-proline was essentially unchanged.",BioInfer.d119.s1,K114E profilin,actin
1335,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,nucleocapsid protein
1336,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,M
1337,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,phosphoprotein
1338,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,NP
1339,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,F0
1340,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,M
1341,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,P
1342,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,membrane protein
1343,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,F0
1344,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,fusion protein
1345,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,HN
1346,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,hemagglutinin-neuraminidase protein
1347,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,M
1348,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,phosphoprotein
1349,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,NP
1350,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,F0
1351,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,M
1352,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,P
1353,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,membrane protein
1354,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,F0
1355,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,fusion protein
1356,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,HN
1357,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,nucleocapsid protein,hemagglutinin-neuraminidase protein
1358,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,phosphoprotein
1359,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,NP
1360,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,F0
1361,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,M
1362,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,P
1363,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,membrane protein
1364,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,F0
1365,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,fusion protein
1366,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,HN
1367,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,hemagglutinin-neuraminidase protein
1368,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,NP
1369,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,F0
1370,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,M
1371,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,P
1372,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,membrane protein
1373,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,F0
1374,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,fusion protein
1375,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,HN
1376,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,phosphoprotein,hemagglutinin-neuraminidase protein
1377,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,F0
1378,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,M
1379,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,P
1380,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,membrane protein
1381,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,F0
1382,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,fusion protein
1383,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,HN
1384,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,NP,hemagglutinin-neuraminidase protein
1385,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,M
1386,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,P
1387,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,membrane protein
1388,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,F0
1389,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,fusion protein
1390,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,HN
1391,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,hemagglutinin-neuraminidase protein
1392,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,P
1393,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,membrane protein
1394,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,F0
1395,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,fusion protein
1396,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,HN
1397,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,M,hemagglutinin-neuraminidase protein
1398,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,membrane protein
1399,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,F0
1400,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,fusion protein
1401,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,HN
1402,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,P,hemagglutinin-neuraminidase protein
1403,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,membrane protein,F0
1404,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,membrane protein,fusion protein
1405,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,membrane protein,HN
1406,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,membrane protein,hemagglutinin-neuraminidase protein
1407,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,fusion protein
1408,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,HN
1409,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,F0,hemagglutinin-neuraminidase protein
1410,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,fusion protein,HN
1411,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,fusion protein,hemagglutinin-neuraminidase protein
1412,BioInfer.d121,False,"By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.",BioInfer.d121.s0,HN,hemagglutinin-neuraminidase protein
1413,BioInfer.d122,True,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,eIF3-p33
1414,BioInfer.d122,True,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3-p33,TIF34
1415,BioInfer.d122,True,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,PRT1
1416,BioInfer.d122,True,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,PRT1,TIF34
1417,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,eIF3
1418,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,PRT1
1419,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,TIF34
1420,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3-p33,eIF3
1421,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3-p33,PRT1
1422,BioInfer.d122,False,"By two-hybrid screening we have identified two partners that directly associate with TIF34: PRT1, a previously characterized eIF3 subunit, and a novel protein of 33 kDa (eIF3-p33) which is part of the eIF3 complex and has an RNA binding domain.",BioInfer.d122.s0,eIF3,TIF34
1423,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,PRT1,p33
1424,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,PRT1,eIF3
1425,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,PRT1,TIF34
1426,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,p33,eIF3
1427,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,p33,TIF34
1428,BioInfer.d122,True,"Our results provide support for both physical and functional interactions between three subunits, TIF34, PRT1 and p33, in the eIF3 complex.",BioInfer.d122.s1,eIF3,TIF34
1429,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,p21
1430,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,waf1
1431,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,histone
1432,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,H3
1433,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,CBP
1434,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,SAGA
1435,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,p300
1436,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,waf1
1437,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,waf1
1438,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,p21
1439,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,E2A
1440,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,waf1
1441,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,histone
1442,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,waf1
1443,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,E2A
1444,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,waf1
1445,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,E2A
1446,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,waf1
1447,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,E2A
1448,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,waf1
1449,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,p21
1450,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,E2A
1451,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,E2A
1452,BioInfer.d123,True,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,E2A
1453,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,H3
1454,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,CBP
1455,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,SAGA
1456,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,p300
1457,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,waf1
1458,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,p21
1459,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,histone
1460,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H4,E2A
1461,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,histone
1462,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,histone
1463,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,CBP
1464,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,SAGA
1465,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,p300
1466,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,waf1
1467,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,p21
1468,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,E2A
1469,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,H3,histone
1470,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,SAGA
1471,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,p300
1472,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,waf1
1473,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,p21
1474,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,histone
1475,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,CBP,histone
1476,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,p300
1477,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,waf1
1478,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,p21
1479,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,histone
1480,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,SAGA,histone
1481,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,waf1
1482,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,p21
1483,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,histone
1484,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p300,histone
1485,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,histone
1486,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,histone
1487,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,p21
1488,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,histone
1489,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,waf1,histone
1490,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,histone
1491,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,p21,histone
1492,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,histone,E2A
1493,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,histone,histone
1494,BioInfer.d123,False,"By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.",BioInfer.d123.s0,E2A,histone
1495,BioInfer.d124,True,Cadherins are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate beta-catenin signaling.,BioInfer.d124.s0,beta-catenin,Cadherins
1496,BioInfer.d124,True,alpha-catenin links beta-catenin to the actin-based cytoskeleton.,BioInfer.d124.s1,alpha-catenin,beta-catenin
1497,BioInfer.d124,True,alpha-catenin links beta-catenin to the actin-based cytoskeleton.,BioInfer.d124.s1,alpha-catenin,actin
1498,BioInfer.d124,True,alpha-catenin links beta-catenin to the actin-based cytoskeleton.,BioInfer.d124.s1,beta-catenin,actin
1499,BioInfer.d126,True,"Calorimetric data show ternary complex formation between talin, vinculin, and actin.",BioInfer.d126.s0,actin,vinculin
1500,BioInfer.d126,True,"Calorimetric data show ternary complex formation between talin, vinculin, and actin.",BioInfer.d126.s0,actin,talin
1501,BioInfer.d126,True,"Calorimetric data show ternary complex formation between talin, vinculin, and actin.",BioInfer.d126.s0,vinculin,talin
1502,BioInfer.d127,True,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,talin,calpain
1503,BioInfer.d127,True,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,actin-binding protein,calpain
1504,BioInfer.d127,False,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,talin,actin-binding protein
1505,BioInfer.d127,False,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,talin,Calpain
1506,BioInfer.d127,False,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,actin-binding protein,Calpain
1507,BioInfer.d127,False,"Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.",BioInfer.d127.s0,calpain,Calpain
1508,BioInfer.d129,True,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,CD26,ADA
1509,BioInfer.d129,True,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,CD26,adenosine deaminase
1510,BioInfer.d129,True,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,dipeptidyl peptidase IV,ADA
1511,BioInfer.d129,True,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,dipeptidyl peptidase IV,adenosine deaminase
1512,BioInfer.d129,False,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,CD26,dipeptidyl peptidase IV
1513,BioInfer.d129,False,"CD26, a T cell activation Ag, also known as dipeptidyl peptidase IV, is directly associated with adenosine deaminase (ADA) on the surface of T cells and T cell lines.",BioInfer.d129.s0,ADA,adenosine deaminase
1514,BioInfer.d130,True,CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.,BioInfer.d130.s0,CD26,adenosine deaminase
1515,BioInfer.d130,True,CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.,BioInfer.d130.s0,CD26,dipeptidyl peptidase IV
1516,BioInfer.d130,False,CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.,BioInfer.d130.s0,adenosine deaminase,dipeptidyl peptidase IV
1517,BioInfer.d131,True,CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.,BioInfer.d131.s0,dipeptidyl peptidase IV,CD26
1518,BioInfer.d131,True,CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.,BioInfer.d131.s0,adenosine deaminase,CD26
1519,BioInfer.d131,False,CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.,BioInfer.d131.s0,dipeptidyl peptidase IV,adenosine deaminase
1520,BioInfer.d134,True,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,cadherin,beta-catenin
1521,BioInfer.d134,True,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,alpha-catenin,beta-catenin
1522,BioInfer.d134,True,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,alpha-catenin,beta-catenin
1523,BioInfer.d134,True,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,beta-catenin,beta-catenin
1524,BioInfer.d134,True,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,beta-catenin,APC
1525,BioInfer.d134,False,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,cadherin,alpha-catenin
1526,BioInfer.d134,False,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,cadherin,beta-catenin
1527,BioInfer.d134,False,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,cadherin,APC
1528,BioInfer.d134,False,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,alpha-catenin,APC
1529,BioInfer.d134,False,"Changes in beta-catenin binding to cadherin or APC protein, and the ensuing effects on cell morphology and adhesion, are independent of beta-catenin binding to alpha-catenin.",BioInfer.d134.s0,beta-catenin,APC
1530,BioInfer.d134,True,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin,alpha-catenin
1531,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin delta C,beta-catenin deltaN131
1532,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin delta C,beta-catenin deltaN151
1533,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin delta C,beta-catenin deltaN90
1534,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin delta C,beta-catenin
1535,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin delta C,alpha-catenin
1536,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN131,beta-catenin deltaN151
1537,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN131,beta-catenin deltaN90
1538,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN131,beta-catenin
1539,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN131,alpha-catenin
1540,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN151,beta-catenin deltaN90
1541,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN151,beta-catenin
1542,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN151,alpha-catenin
1543,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN90,beta-catenin
1544,BioInfer.d134,False,"Full-length beta-catenin, beta-catenin mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the alpha-catenin binding site, or a mutant beta-catenin with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.",BioInfer.d134.s1,beta-catenin deltaN90,alpha-catenin
1545,BioInfer.d135,True,Characterization of actin and poly-L-proline binding sites of Acanthamoeba profilin with monoclonal antibodies and by mutagenesis.,BioInfer.d135.s0,actin,profilin
1546,BioInfer.d135,True,"For example, profilin with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to actin.",BioInfer.d135.s1,actin,profilin
1547,BioInfer.d135,True,The results provide two independent lines of evidence about the binding sites for actin and poly-L-proline on the profilin molecule.,BioInfer.d135.s2,actin,profilin
1548,BioInfer.d136,True,Characterization of a mutant profilin with reduced actin-binding capacity: effects in vitro and in vivo.,BioInfer.d136.s0,profilin,actin
1549,BioInfer.d137,True,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,cofilin,actin
1550,BioInfer.d137,True,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,cofilin,gelsolin
1551,BioInfer.d137,True,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,actin,gelsolin
1552,BioInfer.d137,True,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,actin,gelsolin
1553,BioInfer.d137,True,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,gelsolin,gelsolin
1554,BioInfer.d137,False,Characterization of gelsolin truncates that inhibit actin depolymerization by severing activity of gelsolin and cofilin.,BioInfer.d137.s0,cofilin,gelsolin
1555,BioInfer.d139,True,Characterization of the action of porcine brain profilin on actin polymerization.,BioInfer.d139.s0,brain profilin,actin
1556,BioInfer.d139,True,"Moreover, addition of profilin to steady-state actin filaments causes slow depolymerization.",BioInfer.d139.s1,profilin,actin
1557,BioInfer.d140,True,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,alpha-actinin,alpha-catenin
1558,BioInfer.d140,True,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,alpha-catenin,plakoglobin
1559,BioInfer.d140,True,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,alpha-catenin,beta-catenin
1560,BioInfer.d140,True,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,plakoglobin,beta-catenin
1561,BioInfer.d140,False,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,alpha-actinin,plakoglobin
1562,BioInfer.d140,False,Characterization of the interactions of alpha-catenin with alpha-actinin and beta-catenin/plakoglobin.,BioInfer.d140.s0,alpha-actinin,beta-catenin
1563,BioInfer.d140,True,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,plakoglobin,alpha-catenin
1564,BioInfer.d140,True,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,alpha-catenin,beta-catenin
1565,BioInfer.d140,True,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,alpha-catenin,alpha-actinin
1566,BioInfer.d140,False,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,plakoglobin,beta-catenin
1567,BioInfer.d140,False,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,plakoglobin,alpha-actinin
1568,BioInfer.d140,False,In this study we have used the yeast two-hybrid system to map the domains on alpha-catenin that allow it to associate with beta-catenin/plakoglobin and with alpha-actinin.,BioInfer.d140.s1,beta-catenin,alpha-actinin
1569,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,plakoglobin
1570,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,beta-catenin
1571,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,catenin
1572,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,alpha-catenin
1573,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,actin
1574,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,catenin,alpha-catenin
1575,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,catenin,actin
1576,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,alpha-catenin,plakoglobin
1577,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,alpha-catenin,actin
1578,BioInfer.d140,True,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,alpha-catenin,beta-catenin
1579,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,cadherin
1580,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,catenin
1581,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,alpha-catenin
1582,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,plakoglobin
1583,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,actin
1584,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,beta-catenin
1585,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,beta-catenin
1586,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,cadherin
1587,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,catenin
1588,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,alpha-catenin
1589,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,plakoglobin
1590,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,actin
1591,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,beta-catenin
1592,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,cadherin
1593,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,catenin
1594,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,alpha-catenin
1595,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,plakoglobin
1596,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,actin
1597,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,beta-catenin,beta-catenin
1598,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,plakoglobin
1599,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,cadherin,beta-catenin
1600,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,catenin,plakoglobin
1601,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,catenin,beta-catenin
1602,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,actin
1603,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,plakoglobin,beta-catenin
1604,BioInfer.d140,False,beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.,BioInfer.d140.s2,actin,beta-catenin
1605,BioInfer.d141,True,"Chemical modification of the cysteine residue 374 of actin, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of profilin on actin polymerization.",BioInfer.d141.s0,profilin,actin
1606,BioInfer.d141,True,"Chemical modification of the cysteine residue 374 of actin, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of profilin on actin polymerization.",BioInfer.d141.s0,profilin,actin
1607,BioInfer.d141,True,"Chemical modification of the cysteine residue 374 of actin, both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of profilin on actin polymerization.",BioInfer.d141.s0,actin,actin
1608,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,thymosin beta4
1609,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,gelsolin
1610,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,ADF
1611,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,Tbeta4
1612,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,profilin
1613,BioInfer.d142,True,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,actin depolymerizing factor
1614,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,actin
1615,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,gelsolin
1616,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,ADF
1617,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,Tbeta4
1618,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,actin
1619,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,profilin
1620,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,thymosin beta4,actin depolymerizing factor
1621,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,gelsolin,ADF
1622,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,gelsolin,Tbeta4
1623,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,gelsolin,actin
1624,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,gelsolin,profilin
1625,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,gelsolin,actin depolymerizing factor
1626,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,ADF,Tbeta4
1627,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,ADF,actin
1628,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,ADF,profilin
1629,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,ADF,actin depolymerizing factor
1630,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,Tbeta4,actin
1631,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,Tbeta4,profilin
1632,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,Tbeta4,actin depolymerizing factor
1633,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,profilin
1634,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,actin,actin depolymerizing factor
1635,BioInfer.d142,False,"Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).",BioInfer.d142.s0,profilin,actin depolymerizing factor
1636,BioInfer.d143,True,Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.,BioInfer.d143.s0,class I profilins,actin
1637,BioInfer.d143,True,Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.,BioInfer.d143.s0,actin,Class II profilins
1638,BioInfer.d143,False,Class II profilins had higher affinity for poly-l-proline and sequestered more monomeric actin than did class I profilins.,BioInfer.d143.s0,class I profilins,Class II profilins
1639,BioInfer.d143,True,The actin-sequestering activity of both maize profilin classes was found to be dependent on the concentration of free calcium.,BioInfer.d143.s1,profilin,actin
1640,BioInfer.d143,True,We propose a model in which profilin alters cellular concentrations of actin polymers in response to fluctuations in cytosolic calcium concentration.,BioInfer.d143.s2,profilin,actin
1641,BioInfer.d144,True,Coexpression of the A8R and A23R genes in Escherichia coli was required for in vitro activity.,BioInfer.d144.s0,A23R,A8R
1642,BioInfer.d144,False,"Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.",BioInfer.d144.s1,A23R,VITF-3
1643,BioInfer.d144,False,"Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.",BioInfer.d144.s1,A23R,A8R
1644,BioInfer.d144,False,"Expression of the A8R and A23R genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for VITF-3 in specifically regulating intermediate transcription in vivo.",BioInfer.d144.s1,VITF-3,A8R
1645,BioInfer.d144,False,"We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs A8R and A23R, respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.",BioInfer.d144.s2,A8R,A23R
1646,BioInfer.d147,True,"Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.",BioInfer.d147.s0,Cofilin,actin
1647,BioInfer.d147,False,"Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.",BioInfer.d147.s0,Cofilin,cofilin
1648,BioInfer.d147,False,"Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.",BioInfer.d147.s0,cofilin,actin
1649,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,TRAIL
1650,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,FAP
1651,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,RIP
1652,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,TNF-R1
1653,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,Fas
1654,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,TRADD
1655,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,Fas ligand
1656,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,FAF
1657,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,caspase-8,FADD
1658,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,FAP
1659,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,RIP
1660,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,TNF-R1
1661,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,Fas
1662,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,TRADD
1663,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,Fas ligand
1664,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,FAF
1665,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRAIL,FADD
1666,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,RIP
1667,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,TNF-R1
1668,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,Fas
1669,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,TRADD
1670,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,Fas ligand
1671,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,FAF
1672,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAP,FADD
1673,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,TNF-R1
1674,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,Fas
1675,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,TRADD
1676,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,Fas ligand
1677,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,FAF
1678,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,RIP,FADD
1679,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TNF-R1,Fas
1680,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TNF-R1,TRADD
1681,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TNF-R1,Fas ligand
1682,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TNF-R1,FAF
1683,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TNF-R1,FADD
1684,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas,TRADD
1685,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas,Fas ligand
1686,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas,FAF
1687,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas,FADD
1688,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRADD,Fas ligand
1689,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRADD,FAF
1690,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,TRADD,FADD
1691,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas ligand,FAF
1692,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,Fas ligand,FADD
1693,BioInfer.d148,False,"Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.",BioInfer.d148.s0,FAF,FADD
1694,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,ribonuclease
1695,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,FAF
1696,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,FAP
1697,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,TRADD
1698,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,RIP
1699,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,caspase-8
1700,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,FADD
1701,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,Fas ligand
1702,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,TNFR-1
1703,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRAIL,Fas
1704,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,FAF
1705,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,FAP
1706,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,TRADD
1707,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,RIP
1708,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,caspase-8
1709,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,FADD
1710,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,Fas ligand
1711,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,TNFR-1
1712,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,ribonuclease,Fas
1713,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,FAP
1714,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,TRADD
1715,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,RIP
1716,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,caspase-8
1717,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,FADD
1718,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,Fas ligand
1719,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,TNFR-1
1720,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAF,Fas
1721,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,TRADD
1722,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,RIP
1723,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,caspase-8
1724,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,FADD
1725,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,Fas ligand
1726,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,TNFR-1
1727,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FAP,Fas
1728,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,RIP
1729,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,caspase-8
1730,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,FADD
1731,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,Fas ligand
1732,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,TNFR-1
1733,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TRADD,Fas
1734,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,RIP,caspase-8
1735,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,RIP,FADD
1736,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,RIP,Fas ligand
1737,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,RIP,TNFR-1
1738,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,RIP,Fas
1739,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,caspase-8,FADD
1740,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,caspase-8,Fas ligand
1741,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,caspase-8,TNFR-1
1742,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,caspase-8,Fas
1743,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FADD,Fas ligand
1744,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FADD,TNFR-1
1745,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,FADD,Fas
1746,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,Fas ligand,TNFR-1
1747,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,Fas ligand,Fas
1748,BioInfer.d148,False,"To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.",BioInfer.d148.s1,TNFR-1,Fas
1749,BioInfer.d149,True,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,phosphoprotein
1750,BioInfer.d149,True,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,P,phosphoprotein
1751,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,V
1752,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,V
1753,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,P
1754,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,N
1755,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,phosphoprotein
1756,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,nucleocapsid protein
1757,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,V
1758,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,P
1759,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,N
1760,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,nucleocapsid protein
1761,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,P
1762,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,N
1763,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,phosphoprotein
1764,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,V,nucleocapsid protein
1765,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,P,N
1766,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,P,nucleocapsid protein
1767,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,phosphoprotein
1768,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,N,nucleocapsid protein
1769,BioInfer.d149,False,Complete gene sequences for the nucleocapsid protein (N) and phosphoprotein (P/V) have been determined and recombinant N and V proteins produced in baculovirus.,BioInfer.d149.s0,phosphoprotein,nucleocapsid protein
1770,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,catenins,beta-catenin
1771,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,catenins,gamma-catenin
1772,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,catenins,alpha-catenin
1773,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,beta-catenin,gamma-catenin
1774,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,beta-catenin,alpha-catenin
1775,BioInfer.d150,False,"CONCLUSIONS: The expression of alpha-catenin, beta-catenin, and gamma-catenin is related to histological type and differentiation in NSCLC, although catenins have no independent prognostic value.",BioInfer.d150.s0,gamma-catenin,alpha-catenin
1776,BioInfer.d150,False,"Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.",BioInfer.d150.s1,gamma-catenin,alpha-catenin
1777,BioInfer.d150,False,"Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.",BioInfer.d150.s1,gamma-catenin,beta-catenin
1778,BioInfer.d150,False,"Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.",BioInfer.d150.s1,alpha-catenin,beta-catenin
1779,BioInfer.d151,True,CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.,BioInfer.d151.s0,Aip1,cofilin
1780,BioInfer.d151,True,CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.,BioInfer.d151.s0,Aip1,actin
1781,BioInfer.d151,True,CONCLUSIONS: These results suggest the cooperative modulation of the actin cytoskeleton by cofilin and Aip1.,BioInfer.d151.s0,cofilin,actin
1782,BioInfer.d151,True,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,actin,cofilin
1783,BioInfer.d151,True,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,actin,Aip1
1784,BioInfer.d151,False,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,actin,Aip1
1785,BioInfer.d151,False,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,cofilin,Aip1
1786,BioInfer.d151,False,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,cofilin,Aip1
1787,BioInfer.d151,False,Immunofluorescence staining of a wild-type strain using anti-Aip1 antibodies revealed that Aip1 was distributed in cortical actin patches where cofilin was also co-localized.,BioInfer.d151.s1,Aip1,Aip1
1788,BioInfer.d153,False,"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.",BioInfer.d153.s0,actin,talin
1789,BioInfer.d153,False,"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.",BioInfer.d153.s0,actin,vinculin
1790,BioInfer.d153,False,"Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.",BioInfer.d153.s0,talin,vinculin
1791,BioInfer.d154,True,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,actin,LIMK
1792,BioInfer.d154,True,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,actin,cofilin
1793,BioInfer.d154,True,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,actin,LIMK1-
1794,BioInfer.d154,True,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,LIMK,LIMK1-
1795,BioInfer.d154,False,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,LIMK,cofilin
1796,BioInfer.d154,False,"Conversely, inhibition of LIMK's activity by expressing a dominant negative construct, LIMK1-, or expression of the constitutively active S3A cofilin mutant induces loss of actin filaments at the phagocytic cup and also inhibits phagocytosis.",BioInfer.d154.s0,cofilin,LIMK1-
1797,BioInfer.d155,True,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,alpha-catenin,E-cadherin
1798,BioInfer.d155,True,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,alpha-catenin,beta-catenin
1799,BioInfer.d155,True,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,alpha-catenin,plakoglobin
1800,BioInfer.d155,True,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,E-cadherin,beta-catenin
1801,BioInfer.d155,True,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,E-cadherin,plakoglobin
1802,BioInfer.d155,False,"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.",BioInfer.d155.s0,beta-catenin,plakoglobin
1803,BioInfer.d156,True,Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.,BioInfer.d156.s0,beta-catenin,alpha-catenin
1804,BioInfer.d156,True,Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.,BioInfer.d156.s0,beta-catenin,cadherin
1805,BioInfer.d156,True,Coprecipitations revealed that transfected cadherin molecules are complexed with alpha-catenin and beta-catenin at plasma membranes.,BioInfer.d156.s0,alpha-catenin,cadherin
1806,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,helicase-primase,UL52
1807,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,helicase-primase,UL5
1808,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,helicase-primase,UL8
1809,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL52,UL5
1810,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL52,UL8
1811,BioInfer.d157,True,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL5,UL8
1812,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,helicase-primase,UL29
1813,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,helicase-primase,major DNA-binding protein
1814,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL29,UL52
1815,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL29,major DNA-binding protein
1816,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL29,UL5
1817,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL29,UL8
1818,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,UL52,major DNA-binding protein
1819,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,major DNA-binding protein,UL5
1820,BioInfer.d157,False,"Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.",BioInfer.d157.s0,major DNA-binding protein,UL8
1821,BioInfer.d158,True,Crystallization and preliminary crystallographic analysis of the N-terminal actin binding domain of human fimbrin.,BioInfer.d158.s0,fimbrin,actin
1822,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,L,NP
1823,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,L,nucleocapsid protein
1824,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,L,large protein
1825,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,L,P
1826,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,L,phosphoprotein
1827,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,NP,nucleocapsid protein
1828,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,NP,large protein
1829,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,NP,P
1830,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,NP,phosphoprotein
1831,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,nucleocapsid protein,large protein
1832,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,nucleocapsid protein,P
1833,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,nucleocapsid protein,phosphoprotein
1834,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,large protein,P
1835,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,large protein,phosphoprotein
1836,BioInfer.d159,False,"CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the large protein (L), phosphoprotein (P), and nucleocapsid protein (NP), alone or together, for the expression of biologically active proteins.",BioInfer.d159.s0,P,phosphoprotein
1837,BioInfer.d160,True,"Cytoplasmic staining included stress fibers that colocalized with actin, probably as a consequence of the myosin heavy chain component of the fusion protein.",BioInfer.d160.s0,actin,myosin heavy chain
1838,BioInfer.d161,True,"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.",BioInfer.d161.s0,thymosin beta(4),actin
1839,BioInfer.d161,True,"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.",BioInfer.d161.s0,thymosin beta(4),profilin
1840,BioInfer.d161,True,"Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that profilin, thymosin beta(4), and actin form a ternary complex.",BioInfer.d161.s0,actin,profilin
1841,BioInfer.d161,True,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,thymosin beta(4)
1842,BioInfer.d161,True,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,profilin
1843,BioInfer.d161,True,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),profilin
1844,BioInfer.d161,True,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,thymosin beta(4)
1845,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,actin
1846,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,thymosin beta(4)
1847,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,thymosin beta(4)
1848,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),actin
1849,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),thymosin beta(4)
1850,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),thymosin beta(4)
1851,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,thymosin beta(4)
1852,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,actin,profilin
1853,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),thymosin beta(4)
1854,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),profilin
1855,BioInfer.d161,False,"Experiments using a peptide that corresponds to the N-terminus of thymosin beta(4) (residues 6-22) confirm the presence of an extensive binding surface between actin and thymosin beta(4), and explain why thymosin beta(4) and profilin can bind simultaneously to actin.",BioInfer.d161.s1,thymosin beta(4),profilin
1856,BioInfer.d162,True,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,cyclin D1,HER-2
1857,BioInfer.d162,True,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,p27KIP1,HER-2
1858,BioInfer.d162,True,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,p27KIP1,cyclin-dependent kinase inhibitor
1859,BioInfer.d162,False,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,cyclin D1,p27KIP1
1860,BioInfer.d162,False,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,cyclin D1,cyclin-dependent kinase inhibitor
1861,BioInfer.d162,False,Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.,BioInfer.d162.s0,HER-2,cyclin-dependent kinase inhibitor
1862,BioInfer.d163,False,Data presented here suggest that two of the repressed genes encode the proteins actin and myosin heavy chain.,BioInfer.d163.s0,myosin heavy chain,actin
1863,BioInfer.d163,False,Selective repression of actin and myosin heavy chain expression during the programmed death of insect skeletal muscle.,BioInfer.d163.s1,myosin heavy chain,actin
1864,BioInfer.d163,False,The reduction in actin and myosin heavy chain synthesis presumably plays a role in the rapid dissolution of the muscles.,BioInfer.d163.s2,myosin heavy chain,actin
1865,BioInfer.d164,True,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Death receptors,TRADD
1866,BioInfer.d164,True,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Death receptors,FADD
1867,BioInfer.d164,True,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Death receptors,cysteine proteases
1868,BioInfer.d164,True,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Death receptors,TNF receptor
1869,BioInfer.d164,True,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Caspase-8,cysteine proteases
1870,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Death receptors,Caspase-8
1871,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Caspase-8,TRADD
1872,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Caspase-8,FADD
1873,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,Caspase-8,TNF receptor
1874,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,TRADD,FADD
1875,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,TRADD,cysteine proteases
1876,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,TRADD,TNF receptor
1877,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,FADD,cysteine proteases
1878,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,FADD,TNF receptor
1879,BioInfer.d164,False,Death receptors belong to the TNF receptor family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as TRADD and FADD and cysteine proteases such as Caspase-8.,BioInfer.d164.s0,cysteine proteases,TNF receptor
1880,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR2,SIR3
1881,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR2,SIR1
1882,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR2,SIR4
1883,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR3,SIR1
1884,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR3,SIR4
1885,BioInfer.d165,False,"Deletion and overexpression studies demonstrate that SIR2, but not SIR1, SIR3 or SIR4, is required for this rDNA position effect.",BioInfer.d165.s0,SIR1,SIR4
1886,BioInfer.d166,False,Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.,BioInfer.d166.s0,RAD51,RAD52
1887,BioInfer.d166,False,Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.,BioInfer.d166.s0,RAD51,RAD50
1888,BioInfer.d166,False,Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.,BioInfer.d166.s0,RAD52,RAD50
1889,BioInfer.d166,False,"rad59 mutations completely abolished the ability to generate type II survivors, while rad50 mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.",BioInfer.d166.s1,rad59,rad50
1890,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,mURA3,SIR4
1891,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,mURA3,SIR3
1892,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,mURA3,SIR1
1893,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR4,MET15
1894,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR3,MET15
1895,BioInfer.d167,True,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR1,MET15
1896,BioInfer.d167,False,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,mURA3,MET15
1897,BioInfer.d167,False,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR4,SIR3
1898,BioInfer.d167,False,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR4,SIR1
1899,BioInfer.d167,False,"Deletion of SIR4 enhanced mURA3 and MET15 silencing, but deletion of SIR1 or SIR3 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.",BioInfer.d167.s0,SIR3,SIR1
1900,BioInfer.d168,True,Demembranated stereociliary cores consisted primarily of protein bands corresponding to actin and fimbrin and several proteins ranging from 43 to 63 kDa.,BioInfer.d168.s0,fimbrin,actin
1901,BioInfer.d169,True,"Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.",BioInfer.d169.s0,actin,profilin
1902,BioInfer.d169,True,"Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.",BioInfer.d169.s0,actin,profilin
1903,BioInfer.d169,False,"Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with actin, like mammalian profilin.",BioInfer.d169.s0,profilin,profilin
1904,BioInfer.d169,True,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,A,actin
1905,BioInfer.d169,True,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,A,Tbeta4
1906,BioInfer.d169,True,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,actin,profilin
1907,BioInfer.d169,True,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,actin,Tbeta4
1908,BioInfer.d169,False,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,A,profilin
1909,BioInfer.d169,False,In the presence of magnesium ions birch profilin promoted the polymerization of actin from A:Tbeta4.,BioInfer.d169.s1,profilin,Tbeta4
1910,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta9,thymosin beta4
1911,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta9,actin
1912,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta9,actin
1913,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,profilin,actin
1914,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta4,actin
1915,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta4,actin
1916,BioInfer.d169,True,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,actin,actin
1917,BioInfer.d169,False,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,thymosin beta9,profilin
1918,BioInfer.d169,False,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,profilin,thymosin beta4
1919,BioInfer.d169,False,Recombinant plant (birch) profilin was analyzed for its ability to promote actin polymerization from the actin:thymosin beta4 and beta9 complex.,BioInfer.d169.s2,profilin,actin
1920,BioInfer.d169,True,These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.,BioInfer.d169.s3,DNase I,profilin
1921,BioInfer.d169,True,These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.,BioInfer.d169.s3,DNase I,actin
1922,BioInfer.d169,True,These data indicated a negative co-operativity between the profilin and DNase I binding sites on actin.,BioInfer.d169.s3,profilin,actin
1923,BioInfer.d170,True,Detection of a sequence involved in actin-binding and phosphoinositide-binding in the N-terminal side of cofilin.,BioInfer.d170.s0,actin,cofilin
1924,BioInfer.d170,True,The truncated cofilin molecules produced in E. coli were purified and examined for their actin-binding and PIP2-binding ability.,BioInfer.d170.s1,actin,cofilin
1925,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,BRCA2,RAD52
1926,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,BRCA2,RAD54
1927,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,BRCA2,RAD51
1928,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,BRCA2,BRCA1
1929,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD52,RAD54
1930,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD52,RAD51
1931,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD52,BRCA1
1932,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD54,RAD51
1933,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD54,BRCA1
1934,BioInfer.d171,False,"Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.",BioInfer.d171.s0,RAD51,BRCA1
1935,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,BRCA2,RAD52
1936,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,BRCA2,RAD54
1937,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,BRCA2,RAD51
1938,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,BRCA2,BRCA1
1939,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD52,RAD54
1940,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD52,RAD51
1941,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD52,BRCA1
1942,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD54,RAD51
1943,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD54,BRCA1
1944,BioInfer.d171,False,"LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.",BioInfer.d171.s1,RAD51,BRCA1
1945,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,BRCA1,RAD54
1946,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,BRCA1,RAD51
1947,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,BRCA1,BRCA2
1948,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,BRCA1,RAD52
1949,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,RAD54,RAD51
1950,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,RAD54,BRCA2
1951,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,RAD54,RAD52
1952,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,RAD51,BRCA2
1953,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,RAD51,RAD52
1954,BioInfer.d171,False,"We investigate allelic losses in microsatellites of the RAD51, RAD52, RAD54, BRCA1 and BRCA2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.",BioInfer.d171.s2,BRCA2,RAD52
1955,BioInfer.d172,False,Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle.,BioInfer.d172.s0,myosin heavy chain,actin
1956,BioInfer.d173,True,Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.,BioInfer.d173.s0,myosin heavy chain,alkaline proteinase
1957,BioInfer.d173,True,Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.,BioInfer.d173.s0,actin,alkaline proteinase
1958,BioInfer.d173,False,Digestion of isolated myofibrils with alkaline proteinase resulted in the degradation of myosin heavy chain and actin.,BioInfer.d173.s0,myosin heavy chain,actin
1959,BioInfer.d174,True,Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.,BioInfer.d174.s0,verprolin,N-WASP
1960,BioInfer.d174,True,Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.,BioInfer.d174.s0,actin,N-WASP
1961,BioInfer.d174,False,Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.,BioInfer.d174.s0,verprolin,actin
1962,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,WASP,verprolin
1963,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,WASP,N-WASP
1964,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,WASP,actin
1965,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,verprolin,N-WASP
1966,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,verprolin,Wiskott-Aldrich Syndrome Protein
1967,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,N-WASP,actin
1968,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,N-WASP,Wiskott-Aldrich Syndrome Protein
1969,BioInfer.d174,True,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,actin,Wiskott-Aldrich Syndrome Protein
1970,BioInfer.d174,False,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,WASP,Wiskott-Aldrich Syndrome Protein
1971,BioInfer.d174,False,"Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.",BioInfer.d174.s1,verprolin,actin
1972,BioInfer.d175,True,Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.,BioInfer.d175.s0,PRT1,TIF34
1973,BioInfer.d175,True,Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.,BioInfer.d175.s0,TIF34,TIF35
1974,BioInfer.d175,False,Discrete segments (70-150 amino acids) of PRT1 and TIF35 were found to be responsible for their binding to TIF34.,BioInfer.d175.s0,PRT1,TIF35
1975,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,GCD10,PRT1
1976,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,GCD10,eukaryotic translation initiation factor 3
1977,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,GCD10,TIF34
1978,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,GCD10,eIF3
1979,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,GCD10,SUI1
1980,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,PRT1,eukaryotic translation initiation factor 3
1981,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,PRT1,TIF34
1982,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,PRT1,eIF3
1983,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,PRT1,SUI1
1984,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,eukaryotic translation initiation factor 3,TIF34
1985,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,eukaryotic translation initiation factor 3,eIF3
1986,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,eukaryotic translation initiation factor 3,SUI1
1987,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,TIF34,eIF3
1988,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,TIF34,SUI1
1989,BioInfer.d175,False,"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.",BioInfer.d175.s1,eIF3,SUI1
1990,BioInfer.d177,True,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,actin,RVS167
1991,BioInfer.d177,True,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,END6,RVS167
1992,BioInfer.d177,True,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,RVS161,RVS167
1993,BioInfer.d177,False,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,actin,END6
1994,BioInfer.d177,False,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,actin,RVS161
1995,BioInfer.d177,False,"Disruption of the RVS167 gene, which is homologous to END6/RVS161 and which is also required for correct actin localization, also blocks endocytosis.",BioInfer.d177.s0,END6,RVS161
1996,BioInfer.d178,True,"DNA sequence analysis of the cdc3+ gene reveals that it encodes profilin, an actin-monomer-binding protein.",BioInfer.d178.s0,profilin,cdc3+
1997,BioInfer.d178,True,"DNA sequence analysis of the cdc3+ gene reveals that it encodes profilin, an actin-monomer-binding protein.",BioInfer.d178.s0,profilin,actin
1998,BioInfer.d178,False,"DNA sequence analysis of the cdc3+ gene reveals that it encodes profilin, an actin-monomer-binding protein.",BioInfer.d178.s0,cdc3+,actin
1999,BioInfer.d178,True,"We attribute these effects to potential sequestration of actin monomers by profilin, when present in excess.",BioInfer.d178.s1,profilin,actin
2000,BioInfer.d179,True,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,histone,H3
2001,BioInfer.d179,True,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,H4,histone
2002,BioInfer.d179,False,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,histone,H4
2003,BioInfer.d179,False,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,histone,histone
2004,BioInfer.d179,False,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,H4,H3
2005,BioInfer.d179,False,Double mutants containing N-terminal domain deletions of both histone H3 and histone H4 were inviable.,BioInfer.d179.s0,histone,H3
2006,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,TRADD,FLICE
2007,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,TRADD,FADD
2008,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,TRADD,TRAF2
2009,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,FLICE,FADD
2010,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,FLICE,TRAF2
2011,BioInfer.d180,True,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,FADD,TRAF2
2012,BioInfer.d180,False,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,TRADD,DR3
2013,BioInfer.d180,False,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,DR3,FLICE
2014,BioInfer.d180,False,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,DR3,FADD
2015,BioInfer.d180,False,"DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.",BioInfer.d180.s0,DR3,TRAF2
2016,BioInfer.d181,True,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,p21,cyclin-dependent kinase inhibitors
2017,BioInfer.d181,True,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,p27,cyclin-dependent kinase inhibitors
2018,BioInfer.d181,False,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,p21,p27
2019,BioInfer.d181,False,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,p21,cyclin D1
2020,BioInfer.d181,False,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,p27,cyclin D1
2021,BioInfer.d181,False,"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and p27 increased, whereas expression of cyclin D1 decreased.",BioInfer.d181.s0,cyclin-dependent kinase inhibitors,cyclin D1
2022,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,myosin heavy chain,actin
2023,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,myosin heavy chain,alpha actinin
2024,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,myosin heavy chain,troponin T
2025,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,actin,alpha actinin
2026,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,actin,troponin T
2027,BioInfer.d182,False,"During incubation of whole myofibrils at 37 degrees C, myosin heavy chain, alpha actinin, actin and troponin T suffered degradation.",BioInfer.d182.s0,alpha actinin,troponin T
2028,BioInfer.d183,True,Dynamic actin structures stabilized by profilin.,BioInfer.d183.s0,actin,profilin
2029,BioInfer.d183,True,The distribution of actin filaments is altered by profilin overexpression.,BioInfer.d183.s1,actin,profilin
2030,BioInfer.d183,False,"While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.",BioInfer.d183.s2,actin,actin
2031,BioInfer.d183,False,"While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.",BioInfer.d183.s2,actin,profilin
2032,BioInfer.d183,False,"While parallel actin bundles crossing the cells are virtually absent in cells overexpressing profilin, the submembranous actin network of these cells is denser than in control cells.",BioInfer.d183.s2,actin,profilin
2033,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,profilin
2034,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2035,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2036,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,profilin
2037,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2038,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,actin
2039,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2040,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,annexin I
2041,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,actin
2042,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,annexin I
2043,BioInfer.d184,True,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,actin
2044,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,profilin
2045,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2046,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,actin
2047,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2048,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,profilin
2049,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2050,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,profilin,annexin I
2051,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,actin
2052,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,annexin I,annexin I
2053,BioInfer.d184,False,Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.,BioInfer.d184.s0,actin,annexin I
2054,BioInfer.d185,True,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,actin,macrophage profilin
2055,BioInfer.d185,False,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,actin,acumentin
2056,BioInfer.d185,False,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,actin,gelsolin
2057,BioInfer.d185,False,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,acumentin,gelsolin
2058,BioInfer.d185,False,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,acumentin,macrophage profilin
2059,BioInfer.d185,False,Effects of macrophage profilin on actin in the presence and absence of acumentin and gelsolin.,BioInfer.d185.s0,gelsolin,macrophage profilin
2060,BioInfer.d186,False,"Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.",BioInfer.d186.s0,RAD50,RAD52
2061,BioInfer.d186,False,"Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.",BioInfer.d186.s0,RAD50,RAD51
2062,BioInfer.d186,False,"Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae.",BioInfer.d186.s0,RAD52,RAD51
2063,BioInfer.d187,True,Effects of single amino acid substitutions in the actin-binding site on the biological activity of bovine profilin I.,BioInfer.d187.s0,actin,profilin I
2064,BioInfer.d187,True,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,actin,profilin
2065,BioInfer.d187,True,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,actin,profilin
2066,BioInfer.d187,False,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,actin,actin
2067,BioInfer.d187,False,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,actin,profilin
2068,BioInfer.d187,False,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,actin,profilin
2069,BioInfer.d187,False,"However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.",BioInfer.d187.s1,profilin,profilin
2070,BioInfer.d187,True,"These results emphasize the highly conserved biological function of profilins with low sequence homology, and correlate specifically their actin-binding capacity with cell motility and proliferation.",BioInfer.d187.s2,profilins,actin
2071,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,myosin heavy chain beta,myosin heavy chain alpha
2072,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,myosin heavy chain beta,alpha-cardiac actin
2073,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,myosin heavy chain beta,28S rRNA
2074,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,myosin heavy chain alpha,alpha-cardiac actin
2075,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,myosin heavy chain alpha,28S rRNA
2076,BioInfer.d188,False,Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.,BioInfer.d188.s0,alpha-cardiac actin,28S rRNA
2077,BioInfer.d189,True,"Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing actin and talin.",BioInfer.d189.s0,actin,talin
2078,BioInfer.d190,True,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,End5p,END5
2079,BioInfer.d190,True,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,End5p,actin
2080,BioInfer.d190,True,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,verprolin,END5
2081,BioInfer.d190,True,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,verprolin,actin
2082,BioInfer.d190,False,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,End5p,verprolin
2083,BioInfer.d190,False,"END5 encodes a proline-rich protein (End5p or verprolin) required for a polarised cortical actin cytoskeleton and endocytosis [2,3].",BioInfer.d190.s0,END5,actin
2084,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,muscle-specific actin,myogenin
2085,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,muscle-specific actin,desmin
2086,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,muscle-specific actin,myosin heavy chain
2087,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,myogenin,desmin
2088,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,myogenin,myosin heavy chain
2089,BioInfer.d191,False,"Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of myosin heavy chain, myogenin, desmin, and muscle-specific actin over a 240 h period in culture.",BioInfer.d191.s0,desmin,myosin heavy chain
2090,BioInfer.d192,True,Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.,BioInfer.d192.s0,PRP21,PRP9
2091,BioInfer.d192,True,Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.,BioInfer.d192.s0,PRP21,PRP11
2092,BioInfer.d192,False,Essential domains of the PRP21 splicing factor are implicated in the binding to PRP9 and PRP11 proteins and are conserved through evolution.,BioInfer.d192.s0,PRP9,PRP11
2093,BioInfer.d193,True,Evaluation of the binding of Acanthamoeba profilin to pyrene-labeled actin by fluorescence enhancement.,BioInfer.d193.s0,profilin,actin
2094,BioInfer.d195,True,Evidence for a conformational change in actin induced by fimbrin (N375) binding.,BioInfer.d195.s0,fimbrin,N375
2095,BioInfer.d195,True,Evidence for a conformational change in actin induced by fimbrin (N375) binding.,BioInfer.d195.s0,N375,actin
2096,BioInfer.d195,False,Evidence for a conformational change in actin induced by fimbrin (N375) binding.,BioInfer.d195.s0,fimbrin,actin
2097,BioInfer.d197,False,Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families.,BioInfer.d197.s0,actin,cardiac myosin heavy chain
2098,BioInfer.d199,False,"Exposure of the cells to tumor promoter did, however, result in a loss of actin and talin-rich cell surface elaborations that resemble focal contact precursor structures.",BioInfer.d199.s0,actin,talin
2099,BioInfer.d201,False,"Expression of actin and myosin heavy chain genes in skeletal, cardiac and uterine muscles of young and old rats.",BioInfer.d201.s0,actin,myosin heavy chain
2100,BioInfer.d202,True,Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.,BioInfer.d202.s0,E-cadherin,alpha-catenin
2101,BioInfer.d202,True,Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.,BioInfer.d202.s0,alpha-catenin,beta-catenin
2102,BioInfer.d202,False,Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.,BioInfer.d202.s0,E-cadherin,beta-catenin
2103,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin D1,Cdk2
2104,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin D1,cyclin E
2105,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,Cdk2,cyclin E
2106,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,Cdk2,c-Myc
2107,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin E,c-Myc
2108,BioInfer.d204,True,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin-dependent kinase inhibitor,p21
2109,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin D1,cyclin-dependent kinase inhibitor
2110,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin D1,c-Myc
2111,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin D1,p21
2112,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,Cdk2,cyclin-dependent kinase inhibitor
2113,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,Cdk2,p21
2114,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin E,cyclin-dependent kinase inhibitor
2115,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin E,p21
2116,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,cyclin-dependent kinase inhibitor,c-Myc
2117,BioInfer.d204,False,"Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.",BioInfer.d204.s0,c-Myc,p21
2118,BioInfer.d205,False,"Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.",BioInfer.d205.s0,E-cadherin,beta-catenin
2119,BioInfer.d205,False,"Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.",BioInfer.d205.s0,E-cadherin,alpha-catenin
2120,BioInfer.d205,False,"Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.",BioInfer.d205.s0,beta-catenin,alpha-catenin
2121,BioInfer.d207,False,"Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.",BioInfer.d207.s0,talin,actin
2122,BioInfer.d207,False,"Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.",BioInfer.d207.s0,talin,vinculin
2123,BioInfer.d207,False,"Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.",BioInfer.d207.s0,actin,vinculin
2124,BioInfer.d208,False,"Finally, both receptors can interact with FADD, TRADD, and RIP.",BioInfer.d208.s0,TRADD,RIP
2125,BioInfer.d208,False,"Finally, both receptors can interact with FADD, TRADD, and RIP.",BioInfer.d208.s0,TRADD,FADD
2126,BioInfer.d208,False,"Finally, both receptors can interact with FADD, TRADD, and RIP.",BioInfer.d208.s0,RIP,FADD
2127,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR4,RIP
2128,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR4,TRADD
2129,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR4,FADD
2130,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,RIP,DR5
2131,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,TRADD,DR5
2132,BioInfer.d208,True,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR5,FADD
2133,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR4,DR5
2134,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR4,FADD
2135,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,RIP,TRADD
2136,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,RIP,FADD
2137,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,RIP,FADD
2138,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,TRADD,FADD
2139,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,TRADD,FADD
2140,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,DR5,FADD
2141,BioInfer.d208,False,"Thus, both DR5 and DR4 use FADD, TRADD, and RIP in their signal transduction pathways, and FADD is the common mediator of apoptosis by all known death domain-containing receptors.",BioInfer.d208.s1,FADD,FADD
2142,BioInfer.d209,False,Finally it was shown that the two isoforms of actin can be separated from each other in the absence of profilin also by chromatography on hydroxyapatite.,BioInfer.d209.s0,actin,profilin
2143,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,PCAF
2144,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,histone
2145,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,histone
2146,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,PCAF
2147,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,histones
2148,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,PCAF,H3
2149,BioInfer.d210,True,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,histones
2150,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,H3
2151,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,H4
2152,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,histone
2153,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,H4
2154,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,H3
2155,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,histones
2156,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,histone
2157,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,p53,p53
2158,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,H4
2159,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,H4
2160,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,PCAF
2161,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,H3
2162,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,histones
2163,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,histone
2164,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,p53
2165,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,histone
2166,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,H4
2167,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,PCAF
2168,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,H3
2169,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,histones
2170,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,p53
2171,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,H4
2172,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,PCAF
2173,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,H3
2174,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,histones
2175,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,histone
2176,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,p53
2177,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,H3
2178,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,histone
2179,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H4,p53
2180,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,PCAF,histones
2181,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,PCAF,histone
2182,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,PCAF,p53
2183,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,histone
2184,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,H3,p53
2185,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histones,histone
2186,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histones,p53
2187,BioInfer.d210,False,"Finally, we evaluated the acetylation of three putative PCAF substrates, histones H3 and H4 and the transcription factor p53, and have determined that histone H3 is significantly preferred over the histone H4 and p53 substrates.",BioInfer.d210.s0,histone,p53
2188,BioInfer.d212,False,"First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.",BioInfer.d212.s0,cofilin,verprolin
2189,BioInfer.d212,False,"First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.",BioInfer.d212.s0,cofilin,actin
2190,BioInfer.d212,False,"First, the C-terminal verprolin-cofilin-acidic domain was shown to be essential for the regulation of actin cytoskeleton.",BioInfer.d212.s0,verprolin,actin
2191,BioInfer.d213,True,Fluorescent actin analogs with a high affinity for profilin in vitro exhibit an enhanced gradient of assembly in living cells.,BioInfer.d213.s0,actin,profilin
2192,BioInfer.d213,True,Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.,BioInfer.d213.s1,actin,profilin
2193,BioInfer.d213,False,Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.,BioInfer.d213.s1,actin,actin
2194,BioInfer.d213,False,Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.,BioInfer.d213.s1,profilin,actin
2195,BioInfer.d213,True,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,profilin
2196,BioInfer.d213,True,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,DNase I
2197,BioInfer.d213,True,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,profilin
2198,BioInfer.d213,True,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,profilin,actin
2199,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,actin
2200,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,actin
2201,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,DNase I
2202,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,actin,actin
2203,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,profilin,DNase I
2204,BioInfer.d213,False,"To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.",BioInfer.d213.s2,DNase I,actin
2205,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin depolymerizing factor,profilin
2206,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin depolymerizing factor,actin
2207,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin depolymerizing factor,cofilin
2208,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin depolymerizing factor,actin
2209,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,profilin,actin
2210,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,profilin,cofilin
2211,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,profilin,actin
2212,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin,cofilin
2213,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,actin,actin
2214,BioInfer.d214,False,"Fluorographic analysis showed that the specific activity of soluble actin was two to three times that of its particulate form and that soluble actin, cofilin, actin depolymerizing factor, and profilin were transported at similar rates in slow component b of axonal flow.",BioInfer.d214.s0,cofilin,actin
2215,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin depolymerizing factor,actin
2216,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin depolymerizing factor,cofilin
2217,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin depolymerizing factor,profilin
2218,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,cofilin
2219,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,profilin
2220,BioInfer.d214,True,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,cofilin,profilin
2221,BioInfer.d214,False,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,actin depolymerizing factor
2222,BioInfer.d214,False,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,actin
2223,BioInfer.d214,False,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,cofilin
2224,BioInfer.d214,False,"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and profilin.",BioInfer.d214.s1,actin,profilin
2225,BioInfer.d214,True,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,profilin,actin
2226,BioInfer.d214,True,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,actin,actin depolymerizing factor
2227,BioInfer.d214,True,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,actin,cofilin
2228,BioInfer.d214,False,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,profilin,actin depolymerizing factor
2229,BioInfer.d214,False,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,profilin,cofilin
2230,BioInfer.d214,False,"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.",BioInfer.d214.s2,actin depolymerizing factor,cofilin
2231,BioInfer.d215,True,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,beta-catenin,cadherins
2232,BioInfer.d215,True,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,Armadillo,cadherins
2233,BioInfer.d215,True,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,cadherins,alpha-catenin
2234,BioInfer.d215,True,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,cadherins,trypsin
2235,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,beta-catenin,Armadillo
2236,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,beta-catenin,alpha-catenin
2237,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,beta-catenin,trypsin
2238,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,Armadillo,alpha-catenin
2239,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,Armadillo,trypsin
2240,BioInfer.d215,False,"For example, it is associated with alpha-catenin and beta-catenin (Armadillo), and protected from trypsin digestion only in the presence of Ca2+, as is the case for many of classic cadherins.",BioInfer.d215.s0,alpha-catenin,trypsin
2241,BioInfer.d216,True,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,actin,E-APC
2242,BioInfer.d216,False,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,actin,profilin
2243,BioInfer.d216,False,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,actin,actin
2244,BioInfer.d216,False,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,E-APC,profilin
2245,BioInfer.d216,False,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,E-APC,actin
2246,BioInfer.d216,False,"From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.",BioInfer.d216.s0,profilin,actin
2247,BioInfer.d218,True,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,RAD52
2248,BioInfer.d218,True,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,Rad52,Rad51
2249,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,RAD51
2250,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,RAD51
2251,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,RAD52
2252,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,Rad52
2253,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,RAD52
2254,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,Rad51
2255,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,RAD51
2256,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,Rad52
2257,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,RAD52
2258,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,Rad51
2259,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,RAD52
2260,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,Rad52
2261,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,RAD52
2262,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD51,Rad51
2263,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,Rad52
2264,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,RAD52
2265,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,Rad51
2266,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,Rad52,RAD52
2267,BioInfer.d218,False,"From these observations it is concluded that (i) RAD52 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that RAD51 is not required for intrachromosomal crossovers, and (iii) that RAD51 and RAD52 have different functions, or that RAD52 has functions in addition to those of the Rad51/Rad52 protein complex.",BioInfer.d218.s0,RAD52,Rad51
2268,BioInfer.d222,True,"Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.",BioInfer.d222.s0,extracellular matrix proteins,actin
2269,BioInfer.d222,True,"Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.",BioInfer.d222.s0,extracellular matrix proteins,profilin
2270,BioInfer.d222,True,"Furthermore, a simultaneous expression of profilin, actin and extracellular matrix proteins was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.",BioInfer.d222.s0,actin,profilin
2271,BioInfer.d223,True,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,synaptojanin,actin
2272,BioInfer.d223,True,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,sac6,SJL1
2273,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,synaptojanin,sac6
2274,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,synaptojanin,fimbrin
2275,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,synaptojanin,SJL1
2276,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,sac6,actin
2277,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,sac6,fimbrin
2278,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,actin,fimbrin
2279,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,actin,SJL1
2280,BioInfer.d223,False,"Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.",BioInfer.d223.s0,fimbrin,SJL1
2281,BioInfer.d224,True,"Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.",BioInfer.d224.s0,calmodulin,alpha-actinin2
2282,BioInfer.d224,True,"Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.",BioInfer.d224.s0,alpha-actinin2,NR1
2283,BioInfer.d224,False,"Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.",BioInfer.d224.s0,calmodulin,NR1
2284,BioInfer.d225,True,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,BTG,IL-6
2285,BioInfer.d225,True,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,myosin,talin
2286,BioInfer.d225,True,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,myosin,actin binding protein
2287,BioInfer.d225,True,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,TXB2,IL-6
2288,BioInfer.d225,True,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,talin,actin binding protein
2289,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,BTG,myosin
2290,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,BTG,TXB2
2291,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,BTG,talin
2292,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,BTG,actin binding protein
2293,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,myosin,TXB2
2294,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,myosin,IL-6
2295,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,TXB2,talin
2296,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,TXB2,actin binding protein
2297,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,talin,IL-6
2298,BioInfer.d225,False,"Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.",BioInfer.d225.s0,actin binding protein,IL-6
2299,BioInfer.d226,True,"Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.",BioInfer.d226.s0,integrins,actin
2300,BioInfer.d226,True,"Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.",BioInfer.d226.s0,integrins,talin
2301,BioInfer.d226,True,"Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.",BioInfer.d226.s0,actin,talin
2302,BioInfer.d226,True,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,actin,vinculin
2303,BioInfer.d226,True,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,actin,paxillin
2304,BioInfer.d226,True,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,actin,talin
2305,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,actin,fibronectin
2306,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,vinculin,fibronectin
2307,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,vinculin,paxillin
2308,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,vinculin,talin
2309,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,fibronectin,paxillin
2310,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,fibronectin,talin
2311,BioInfer.d226,False,"Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.",BioInfer.d226.s1,paxillin,talin
2312,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,vinculin
2313,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,plakoglobin
2314,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,p120
2315,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,alpha-catenin
2316,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,beta-catenin
2317,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-actinin,N-cadherin
2318,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,vinculin,plakoglobin
2319,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,vinculin,p120
2320,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,vinculin,alpha-catenin
2321,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,vinculin,beta-catenin
2322,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,vinculin,N-cadherin
2323,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,plakoglobin,p120
2324,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,plakoglobin,alpha-catenin
2325,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,plakoglobin,beta-catenin
2326,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,plakoglobin,N-cadherin
2327,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,p120,alpha-catenin
2328,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,p120,beta-catenin
2329,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,p120,N-cadherin
2330,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-catenin,beta-catenin
2331,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,alpha-catenin,N-cadherin
2332,BioInfer.d227,False,"Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.",BioInfer.d227.s0,beta-catenin,N-cadherin
2333,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,actin,myosin heavy chain
2334,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,actin,myosin
2335,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,actin,MHC
2336,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,myosin heavy chain,myosin
2337,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,myosin heavy chain,MHC
2338,BioInfer.d229,False,Gel electrophoresis was used to measure changes in the relative amounts of actin or myosin and of myosin heavy chain (MHC) isoforms.,BioInfer.d229.s0,myosin,MHC
2339,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,actin binding protein,myosin heavy chain
2340,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,actin binding protein,talin
2341,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,actin binding protein,ABP
2342,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,myosin heavy chain,talin
2343,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,myosin heavy chain,ABP
2344,BioInfer.d230,False,"Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.",BioInfer.d230.s0,talin,ABP
2345,BioInfer.d232,False,Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles.,BioInfer.d232.s0,actin,myosin heavy chain
2346,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,Mhc36B
2347,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,myosin heavy chain
2348,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,Act88F
2349,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,actin
2350,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,Mhc36B
2351,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Mhc36B,myosin heavy chain
2352,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Mhc36B,Act88F
2353,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Mhc36B,actin
2354,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Mhc36B,Mhc36B
2355,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,myosin heavy chain,Act88F
2356,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,myosin heavy chain,actin
2357,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,myosin heavy chain,Mhc36B
2358,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,actin
2359,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,Act88F,Mhc36B
2360,BioInfer.d232,False,"We find that heterozygotes for actin (Act88F) or myosin heavy chain (Mhc36B) null alleles have complex myofibrillar defects, whereas Mhc36B-/+; Act88F-/+ double heterozygotes have nearly normal myofibrils.",BioInfer.d232.s1,actin,Mhc36B
2361,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH3,MSH6
2362,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH3,MLH1
2363,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH3,MSH2
2364,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH3,PMS2
2365,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH6,MLH1
2366,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH6,MSH2
2367,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH6,PMS2
2368,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MLH1,MSH2
2369,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MLH1,PMS2
2370,BioInfer.d233,False,"Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.",BioInfer.d233.s0,MSH2,PMS2
2371,BioInfer.d234,True,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,Tax
2372,BioInfer.d234,True,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,CBP
2373,BioInfer.d234,True,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,CREB
2374,BioInfer.d234,True,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,Tax
2375,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,CBP
2376,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,CREB
2377,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,Glutathione S-transferase
2378,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,Tax
2379,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,p300,Tax
2380,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,Glutathione S-transferase
2381,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,Tax
2382,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CBP,CREB
2383,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CBP,Glutathione S-transferase
2384,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CBP,Tax
2385,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CBP,Tax
2386,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CREB,Glutathione S-transferase
2387,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CREB,Tax
2388,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,CREB,Tax
2389,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Glutathione S-transferase,Tax
2390,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Glutathione S-transferase,Tax
2391,BioInfer.d234,False,Glutathione S-transferase pull-down performed with Tax deletion mutants and peptide competition have localized the site in Tax critical for binding CBP/p300 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for CREB binding and Tax subunit dimerization.,BioInfer.d234.s0,Tax,Tax
2392,BioInfer.d236,True,"Hence, we conclude that in its dimeric form, which is used in actin and lipid binding, talin is a dumbbell-shaped molecule built of two antiparallel subunits.",BioInfer.d236.s0,actin,talin
2393,BioInfer.d236,True,"The talin dimer, which is crucial for actin and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.",BioInfer.d236.s1,talin,actin
2394,BioInfer.d237,True,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD52,RAD51
2395,BioInfer.d237,False,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD52,RAD51
2396,BioInfer.d237,False,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD52,RAD52
2397,BioInfer.d237,False,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD52,RAD51
2398,BioInfer.d237,False,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD51,RAD52
2399,BioInfer.d237,False,"Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.",BioInfer.d237.s0,RAD51,RAD51
2400,BioInfer.d237,True,Interaction of the yeast RAD51 and RAD52 proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.,BioInfer.d237.s1,RAD51,RAD52
2401,BioInfer.d237,True,Specific interactions between the human RAD51 and RAD52 proteins.,BioInfer.d237.s2,RAD52,RAD51
2402,BioInfer.d237,True,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD52
2403,BioInfer.d237,True,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD51
2404,BioInfer.d237,True,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD51,RAD52
2405,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD51
2406,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD52
2407,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD51
2408,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD51
2409,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD52
2410,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD51,RAD51
2411,BioInfer.d237,False,"The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.",BioInfer.d237.s3,RAD52,RAD51
2412,BioInfer.d237,True,These results suggest that RAD52 may modulate the catalytic activities of RAD51 protein such as homologous pairing and strand exchange through a direct physical interaction.,BioInfer.d237.s4,RAD52,RAD51
2413,BioInfer.d238,True,Here we demonstrate that accessory receptor triggering induces the transient association of cofilin with the actin cytoskeleton.,BioInfer.d238.s0,actin,cofilin
2414,BioInfer.d238,True,"Recently, we have shown that the small actin-depolymerizing protein cofilin represents a component of a co-stimulatory signaling pathway in human T cells.",BioInfer.d238.s1,cofilin,actin
2415,BioInfer.d238,True,These results suggest that cofilin provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the actin cytoskeleton.,BioInfer.d238.s2,actin,cofilin
2416,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,cyclin D3
2417,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,kinase
2418,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,cyclin-dependent kinase inhibitor
2419,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin E
2420,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,kinase
2421,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,kinase
2422,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin E
2423,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,p27
2424,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin D3,kinase
2425,BioInfer.d239,True,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,p27
2426,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,p27
2427,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,CDK2
2428,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,cyclin-dependent kinase inhibitor
2429,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,cyclin E
2430,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,CDK2
2431,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,cyclin E
2432,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK4,p27
2433,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,CDK2
2434,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,cyclin E
2435,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,CDK2
2436,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,cyclin D3
2437,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,cyclin E
2438,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,p27
2439,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,kinase
2440,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin-dependent kinase inhibitor
2441,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,CDK2
2442,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin D3
2443,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin E
2444,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,p27
2445,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,cyclin E
2446,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,CDK2
2447,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,cyclin D3
2448,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,cyclin E
2449,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,p27
2450,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin-dependent kinase inhibitor,kinase
2451,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,CDK2
2452,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,cyclin D3
2453,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,cyclin E
2454,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,p27
2455,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,cyclin D3
2456,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,CDK2,kinase
2457,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin D3,cyclin E
2458,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin D3,p27
2459,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,cyclin E,kinase
2460,BioInfer.d239,False,"Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the cyclin-dependent kinase inhibitor p27, enhanced association of p27 with cyclin E/CDK2 complexes and suppression of kinase activity associated to cyclin E/CDK2 (but not to cyclin D3/CDK4).",BioInfer.d239.s0,p27,kinase
2461,BioInfer.d240,True,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,type XIII collagen,talin
2462,BioInfer.d240,True,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,type XIII collagen,vinculin
2463,BioInfer.d240,True,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,type XIII collagen,actin
2464,BioInfer.d240,False,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,talin,vinculin
2465,BioInfer.d240,False,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,talin,actin
2466,BioInfer.d240,False,"Here we demonstrate that type XIII collagen is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of actin stress fibers, co-localizing with the known focal adhesion components talin and vinculin.",BioInfer.d240.s0,vinculin,actin
2467,BioInfer.d241,False,"Here, we describe proline-rich proteins involved in regulating actin polymerization and classify them according to their role in recruiting profilin to the membrane.",BioInfer.d241.s0,actin,profilin
2468,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,p55
2469,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,acid SMase
2470,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,A-SMase
2471,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,FADD,p55
2472,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,FADD,acid SMase
2473,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,FADD,A-SMase
2474,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF,acid SMase
2475,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF,A-SMase
2476,BioInfer.d242,True,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,p55,TNF receptor
2477,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,FADD
2478,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,TNF
2479,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TRADD,TNF receptor
2480,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,FADD,TNF
2481,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,FADD,TNF receptor
2482,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF,p55
2483,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF,TNF receptor
2484,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,p55,acid SMase
2485,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,p55,A-SMase
2486,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF receptor,acid SMase
2487,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,TNF receptor,A-SMase
2488,BioInfer.d242,False,Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.,BioInfer.d242.s0,acid SMase,A-SMase
2489,BioInfer.d242,True,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,TRADD,acid sphingomyelinase
2490,BioInfer.d242,True,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,TRADD,TNF receptor
2491,BioInfer.d242,True,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,acid sphingomyelinase,FADD
2492,BioInfer.d242,True,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,FADD,TNF receptor
2493,BioInfer.d242,False,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,TRADD,FADD
2494,BioInfer.d242,False,TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase.,BioInfer.d242.s1,acid sphingomyelinase,TNF receptor
2495,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,TEC1
2496,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,CDC39
2497,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,NAB1
2498,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,STE12
2499,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,CDC55
2500,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,WHI3
2501,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,TPM1
2502,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,DBR1
2503,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,BNI1
2504,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,DFG10
2505,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,DFG16
2506,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,DFG9
2507,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,SPA2
2508,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,SRV2
2509,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BUD8,DFG5
2510,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,CDC39
2511,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,NAB1
2512,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,STE12
2513,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,CDC55
2514,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,WHI3
2515,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,TPM1
2516,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,DBR1
2517,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,BNI1
2518,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,DFG10
2519,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,DFG16
2520,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,DFG9
2521,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,SPA2
2522,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,SRV2
2523,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TEC1,DFG5
2524,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,NAB1
2525,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,STE12
2526,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,CDC55
2527,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,WHI3
2528,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,TPM1
2529,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,DBR1
2530,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,BNI1
2531,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,DFG10
2532,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,DFG16
2533,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,DFG9
2534,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,SPA2
2535,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,SRV2
2536,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC39,DFG5
2537,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,STE12
2538,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,CDC55
2539,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,WHI3
2540,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,TPM1
2541,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,DBR1
2542,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,BNI1
2543,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,DFG10
2544,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,DFG16
2545,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,DFG9
2546,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,SPA2
2547,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,SRV2
2548,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,NAB1,DFG5
2549,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,CDC55
2550,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,WHI3
2551,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,TPM1
2552,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,DBR1
2553,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,BNI1
2554,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,DFG10
2555,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,DFG16
2556,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,DFG9
2557,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,SPA2
2558,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,SRV2
2559,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,STE12,DFG5
2560,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,WHI3
2561,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,TPM1
2562,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,DBR1
2563,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,BNI1
2564,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,DFG10
2565,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,DFG16
2566,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,DFG9
2567,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,SPA2
2568,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,SRV2
2569,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,CDC55,DFG5
2570,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,TPM1
2571,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,DBR1
2572,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,BNI1
2573,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,DFG10
2574,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,DFG16
2575,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,DFG9
2576,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,SPA2
2577,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,SRV2
2578,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,WHI3,DFG5
2579,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,DBR1
2580,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,BNI1
2581,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,DFG10
2582,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,DFG16
2583,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,DFG9
2584,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,SPA2
2585,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,SRV2
2586,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,TPM1,DFG5
2587,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,BNI1
2588,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,DFG10
2589,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,DFG16
2590,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,DFG9
2591,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,SPA2
2592,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,SRV2
2593,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DBR1,DFG5
2594,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,DFG10
2595,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,DFG16
2596,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,DFG9
2597,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,SPA2
2598,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,SRV2
2599,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,BNI1,DFG5
2600,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG10,DFG16
2601,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG10,DFG9
2602,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG10,SPA2
2603,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG10,SRV2
2604,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG10,DFG5
2605,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG16,DFG9
2606,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG16,SPA2
2607,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG16,SRV2
2608,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG16,DFG5
2609,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG9,SPA2
2610,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG9,SRV2
2611,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,DFG9,DFG5
2612,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,SPA2,SRV2
2613,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,SPA2,DFG5
2614,BioInfer.d243,False,"Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.",BioInfer.d243.s0,SRV2,DFG5
2615,BioInfer.d244,True,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,non-muscle myosin heavy chain,actin
2616,BioInfer.d244,False,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,non-muscle myosin heavy chain,myosin heavy chain
2617,BioInfer.d244,False,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,non-muscle myosin heavy chain,non-muscle myosin heavy chain
2618,BioInfer.d244,False,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,non-muscle myosin heavy chain,actin
2619,BioInfer.d244,False,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,myosin heavy chain,non-muscle myosin heavy chain
2620,BioInfer.d244,False,"Here, we have detected a polypeptide in rat rod outer segments that is recognized by myosin heavy chain antibodies and was found to possess other characteristics of conventional non-muscle myosin heavy chain: it comigrates in SDS-PAGE with non-muscle myosin heavy chain; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified actin filaments in the absence of ATP.",BioInfer.d244.s0,myosin heavy chain,actin
2621,BioInfer.d245,True,Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.,BioInfer.d245.s0,alpha-catenin,beta-catenin
2622,BioInfer.d245,True,Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.,BioInfer.d245.s0,alpha-catenin,plakoglobin
2623,BioInfer.d245,False,Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.,BioInfer.d245.s0,beta-catenin,plakoglobin
2624,BioInfer.d245,True,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,plakoglobin,alpha-catenin
2625,BioInfer.d245,True,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,plakoglobin,E-cadherin
2626,BioInfer.d245,True,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,alpha-catenin,beta-catenin
2627,BioInfer.d245,True,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,alpha-catenin,E-cadherin
2628,BioInfer.d245,True,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,beta-catenin,E-cadherin
2629,BioInfer.d245,False,"It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.",BioInfer.d245.s1,plakoglobin,beta-catenin
2630,BioInfer.d245,True,"Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.",BioInfer.d245.s2,alpha-catenin,beta-catenin
2631,BioInfer.d245,True,"Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.",BioInfer.d245.s2,alpha-catenin,plakoglobin
2632,BioInfer.d245,False,"Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.",BioInfer.d245.s2,beta-catenin,plakoglobin
2633,BioInfer.d246,True,"Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.",BioInfer.d246.s0,cofilin,actin-binding protein
2634,BioInfer.d246,True,"Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.",BioInfer.d246.s0,cofilin,actin
2635,BioInfer.d246,False,"Here we identify a pathway for the regulation of cofilin, a ubiquitous actin-binding protein that is essential for effective depolymerization of actin filaments.",BioInfer.d246.s0,actin-binding protein,actin
2636,BioInfer.d246,False,Our results define a mechanism for the regulation of cofilin and hence of actin dynamics in vivo.,BioInfer.d246.s1,actin,cofilin
2637,BioInfer.d246,True,"Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.",BioInfer.d246.s2,actin,cofilin
2638,BioInfer.d246,True,"Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.",BioInfer.d246.s2,actin,LIM-kinase 1
2639,BioInfer.d246,True,"Phosphorylation by LIM-kinase 1 inactivates cofilin, leading to accumulation of actin filaments.",BioInfer.d246.s2,cofilin,LIM-kinase 1
2640,BioInfer.d246,True,Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.,BioInfer.d246.s3,actin,cofilin
2641,BioInfer.d246,True,Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.,BioInfer.d246.s3,actin,LIM-kinase
2642,BioInfer.d246,True,Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase.,BioInfer.d246.s3,cofilin,LIM-kinase
2643,BioInfer.d247,True,"Here, we prepared a profilin mutant (H119E) defective in actin binding, but retaining the ability to bind to other proteins.",BioInfer.d247.s0,profilin H119E,actin
2644,BioInfer.d247,True,The essential role of profilin in the assembly of actin for microspike formation.,BioInfer.d247.s1,actin,profilin
2645,BioInfer.d247,True,These findings provide the first evidence that profilin is a key molecule linking a signaling network to rapid actin polymerization in microspike formation.,BioInfer.d247.s2,actin,profilin
2646,BioInfer.d247,True,"This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.",BioInfer.d247.s3,profilin I,N-WASP
2647,BioInfer.d247,True,"This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.",BioInfer.d247.s3,profilin I,actin
2648,BioInfer.d247,True,"This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.",BioInfer.d247.s3,N-WASP,actin
2649,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,E-cadherin,p120
2650,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,E-cadherin,alpha-catenin
2651,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,E-cadherin,plakoglobin
2652,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,E-cadherin,beta-catenin
2653,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,p120,alpha-catenin
2654,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,p120,plakoglobin
2655,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,p120,beta-catenin
2656,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,alpha-catenin,plakoglobin
2657,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,alpha-catenin,beta-catenin
2658,BioInfer.d248,True,"Here we report that p120 associates with a complex containing E-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d248.s0,plakoglobin,beta-catenin
2659,BioInfer.d249,True,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,H119E profilin I,actin
2660,BioInfer.d249,False,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,H119E profilin I,profilin
2661,BioInfer.d249,False,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,H119E profilin I,actin
2662,BioInfer.d249,False,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,profilin,actin
2663,BioInfer.d249,False,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,profilin,actin
2664,BioInfer.d249,False,"Here we report the functional importance of profilin in various actin-mediated morphological changes using H119E mutant profilin I, which is deficient only in actin binding.",BioInfer.d249.s0,actin,actin
2665,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,cdc12p,fus1
2666,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,cdc12p,actin
2667,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,cdc12p,BNI1
2668,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,cdc12p,diaphanous
2669,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,fus1,actin
2670,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,fus1,BNI1
2671,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,fus1,diaphanous
2672,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,actin,BNI1
2673,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,actin,diaphanous
2674,BioInfer.d250,False,"Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.",BioInfer.d250.s0,BNI1,diaphanous
2675,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,p300,histone
2676,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,p300,CREB-binding protein
2677,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,p300,CBP
2678,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,histone,CREB-binding protein
2679,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,histone,CBP
2680,BioInfer.d251,True,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,histone,EID-1
2681,BioInfer.d251,False,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,p300,EID-1
2682,BioInfer.d251,False,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,CREB-binding protein,CBP
2683,BioInfer.d251,False,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,CREB-binding protein,EID-1
2684,BioInfer.d251,False,"Here, we show that EID-1 is a potent inhibitor of differentiation and link this activity to its ability to inhibit p300 (and the highly related molecule, CREB-binding protein, or CBP) histone acetylation activity.",BioInfer.d251.s0,CBP,EID-1
2685,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,ActA
2686,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,Arp 3
2687,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,ActA
2688,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,Arp 3
2689,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,actin,ActA
2690,BioInfer.d252,True,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp 3,ActA
2691,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,Arp2
2692,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,Arp2
2693,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,actin
2694,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,Arp 3
2695,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,Arp 3
2696,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,profilin,WASp
2697,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,Arp2
2698,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,actin
2699,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,Arp 3
2700,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,WASp
2701,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,actin
2702,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,Arp 3
2703,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,WASp
2704,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp2,ActA
2705,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,actin,Arp 3
2706,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,actin,Arp 3
2707,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,actin,WASp
2708,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp 3,Arp 3
2709,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp 3,WASp
2710,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp 3,WASp
2711,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,Arp 3,ActA
2712,BioInfer.d252,False,"Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.",BioInfer.d252.s0,WASp,ActA
2713,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,rad57,RAD51
2714,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,rad57,rad55
2715,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,rad57,RAD52
2716,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,RAD51,rad55
2717,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,RAD51,RAD52
2718,BioInfer.d254,False,"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of RAD51 or RAD52.",BioInfer.d254.s0,rad55,RAD52
2719,BioInfer.d255,True,"alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.",BioInfer.d255.s0,syntaxin,alpha-SNAP
2720,BioInfer.d255,True,"alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.",BioInfer.d255.s0,syntaxin,SNAP-25
2721,BioInfer.d255,True,"alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.",BioInfer.d255.s0,alpha-SNAP,SNAP-25
2722,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,beta-catenin,E-cadherin
2723,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,beta-catenin,alpha-catenin
2724,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,beta-catenin,plakoglobin
2725,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,E-cadherin,alpha-catenin
2726,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,E-cadherin,plakoglobin
2727,BioInfer.d256,False,"Here, we sought to determine the spatial distributions of E-cadherin, alpha-catenin, beta-catenin, and plakoglobin, and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.",BioInfer.d256.s0,alpha-catenin,plakoglobin
2728,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,UL52,helicase-primase
2729,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,UL52,UL5
2730,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,UL52,UL8
2731,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,helicase-primase,UL5
2732,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,helicase-primase,UL8
2733,BioInfer.d257,True,"Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.",BioInfer.d257.s0,UL5,UL8
2734,BioInfer.d258,True,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,UL8,helicase-primase
2735,BioInfer.d258,True,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,UL5,helicase-primase
2736,BioInfer.d258,True,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,helicase-primase,UL52
2737,BioInfer.d258,False,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,UL8,UL5
2738,BioInfer.d258,False,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,UL8,UL52
2739,BioInfer.d258,False,"Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.",BioInfer.d258.s0,UL5,UL52
2740,BioInfer.d258,True,The interactions of the UL52 protein with the UL8 and UL5 proteins were analysed by using the yeast two-hybrid system.,BioInfer.d258.s1,UL5,UL52
2741,BioInfer.d258,True,The interactions of the UL52 protein with the UL8 and UL5 proteins were analysed by using the yeast two-hybrid system.,BioInfer.d258.s1,UL8,UL52
2742,BioInfer.d258,False,The interactions of the UL52 protein with the UL8 and UL5 proteins were analysed by using the yeast two-hybrid system.,BioInfer.d258.s1,UL5,UL8
2743,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,UL8,UL52
2744,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,UL8,helicase-primase
2745,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,UL8,UL5
2746,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,UL52,helicase-primase
2747,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,UL52,UL5
2748,BioInfer.d259,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).",BioInfer.d259.s0,helicase-primase,UL5
2749,BioInfer.d260,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,helicase-primase,UL8
2750,BioInfer.d260,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,helicase-primase,UL5
2751,BioInfer.d260,True,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,helicase-primase,UL52
2752,BioInfer.d260,False,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,UL8,UL5
2753,BioInfer.d260,False,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,UL8,UL52
2754,BioInfer.d260,False,"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.",BioInfer.d260.s0,UL5,UL52
2755,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,UL8,helicase-primase
2756,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,UL8,UL5
2757,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,UL8,UL52
2758,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,helicase-primase,UL5
2759,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,helicase-primase,UL52
2760,BioInfer.d261,True,"Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric helicase-primase composed of the products of the three DNA replication-specific genes UL5, UL8, and UL52 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).",BioInfer.d261.s0,UL5,UL52
2761,BioInfer.d262,True,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,alpha-catenin,E-cadherin
2762,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,SF,alpha-catenin
2763,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,SF,E-cadherin
2764,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,SF,HGF
2765,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,SF,beta-catenin
2766,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,alpha-catenin,HGF
2767,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,alpha-catenin,beta-catenin
2768,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,E-cadherin,HGF
2769,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,E-cadherin,beta-catenin
2770,BioInfer.d262,False,"HGF/SF treatment of LoVo reduced the amount of alpha-catenin complexed with E-cadherin more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of beta-catenin, suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.",BioInfer.d262.s0,HGF,beta-catenin
2771,BioInfer.d263,True,High levels of profilin suppress the lethality caused by overproduction of actin in yeast cells.,BioInfer.d263.s0,profilin,actin
2772,BioInfer.d263,True,"In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.",BioInfer.d263.s1,actin-binding protein,PFY1
2773,BioInfer.d263,True,"In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.",BioInfer.d263.s1,actin-binding protein,profilin
2774,BioInfer.d263,False,"In contrast, overexpression of the profilin gene, PFY1, encoding an actin-binding protein, leads to no very obvious phenotype.",BioInfer.d263.s1,PFY1,profilin
2775,BioInfer.d263,True,"Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.",BioInfer.d263.s2,actin,profilin
2776,BioInfer.d263,True,"Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.",BioInfer.d263.s2,actin,profilin
2777,BioInfer.d263,False,"Interestingly, profilin overproduction can compensate for the deleterious effects of too much actin in a profilin concentration-dependent manner.",BioInfer.d263.s2,profilin,profilin
2778,BioInfer.d264,True,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,H4
2779,BioInfer.d264,True,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,Histone,H3
2780,BioInfer.d264,True,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,H2B.1,histone
2781,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,Histone
2782,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,H2B.1
2783,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,histone
2784,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,H3
2785,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,Histone,H2B.1
2786,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,Histone,histone
2787,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,Histone,H4
2788,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,H2B.1,H4
2789,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,H2B.1,H3
2790,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,H4
2791,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,histone,H3
2792,BioInfer.d264,False,"Histone H3 showed at least seven sites of acetylation, histone H2B.1 had six sites and histone H4 had five sites.",BioInfer.d264.s0,H4,H3
2793,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,p27
2794,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,p27
2795,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Myc,Ras
2796,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Myc,cyclin E-dependent kinase
2797,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,cyclin E-dependent kinase
2798,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CDK,Ras
2799,BioInfer.d266,True,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,p27,cyclin E-dependent kinase
2800,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,CKI
2801,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,Myc
2802,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,Ras
2803,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,CDK
2804,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,Ras
2805,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,cyclin-dependent kinase inhibitor,cyclin E-dependent kinase
2806,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,Myc
2807,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,Ras
2808,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,CDK
2809,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,Ras
2810,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CKI,cyclin E-dependent kinase
2811,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Myc,CDK
2812,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Myc,Ras
2813,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Myc,p27
2814,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,CDK
2815,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,Ras
2816,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,p27
2817,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CDK,p27
2818,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,CDK,cyclin E-dependent kinase
2819,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,p27
2820,BioInfer.d266,False,"However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).",BioInfer.d266.s0,Ras,cyclin E-dependent kinase
2821,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,HHR23B
2822,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,p58
2823,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,HHR23A
2824,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23B,p58
2825,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23B,HHR23A
2826,BioInfer.d267,True,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,p58,HHR23A
2827,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,XPD
2828,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,ERCC1
2829,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,ERCC2
2830,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPC,RAD51
2831,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,HHR23B
2832,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,p58
2833,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,HHR23A
2834,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,ERCC1
2835,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,ERCC2
2836,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,XPD,RAD51
2837,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23B,ERCC1
2838,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23B,ERCC2
2839,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23B,RAD51
2840,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,p58,ERCC1
2841,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,p58,ERCC2
2842,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,p58,RAD51
2843,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23A,ERCC1
2844,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23A,ERCC2
2845,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,HHR23A,RAD51
2846,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,ERCC1,ERCC2
2847,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,ERCC1,RAD51
2848,BioInfer.d267,False,"However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include ERCC1, ERCC2 (XPD), mouse RAD51, and the HHR23B/p58 and HHR23A subunits of XPC.",BioInfer.d267.s0,ERCC2,RAD51
2849,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,HRR25,RAD52
2850,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,HRR25,RAD23
2851,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,HRR25,RAD51
2852,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,RAD52,RAD23
2853,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,RAD52,RAD51
2854,BioInfer.d267,False,NLS-less S.cerevisiae proteins include both RAD51 and RAD52 that function in the recombination and in the repair of double-strand breaks as well as the RAD23 and HRR25 molecules.,BioInfer.d267.s1,RAD23,RAD51
2855,BioInfer.d268,True,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,verprolin,actin
2856,BioInfer.d268,True,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,verprolin,actin
2857,BioInfer.d268,False,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,verprolin,verprolin
2858,BioInfer.d268,False,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,verprolin,actin
2859,BioInfer.d268,False,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,actin,verprolin
2860,BioInfer.d268,False,"However, disassembly of the actin cytoskeleton using Latrunculin-A does not alter verprolin's location, indicating that verprolin establishes and maintains its location independent of the actin cytoskeleton.",BioInfer.d268.s0,actin,actin
2861,BioInfer.d268,True,"Using the two-hybrid system, we show that verprolin binds actin.",BioInfer.d268.s1,verprolin,actin
2862,BioInfer.d269,False,"However, immunofluorescence staining revealed a similar organisation of actin microfilaments, talin and phosphotyrosyl-containing proteins on both substrates.",BioInfer.d269.s0,talin,actin
2863,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,actin,tropomyosin
2864,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,actin,vimentin
2865,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,actin,myosin heavy chain
2866,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,tropomyosin,vimentin
2867,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,tropomyosin,myosin heavy chain
2868,BioInfer.d270,False,"However, increases were also selective in nature, with increases in certain individual proteins, including actin (twofold to threefold), vimentin (2.5-fold to sevenfold), tropomyosin (threefold to sixfold), and myosin heavy chain, far exceeding overall increases in cellular protein content (20-40%).",BioInfer.d270.s0,vimentin,myosin heavy chain
2869,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle myosin heavy chain,muscle tropomyosin
2870,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle myosin heavy chain,muscle myogenin
2871,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle myosin heavy chain,muscle actin
2872,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle tropomyosin,muscle myogenin
2873,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle tropomyosin,muscle actin
2874,BioInfer.d272,False,"However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.",BioInfer.d272.s0,muscle myogenin,muscle actin
2875,BioInfer.d272,True,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,myogenin,tropomyosin
2876,BioInfer.d272,False,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,muscle actin,myogenin
2877,BioInfer.d272,False,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,muscle actin,myosin heavy chain
2878,BioInfer.d272,False,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,muscle actin,tropomyosin
2879,BioInfer.d272,False,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,myogenin,myosin heavy chain
2880,BioInfer.d272,False,These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.,BioInfer.d272.s1,myosin heavy chain,tropomyosin
2881,BioInfer.d274,True,"However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.",BioInfer.d274.s0,alpha-syntrophin,utrophin
2882,BioInfer.d274,False,"However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.",BioInfer.d274.s0,alpha-syntrophin,dystrophin
2883,BioInfer.d274,False,"However, similar to utrophin, alpha-syntrophin is only present at the neuromuscular junction in mdx mouse muscle in which dystrophin is absent.",BioInfer.d274.s0,dystrophin,utrophin
2884,BioInfer.d274,True,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,alpha-syntrophin,dystrophin
2885,BioInfer.d274,True,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,alpha-syntrophin,syntrophin triplet
2886,BioInfer.d274,True,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,alpha-syntrophin,utrophin
2887,BioInfer.d274,False,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,dystrophin,syntrophin triplet
2888,BioInfer.d274,False,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,dystrophin,utrophin
2889,BioInfer.d274,False,"Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.",BioInfer.d274.s1,syntrophin triplet,utrophin
2890,BioInfer.d275,False,"However, smooth muscle contents of actin (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and myosin heavy chain (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.",BioInfer.d275.s0,myosin heavy chain,actin
2891,BioInfer.d276,True,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,profilin,actin
2892,BioInfer.d276,True,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,profilin,actin
2893,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,profilin,actin
2894,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,profilin,actin
2895,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2896,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2897,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2898,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2899,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2900,BioInfer.d276,False,"However, some proteins (e.g., profilin) and other agents (e.g., cytochalasin D) that bind to actin are affected by the presence of fluorescent labels, making actin intrinsic fluorescence potentially useful in investigating the interaction of these agents with actin, and in validating data obtained using labeled actin.",BioInfer.d276.s0,actin,actin
2901,BioInfer.d278,True,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,actin,cofilin
2902,BioInfer.d278,True,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,cofilin,cofilin
2903,BioInfer.d278,False,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,actin,cofilin
2904,BioInfer.d278,False,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,actin,TSH
2905,BioInfer.d278,False,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,cofilin,TSH
2906,BioInfer.d278,False,"However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.",BioInfer.d278.s0,TSH,cofilin
2907,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,ADF,TSH
2908,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,ADF,actin
2909,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,TSH,actin
2910,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,TSH,destrin
2911,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,TSH,cofilin
2912,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,actin,destrin
2913,BioInfer.d278,True,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,actin,cofilin
2914,BioInfer.d278,False,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,ADF,destrin
2915,BioInfer.d278,False,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,ADF,cofilin
2916,BioInfer.d278,False,This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.,BioInfer.d278.s1,destrin,cofilin
2917,BioInfer.d279,True,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,cofilin,actin
2918,BioInfer.d279,False,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,cofilin,cofilin
2919,BioInfer.d279,False,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,cofilin,actin
2920,BioInfer.d279,False,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,cofilin,actin
2921,BioInfer.d279,False,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,cofilin,actin
2922,BioInfer.d279,False,"However, upon treatment with DMSO, cytoplasmic actin filaments were disrupted and intranuclear rod structures containing cofilin and actin were apparently larger and thicker in cells overexpressing cofilin than in normal cells.",BioInfer.d279.s0,actin,actin
2923,BioInfer.d279,True,"In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.",BioInfer.d279.s1,ADF,actin
2924,BioInfer.d279,True,"In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.",BioInfer.d279.s1,actin,cofilin
2925,BioInfer.d279,False,"In cultured cells, cofilin, as well as ADF, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.",BioInfer.d279.s1,ADF,cofilin
2926,BioInfer.d279,True,Stimulus-dependent disorganization of actin filaments induced by overexpression of cofilin in C2 myoblasts.,BioInfer.d279.s2,actin,cofilin
2927,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,beta-catenin,E-cadherin
2928,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,beta-catenin,gamma-catenin
2929,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,beta-catenin,alpha-catenin
2930,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,E-cadherin,gamma-catenin
2931,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,E-cadherin,alpha-catenin
2932,BioInfer.d280,False,"However, when all of the four proteins (E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.",BioInfer.d280.s0,gamma-catenin,alpha-catenin
2933,BioInfer.d280,False,"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.",BioInfer.d280.s1,beta-catenin,gamma-catenin
2934,BioInfer.d280,False,"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.",BioInfer.d280.s1,beta-catenin,alpha-catenin
2935,BioInfer.d280,False,"Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for alpha-catenin, in 50 (55.6 per cent) for beta-catenin, and in 50 (55.6 per cent) for gamma-catenin.",BioInfer.d280.s1,gamma-catenin,alpha-catenin
2936,BioInfer.d281,True,"Human profilins are multifunctional, single-domain proteins which directly link the actin microfilament system to a variety of signalling pathways via two spatially distinct binding sites.",BioInfer.d281.s0,actin,profilins
2937,BioInfer.d282,True,"Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.",BioInfer.d282.s0,actin binding protein,platelet P-235
2938,BioInfer.d282,True,"Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.",BioInfer.d282.s0,platelet P-235,talin
2939,BioInfer.d282,False,"Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.",BioInfer.d282.s0,actin binding protein,talin
2940,BioInfer.d283,True,"Human platelets contain profilin, a potential regulator of actin polymerisability.",BioInfer.d283.s0,actin,profilin
2941,BioInfer.d284,True,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Cas,Fyn
2942,BioInfer.d284,True,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,beta-catenin,Fyn
2943,BioInfer.d284,True,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,p120,Fyn
2944,BioInfer.d284,True,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Fyn,alpha-catenin
2945,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Cas,beta-catenin
2946,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Cas,p120
2947,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Cas,alpha-catenin
2948,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Cas,beta-catenin
2949,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,beta-catenin,p120
2950,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,beta-catenin,alpha-catenin
2951,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,beta-catenin,beta-catenin
2952,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,p120,alpha-catenin
2953,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,p120,beta-catenin
2954,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,Fyn,beta-catenin
2955,BioInfer.d284,False,"Hypertonicity provoked Fyn-dependent tyrosine phosphorylation in beta-catenin, alpha-catenin, and p120(Cas) and caused the dissociation of beta-catenin from the contacts.",BioInfer.d284.s0,alpha-catenin,beta-catenin
2956,BioInfer.d285,True,"Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.",BioInfer.d285.s0,beta-catenin,plakoglobin
2957,BioInfer.d285,True,"Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.",BioInfer.d285.s0,beta-catenin,E-cadherin
2958,BioInfer.d285,True,"Immediately after synthesis, E-cadherin, beta-catenin, and plakoglobin cosedimented as complexes.",BioInfer.d285.s0,plakoglobin,E-cadherin
2959,BioInfer.d285,True,"alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.",BioInfer.d285.s1,E-cadherin,alpha-catenin
2960,BioInfer.d285,False,"alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.",BioInfer.d285.s1,E-cadherin,alpha-Catenin
2961,BioInfer.d285,False,"alpha-Catenin was not associated with these complexes after synthesis, but a subpopulation of alpha-catenin joined the complex at a time coincident with the arrival of E-cadherin at the plasma membrane.",BioInfer.d285.s1,alpha-catenin,alpha-Catenin
2962,BioInfer.d287,False,Immunocytochemical localisation of actin and profilin in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).,BioInfer.d287.s0,actin,profilin
2963,BioInfer.d287,False,We attribute the detection of actin and profilin to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.,BioInfer.d287.s1,actin,profilin
2964,BioInfer.d288,True,"Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.",BioInfer.d288.s0,Abp1p,actin
2965,BioInfer.d288,True,"Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.",BioInfer.d288.s0,actin,cofilin
2966,BioInfer.d288,False,"Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.",BioInfer.d288.s0,Abp1p,cofilin
2967,BioInfer.d288,False,"In this study, we demonstrate using viscosity, sedimentation, and actin assembly rate assays that yeast cofilin (16 kD) possesses all of these properties.",BioInfer.d288.s1,cofilin,actin
2968,BioInfer.d288,True,"The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.",BioInfer.d288.s2,Abp1p,cofilin
2969,BioInfer.d288,True,"The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.",BioInfer.d288.s2,Abp1p,actin
2970,BioInfer.d288,False,"The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.",BioInfer.d288.s2,cofilin,actin
2971,BioInfer.d288,True,We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian actin binding protein cofilin.,BioInfer.d288.s3,actin binding protein,cofilin
2972,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,plakoglobin,beta-catenin
2973,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,plakoglobin,cadherin-5
2974,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,plakoglobin,alpha-catenin
2975,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,beta-catenin,cadherin-5
2976,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,beta-catenin,alpha-catenin
2977,BioInfer.d289,True,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,cadherin-5,alpha-catenin
2978,BioInfer.d289,False,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,TGF-beta1,plakoglobin
2979,BioInfer.d289,False,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,TGF-beta1,beta-catenin
2980,BioInfer.d289,False,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,TGF-beta1,cadherin-5
2981,BioInfer.d289,False,"Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.",BioInfer.d289.s0,TGF-beta1,alpha-catenin
2982,BioInfer.d291,False,Immunohistochemical identification and localization of actin and fimbrin in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.,BioInfer.d291.s0,actin,fimbrin
2983,BioInfer.d292,True,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,actin,paxillin
2984,BioInfer.d292,True,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,actin,talin
2985,BioInfer.d292,True,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,actin,vinculin
2986,BioInfer.d292,False,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,paxillin,talin
2987,BioInfer.d292,False,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,paxillin,vinculin
2988,BioInfer.d292,False,"Immunohistochemical investigation of actin-anchoring proteins vinculin, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.",BioInfer.d292.s0,talin,vinculin
2989,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,desmin,alpha-smooth muscle actin
2990,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,desmin,nonmuscle myosin heavy chain II-B
2991,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,desmin,smooth muscle myosin heavy chain
2992,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,alpha-smooth muscle actin,nonmuscle myosin heavy chain II-B
2993,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,alpha-smooth muscle actin,smooth muscle myosin heavy chain
2994,BioInfer.d293,False,Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.,BioInfer.d293.s0,nonmuscle myosin heavy chain II-B,smooth muscle myosin heavy chain
2995,BioInfer.d294,True,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,cytokeratins 10
2996,BioInfer.d294,True,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,cytokeratins 18
2997,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,cytokeratins 8
2998,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,S-100
2999,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,glial fibrillary acid protein
3000,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,EMA
3001,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,epithelial membrane antigen
3002,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,type IV collagen
3003,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,vimentin
3004,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,smooth muscle myosin heavy chain
3005,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,smooth muscle actin
3006,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,CD34
3007,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,cytokeratins 20
3008,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,cytokeratins 7
3009,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,calponin
3010,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,CKs
3011,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 1,cytokeratins 18
3012,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,S-100
3013,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,glial fibrillary acid protein
3014,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,EMA
3015,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,epithelial membrane antigen
3016,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,type IV collagen
3017,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,vimentin
3018,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,smooth muscle myosin heavy chain
3019,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,smooth muscle actin
3020,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,CD34
3021,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,cytokeratins 20
3022,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,cytokeratins 7
3023,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,calponin
3024,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,CKs
3025,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 8,cytokeratins 10
3026,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,glial fibrillary acid protein
3027,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,EMA
3028,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,epithelial membrane antigen
3029,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,type IV collagen
3030,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,vimentin
3031,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,smooth muscle myosin heavy chain
3032,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,smooth muscle actin
3033,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,CD34
3034,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,cytokeratins 20
3035,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,cytokeratins 7
3036,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,calponin
3037,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,CKs
3038,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,cytokeratins 10
3039,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,S-100,cytokeratins 18
3040,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,EMA
3041,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,epithelial membrane antigen
3042,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,type IV collagen
3043,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,vimentin
3044,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,smooth muscle myosin heavy chain
3045,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,smooth muscle actin
3046,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,CD34
3047,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,cytokeratins 20
3048,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,cytokeratins 7
3049,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,calponin
3050,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,CKs
3051,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,cytokeratins 10
3052,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,glial fibrillary acid protein,cytokeratins 18
3053,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,epithelial membrane antigen
3054,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,type IV collagen
3055,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,vimentin
3056,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,smooth muscle myosin heavy chain
3057,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,smooth muscle actin
3058,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,CD34
3059,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,cytokeratins 20
3060,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,cytokeratins 7
3061,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,calponin
3062,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,CKs
3063,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,cytokeratins 10
3064,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,EMA,cytokeratins 18
3065,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,type IV collagen
3066,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,vimentin
3067,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,smooth muscle myosin heavy chain
3068,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,smooth muscle actin
3069,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,CD34
3070,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,cytokeratins 20
3071,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,cytokeratins 7
3072,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,calponin
3073,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,CKs
3074,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,cytokeratins 10
3075,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,epithelial membrane antigen,cytokeratins 18
3076,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,vimentin
3077,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,smooth muscle myosin heavy chain
3078,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,smooth muscle actin
3079,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,CD34
3080,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,cytokeratins 20
3081,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,cytokeratins 7
3082,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,calponin
3083,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,CKs
3084,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,cytokeratins 10
3085,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,type IV collagen,cytokeratins 18
3086,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,smooth muscle myosin heavy chain
3087,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,smooth muscle actin
3088,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,CD34
3089,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,cytokeratins 20
3090,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,cytokeratins 7
3091,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,calponin
3092,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,CKs
3093,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,cytokeratins 10
3094,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,vimentin,cytokeratins 18
3095,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,smooth muscle actin
3096,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,CD34
3097,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,cytokeratins 20
3098,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,cytokeratins 7
3099,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,calponin
3100,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,CKs
3101,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,cytokeratins 10
3102,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle myosin heavy chain,cytokeratins 18
3103,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,CD34
3104,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,cytokeratins 20
3105,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,cytokeratins 7
3106,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,calponin
3107,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,CKs
3108,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,cytokeratins 10
3109,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,smooth muscle actin,cytokeratins 18
3110,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,cytokeratins 20
3111,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,cytokeratins 7
3112,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,calponin
3113,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,CKs
3114,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,cytokeratins 10
3115,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CD34,cytokeratins 18
3116,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 20,cytokeratins 7
3117,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 20,calponin
3118,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 20,CKs
3119,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 20,cytokeratins 10
3120,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 20,cytokeratins 18
3121,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 7,calponin
3122,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 7,CKs
3123,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 7,cytokeratins 10
3124,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 7,cytokeratins 18
3125,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,calponin,CKs
3126,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,calponin,cytokeratins 10
3127,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,calponin,cytokeratins 18
3128,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CKs,cytokeratins 10
3129,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,CKs,cytokeratins 18
3130,BioInfer.d294,False,"Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.",BioInfer.d294.s0,cytokeratins 10,cytokeratins 18
3131,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,alpha-smooth muscle actin,vimentin
3132,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,alpha-smooth muscle actin,smooth muscle myosin heavy chain
3133,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,alpha-smooth muscle actin,desmin
3134,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,vimentin,smooth muscle myosin heavy chain
3135,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,vimentin,desmin
3136,BioInfer.d295,False,"Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to alpha-smooth muscle actin, smooth muscle myosin heavy chain and vimentin (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to desmin ('-' and '+').",BioInfer.d295.s0,smooth muscle myosin heavy chain,desmin
3137,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,beta-catenin,E-cadherin
3138,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,beta-catenin,E-cad
3139,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,beta-catenin,alpha-catenin
3140,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,beta-catenin,CD44
3141,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,E-cadherin,E-cad
3142,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,E-cadherin,alpha-catenin
3143,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,E-cadherin,CD44
3144,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,E-cad,alpha-catenin
3145,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,E-cad,CD44
3146,BioInfer.d296,False,"Immunolocalization of E-cadherin (E-cad), alpha-catenin, beta-catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC).",BioInfer.d296.s0,alpha-catenin,CD44
3147,BioInfer.d296,False,"In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.",BioInfer.d296.s1,E-cad,beta-catenin
3148,BioInfer.d296,False,"In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.",BioInfer.d296.s1,E-cad,alpha-catenin
3149,BioInfer.d296,False,"In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.",BioInfer.d296.s1,beta-catenin,alpha-catenin
3150,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,CD44s
3151,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,CD44v10
3152,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,CD44v6
3153,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,E-cad
3154,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,CD44v5
3155,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,alpha-catenin
3156,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,beta-catenin,CD44v7-8
3157,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,E-cad
3158,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,alpha-catenin
3159,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v10,E-cad
3160,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v10,alpha-catenin
3161,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v6,E-cad
3162,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v6,alpha-catenin
3163,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,E-cad,CD44v5
3164,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,E-cad,alpha-catenin
3165,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,E-cad,CD44v7-8
3166,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v5,alpha-catenin
3167,BioInfer.d296,True,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,alpha-catenin,CD44v7-8
3168,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,CD44v10
3169,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,CD44v6
3170,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,CD44v5
3171,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44s,CD44v7-8
3172,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v10,CD44v6
3173,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v10,CD44v5
3174,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v10,CD44v7-8
3175,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v6,CD44v5
3176,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v6,CD44v7-8
3177,BioInfer.d296,False,"In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.",BioInfer.d296.s2,CD44v5,CD44v7-8
3178,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,c-erbB2
3179,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,c-erbB2
3180,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,p53
3181,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,c-erbB2
3182,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,p53
3183,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,alpha-catenin
3184,BioInfer.d296,True,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,p53,alpha-catenin
3185,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,E-cad
3186,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,beta-catenin
3187,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,c-erbB2
3188,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,p53
3189,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,alpha-catenin
3190,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,Ki-67
3191,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,beta-catenin
3192,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,c-erbB2
3193,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,alpha-catenin
3194,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,E-cad,Ki-67
3195,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,c-erbB2
3196,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,alpha-catenin
3197,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,beta-catenin,Ki-67
3198,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,p53
3199,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,c-erbB2
3200,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,Ki-67
3201,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,p53,c-erbB2
3202,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,p53,Ki-67
3203,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,alpha-catenin
3204,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,c-erbB2,Ki-67
3205,BioInfer.d296,False,"We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.",BioInfer.d296.s3,alpha-catenin,Ki-67
3206,BioInfer.d297,False,"Immunoprecipitation of alpha-catenin was increased in response to both doses of CdCl2, while the immunoprecipitation of beta-catenin was little changed by either cadmium dose.",BioInfer.d297.s0,alpha-catenin,beta-catenin
3207,BioInfer.d298,True,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,HECD-1
3208,BioInfer.d298,True,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,HECD-1,E-cadherin
3209,BioInfer.d298,True,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,HECD-1,alpha-catenin
3210,BioInfer.d298,True,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,HECD-1,gamma-catenin
3211,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,beta-catenin
3212,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,E-cadherin
3213,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,alpha-catenin
3214,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,gamma-catenin
3215,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,HECD-1
3216,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,E-cadherin
3217,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,alpha-catenin
3218,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,beta-catenin,gamma-catenin
3219,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,E-cadherin,alpha-catenin
3220,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,E-cadherin,gamma-catenin
3221,BioInfer.d298,False,"Immunoprecipitation of metabolically labeled proteins with HECD-1 revealed three bands corresponding to E-cadherin, alpha-catenin, and gamma-catenin and a 79-kDa band which was apparently smaller than that of normal beta-catenin, indicating truncated beta-catenin.",BioInfer.d298.s0,alpha-catenin,gamma-catenin
3222,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,E-cadherin
3223,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,alpha-catenin
3224,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,E-cadherin
3225,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,plakoglobin
3226,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,alpha-catenin
3227,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,plakoglobin,alpha-catenin
3228,BioInfer.d299,True,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,alpha-catenin
3229,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,catenin
3230,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,E-cadherin
3231,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,E-cadherin
3232,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,plakoglobin
3233,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,beta-catenin,alpha-catenin
3234,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,E-cadherin
3235,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,plakoglobin
3236,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,alpha-catenin
3237,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,E-cadherin
3238,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,catenin,alpha-catenin
3239,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,E-cadherin
3240,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,plakoglobin
3241,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,alpha-catenin
3242,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,E-cadherin
3243,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,alpha-catenin
3244,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,E-cadherin
3245,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,E-cadherin,alpha-catenin
3246,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,plakoglobin,E-cadherin
3247,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,plakoglobin,alpha-catenin
3248,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,alpha-catenin,E-cadherin
3249,BioInfer.d299,False,"Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d299.s0,alpha-catenin,alpha-catenin
3250,BioInfer.d300,True,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,E-cadherin,catenins
3251,BioInfer.d300,True,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,alpha-catenin,E-cadherin
3252,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,E-cadherin,beta-catenin
3253,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,E-cadherin,alpha-catenin
3254,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,E-cadherin,alpha- catenin
3255,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,E-cadherin,E-cadherin
3256,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,beta-catenin,alpha-catenin
3257,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,beta-catenin,alpha- catenin
3258,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,beta-catenin,catenins
3259,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,beta-catenin,E-cadherin
3260,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,alpha-catenin,alpha- catenin
3261,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,alpha-catenin,catenins
3262,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,alpha- catenin,catenins
3263,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,alpha- catenin,E-cadherin
3264,BioInfer.d300,False,"Immunoprecipitation with an E-cadherin mAb, which is known to co-precipitate the catenins, demonstrated that the three poorly differentiated cell lines expressing E-cadherin did not co-precipitate alpha-catenin, although all of the moderately-well differentiated cell lines expressed both alpha- and beta-catenin.",BioInfer.d300.s0,catenins,E-cadherin
3265,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,E-cadherin,beta-catenin
3266,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,E-cadherin,alpha-catenin
3267,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,E-cadherin,gamma-catenin
3268,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,beta-catenin,alpha-catenin
3269,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,beta-catenin,gamma-catenin
3270,BioInfer.d301,False,"Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.",BioInfer.d301.s0,alpha-catenin,gamma-catenin
3271,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,alpha-catenin,pan-cadherin
3272,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,alpha-catenin,p120
3273,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,alpha-catenin,E-cadherin
3274,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,alpha-catenin,beta-catenin
3275,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,pan-cadherin,p120
3276,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,pan-cadherin,E-cadherin
3277,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,pan-cadherin,beta-catenin
3278,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,p120,E-cadherin
3279,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,p120,beta-catenin
3280,BioInfer.d302,False,"Immunoreactivity for pan-cadherin, E-cadherin, alpha-catenin, beta-catenin, and p120 was observed in all 15 specimens.",BioInfer.d302.s0,E-cadherin,beta-catenin
3281,BioInfer.d304,True,Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.,BioInfer.d304.s0,profilin,actin
3282,BioInfer.d304,False,Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.,BioInfer.d304.s0,profilin,actin
3283,BioInfer.d304,False,Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.,BioInfer.d304.s0,actin,actin
3284,BioInfer.d305,True,"In 50 mM KCl, high concentrations of Acanthamoeba profilin inhibit the elongation rate of muscle actin filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.",BioInfer.d305.s0,profilin,muscle actin
3285,BioInfer.d306,True,"In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.",BioInfer.d306.s0,profilin,actin
3286,BioInfer.d306,True,"In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.",BioInfer.d306.s0,profilin,actin
3287,BioInfer.d306,False,"In a blot overlay experiment, purified 125I-labeled recombinant profilin bound not only to plant actin, but also to mammalian actin, demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.",BioInfer.d306.s0,actin,actin
3288,BioInfer.d307,True,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,capping protein,actin
3289,BioInfer.d307,True,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,actin,profilin
3290,BioInfer.d307,True,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,profilin,actin
3291,BioInfer.d307,False,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,capping protein,actin
3292,BioInfer.d307,False,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,capping protein,profilin
3293,BioInfer.d307,False,"In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.",BioInfer.d307.s0,actin,actin
3294,BioInfer.d308,True,"In Acanthamoeba, the two isoforms of profilin may have specialized functions on the basis of their identical (approximately 10 microM) affinities for actin monomers and different affinities for PIP2.",BioInfer.d308.s0,actin,profilin
3295,BioInfer.d309,True,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,INK4A,cyclin-dependent kinase inhibitor
3296,BioInfer.d309,True,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,INK4A,Rb
3297,BioInfer.d309,True,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,cyclin D1,Rb
3298,BioInfer.d309,True,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,cyclin-dependent kinase inhibitor,p16
3299,BioInfer.d309,True,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,p16,Rb
3300,BioInfer.d309,False,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,INK4A,cyclin D1
3301,BioInfer.d309,False,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,INK4A,p16
3302,BioInfer.d309,False,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,cyclin D1,cyclin-dependent kinase inhibitor
3303,BioInfer.d309,False,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,cyclin D1,p16
3304,BioInfer.d309,False,Inactivation of the Rb pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the cyclin-dependent kinase inhibitor p16(INK4A) and/or up-regulation of cyclin D1.,BioInfer.d309.s0,cyclin-dependent kinase inhibitor,Rb
3305,BioInfer.d311,False,"In addition to their role in mismatch repair (MMR), the MSH2 and MSH3 gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.",BioInfer.d311.s0,MSH2,MSH3
3306,BioInfer.d312,True,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,myosin heavy chain,TNF-alpha
3307,BioInfer.d312,True,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,actin,TNF-alpha
3308,BioInfer.d312,False,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,myosin heavy chain,actin
3309,BioInfer.d312,False,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,myosin heavy chain,TNF-alpha
3310,BioInfer.d312,False,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,actin,TNF-alpha
3311,BioInfer.d312,False,"In addition to the TNF-alpha-induced increase in the general protein synthesis, stimulation with TNF-alpha led to a 2.4-fold increase in net actin protein synthesis and a 3.3-fold increase in net myosin heavy chain synthesis.",BioInfer.d312.s0,TNF-alpha,TNF-alpha
3312,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,H4
3313,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,H3,EF-1alpha
3314,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,H3,HRG
3315,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,H3,histone
3316,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,EF-1alpha,HRG
3317,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,EF-1alpha,H4
3318,BioInfer.d313,True,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,HRG,H4
3319,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,H3
3320,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,EF-1alpha
3321,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,HRG
3322,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,histone
3323,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,H3,H4
3324,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,EF-1alpha,histone
3325,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,HRG,histone
3326,BioInfer.d313,False,"In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.",BioInfer.d313.s0,histone,H4
3327,BioInfer.d314,True,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,actin,cofilin
3328,BioInfer.d314,True,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,cofilin,actin
3329,BioInfer.d314,True,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,actin,gelsolin
3330,BioInfer.d314,False,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,actin,actin
3331,BioInfer.d314,False,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,actin,gelsolin
3332,BioInfer.d314,False,"In addition, we demonstrate that cofilin and its actin binding peptide compete with gelsolin segments 2-3 for binding to actin filaments.",BioInfer.d314.s0,cofilin,gelsolin
3333,BioInfer.d315,True,"In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.",BioInfer.d315.s0,SIR4,rap1
3334,BioInfer.d315,True,"In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.",BioInfer.d315.s0,rap1,SIR1
3335,BioInfer.d315,False,"In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.",BioInfer.d315.s0,SIR4,SIR1
3336,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,myogenin
3337,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,sarcomeric actin
3338,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,Myf-5
3339,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,nestin
3340,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,myosin heavy chain
3341,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,MyoD
3342,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,desmin
3343,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,Myf-5
3344,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,sarcomeric actin
3345,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,Myf-5
3346,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,nestin
3347,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,myosin heavy chain
3348,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,MyoD
3349,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,desmin
3350,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myogenin,Myf-5
3351,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,Myf-5
3352,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,nestin
3353,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,myosin heavy chain
3354,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,MyoD
3355,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,desmin
3356,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,sarcomeric actin,Myf-5
3357,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,Myf-5,nestin
3358,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,Myf-5,myosin heavy chain
3359,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,Myf-5,MyoD
3360,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,Myf-5,desmin
3361,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,Myf-5,Myf-5
3362,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,nestin,myosin heavy chain
3363,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,nestin,MyoD
3364,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,nestin,desmin
3365,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,nestin,Myf-5
3366,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myosin heavy chain,MyoD
3367,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myosin heavy chain,desmin
3368,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,myosin heavy chain,Myf-5
3369,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,desmin
3370,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,MyoD,Myf-5
3371,BioInfer.d316,False,"In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.",BioInfer.d316.s0,desmin,Myf-5
3372,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,c-Jun N-terminal kinase,stress-activated protein kinase
3373,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,c-Jun N-terminal kinase,AP-1
3374,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,c-Jun N-terminal kinase,JNK
3375,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,c-Jun N-terminal kinase,SAPK
3376,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,stress-activated protein kinase,AP-1
3377,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,stress-activated protein kinase,JNK
3378,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,stress-activated protein kinase,SAPK
3379,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,AP-1,JNK
3380,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,AP-1,SAPK
3381,BioInfer.d317,False,"In addition, we report that radiation induced transient activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activation and the transcription factor, AP-1.",BioInfer.d317.s0,JNK,SAPK
3382,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP9,TFIIIC
3383,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP9,PRP21
3384,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,TFIIIC,PRP21
3385,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,TFIIIC,PRP11
3386,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,TFIIIC,PRP21
3387,BioInfer.d319,True,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP21,PRP11
3388,BioInfer.d319,False,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP9,PRP21
3389,BioInfer.d319,False,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP9,PRP11
3390,BioInfer.d319,False,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP21,PRP21
3391,BioInfer.d319,False,"In a model system, the interacting proteins recruiting TFIIIC to DNA were PRP21 and PRP9 or PRP21 and PRP11.",BioInfer.d319.s0,PRP11,PRP21
3392,BioInfer.d320,True,"In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.",BioInfer.d320.s0,fimbrin,actin
3393,BioInfer.d320,True,"In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.",BioInfer.d320.s0,villin,actin
3394,BioInfer.d320,False,"In brush cells, villin and fimbrin are not only present in the actin filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.",BioInfer.d320.s0,fimbrin,villin
3395,BioInfer.d320,True,"In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.",BioInfer.d320.s1,villin,actin
3396,BioInfer.d320,True,"In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.",BioInfer.d320.s1,actin,fimbrin
3397,BioInfer.d320,False,"In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against villin and fimbrin, two proteins that crosslink actin filaments to form bundles.",BioInfer.d320.s1,villin,fimbrin
3398,BioInfer.d321,False,"In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).",BioInfer.d321.s0,E-cadherin,alpha-catenin
3399,BioInfer.d321,False,"In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).",BioInfer.d321.s0,E-cadherin,beta-catenin
3400,BioInfer.d321,False,"In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).",BioInfer.d321.s0,alpha-catenin,beta-catenin
3401,BioInfer.d321,False,"In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.",BioInfer.d321.s1,beta-catenin,alpha-catenin
3402,BioInfer.d321,False,"In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.",BioInfer.d321.s1,beta-catenin,E-cadherin
3403,BioInfer.d321,False,"In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.",BioInfer.d321.s1,alpha-catenin,E-cadherin
3404,BioInfer.d322,True,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,WAF1
3405,BioInfer.d322,True,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,CIP1
3406,BioInfer.d322,True,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,p21
3407,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,proliferating cell nuclear antigen
3408,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,DNA polymerase delta
3409,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,cyclin-dependent kinase inhibitor,Pol
3410,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,WAF1,proliferating cell nuclear antigen
3411,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,WAF1,CIP1
3412,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,WAF1,p21
3413,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,WAF1,DNA polymerase delta
3414,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,WAF1,Pol
3415,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,proliferating cell nuclear antigen,CIP1
3416,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,proliferating cell nuclear antigen,p21
3417,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,proliferating cell nuclear antigen,DNA polymerase delta
3418,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,proliferating cell nuclear antigen,Pol
3419,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,CIP1,p21
3420,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,CIP1,DNA polymerase delta
3421,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,CIP1,Pol
3422,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,p21,DNA polymerase delta
3423,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,p21,Pol
3424,BioInfer.d322,False,"In cell extracts, we found that complementary strand synthesis was inhibited by the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and rescued by the addition of proliferating cell nuclear antigen, arguing for the involvement of DNA polymerase (Pol) delta in the conversion reaction.",BioInfer.d322.s0,DNA polymerase delta,Pol
3425,BioInfer.d323,False,"In cells lacking the myosin-II heavy chain, the bundles, which were induced by an over-expression of cofilin, shortened and became straight following hyperosmotic stress, forming a polygonal structure.",BioInfer.d323.s0,myosin-II heavy chain,cofilin
3426,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,tropomyosin,act1-159
3427,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,tropomyosin,actin
3428,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,Mdm20p,act1-159
3429,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,Mdm20p,actin
3430,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,fimbrin,act1-159
3431,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,fimbrin,actin
3432,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,act1-159,tropomyosin
3433,BioInfer.d324,True,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,actin,tropomyosin
3434,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,tropomyosin,Mdm20p
3435,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,tropomyosin,fimbrin
3436,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,tropomyosin,tropomyosin
3437,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,Mdm20p,fimbrin
3438,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,Mdm20p,tropomyosin
3439,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,fimbrin,tropomyosin
3440,BioInfer.d324,False,"In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.",BioInfer.d324.s0,act1-159,actin
3441,BioInfer.d325,True,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,talin,actin
3442,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,lymphocyte talin,platelet talin
3443,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,lymphocyte talin,talin
3444,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,lymphocyte talin,actin
3445,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,lymphocyte talin,gizzard talin
3446,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,platelet talin,talin
3447,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,platelet talin,actin
3448,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,platelet talin,gizzard talin
3449,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,talin,gizzard talin
3450,BioInfer.d325,False,"In contrast, talin, another putative actin-membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken gizzard talin, which reacted with human platelet and lymphocyte talin.",BioInfer.d325.s0,actin,gizzard talin
3451,BioInfer.d327,False,"In contrast, the RAD51 and RAD52 genes are essential for homothallic mating-type switching.",BioInfer.d327.s0,RAD52,RAD51
3452,BioInfer.d329,True,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,utrophin
3453,BioInfer.d329,True,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,fimbrin,actin
3454,BioInfer.d329,True,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,utrophin
3455,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,fimbrin
3456,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,actin
3457,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,actin
3458,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,fimbrin,actin
3459,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,fimbrin,utrophin
3460,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,actin,actin
3461,BioInfer.d329,False,"In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.",BioInfer.d329.s0,utrophin,actin
3462,BioInfer.d330,True,"In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.",BioInfer.d330.s0,profilin,N-WASP Deltap
3463,BioInfer.d330,False,"In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.",BioInfer.d330.s0,actin,profilin
3464,BioInfer.d330,False,"In COS-7 cells overexpressing a N-WASP mutant lacking the proline-rich domain (Deltap) unable to interact with profilin, the actin tail formation of intracellular Shigella was inhibited.",BioInfer.d330.s0,actin,N-WASP Deltap
3465,BioInfer.d331,True,Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.,BioInfer.d331.s0,talin,beta1D integrin
3466,BioInfer.d331,True,Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.,BioInfer.d331.s0,talin,actin
3467,BioInfer.d331,True,Increased interaction of beta1D integrin with the actin cytoskeleton is consistent with and might be mediated by its enhanced binding to talin.,BioInfer.d331.s0,beta1D integrin,actin
3468,BioInfer.d332,True,"Increasing the ionic strength within a relatively narrow range significantly decreased ability of talin to bind to actin, regardless of pH.",BioInfer.d332.s0,talin,actin
3469,BioInfer.d332,True,Interaction of talin with actin: sensitive modulation of filament crosslinking activity.,BioInfer.d332.s1,talin,actin
3470,BioInfer.d333,True,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,sarcomeric actin,EGF
3471,BioInfer.d333,True,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,SMHC,EGF
3472,BioInfer.d333,True,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,EGF,sarcomeric myosin heavy chain
3473,BioInfer.d333,False,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,sarcomeric actin,SMHC
3474,BioInfer.d333,False,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,sarcomeric actin,sarcomeric myosin heavy chain
3475,BioInfer.d333,False,"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.",BioInfer.d333.s0,SMHC,sarcomeric myosin heavy chain
3476,BioInfer.d334,False,"In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.",BioInfer.d334.s0,actin,profilin I
3477,BioInfer.d334,False,"In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.",BioInfer.d334.s0,actin,profilin II
3478,BioInfer.d334,False,"In extracts from mouse brain, profilin I and profilin II can form complexes with regulators of endocytosis, synaptic vesicle recycling and actin assembly.",BioInfer.d334.s0,profilin I,profilin II
3479,BioInfer.d334,False,In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.,BioInfer.d334.s1,profilin II,actin
3480,BioInfer.d334,False,In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.,BioInfer.d334.s1,profilin II,profilin I
3481,BioInfer.d334,False,In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly.,BioInfer.d334.s1,actin,profilin I
3482,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,actin
3483,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,profilin II
3484,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,profilin I
3485,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,clathrin,actin
3486,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,clathrin,profilin II
3487,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,clathrin,profilin I
3488,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,profilin II
3489,BioInfer.d334,True,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,profilin I
3490,BioInfer.d334,False,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,actin,clathrin
3491,BioInfer.d334,False,"Our findings strongly suggest that in brain profilin I and profilin II complexes link the actin cytoskeleton and endocytic membrane flow, directing actin and clathrin assembly to distinct membrane domains.",BioInfer.d334.s2,profilin II,profilin I
3492,BioInfer.d335,True,"In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.",BioInfer.d335.s0,actin,cofilin
3493,BioInfer.d335,True,"In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.",BioInfer.d335.s0,cofilin,actin
3494,BioInfer.d335,False,"In flattened cells under starvation stress, cofilin localized at dramatically reorganizing actin-cytoskeletons in ruffling membranes of the leading edge, but not at rigid actin meshwork in focal adhesion plaques.",BioInfer.d335.s0,actin,actin
3495,BioInfer.d335,True,These results suggest that cofilin may be involved in dynamic reorganization of membranous actin cytoskeletons.,BioInfer.d335.s1,actin,cofilin
3496,BioInfer.d336,False,"In growth cones, myosin heavy chain B was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, actin-rich peripheral region.",BioInfer.d336.s0,myosin heavy chain B,actin
3497,BioInfer.d336,True,Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.,BioInfer.d336.s1,actin,Myosin heavy chain A
3498,BioInfer.d336,True,Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.,BioInfer.d336.s1,actin,myosin heavy chain B
3499,BioInfer.d336,False,Myosin heavy chain A staining was dimmer and its colocalization with filamentous actin bundles in growth cones was less striking than that of myosin heavy chain B.,BioInfer.d336.s1,Myosin heavy chain A,myosin heavy chain B
3500,BioInfer.d337,False,"Inhibition of 12P-CRE binding was also observed in the presence of an antibody to CREB-binding protein (265-kDa CBP), an integrator and coactivator of cAMP-responsive genes.",BioInfer.d337.s0,CREB-binding protein,CBP
3501,BioInfer.d338,True,Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.,BioInfer.d338.s0,actin,cofilin
3502,BioInfer.d338,False,Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.,BioInfer.d338.s0,actin,actin
3503,BioInfer.d338,False,Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.,BioInfer.d338.s0,actin,cofilin
3504,BioInfer.d339,True,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,profilin,actin
3505,BioInfer.d339,True,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,profilin,skeletal muscle actin
3506,BioInfer.d339,False,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,profilin,profilin
3507,BioInfer.d339,False,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,profilin,skeletal muscle actin
3508,BioInfer.d339,False,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,actin,profilin
3509,BioInfer.d339,False,"Inhibition of actin polymerization in KCl was stronger than that of the parental profilin, and the Kd value of its interaction with rabbit skeletal muscle actin, as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine profilin).",BioInfer.d339.s0,actin,skeletal muscle actin
3510,BioInfer.d340,True,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,actomyosin,ATPase
3511,BioInfer.d340,True,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,actomyosin,myosin heavy chain
3512,BioInfer.d340,True,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,actin,myosin heavy chain
3513,BioInfer.d340,False,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,actomyosin,actin
3514,BioInfer.d340,False,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,actin,ATPase
3515,BioInfer.d340,False,Inhibition of actomyosin subfragment 1 ATPase activity by analog peptides of the actin-binding site around the Cys(SH1) of myosin heavy chain.,BioInfer.d340.s0,ATPase,myosin heavy chain
3516,BioInfer.d342,True,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,cofilin,actin
3517,BioInfer.d342,True,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,deoxyribonuclease I,actin
3518,BioInfer.d342,True,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,actin,destrin
3519,BioInfer.d342,False,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,cofilin,deoxyribonuclease I
3520,BioInfer.d342,False,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,cofilin,destrin
3521,BioInfer.d342,False,"Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.",BioInfer.d342.s0,deoxyribonuclease I,destrin
3522,BioInfer.d343,True,"In higher plants, a large number of isoforms for the actin monomer-binding protein profilin have been identified, whereas other organisms express only few profilins.",BioInfer.d343.s0,actin,profilin
3523,BioInfer.d343,False,"In higher plants, a large number of isoforms for the actin monomer-binding protein profilin have been identified, whereas other organisms express only few profilins.",BioInfer.d343.s0,actin,profilins
3524,BioInfer.d343,False,"In higher plants, a large number of isoforms for the actin monomer-binding protein profilin have been identified, whereas other organisms express only few profilins.",BioInfer.d343.s0,profilins,profilin
3525,BioInfer.d346,False,"In isolated hearts, PD 81,723 alone produced only a small stimulus to His bundle (S-H) interval prolongation of 1.5 to 4 msec, which was completely reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase.",BioInfer.d346.s0,adenosine deaminase,A1 adenosine receptor
3526,BioInfer.d347,False,"In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.",BioInfer.d347.s0,profilin,epidermal growth factor
3527,BioInfer.d347,False,"In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.",BioInfer.d347.s0,profilin,actin
3528,BioInfer.d347,False,"In localization studies with mammalian cells, all fusion proteins showed the localization expected for profilin in areas of high actin dynamics, such as leading lamellae and ruffles induced by epidermal growth factor.",BioInfer.d347.s0,epidermal growth factor,actin
3529,BioInfer.d348,True,"In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.",BioInfer.d348.s0,actin,cofilin
3530,BioInfer.d348,False,"In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.",BioInfer.d348.s0,actin,cofilin
3531,BioInfer.d348,False,"In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.",BioInfer.d348.s0,cofilin,cofilin
3532,BioInfer.d348,True,"The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.",BioInfer.d348.s1,cofilin,actin
3533,BioInfer.d348,True,"The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.",BioInfer.d348.s1,ADF,actin
3534,BioInfer.d348,False,"The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.",BioInfer.d348.s1,cofilin,ADF
3535,BioInfer.d348,True,These results suggest that the subcellular distribution of cofilin as well as its interaction with actin in vivo is regulated by its phosphorylation and dephosphorylation.,BioInfer.d348.s2,actin,cofilin
3536,BioInfer.d350,True,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin dependent kinase inhibitor,p27
3537,BioInfer.d350,False,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin dependent kinase inhibitor,cyclin D1
3538,BioInfer.d350,False,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin dependent kinase inhibitor,cyclin D1
3539,BioInfer.d350,False,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin D1,cyclin D1
3540,BioInfer.d350,False,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin D1,p27
3541,BioInfer.d350,False,"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.",BioInfer.d350.s0,cyclin D1,p27
3542,BioInfer.d351,True,"In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.",BioInfer.d351.s0,fimbrin,actin
3543,BioInfer.d351,True,"In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.",BioInfer.d351.s0,actin,villin
3544,BioInfer.d351,False,"In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.",BioInfer.d351.s0,fimbrin,villin
3545,BioInfer.d352,True,"In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.",BioInfer.d352.s0,actin,beta2 integrins
3546,BioInfer.d352,True,"In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.",BioInfer.d352.s0,actin,talin
3547,BioInfer.d352,True,"In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.",BioInfer.d352.s0,beta2 integrins,talin
3548,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD54,RAD51
3549,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD54,RAD52
3550,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD54,immunoglobulin
3551,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD51,RAD52
3552,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD51,immunoglobulin
3553,BioInfer.d353,False,"In search for genes which might participate in chicken immunoglobulin gene conversion, we have identified chicken counterparts of the yeast RAD51, RAD52, and RAD54 genes.",BioInfer.d353.s0,RAD52,immunoglobulin
3554,BioInfer.d354,False,"Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.",BioInfer.d354.s0,actin,Insulin-like growth factor-I
3555,BioInfer.d354,False,"Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.",BioInfer.d354.s0,actin,myosin heavy chain
3556,BioInfer.d354,False,"Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.",BioInfer.d354.s0,Insulin-like growth factor-I,myosin heavy chain
3557,BioInfer.d355,True,Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.,BioInfer.d355.s0,cardiac myosin heavy chain,Insulin-like growth factor I
3558,BioInfer.d355,True,Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.,BioInfer.d355.s0,actin,Insulin-like growth factor I
3559,BioInfer.d355,False,Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.,BioInfer.d355.s0,cardiac myosin heavy chain,actin
3560,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,actin,myosin heavy chain
3561,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,actin,insulin-like growth factor I
3562,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,actin,IGF-I
3563,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,actin,IGF-I
3564,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,myosin heavy chain,insulin-like growth factor I
3565,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,myosin heavy chain,IGF-I
3566,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,myosin heavy chain,IGF-I
3567,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,insulin-like growth factor I,IGF-I
3568,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,insulin-like growth factor I,IGF-I
3569,BioInfer.d355,False,"To determine the effect of insulin-like growth factor I (IGF-I) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into myosin heavy chain and actin during intravenous infusions (4 h) of either saline or IGF-I (1 microgram. kg-1. min-1) in awake rats.",BioInfer.d355.s1,IGF-I,IGF-I
3570,BioInfer.d356,True,Integrating the actin and vimentin cytoskeletons.,BioInfer.d356.s0,vimentin,actin
3571,BioInfer.d357,True,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,Integrin beta chains,actin-binding proteins
3572,BioInfer.d357,True,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,actin-binding proteins,talin
3573,BioInfer.d357,True,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,actin-binding proteins,filamin
3574,BioInfer.d357,False,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,Integrin beta chains,talin
3575,BioInfer.d357,False,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,Integrin beta chains,filamin
3576,BioInfer.d357,False,"Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.",BioInfer.d357.s0,talin,filamin
3577,BioInfer.d358,True,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,talin,calpain
3578,BioInfer.d358,False,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,talin,actin
3579,BioInfer.d358,False,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,talin,Integrin
3580,BioInfer.d358,False,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,calpain,actin
3581,BioInfer.d358,False,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,calpain,Integrin
3582,BioInfer.d358,False,"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by calpain.",BioInfer.d358.s0,actin,Integrin
3583,BioInfer.d359,True,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,P
3584,BioInfer.d359,True,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,phosphoprotein
3585,BioInfer.d359,True,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,P
3586,BioInfer.d359,True,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,P,nucleocapsid protein
3587,BioInfer.d359,True,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,phosphoprotein,nucleocapsid protein
3588,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,NP
3589,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,nucleocapsid protein
3590,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,P
3591,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,P
3592,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,phosphoprotein
3593,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,NP,nucleocapsid protein
3594,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,P,phosphoprotein
3595,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,P,P
3596,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,phosphoprotein,P
3597,BioInfer.d359,False,Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.,BioInfer.d359.s0,nucleocapsid protein,P
3598,BioInfer.d360,True,Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.,BioInfer.d360.s0,Munc-18-2,syntaxin 3
3599,BioInfer.d360,True,Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.,BioInfer.d360.s0,Munc-18-2,SNAREs
3600,BioInfer.d360,True,Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.,BioInfer.d360.s0,syntaxin 3,SNAREs
3601,BioInfer.d360,True,The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of Munc-18-2 to associate with syntaxin 3 in vitro.,BioInfer.d360.s1,Munc-18-2,syntaxin 3
3602,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,cofilin
3603,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,ADF
3604,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,actin
3605,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,capping protein
3606,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,Arp2
3607,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp 3,profilin
3608,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,cofilin,actin
3609,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,cofilin,capping protein
3610,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,cofilin,Arp2
3611,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,cofilin,profilin
3612,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,ADF,actin
3613,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,ADF,capping protein
3614,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,ADF,Arp2
3615,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,ADF,profilin
3616,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,actin,capping protein
3617,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,actin,Arp2
3618,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,actin,profilin
3619,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,capping protein,Arp2
3620,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,capping protein,profilin
3621,BioInfer.d361,True,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,Arp2,profilin
3622,BioInfer.d361,False,"Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.",BioInfer.d361.s0,cofilin,ADF
3623,BioInfer.d364,True,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR4,SIR
3624,BioInfer.d364,True,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR1,SIR
3625,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR4,SIR1
3626,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR4,SIR
3627,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR4,ADE2
3628,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR1,SIR
3629,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR1,ADE2
3630,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR,ADE2
3631,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,SIR,SIR
3632,BioInfer.d364,False,"In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.",BioInfer.d364.s0,ADE2,SIR
3633,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,P-cadherin
3634,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,pan-desmocollin
3635,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,gamma-catenin
3636,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,E-cadherin
3637,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,alpha-catenin
3638,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmoglein,beta-catenin
3639,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,P-cadherin,pan-desmocollin
3640,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,P-cadherin,gamma-catenin
3641,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,P-cadherin,E-cadherin
3642,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,P-cadherin,alpha-catenin
3643,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,P-cadherin,beta-catenin
3644,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmocollin,gamma-catenin
3645,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmocollin,E-cadherin
3646,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmocollin,alpha-catenin
3647,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,pan-desmocollin,beta-catenin
3648,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,gamma-catenin,E-cadherin
3649,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,gamma-catenin,alpha-catenin
3650,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,gamma-catenin,beta-catenin
3651,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,E-cadherin,alpha-catenin
3652,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,E-cadherin,beta-catenin
3653,BioInfer.d365,False,"In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.",BioInfer.d365.s0,alpha-catenin,beta-catenin
3654,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC2,RAD17
3655,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC2,RAD24
3656,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC2,RAD9
3657,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC2,MEC3
3658,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC2,MEC1
3659,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD17,RAD24
3660,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD17,RAD9
3661,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD17,MEC3
3662,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD17,MEC1
3663,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD24,RAD9
3664,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD24,MEC3
3665,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD24,MEC1
3666,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD9,MEC3
3667,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,RAD9,MEC1
3668,BioInfer.d366,False,"In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.",BioInfer.d366.s0,MEC3,MEC1
3669,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,Ras,MAP kinase
3670,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,Ras,AP-1
3671,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,Ras,mitogen-activated protein kinase
3672,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,Ras,Raf
3673,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,MAP kinase,AP-1
3674,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,MAP kinase,mitogen-activated protein kinase
3675,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,MAP kinase,Raf
3676,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,AP-1,mitogen-activated protein kinase
3677,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,AP-1,Raf
3678,BioInfer.d367,True,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,mitogen-activated protein kinase,Raf
3679,BioInfer.d367,False,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,Ras,HBx
3680,BioInfer.d367,False,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,MAP kinase,HBx
3681,BioInfer.d367,False,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,HBx,AP-1
3682,BioInfer.d367,False,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,HBx,mitogen-activated protein kinase
3683,BioInfer.d367,False,"In the cytoplasm, HBx was shown to stimulate the Ras-Raf-mitogen-activated protein kinase (MAP kinase) cascade, which is essential for activation of transcription factor AP-1.",BioInfer.d367.s0,HBx,Raf
3684,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,plakoglobin,beta-catenin
3685,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,plakoglobin,alpha-catenin
3686,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,plakoglobin,vascular endothelial cadherin
3687,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,plakoglobin,tumor necrosis factor
3688,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,beta-catenin,alpha-catenin
3689,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,beta-catenin,vascular endothelial cadherin
3690,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,beta-catenin,tumor necrosis factor
3691,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,alpha-catenin,vascular endothelial cadherin
3692,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,alpha-catenin,tumor necrosis factor
3693,BioInfer.d370,False,"In the present paper, using indirect immunofluorescence, we found that PMN adhesion to tumor necrosis factor-activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: vascular endothelial (VE)-cadherin, alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d370.s0,vascular endothelial cadherin,tumor necrosis factor
3694,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,ICSBP
3695,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,CREBbinding protein
3696,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,PU.1
3697,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,IRF1
3698,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,CBP
3699,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,ICSBP,CYBB
3700,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,CREBbinding protein,CYBB
3701,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,PU.1,CYBB
3702,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,IRF1,CYBB
3703,BioInfer.d372,True,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,CBP,CYBB
3704,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,NCF2,CYBB
3705,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,ICSBP,CREBbinding protein
3706,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,ICSBP,PU.1
3707,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,ICSBP,IRF1
3708,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,ICSBP,CBP
3709,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,CREBbinding protein,PU.1
3710,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,CREBbinding protein,IRF1
3711,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,CREBbinding protein,CBP
3712,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,PU.1,IRF1
3713,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,PU.1,CBP
3714,BioInfer.d372,False,"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.",BioInfer.d372.s0,IRF1,CBP
3715,BioInfer.d373,True,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,profilin,actin
3716,BioInfer.d373,True,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,profilin,actin
3717,BioInfer.d373,True,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,profilin,actin-binding protein
3718,BioInfer.d373,False,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,actin,actin
3719,BioInfer.d373,False,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,actin,actin-binding protein
3720,BioInfer.d373,False,"In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.",BioInfer.d373.s0,actin,actin-binding protein
3721,BioInfer.d374,False,"In this case, efficient repair does not require RAD1 and MSH2, consistent with our previous observations.",BioInfer.d374.s0,MSH2,RAD1
3722,BioInfer.d375,True,"In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.",BioInfer.d375.s0,profilin,actin
3723,BioInfer.d375,True,"In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.",BioInfer.d375.s0,profilin,actin
3724,BioInfer.d375,False,"In this model, profilin can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.",BioInfer.d375.s0,actin,actin
3725,BioInfer.d375,True,Quantitative analysis of the effect of Acanthamoeba profilin on actin filament nucleation and elongation.,BioInfer.d375.s1,profilin,actin
3726,BioInfer.d375,True,"The current view of the mechanism of action of Acanthamoeba profilin is that it binds to actin monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].",BioInfer.d375.s2,actin,profilin
3727,BioInfer.d375,True,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,profilin,actin
3728,BioInfer.d375,True,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,profilin,actin
3729,BioInfer.d375,False,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,profilin,profilin
3730,BioInfer.d375,False,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,profilin,actin
3731,BioInfer.d375,False,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,profilin,actin
3732,BioInfer.d375,False,This model includes two different Kd's--one for profilin bound to actin monomers and one for profilin bound to an actin molecule at the barbed end of a filament.,BioInfer.d375.s3,actin,actin
3733,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,DRP,beta 1-syntrophin
3734,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,DRP,dystrophin
3735,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,dystrophin related protein,beta 1-syntrophin
3736,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,dystrophin related protein,dystrophin
3737,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,87K postsynaptic protein,beta 1-syntrophin
3738,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,87K postsynaptic protein,dystrophin
3739,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,utrophin,beta 1-syntrophin
3740,BioInfer.d376,True,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,utrophin,dystrophin
3741,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,DRP,dystrophin related protein
3742,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,DRP,87K postsynaptic protein
3743,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,DRP,utrophin
3744,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,dystrophin related protein,87K postsynaptic protein
3745,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,dystrophin related protein,utrophin
3746,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,87K postsynaptic protein,utrophin
3747,BioInfer.d376,False,"In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.",BioInfer.d376.s0,beta 1-syntrophin,dystrophin
3748,BioInfer.d377,True,"In this study, by immunoprecipitation and affinity chromatography it is shown that adenosine deaminase and A1 adenosine receptors interact in pig brain cortical membranes.",BioInfer.d377.s0,A1 adenosine receptors,adenosine deaminase
3749,BioInfer.d378,True,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,SM2,smooth muscle myosin heavy-chain
3750,BioInfer.d378,True,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,smooth muscle myosin heavy-chain,SM1
3751,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,SM2
3752,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,desmin
3753,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,polymerase
3754,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,smooth muscle myosin heavy-chain
3755,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,alpha-smooth muscle actin
3756,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,basic calponin,SM1
3757,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,SM2,desmin
3758,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,SM2,polymerase
3759,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,SM2,alpha-smooth muscle actin
3760,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,SM2,SM1
3761,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,desmin,polymerase
3762,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,desmin,smooth muscle myosin heavy-chain
3763,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,desmin,alpha-smooth muscle actin
3764,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,desmin,SM1
3765,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,polymerase,smooth muscle myosin heavy-chain
3766,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,polymerase,alpha-smooth muscle actin
3767,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,polymerase,SM1
3768,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,smooth muscle myosin heavy-chain,alpha-smooth muscle actin
3769,BioInfer.d378,False,"In this study, the expressions of smooth muscle-specific proteins (desmin, alpha-smooth muscle actin, basic calponin and the smooth muscle myosin heavy-chain isoforms of SM1 and SM2) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription-polymerase chain reaction (RT-PCR).",BioInfer.d378.s0,alpha-smooth muscle actin,SM1
3770,BioInfer.d379,True,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH6
3771,BioInfer.d379,True,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH3
3772,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,msh3
3773,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,msh2
3774,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,msh6
3775,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH2
3776,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH6
3777,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH3
3778,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,MSH3
3779,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,msh3
3780,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,msh2
3781,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,msh6
3782,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,MSH2
3783,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,MSH6
3784,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,MSH3
3785,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,msh3
3786,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,msh2
3787,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,msh6
3788,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,MSH2
3789,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,MSH6
3790,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH3,MSH3
3791,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh3,msh2
3792,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh3,msh6
3793,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh3,MSH2
3794,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh3,MSH6
3795,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh3,MSH3
3796,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh2,msh6
3797,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh2,MSH2
3798,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh2,MSH6
3799,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh2,MSH3
3800,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh6,MSH2
3801,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh6,MSH6
3802,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,msh6,MSH3
3803,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH6
3804,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH2,MSH3
3805,BioInfer.d379,False,"In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.",BioInfer.d379.s0,MSH6,MSH3
3806,BioInfer.d379,False,Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.,BioInfer.d379.s1,MSH2,MSH3
3807,BioInfer.d379,False,Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.,BioInfer.d379.s1,MSH2,MSH6
3808,BioInfer.d379,False,Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.,BioInfer.d379.s1,MSH3,MSH6
3809,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3810,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3811,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH6,MSH2
3812,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH3,MSH2
3813,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3814,BioInfer.d379,True,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH6,MSH2
3815,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3816,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH6
3817,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH3
3818,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3819,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH6
3820,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH6
3821,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH3
3822,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH2
3823,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH6
3824,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH6,MSH3
3825,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH6,MSH2
3826,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH6,MSH6
3827,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH3,MSH2
3828,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH3,MSH6
3829,BioInfer.d379,False,"The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.",BioInfer.d379.s2,MSH2,MSH6
3830,BioInfer.d381,True,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,histone,H3
3831,BioInfer.d381,True,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,H4,H3
3832,BioInfer.d381,True,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,H4,histone
3833,BioInfer.d381,False,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,histone,H4
3834,BioInfer.d381,False,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,histone,histone
3835,BioInfer.d381,False,In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.,BioInfer.d381.s0,H3,histone
3836,BioInfer.d384,True,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,APC,beta-catenin
3837,BioInfer.d384,True,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,alpha-catenin,beta-catenin
3838,BioInfer.d384,False,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,APC,alpha-catenin
3839,BioInfer.d384,False,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,APC,CTNNB1
3840,BioInfer.d384,False,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,alpha-catenin,CTNNB1
3841,BioInfer.d384,False,"In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.",BioInfer.d384.s0,beta-catenin,CTNNB1
3842,BioInfer.d385,True,Introduction of high concentrations of profilin (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of actin tail elongation and bacterial migration.,BioInfer.d385.s0,profilin,actin
3843,BioInfer.d387,True,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,PDGF-AB
3844,BioInfer.d387,True,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,mitogen-activated protein kinase kinases
3845,BioInfer.d387,True,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK1,mitogen-activated protein kinase kinases
3846,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,MEK 2
3847,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,AP-1
3848,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,ERK
3849,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,ERK 2
3850,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,MEK1
3851,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,ERK1
3852,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF receptor,mitogen-activated protein kinase kinases
3853,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,AP-1
3854,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,ERK
3855,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,ERK 2
3856,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,MEK1
3857,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,PDGF-AB
3858,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK 2,ERK1
3859,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,ERK
3860,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,ERK 2
3861,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,MEK1
3862,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,PDGF-AB
3863,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,ERK1
3864,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,AP-1,mitogen-activated protein kinase kinases
3865,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK,ERK 2
3866,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK,MEK1
3867,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK,PDGF-AB
3868,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK,ERK1
3869,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK,mitogen-activated protein kinase kinases
3870,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK 2,MEK1
3871,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK 2,PDGF-AB
3872,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK 2,ERK1
3873,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK 2,mitogen-activated protein kinase kinases
3874,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK1,PDGF-AB
3875,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,MEK1,ERK1
3876,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF-AB,ERK1
3877,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,PDGF-AB,mitogen-activated protein kinase kinases
3878,BioInfer.d387,False,"In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.",BioInfer.d387.s0,ERK1,mitogen-activated protein kinase kinases
3879,BioInfer.d388,True,In vivo importance of actin nucleotide exchange catalyzed by profilin.,BioInfer.d388.s0,actin,profilin
3880,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,pfy1-4,act1-157
3881,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,pfy1-4,actin
3882,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,pfy1-4,actin
3883,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,act1-157,profilin
3884,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,act1-157,actin
3885,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,profilin,actin
3886,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,profilin,actin
3887,BioInfer.d388,True,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,actin,actin
3888,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,pfy1-4,profilin
3889,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,pfy1-4,actin
3890,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,act1-157,actin
3891,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,act1-157,actin
3892,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,profilin,actin
3893,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,actin,actin
3894,BioInfer.d388,False,"act1-157, an actin mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in actin organization, cell growth, and fluid-phase endocytosis of pfy1-4, a profilin mutant defective in actin binding.",BioInfer.d388.s1,actin,actin
3895,BioInfer.d388,True,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,profilin
3896,BioInfer.d388,True,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,actin
3897,BioInfer.d388,True,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,profilin
3898,BioInfer.d388,True,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,profilin
3899,BioInfer.d388,False,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,actin
3900,BioInfer.d388,False,"The actin monomer-binding protein, profilin, influences the dynamics of actin filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on actin, and promoting barbed-end assembly.",BioInfer.d388.s2,actin,actin
3901,BioInfer.d388,True,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,actin,profilin
3902,BioInfer.d388,True,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,actin,PFY1
3903,BioInfer.d388,False,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,actin,profilin
3904,BioInfer.d388,False,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,profilin,profilin
3905,BioInfer.d388,False,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,profilin,PFY1
3906,BioInfer.d388,False,"To study profilin function, we extensively mutagenized the Saccharomyces cerevisiae profilin gene (PFY1) and examined the consequences of specific point mutations on growth and actin organization.",BioInfer.d388.s3,profilin,PFY1
3907,BioInfer.d389,True,Involvement of profilin in the actin-based motility of L. monocytogenes in cells and in cell-free extracts.,BioInfer.d389.s0,actin,profilin
3908,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,MORT-1
3909,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,FADD
3910,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,TRAF-2
3911,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,TRAF-1
3912,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,TRAF-3
3913,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,TNF-RI
3914,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,TRADD
3915,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,Fas
3916,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF,RIP
3917,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,FADD
3918,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,TRAF-2
3919,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,TRAF-1
3920,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,TRAF-3
3921,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,TNF-RI
3922,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,TRADD
3923,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,Fas
3924,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,MORT-1,RIP
3925,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,TRAF-2
3926,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,TRAF-1
3927,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,TRAF-3
3928,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,TNF-RI
3929,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,TRADD
3930,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,Fas
3931,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,FADD,RIP
3932,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,TRAF-1
3933,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,TRAF-3
3934,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,TNF-RI
3935,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,TRADD
3936,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,Fas
3937,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-2,RIP
3938,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-1,TRAF-3
3939,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-1,TNF-RI
3940,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-1,TRADD
3941,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-1,Fas
3942,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-1,RIP
3943,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-3,TNF-RI
3944,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-3,TRADD
3945,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-3,Fas
3946,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRAF-3,RIP
3947,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TNF-RI,TRADD
3948,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TNF-RI,Fas
3949,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TNF-RI,RIP
3950,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRADD,Fas
3951,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,TRADD,RIP
3952,BioInfer.d390,False,"Isolation and characterization of death domain (TNF-RI, Fas, TRADD, FADD/MORT-1, RIP) and TRAF domain-containing proteins (TRAF-1, TRAF-2, TRAF-3) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.",BioInfer.d390.s0,Fas,RIP
3953,BioInfer.d391,True,Isolation of profilin from embryonic chicken skeletal muscle and evaluation of its interaction with different actin isoforms.,BioInfer.d391.s0,actin,profilin
3954,BioInfer.d391,True,"These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.",BioInfer.d391.s1,profilin,sarcomeric actins
3955,BioInfer.d391,True,"These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.",BioInfer.d391.s1,profilin,cytoskeletal actins
3956,BioInfer.d391,False,"These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.",BioInfer.d391.s1,sarcomeric actins,cytoskeletal actins
3957,BioInfer.d392,True,Isolation of human delta-catenin and its binding specificity with presenilin 1.,BioInfer.d392.s0,presenilin 1,delta-catenin
3958,BioInfer.d393,False,Isolation of human skeletal muscle myosin heavy chain and actin for measurement of fractional synthesis rates.,BioInfer.d393.s0,actin,skeletal muscle myosin heavy chain
3959,BioInfer.d393,False,"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.",BioInfer.d393.s1,actin,myosin heavy chain
3960,BioInfer.d393,False,"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.",BioInfer.d393.s1,actin,MHC
3961,BioInfer.d393,False,"Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate myosin heavy chain (MHC) and actin from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.",BioInfer.d393.s1,myosin heavy chain,MHC
3962,BioInfer.d394,True,"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.",BioInfer.d394.s0,profilin,actin
3963,BioInfer.d394,False,"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.",BioInfer.d394.s0,profilin,actin
3964,BioInfer.d394,False,"It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G actin from profilin or promoting the cross-linking of actin or its anchorage to the plasma membrane.",BioInfer.d394.s0,actin,actin
3965,BioInfer.d395,True,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,phosphoprotein,P
3966,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,L,actin
3967,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,L,phosphoprotein
3968,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,L,P
3969,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,L,profilin
3970,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,actin,phosphoprotein
3971,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,actin,P
3972,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,actin,profilin
3973,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,phosphoprotein,profilin
3974,BioInfer.d395,False,"It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of L, 120 molecules of phosphoprotein P, and 60 molecules each of actin and profilin.",BioInfer.d395.s0,P,profilin
3975,BioInfer.d395,True,"Native profilin, purified from extracts of lung epithelial cells by affinity binding to a poly-L-proline matrix, stimulated the actin-saturated RSV transcription by 2.5- to 3-fold.",BioInfer.d395.s1,actin,profilin
3976,BioInfer.d396,False,It reduced the rate of actin polymerization as reported in the cases of profilins from other organisms.,BioInfer.d396.s0,profilins,actin
3977,BioInfer.d397,True,It therefore appears that myosin heavy chain and actin multigene families are both expressed in a species specific fashion but are independently regulated within a species.,BioInfer.d397.s0,myosin heavy chain,actin
3978,BioInfer.d397,False,Regulation of myosin heavy chain and actin isogenes expression during cardiac growth.,BioInfer.d397.s1,actin,myosin heavy chain
3979,BioInfer.d397,False,"The cardiac ventricular myosin heavy chain phenotype is developmentally and hormonally regulated, but less is known concerning the actin phenotype.",BioInfer.d397.s2,actin,cardiac ventricular myosin heavy chain
3980,BioInfer.d398,True,"Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.",BioInfer.d398.s0,actin,profilin
3981,BioInfer.d398,True,"Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.",BioInfer.d398.s0,actin,actin
3982,BioInfer.d398,True,"Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.",BioInfer.d398.s0,profilin,actin
3983,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,actin
3984,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,actin
3985,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,profilin
3986,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,actin
3987,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,profilin
3988,BioInfer.d398,True,The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.,BioInfer.d398.s1,actin,profilin
3989,BioInfer.d399,True,Kinetic studies on the effect of yeast cofilin on yeast actin polymerization.,BioInfer.d399.s0,cofilin,actin
3990,BioInfer.d399,True,The results suggest some cooperativity with respect to cofilin binding to filamentous actin which may be pH dependent.,BioInfer.d399.s1,actin,cofilin
3991,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,talin,actin
3992,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,talin,actin
3993,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,talin,alpha-spectrin
3994,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,actin,actin
3995,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,actin,alpha-spectrin
3996,BioInfer.d400,False,"Lack of detection in these preparations of a constituent that binds RBC alpha-spectrin antibody plus the presence of significant quantities of actin, further suggests that the principal membrane skeletal element is actin with perhaps smaller quantities of a 240-kd component, identified by others as the protein talin.",BioInfer.d400.s0,actin,alpha-spectrin
3997,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,rad54
3998,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,RAD24
3999,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,RAD9
4000,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,MEC3
4001,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,RAD17
4002,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,srs2Delta
4003,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,rad54Delta
4004,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,srs2Delta
4005,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,rdh54Delta
4006,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,srs2
4007,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,rdh54
4008,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,RAD24
4009,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,RAD9
4010,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,MEC3
4011,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,RAD17
4012,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,srs2Delta
4013,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,rad54Delta
4014,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,srs2Delta
4015,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,rdh54Delta
4016,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,srs2
4017,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54,rdh54
4018,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,RAD9
4019,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,MEC3
4020,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,RAD17
4021,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,srs2Delta
4022,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,rad54Delta
4023,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,srs2Delta
4024,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,rdh54Delta
4025,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,srs2
4026,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD24,rdh54
4027,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,MEC3
4028,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,RAD17
4029,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,srs2Delta
4030,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,rad54Delta
4031,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,srs2Delta
4032,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,rdh54Delta
4033,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,srs2
4034,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD9,rdh54
4035,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,RAD17
4036,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,srs2Delta
4037,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,rad54Delta
4038,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,srs2Delta
4039,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,rdh54Delta
4040,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,srs2
4041,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,MEC3,rdh54
4042,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,srs2Delta
4043,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,rad54Delta
4044,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,srs2Delta
4045,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,rdh54Delta
4046,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,srs2
4047,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,RAD17,rdh54
4048,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,rad54Delta
4049,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,srs2Delta
4050,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,rdh54Delta
4051,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,srs2
4052,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,rdh54
4053,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54Delta,srs2Delta
4054,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54Delta,rdh54Delta
4055,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54Delta,srs2
4056,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rad54Delta,rdh54
4057,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,rdh54Delta
4058,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,srs2
4059,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2Delta,rdh54
4060,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rdh54Delta,srs2
4061,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,rdh54Delta,rdh54
4062,BioInfer.d401,False,"Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.",BioInfer.d401.s0,srs2,rdh54
4063,BioInfer.d404,False,"Like the spectrin alpha-chain, the major central part of the spectrin beta-chain is made up of repeat units of 106 amino-acids.",BioInfer.d404.s0,spectrin beta-chain,spectrin alpha-chain
4064,BioInfer.d405,True,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin,LIMK1
4065,BioInfer.d405,True,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin,LIM-kinase 1
4066,BioInfer.d405,True,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin-depolymerizing factor,cofilin
4067,BioInfer.d405,True,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,cofilin,LIMK1
4068,BioInfer.d405,True,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,cofilin,LIM-kinase 1
4069,BioInfer.d405,False,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin,actin-depolymerizing factor
4070,BioInfer.d405,False,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin,cofilin
4071,BioInfer.d405,False,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin-depolymerizing factor,LIMK1
4072,BioInfer.d405,False,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,actin-depolymerizing factor,LIM-kinase 1
4073,BioInfer.d405,False,"LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.",BioInfer.d405.s0,LIMK1,LIM-kinase 1
4074,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH6,MLH1
4075,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH6,MSH3
4076,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH6,MSH2
4077,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH6,GTBP
4078,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MLH1,MSH3
4079,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MLH1,MSH2
4080,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MLH1,GTBP
4081,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH3,MSH2
4082,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH3,GTBP
4083,BioInfer.d406,False,"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and MSH6 (GTBP) was investigated.",BioInfer.d406.s0,MSH2,GTBP
4084,BioInfer.d407,True,Live dynamics of Dictyostelium cofilin suggests a role in remodeling actin latticework into bundles.,BioInfer.d407.s0,actin,cofilin
4085,BioInfer.d407,True,These results demonstrate that cofilin plays a crucial role in vivo in rapid remodeling of the cortical actin meshwork into bundles.,BioInfer.d407.s1,actin,cofilin
4086,BioInfer.d408,True,"Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.",BioInfer.d408.s0,profilin,actin
4087,BioInfer.d408,True,"Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.",BioInfer.d408.s0,profilin,VASP
4088,BioInfer.d408,False,"Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.",BioInfer.d408.s0,actin,VASP
4089,BioInfer.d409,False,Location of profilin at presynaptic sites in the cerebellar cortex; implication for the regulation of the actin-polymerization state during axonal elongation and synaptogenesis.,BioInfer.d409.s0,profilin,actin
4090,BioInfer.d410,False,"Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.",BioInfer.d410.s0,E-cadherin,beta-catenin
4091,BioInfer.d410,False,"Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.",BioInfer.d410.s0,E-cadherin,alpha-catenin
4092,BioInfer.d410,False,"Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively.",BioInfer.d410.s0,beta-catenin,alpha-catenin
4093,BioInfer.d410,False,"There was a trend towards an association between advanced tumour stage and loss of membranous expression of alpha-catenin or beta-catenin, although these associations were not statistically significant.",BioInfer.d410.s1,alpha-catenin,beta-catenin
4094,BioInfer.d411,False,"Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, RAD51 and RAD54, have been isolated.",BioInfer.d411.s0,RAD54,RAD51
4095,BioInfer.d412,True,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,actin,LIMKs
4096,BioInfer.d412,True,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,actin,LIM-kinases
4097,BioInfer.d412,True,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,LIMKs,cofilin
4098,BioInfer.d412,True,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,LIM-kinases,cofilin
4099,BioInfer.d412,False,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,actin,cofilin
4100,BioInfer.d412,False,Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d412.s0,LIMKs,LIM-kinases
4101,BioInfer.d413,True,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,myosin,actin
4102,BioInfer.d413,True,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,myosin,myosin heavy chain
4103,BioInfer.d413,True,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,myosin,Myh
4104,BioInfer.d413,True,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,actin,myosin heavy chain
4105,BioInfer.d413,True,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,actin,Myh
4106,BioInfer.d413,False,MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.,BioInfer.d413.s0,myosin heavy chain,Myh
4107,BioInfer.d416,True,Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.,BioInfer.d416.s0,p21,cyclin-dependent kinase inhibitor
4108,BioInfer.d416,False,Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.,BioInfer.d416.s0,proliferating cell nuclear antigen,p21
4109,BioInfer.d416,False,Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21.,BioInfer.d416.s0,proliferating cell nuclear antigen,cyclin-dependent kinase inhibitor
4110,BioInfer.d417,True,Mechanism of regulation of actin polymerization by Physarum profilin.,BioInfer.d417.s0,profilin,actin
4111,BioInfer.d417,True,The apparent critical concentration for polymerization of actin is increased by the addition of profilin.,BioInfer.d417.s1,actin,profilin
4112,BioInfer.d418,True,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,gamma-catenin,alpha-catenin
4113,BioInfer.d418,True,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,gamma-catenin,E-cadherin
4114,BioInfer.d418,True,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,alpha-catenin,E-cadherin
4115,BioInfer.d418,False,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,gamma-catenin,beta-catenin
4116,BioInfer.d418,False,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,alpha-catenin,beta-catenin
4117,BioInfer.d418,False,"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.",BioInfer.d418.s0,E-cadherin,beta-catenin
4118,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,beta-catenin,alpha-catenin
4119,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,beta-catenin,E-cadherin
4120,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,beta-catenin,plakoglobin
4121,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,alpha-catenin,E-cadherin
4122,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,alpha-catenin,plakoglobin
4123,BioInfer.d420,False,"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.",BioInfer.d420.s0,E-cadherin,plakoglobin
4124,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,alpha-SMA,myosin heavy chain
4125,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,alpha-SMA,smoothelin
4126,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,alpha-SMA,alpha-smooth muscle actin
4127,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,myosin heavy chain,smoothelin
4128,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,myosin heavy chain,alpha-smooth muscle actin
4129,BioInfer.d421,False,"METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.",BioInfer.d421.s0,smoothelin,alpha-smooth muscle actin
4130,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,alpha-SMA
4131,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,Cx43
4132,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,connexin 43
4133,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,MHC
4134,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,alpha-smooth muscle actin
4135,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,TnI
4136,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,myosin heavy chain
4137,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,troponin I
4138,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,myosin light chain
4139,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MLC,desmin
4140,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,Cx43
4141,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,connexin 43
4142,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,MHC
4143,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,alpha-smooth muscle actin
4144,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,TnI
4145,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,myosin heavy chain
4146,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,troponin I
4147,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,myosin light chain
4148,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-SMA,desmin
4149,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,connexin 43
4150,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,MHC
4151,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,alpha-smooth muscle actin
4152,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,TnI
4153,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,myosin heavy chain
4154,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,troponin I
4155,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,myosin light chain
4156,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,Cx43,desmin
4157,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,MHC
4158,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,alpha-smooth muscle actin
4159,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,TnI
4160,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,myosin heavy chain
4161,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,troponin I
4162,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,myosin light chain
4163,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,connexin 43,desmin
4164,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,alpha-smooth muscle actin
4165,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,TnI
4166,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,myosin heavy chain
4167,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,troponin I
4168,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,myosin light chain
4169,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,MHC,desmin
4170,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-smooth muscle actin,TnI
4171,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-smooth muscle actin,myosin heavy chain
4172,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-smooth muscle actin,troponin I
4173,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-smooth muscle actin,myosin light chain
4174,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,alpha-smooth muscle actin,desmin
4175,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,TnI,myosin heavy chain
4176,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,TnI,troponin I
4177,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,TnI,myosin light chain
4178,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,TnI,desmin
4179,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,myosin heavy chain,troponin I
4180,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,myosin heavy chain,myosin light chain
4181,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,myosin heavy chain,desmin
4182,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,troponin I,myosin light chain
4183,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,troponin I,desmin
4184,BioInfer.d423,False,"METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.",BioInfer.d423.s0,myosin light chain,desmin
4185,BioInfer.d425,True,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,beta-catenin,V12Ras
4186,BioInfer.d425,True,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,E-cadherin,V12Ras
4187,BioInfer.d425,True,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,alpha-catenin,V12Ras
4188,BioInfer.d425,False,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,beta-catenin,E-cadherin
4189,BioInfer.d425,False,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,beta-catenin,alpha-catenin
4190,BioInfer.d425,False,Microinjection or stable expression of V12Ras into keratinocytes promotes the loss of E-cadherin and alpha-catenin and relocalization of beta-catenin to the cytoplasm and nucleus.,BioInfer.d425.s0,E-cadherin,alpha-catenin
4191,BioInfer.d427,True,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,CREB
4192,BioInfer.d427,True,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,methyltransferase
4193,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,CBP
4194,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,CBP
4195,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,CREB
4196,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,MLL
4197,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,MLL,methyltransferase
4198,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,CBP
4199,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,CREB
4200,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,MLL
4201,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,methyltransferase
4202,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,MLL
4203,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CBP,methyltransferase
4204,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CREB,MLL
4205,BioInfer.d427,False,"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.",BioInfer.d427.s0,CREB,methyltransferase
4206,BioInfer.d428,True,Modifying preselected sites on proteins: the stretch of residues 633-642 of the myosin heavy chain is part of the actin-binding site.,BioInfer.d428.s0,actin,myosin heavy chain
4207,BioInfer.d429,True,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,beta-catenin,cadherin
4208,BioInfer.d429,True,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,beta-catenin,catenin
4209,BioInfer.d429,True,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,beta-catenin,alpha-catenin
4210,BioInfer.d429,True,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,beta-catenin,E-cadherin
4211,BioInfer.d429,True,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,cadherin,catenin
4212,BioInfer.d429,False,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,cadherin,alpha-catenin
4213,BioInfer.d429,False,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,cadherin,E-cadherin
4214,BioInfer.d429,False,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,catenin,alpha-catenin
4215,BioInfer.d429,False,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,catenin,E-cadherin
4216,BioInfer.d429,False,"Molecular analysis of the cadherin-catenin complex elucidated the central role of beta-catenin in this adhesion complex, as it binds to the cytoplasmic domain of E-cadherin and to alpha-catenin.",BioInfer.d429.s0,alpha-catenin,E-cadherin
4217,BioInfer.d429,True,"beta-Catenin may also function in signalling pathways, given its homology to the gene product of the Drosophila segment polarity gene armadillo, which is known to be involved in the wingless signalling cascade.",BioInfer.d429.s1,armadillo,beta-Catenin
4218,BioInfer.d430,True,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,plakoglobin,beta-catenin
4219,BioInfer.d430,True,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,armadillo,beta-catenin
4220,BioInfer.d430,True,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,vinculin,alpha-catenin
4221,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,plakoglobin,armadillo
4222,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,plakoglobin,vinculin
4223,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,plakoglobin,alpha-catenin
4224,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,armadillo,vinculin
4225,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,armadillo,alpha-catenin
4226,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,vinculin,beta-catenin
4227,BioInfer.d430,False,Molecular cloning and primary structure analysis demonstrated that alpha-catenin is homologous to vinculin and the beta-catenin is homologous to human plakoglobin and the Drosophila gene product armadillo.,BioInfer.d430.s0,beta-catenin,alpha-catenin
4228,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,plakoglobin
4229,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,alpha-catenin
4230,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,plakoglobin,alpha-catenin
4231,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,alpha- catenin,E-cadherin
4232,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,alpha- catenin,beta-catenin
4233,BioInfer.d430,True,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,beta-catenin
4234,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,alpha- catenin
4235,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,E-cadherin
4236,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,E-cadherin,beta-catenin
4237,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,plakoglobin,alpha- catenin
4238,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,plakoglobin,E-cadherin
4239,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,plakoglobin,beta-catenin
4240,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,alpha- catenin,alpha-catenin
4241,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,alpha-catenin,E-cadherin
4242,BioInfer.d430,False,"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and plakoglobin.",BioInfer.d430.s1,alpha-catenin,beta-catenin
4243,BioInfer.d431,True,[Molecular functions of cofilin which regulates reorganization of actin cytoskeleton].,BioInfer.d431.s0,actin,cofilin
4244,BioInfer.d432,True,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,beta-catenin,actin
4245,BioInfer.d432,True,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,plakoglobin,actin
4246,BioInfer.d432,True,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,zyxin,actin
4247,BioInfer.d432,True,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,actin,alpha-catenin
4248,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,beta-catenin,plakoglobin
4249,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,beta-catenin,zyxin
4250,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,beta-catenin,alpha-catenin
4251,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,plakoglobin,zyxin
4252,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,plakoglobin,alpha-catenin
4253,BioInfer.d432,False,"Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.",BioInfer.d432.s0,zyxin,alpha-catenin
4254,BioInfer.d432,True,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,vinculin,actin
4255,BioInfer.d432,True,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,actin,ezrin
4256,BioInfer.d432,True,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,actin,talin
4257,BioInfer.d432,False,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,vinculin,ezrin
4258,BioInfer.d432,False,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,vinculin,talin
4259,BioInfer.d432,False,"Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.",BioInfer.d432.s1,ezrin,talin
4260,BioInfer.d433,True,Monoclonal antibodies recognizing the N- and C-terminal regions of talin disrupt actin stress fibers when microinjected into human fibroblasts.,BioInfer.d433.s0,talin,actin
4261,BioInfer.d433,True,"These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.",BioInfer.d433.s1,talin,TD77
4262,BioInfer.d433,True,"These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.",BioInfer.d433.s1,talin,actin
4263,BioInfer.d433,False,"These results show that the C-terminal actin-binding site is distinct from the region recognized by the anti-functional antibody TD77, raising the possibility that it binds to a novel functionally important ligand-binding site in the talin molecule.",BioInfer.d433.s1,TD77,actin
4264,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,talin,TD77
4265,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,talin,actin
4266,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,talin,actin
4267,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,talin,TD77
4268,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,talin,actin
4269,BioInfer.d433,True,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,TD77,actin
4270,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,TD77,actin
4271,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,TD77,actin
4272,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,TD77,TD77
4273,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,actin,actin
4274,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,actin,TD77
4275,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,actin,actin
4276,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,actin,TD77
4277,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,actin,actin
4278,BioInfer.d433,False,"To investigate the possibility that TD77 disrupts actin stress fibers by binding directly to the C-terminal actin binding site, additional talin fusion proteins were generated and analyzed for TD77 and actin binding.",BioInfer.d433.s2,TD77,actin
4279,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,plakoglobin,alpha-catenin
4280,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,plakoglobin,beta-catenin
4281,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,plakoglobin,VE-cadherin
4282,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,alpha-catenin,beta-catenin
4283,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,alpha-catenin,VE-cadherin
4284,BioInfer.d434,False,"Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of VE-cadherin, alpha-catenin, beta-catenin, and plakoglobin during transendothelial migration under physiological flow conditions.",BioInfer.d434.s0,beta-catenin,VE-cadherin
4285,BioInfer.d435,True,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,actin,vinculin
4286,BioInfer.d435,True,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,actin,tubulin
4287,BioInfer.d435,True,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,actin,talin
4288,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,actin,CD31
4289,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,vinculin,tubulin
4290,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,vinculin,talin
4291,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,vinculin,CD31
4292,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,tubulin,talin
4293,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,tubulin,CD31
4294,BioInfer.d435,False,"Moreover, talin, but not vinculin or tubulin, appears to co-localize with actin microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following CD31 cross-linking.",BioInfer.d435.s0,talin,CD31
4295,BioInfer.d437,False,"Moreover, in the presence of cofilin, rapid interconversion of monomeric and polymeric forms of actin can be induced by simply changing the pH of the medium.",BioInfer.d437.s0,actin,cofilin
4296,BioInfer.d437,True,pH control of actin polymerization by cofilin.,BioInfer.d437.s1,cofilin,actin
4297,BioInfer.d438,False,"Moreover, the virus-encoded profilin homolog was not required for actin-associated events, including intracellular virus movement to the periphery of the cell, formation of specialized microvilli, or release of mature virions, as shown by electron microscopy and yields of infectious intra- and extracellular virus.",BioInfer.d438.s0,profilin,actin
4298,BioInfer.d440,True,Most previous studies have focused on profilin itself rather than its complex with actin.,BioInfer.d440.s0,profilin,actin
4299,BioInfer.d441,True,Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: gelsolin and profilin.,BioInfer.d441.s0,gelsolin,actin-binding proteins
4300,BioInfer.d441,True,Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: gelsolin and profilin.,BioInfer.d441.s0,profilin,actin-binding proteins
4301,BioInfer.d441,False,Motile areas of leech neurites are rich in microfilaments and two actin-binding proteins: gelsolin and profilin.,BioInfer.d441.s0,gelsolin,profilin
4302,BioInfer.d441,True,"The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.",BioInfer.d441.s1,profilin,actin
4303,BioInfer.d441,True,"The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.",BioInfer.d441.s1,profilin,gelsolin
4304,BioInfer.d441,True,"The colocalization of gelsolin and profilin in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the actin dynamics that underlie neurite growth.",BioInfer.d441.s1,actin,gelsolin
4305,BioInfer.d442,True,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,tropomyosin,cdc8
4306,BioInfer.d442,True,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,cdc3,profilin
4307,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,tropomyosin,cdc3
4308,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,tropomyosin,profilin
4309,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,tropomyosin,actin
4310,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,cdc3,cdc8
4311,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,cdc3,actin
4312,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,profilin,cdc8
4313,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,profilin,actin
4314,BioInfer.d442,False,"Mutants of cdc3 and cdc8, which encode profilin and tropomyosin respectively, display disorganized actin patches in all cells.",BioInfer.d442.s0,cdc8,actin
4315,BioInfer.d443,False,"Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).",BioInfer.d443.s0,BUD4,AXL1
4316,BioInfer.d443,False,"Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).",BioInfer.d443.s0,BUD4,BUD3
4317,BioInfer.d443,False,"Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).",BioInfer.d443.s0,AXL1,BUD3
4318,BioInfer.d444,True,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,RVS167,amphiphysin
4319,BioInfer.d444,True,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,RVS167,actin
4320,BioInfer.d444,True,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,amphiphysin,RVS161
4321,BioInfer.d444,True,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,actin,RVS161
4322,BioInfer.d444,False,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,RVS167,RVS161
4323,BioInfer.d444,False,"Mutations in RVS161 and RVS167, the two yeast amphiphysin homologs, cause very similar growth phenotypes, a depolarized actin cytoskeleton, and a defect in the internalization step of endocytosis.",BioInfer.d444.s0,amphiphysin,actin
4324,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,RAD24
4325,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,DUN1
4326,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,RAD9
4327,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,CHK1
4328,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,PDS1
4329,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,RAD17
4330,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,RAD53
4331,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,DPB11
4332,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,MEC1
4333,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,RFC5
4334,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,MEC3
4335,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,BUB3
4336,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DDC2,MAD3
4337,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,DUN1
4338,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,RAD9
4339,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,CHK1
4340,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,PDS1
4341,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,RAD17
4342,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,RAD53
4343,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,DPB11
4344,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,MEC1
4345,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,RFC5
4346,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,MEC3
4347,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,BUB3
4348,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD24,MAD3
4349,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,RAD9
4350,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,CHK1
4351,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,PDS1
4352,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,RAD17
4353,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,RAD53
4354,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,DPB11
4355,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,MEC1
4356,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,RFC5
4357,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,MEC3
4358,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,BUB3
4359,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DUN1,MAD3
4360,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,CHK1
4361,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,PDS1
4362,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,RAD17
4363,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,RAD53
4364,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,DPB11
4365,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,MEC1
4366,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,RFC5
4367,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,MEC3
4368,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,BUB3
4369,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD9,MAD3
4370,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,PDS1
4371,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,RAD17
4372,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,RAD53
4373,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,DPB11
4374,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,MEC1
4375,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,RFC5
4376,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,MEC3
4377,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,BUB3
4378,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,CHK1,MAD3
4379,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,RAD17
4380,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,RAD53
4381,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,DPB11
4382,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,MEC1
4383,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,RFC5
4384,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,MEC3
4385,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,BUB3
4386,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,PDS1,MAD3
4387,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,RAD53
4388,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,DPB11
4389,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,MEC1
4390,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,RFC5
4391,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,MEC3
4392,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,BUB3
4393,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD17,MAD3
4394,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,DPB11
4395,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,MEC1
4396,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,RFC5
4397,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,MEC3
4398,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,BUB3
4399,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RAD53,MAD3
4400,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DPB11,MEC1
4401,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DPB11,RFC5
4402,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DPB11,MEC3
4403,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DPB11,BUB3
4404,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,DPB11,MAD3
4405,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC1,RFC5
4406,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC1,MEC3
4407,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC1,BUB3
4408,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC1,MAD3
4409,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RFC5,MEC3
4410,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RFC5,BUB3
4411,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,RFC5,MAD3
4412,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC3,BUB3
4413,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,MEC3,MAD3
4414,BioInfer.d446,False,"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.",BioInfer.d446.s0,BUB3,MAD3
4415,BioInfer.d447,True,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,CUS1,HSH49
4416,BioInfer.d447,True,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,CUS1,HSH49
4417,BioInfer.d447,False,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,CUS1,CUS1
4418,BioInfer.d447,False,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,CUS1,HSH49
4419,BioInfer.d447,False,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,HSH49,CUS1
4420,BioInfer.d447,False,"Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.",BioInfer.d447.s0,HSH49,HSH49
4421,BioInfer.d447,True,Recombinant HSH49 protein has a general RNA-binding activity that does not require CUS1.,BioInfer.d447.s1,CUS1,HSH49
4422,BioInfer.d448,True,Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.,BioInfer.d448.s0,actin,Myo2p
4423,BioInfer.d448,True,Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.,BioInfer.d448.s0,Myo2p,type II myosin heavy chain
4424,BioInfer.d448,False,Myo2p shows homology to the head domains and the coiledcoil tail of the conventional type II myosin heavy chain and carries putative binding sites for ATP and actin.,BioInfer.d448.s0,actin,type II myosin heavy chain
4425,BioInfer.d449,False,"alpha-Skeletal actin and fast myosin heavy chain mRNAs were detected precociously, before the young myotube stage.",BioInfer.d449.s1,alpha-Skeletal actin,fast myosin heavy chain
4426,BioInfer.d450,True,"Neither can profilin I, in the presence of the peptide, promote actin polymerization during its early phase consistent with a lower affinity.",BioInfer.d450.s0,profilin I,actin
4427,BioInfer.d450,True,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,actin,profilin II
4428,BioInfer.d450,True,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,actin,thymosin beta4
4429,BioInfer.d450,True,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,actin,profilin II
4430,BioInfer.d450,False,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,profilin II,thymosin beta4
4431,BioInfer.d450,False,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,profilin II,profilin II
4432,BioInfer.d450,False,The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.,BioInfer.d450.s1,thymosin beta4,profilin II
4433,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,G proteins
4434,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,RAFT1
4435,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,actin-binding proteins
4436,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,gephyrin
4437,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,Rac
4438,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,RAFT1,actin-binding proteins
4439,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,RAFT1,gephyrin
4440,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,profilin,actin-binding proteins
4441,BioInfer.d451,True,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,actin-binding proteins,gephyrin
4442,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,G proteins
4443,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,RAFT1
4444,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,profilin
4445,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,actin-binding proteins
4446,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,gephyrin
4447,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,Rho,Rac
4448,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,G proteins
4449,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,RAFT1
4450,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,profilin
4451,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,actin-binding proteins
4452,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,gephyrin
4453,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,Rac
4454,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,G proteins,profilin
4455,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,RAFT1,profilin
4456,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,RAFT1,Rac
4457,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,profilin,gephyrin
4458,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,profilin,Rac
4459,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,actin-binding proteins,Rac
4460,BioInfer.d451,False,"Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.",BioInfer.d451.s0,gephyrin,Rac
4461,BioInfer.d452,True,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,actin-binding proteins,profilin
4462,BioInfer.d452,True,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,actin-binding proteins,gelsolin
4463,BioInfer.d452,True,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,profilin,actin
4464,BioInfer.d452,True,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,actin,gelsolin
4465,BioInfer.d452,False,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,actin-binding proteins,actin
4466,BioInfer.d452,False,"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.",BioInfer.d452.s0,profilin,gelsolin
4467,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,P,N
4468,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,P,nucleocapsid proteins
4469,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,P,phosphoprotein proteins
4470,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,P,M
4471,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,P,matrix proteins
4472,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,N,nucleocapsid proteins
4473,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,N,phosphoprotein proteins
4474,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,N,M
4475,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,N,matrix proteins
4476,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,nucleocapsid proteins,phosphoprotein proteins
4477,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,nucleocapsid proteins,M
4478,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,nucleocapsid proteins,matrix proteins
4479,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,phosphoprotein proteins,M
4480,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,phosphoprotein proteins,matrix proteins
4481,BioInfer.d453,False,"No evidence for the surface expression of the phosphoprotein (P), matrix (M) or nucleocapsid (N) proteins was found.",BioInfer.d453.s0,M,matrix proteins
4482,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,beta 1-integrin,vinculin
4483,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,beta 1-integrin,actin
4484,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,beta 1-integrin,talin
4485,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,vinculin,actin
4486,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,vinculin,talin
4487,BioInfer.d454,False,"No significant changes in glomerular vinculin, talin, beta 1-integrin, or total actin expression occurred at any time point during disease development.",BioInfer.d454.s0,actin,talin
4488,BioInfer.d455,True,"Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.",BioInfer.d455.s0,FADD,A-SMase
4489,BioInfer.d455,True,"Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.",BioInfer.d455.s0,TRADD,A-SMase
4490,BioInfer.d455,False,"Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.",BioInfer.d455.s0,FADD,TRADD
4491,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,collagenase
4492,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,interleukin-1alpha
4493,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,IL-1alpha
4494,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,collagen
4495,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,cytokines
4496,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,interleukin-1alpha
4497,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,IL-1alpha
4498,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,OSM
4499,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,interleukin-1alpha
4500,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,IL-1alpha
4501,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,collagen
4502,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,glycoprotein 130
4503,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,gp130
4504,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,interleukin-1alpha,collagen
4505,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,interleukin-1alpha,OSM
4506,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,IL-1alpha,collagen
4507,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,IL-1alpha,OSM
4508,BioInfer.d456,True,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagen,OSM
4509,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,cytokines
4510,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,glycoprotein 130
4511,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,OSM
4512,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,oncostatin M,gp130
4513,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,collagen
4514,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,glycoprotein 130
4515,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagenase,gp130
4516,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,cytokines,OSM
4517,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,interleukin-1alpha,IL-1alpha
4518,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,interleukin-1alpha,glycoprotein 130
4519,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,interleukin-1alpha,gp130
4520,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,IL-1alpha,glycoprotein 130
4521,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,IL-1alpha,gp130
4522,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagen,glycoprotein 130
4523,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,collagen,gp130
4524,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,glycoprotein 130,OSM
4525,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,glycoprotein 130,gp130
4526,BioInfer.d456,False,"OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.",BioInfer.d456.s0,OSM,gp130
4527,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,nucleocapsid protein,N
4528,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,nucleocapsid protein,phosphoprotein
4529,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,nucleocapsid protein,P protein
4530,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,N,phosphoprotein
4531,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,N,P protein
4532,BioInfer.d457,False,"Of the five major structural proteins of MV, only nucleocapsid (N) protein and phosphoprotein (P protein) were consistently detected in diseased brain areas.",BioInfer.d457.s0,phosphoprotein,P protein
4533,BioInfer.d459,True,"Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.",BioInfer.d459.s0,actin,profilin
4534,BioInfer.d459,False,"Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.",BioInfer.d459.s0,actin,actin
4535,BioInfer.d459,False,"Once the actin monomer is bound to the filament, the profilin is released, and is available to bind to additional actin monomers.",BioInfer.d459.s0,profilin,actin
4536,BioInfer.d460,True,"One involves talin, which has recently been shown to bind actin directly.",BioInfer.d460.s0,talin,actin
4537,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,TRADD
4538,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,p55-R
4539,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,APO1
4540,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,Fas
4541,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,Fas
4542,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,p55
4543,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,FADD
4544,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,RIP
4545,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,APO1
4546,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,Fas
4547,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,RIP
4548,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,Fas,RIP
4549,BioInfer.d461,True,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TNF receptor,p55
4550,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,MORT1
4551,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,p55-R
4552,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,FADD
4553,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,APO1
4554,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,Fas
4555,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,TNF receptor
4556,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,RIP
4557,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,Fas
4558,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,p55
4559,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,TRADD
4560,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,FADD
4561,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,TNF receptor
4562,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,RIP
4563,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,Fas
4564,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,MORT1,p55
4565,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,p55-R
4566,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,FADD
4567,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,APO1
4568,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,Fas
4569,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,TNF receptor
4570,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TRADD,RIP
4571,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,APO1
4572,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,Fas
4573,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,TNF receptor
4574,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,Fas
4575,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,p55-R,p55
4576,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,TNF receptor
4577,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,RIP
4578,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,Fas
4579,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,FADD,p55
4580,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,Fas
4581,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,TNF receptor
4582,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,Fas
4583,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,APO1,p55
4584,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,Fas,TNF receptor
4585,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,Fas,Fas
4586,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,Fas,p55
4587,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TNF receptor,RIP
4588,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,TNF receptor,Fas
4589,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,RIP,Fas
4590,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,RIP,p55
4591,BioInfer.d461,False,"One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.",BioInfer.d461.s0,Fas,p55
4592,BioInfer.d463,True,"One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).",BioInfer.d463.s0,actin-binding protein,Sac6p
4593,BioInfer.d463,True,"One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).",BioInfer.d463.s0,Sac6p,fimbrin
4594,BioInfer.d463,False,"One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).",BioInfer.d463.s0,actin-binding protein,fimbrin
4595,BioInfer.d464,True,"Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.",BioInfer.d464.s0,actin,cofilin
4596,BioInfer.d464,False,"Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.",BioInfer.d464.s0,cofilin,actin
4597,BioInfer.d464,False,"Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.",BioInfer.d464.s0,cofilin,cofilin
4598,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,UL9
4599,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,ICP8
4600,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,helicase-primase
4601,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,single-stranded DNA-binding protein
4602,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,UL5
4603,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,UL8
4604,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL52,origin-binding protein
4605,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,ICP8
4606,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,single-stranded DNA-binding protein
4607,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,UL5
4608,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,UL8
4609,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,ICP8,UL5
4610,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,ICP8,UL8
4611,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,ICP8,origin-binding protein
4612,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,helicase-primase,UL5
4613,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,helicase-primase,UL8
4614,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,single-stranded DNA-binding protein,UL5
4615,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,single-stranded DNA-binding protein,UL8
4616,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,single-stranded DNA-binding protein,origin-binding protein
4617,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL5,UL8
4618,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL5,origin-binding protein
4619,BioInfer.d465,True,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL8,origin-binding protein
4620,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,helicase-primase
4621,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,UL9,origin-binding protein
4622,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,ICP8,helicase-primase
4623,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,ICP8,single-stranded DNA-binding protein
4624,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,helicase-primase,single-stranded DNA-binding protein
4625,BioInfer.d465,False,"On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.",BioInfer.d465.s0,helicase-primase,origin-binding protein
4626,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,ICP8,UL9
4627,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,ICP8,UL52
4628,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,ICP8,UL8
4629,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,ICP8,UL5
4630,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL29,UL9
4631,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL29,UL52
4632,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL29,UL8
4633,BioInfer.d465,True,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL29,UL5
4634,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,ICP8,UL29
4635,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL9,UL52
4636,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL9,UL8
4637,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL9,UL5
4638,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL52,UL8
4639,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL52,UL5
4640,BioInfer.d465,False,"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.",BioInfer.d465.s1,UL8,UL5
4641,BioInfer.d466,False,"On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.",BioInfer.d466.s0,vinculin,talin
4642,BioInfer.d466,False,"On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.",BioInfer.d466.s0,vinculin,actin
4643,BioInfer.d466,False,"On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.",BioInfer.d466.s0,talin,actin
4644,BioInfer.d467,True,"On the other hand, we have recently proposed the importance of cofilin, an actin-binding phosphoprotein, in phagocyte functions through dephosphorylation and translocation to the plasma membrane regions.",BioInfer.d467.s0,actin,cofilin
4645,BioInfer.d468,False,Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.,BioInfer.d468.s0,profilin,actin
4646,BioInfer.d468,False,Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.,BioInfer.d468.s0,profilin,cofilin
4647,BioInfer.d468,False,Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.,BioInfer.d468.s0,actin,cofilin
4648,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,CapG,pp60
4649,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,CapG,c-src
4650,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,CapG,actin-binding proteins
4651,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,fragmin,pp60
4652,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,fragmin,c-src
4653,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,fragmin,actin-binding proteins
4654,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,pp60,profilin
4655,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,c-src,profilin
4656,BioInfer.d469,True,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,actin-binding proteins,profilin
4657,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,CapG,fragmin
4658,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,CapG,profilin
4659,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,fragmin,profilin
4660,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,pp60,c-src
4661,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,pp60,actin-binding proteins
4662,BioInfer.d469,False,Other mammalian actin-binding proteins such as profilin and CapG but also fragmin from Physarum polycephalum are similar targets for PIP2-stimulated pp60(c-src) phosphorylation.,BioInfer.d469.s0,c-src,actin-binding proteins
4663,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,p53,caspase
4664,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,p53,TnI
4665,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,p53,lamin B
4666,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,caspase,TnI
4667,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,caspase,lamin B
4668,BioInfer.d470,False,p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.,BioInfer.d470.s0,TnI,lamin B
4669,BioInfer.d471,True,"Other than monomeric actin, no major profilin ligands are detected in crude extracts.",BioInfer.d471.s0,actin,profilin
4670,BioInfer.d471,True,Our results show that the major pool of polymerizable actin monomers is complexed with profilin and spread throughout the cytoplasm.,BioInfer.d471.s1,profilin,actin
4671,BioInfer.d471,True,Selective monoclonal antibodies confirm that most of the profilin is bound to actin: 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.,BioInfer.d471.s2,profilin,actin
4672,BioInfer.d471,True,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,Arp2,profilin
4673,BioInfer.d471,True,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,Arp2,Arp 3
4674,BioInfer.d471,True,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,profilin,actin
4675,BioInfer.d471,True,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,profilin,Arp 3
4676,BioInfer.d471,False,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,Arp2,actin
4677,BioInfer.d471,False,"We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much profilin is bound to its known ligands: actin, membrane PIP(2), Arp2/3 complex and polyproline sequences.",BioInfer.d471.s3,actin,Arp 3
4678,BioInfer.d473,True,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,profilin,protein kinase
4679,BioInfer.d473,True,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,profilin,protein phosphatase
4680,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,actin,profilin
4681,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,actin,profilin
4682,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,actin,protein kinase
4683,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,actin,protein phosphatase
4684,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,profilin,profilin
4685,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,profilin,protein kinase
4686,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,profilin,protein phosphatase
4687,BioInfer.d473,False,"Our data, which suggest that pollen profilin can regulate actin-based cytoskeletal protein assembly and protein kinase or phosphatase activity, indicate a possible role for the involvement of profilin in signaling pathways that may regulate pollen tube growth.",BioInfer.d473.s0,protein kinase,protein phosphatase
4688,BioInfer.d474,True,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,Stat1,TRADD
4689,BioInfer.d474,True,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,Stat1,TNFR1
4690,BioInfer.d474,True,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,Stat1,FADD
4691,BioInfer.d474,False,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,TRADD,TNFR1
4692,BioInfer.d474,False,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,TRADD,FADD
4693,BioInfer.d474,False,Our in vitro recombinant protein-protein interaction studies demonstrated that Stat1 could directly interact with TNFR1 and TRADD but not with FADD.,BioInfer.d474.s0,TNFR1,FADD
4694,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21,PCNA
4695,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21,proliferating cell nuclear antigen
4696,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21,cyclin-dependent kinase inhibitor
4697,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,PCNA,Cip1
4698,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,PCNA,p21WAF1
4699,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,Cip1,proliferating cell nuclear antigen
4700,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,Cip1,cyclin-dependent kinase inhibitor
4701,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21WAF1,proliferating cell nuclear antigen
4702,BioInfer.d479,True,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21WAF1,cyclin-dependent kinase inhibitor
4703,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21,Cip1
4704,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,p21,p21WAF1
4705,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,PCNA,proliferating cell nuclear antigen
4706,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,PCNA,cyclin-dependent kinase inhibitor
4707,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,Cip1,p21WAF1
4708,BioInfer.d479,False,"p21 (p21WAF1/Cip1), a cyclin-dependent kinase inhibitor, induces G1 arrest and can inhibit the activity of the proliferating cell nuclear antigen (PCNA).",BioInfer.d479.s0,proliferating cell nuclear antigen,cyclin-dependent kinase inhibitor
4709,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,F
4710,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,fusion proteins
4711,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,matrix proteins
4712,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,haemagglutinin proteins
4713,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,nucleocapsid protein proteins
4714,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,H proteins
4715,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,P proteins
4716,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,phosphoprotein proteins
4717,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,F proteins
4718,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,H
4719,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,P
4720,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,NP
4721,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP proteins,M
4722,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,fusion proteins
4723,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,matrix proteins
4724,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,haemagglutinin proteins
4725,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,nucleocapsid protein proteins
4726,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,H proteins
4727,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,P proteins
4728,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,phosphoprotein proteins
4729,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,F proteins
4730,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,H
4731,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,P
4732,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,NP
4733,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F,M
4734,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,matrix proteins
4735,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,haemagglutinin proteins
4736,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,nucleocapsid protein proteins
4737,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,H proteins
4738,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,P proteins
4739,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,phosphoprotein proteins
4740,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,F proteins
4741,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,H
4742,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,P
4743,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,NP
4744,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,fusion proteins,M
4745,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,haemagglutinin proteins
4746,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,nucleocapsid protein proteins
4747,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,H proteins
4748,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,P proteins
4749,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,phosphoprotein proteins
4750,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,F proteins
4751,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,H
4752,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,P
4753,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,NP
4754,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,matrix proteins,M
4755,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,nucleocapsid protein proteins
4756,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,H proteins
4757,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,P proteins
4758,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,phosphoprotein proteins
4759,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,F proteins
4760,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,H
4761,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,P
4762,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,NP
4763,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,haemagglutinin proteins,M
4764,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,H proteins
4765,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,P proteins
4766,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,phosphoprotein proteins
4767,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,F proteins
4768,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,H
4769,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,P
4770,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,NP
4771,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,nucleocapsid protein proteins,M
4772,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,P proteins
4773,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,phosphoprotein proteins
4774,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,F proteins
4775,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,H
4776,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,P
4777,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,NP
4778,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H proteins,M
4779,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,phosphoprotein proteins
4780,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,F proteins
4781,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,H
4782,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,P
4783,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,NP
4784,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P proteins,M
4785,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,phosphoprotein proteins,F proteins
4786,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,phosphoprotein proteins,H
4787,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,phosphoprotein proteins,P
4788,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,phosphoprotein proteins,NP
4789,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,phosphoprotein proteins,M
4790,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F proteins,H
4791,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F proteins,P
4792,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F proteins,NP
4793,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,F proteins,M
4794,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H,P
4795,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H,NP
4796,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,H,M
4797,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P,NP
4798,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,P,M
4799,BioInfer.d480,False,"Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.",BioInfer.d480.s0,NP,M
4800,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,actin,talin
4801,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,actin,vinculin
4802,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,actin,beta 1-integrin
4803,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,talin,vinculin
4804,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,talin,beta 1-integrin
4805,BioInfer.d481,False,"Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.",BioInfer.d481.s0,vinculin,beta 1-integrin
4806,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,alpha-catenin,E-cadherin
4807,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,alpha-catenin,beta-catenin
4808,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,alpha-catenin,P-cadherin
4809,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,alpha-catenin,N-cadherin
4810,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,E-cadherin,beta-catenin
4811,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,E-cadherin,P-cadherin
4812,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,E-cadherin,N-cadherin
4813,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,beta-catenin,P-cadherin
4814,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,beta-catenin,N-cadherin
4815,BioInfer.d482,False,"P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.",BioInfer.d482.s0,P-cadherin,N-cadherin
4816,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,gamma-catenin,E-cadherin
4817,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,gamma-catenin,plakoglobin
4818,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,gamma-catenin,beta-catenin
4819,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,gamma-catenin,alpha-catenin
4820,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,E-cadherin,plakoglobin
4821,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,E-cadherin,beta-catenin
4822,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,E-cadherin,alpha-catenin
4823,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,plakoglobin,beta-catenin
4824,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,plakoglobin,alpha-catenin
4825,BioInfer.d484,False,"Pervanadate caused a dramatic augmentation of the phosphorylation of E-cadherin, beta-catenin, and gamma-catenin (plakoglobin), but alpha-catenin was not detectably phosphorylated.",BioInfer.d484.s0,beta-catenin,alpha-catenin
4826,BioInfer.d486,False,Phosphoinositides bind to profilin and regulate actin-based cytoskeletal protein assembly.,BioInfer.d486.s0,actin,profilin
4827,BioInfer.d486,True,Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.,BioInfer.d486.s1,actin,profilin
4828,BioInfer.d486,True,Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.,BioInfer.d486.s1,actin,PKC
4829,BioInfer.d486,True,Phosphorylation of profilin by PKC was not affected by the presence of various concentrations of actin.,BioInfer.d486.s1,profilin,PKC
4830,BioInfer.d487,True,"Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.",BioInfer.d487.s0,actin,fimbrin
4831,BioInfer.d487,True,"Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.",BioInfer.d487.s0,fimbrin,fimbrin
4832,BioInfer.d487,False,"Phosphorylation of the headpiece domain could regulate the actin binding and bundling properties of fimbrin, or it could regulate the interaction of fimbrin with other proteins.",BioInfer.d487.s0,actin,fimbrin
4833,BioInfer.d488,True,Photochemical cleavage of myosin heavy chain and the effect on the interaction with actin.,BioInfer.d488.s0,actin,myosin heavy chain
4834,BioInfer.d490,False,Polyacrylamide gels of platelets heated at 45 degrees C for 90 minutes showed an increase in talin incorporation into heated platelet cytoskeletons but no increase in filamentous actin.,BioInfer.d490.s0,actin,talin
4835,BioInfer.d492,False,"Previously, we have shown that in the absence of RAD52, repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking RAD51, gene conversion is absent but cells can repair the DSB by BIR.",BioInfer.d492.s0,RAD52,RAD51
4836,BioInfer.d493,True,"Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.",BioInfer.d493.s0,profilin,actin
4837,BioInfer.d493,True,"Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.",BioInfer.d493.s0,profilin,actin
4838,BioInfer.d493,False,"Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.",BioInfer.d493.s0,actin,actin
4839,BioInfer.d494,True,Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.,BioInfer.d494.s0,actin,gelsolin
4840,BioInfer.d494,True,Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.,BioInfer.d494.s0,actin,profilin
4841,BioInfer.d494,False,Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of gelsolin and profilin with actin.,BioInfer.d494.s0,gelsolin,profilin
4842,BioInfer.d495,True,"Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.",BioInfer.d495.s0,actin,profilin II
4843,BioInfer.d495,True,"Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.",BioInfer.d495.s0,actin,Profilin I
4844,BioInfer.d495,True,"Profilin I and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.",BioInfer.d495.s0,profilin II,Profilin I
4845,BioInfer.d496,True,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,actin
4846,BioInfer.d496,True,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,Profilin II,actin
4847,BioInfer.d496,True,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,Profilin II,actin
4848,BioInfer.d496,True,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,actin
4849,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,Profilin II
4850,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,profilin I
4851,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,actin
4852,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,Profilin II,profilin I
4853,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,profilin I,actin
4854,BioInfer.d496,False,"Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.",BioInfer.d496.s0,actin,actin
4855,BioInfer.d496,True,"Since functional characteristics for profilin II are lacking, we assayed the actin, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.",BioInfer.d496.s1,profilin II,actin
4856,BioInfer.d497,True,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,actin,profilin
4857,BioInfer.d497,True,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,Profilin,actin
4858,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,actin,Profilin
4859,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,actin,actin
4860,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,actin,profilin
4861,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,Profilin,profilin
4862,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,Profilin,profilin
4863,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,profilin,actin
4864,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,profilin,profilin
4865,BioInfer.d497,False,"Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.",BioInfer.d497.s0,actin,profilin
4866,BioInfer.d497,True,The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.,BioInfer.d497.s1,actin-binding protein,profilin
4867,BioInfer.d497,False,The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.,BioInfer.d497.s1,actin-binding protein,phospholipase C
4868,BioInfer.d497,False,The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.,BioInfer.d497.s1,profilin,phospholipase C
4869,BioInfer.d497,True,The cellular concentrations and binding characteristics of these molecules are consistent with profilin being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of actin polymerization.,BioInfer.d497.s2,actin,profilin
4870,BioInfer.d498,True,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,profilin
4871,BioInfer.d498,True,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,Profilins
4872,BioInfer.d498,True,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,profilin,Profilins
4873,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,actin
4874,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,profilin
4875,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,profilin,actin
4876,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,profilin,profilin
4877,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,Profilins
4878,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,actin,profilin
4879,BioInfer.d498,False,"Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.",BioInfer.d498.s0,Profilins,profilin
4880,BioInfer.d500,False,"Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.",BioInfer.d500.s0,actin,myosin heavy-chain
4881,BioInfer.d500,False,"Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.",BioInfer.d500.s0,actin,casein
4882,BioInfer.d500,False,"Proteolytic activity was not detected with casein, actin, or myosin heavy-chain substrates.",BioInfer.d500.s0,myosin heavy-chain,casein
4883,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,PS1,beta-catenin
4884,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,PS1,E-cadherin
4885,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,PS1,alpha-catenin
4886,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,beta-catenin,E-cadherin
4887,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,beta-catenin,alpha-catenin
4888,BioInfer.d501,True,"PS1 fragments form complexes with E-cadherin, beta-catenin, and alpha-catenin, all components of adherens junctions.",BioInfer.d501.s0,E-cadherin,alpha-catenin
4889,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,filamin,actin
4890,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,filamin,talin
4891,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,filamin,myosin
4892,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,actin,talin
4893,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,actin,myosin
4894,BioInfer.d502,False,"PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.",BioInfer.d502.s0,talin,myosin
4895,BioInfer.d502,True,The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.,BioInfer.d502.s1,actin,talin
4896,BioInfer.d502,False,The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.,BioInfer.d502.s1,actin,filamin
4897,BioInfer.d502,False,The presence of filamin in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a talin mediated mechanism for the attachment of actin filaments to the cell surfaces in the cleavage furrow.,BioInfer.d502.s1,talin,filamin
4898,BioInfer.d505,True,Pyrenyliodoacetamide labeling of cysteine 374 of muscle actin reduces the affinity for profilin 10-fold.,BioInfer.d505.s0,muscle actin,profilin
4899,BioInfer.d505,True,Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of profilin for actin.,BioInfer.d505.s1,actin,profilin
4900,BioInfer.d505,True,"Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.",BioInfer.d505.s2,actin,profilins
4901,BioInfer.d505,False,"Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.",BioInfer.d505.s2,actin,profilin
4902,BioInfer.d505,False,"Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.",BioInfer.d505.s2,profilin,profilins
4903,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,actin,X22
4904,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,actin,titin
4905,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,actin,desmin
4906,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,actin,myosin heavy chain
4907,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,titin
4908,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,desmin
4909,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,myosin heavy chain
4910,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,titin,desmin
4911,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,titin,myosin heavy chain
4912,BioInfer.d506,True,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,desmin,myosin heavy chain
4913,BioInfer.d506,False,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,actin,X22
4914,BioInfer.d506,False,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,X22
4915,BioInfer.d506,False,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,titin,X22
4916,BioInfer.d506,False,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,desmin
4917,BioInfer.d506,False,"Quantitation of the appearance of X22 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: X22, titin, myosin heavy chain, actin, and desmin.",BioInfer.d506.s0,X22,myosin heavy chain
4918,BioInfer.d507,True,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,fimbrin/plastin,actin
4919,BioInfer.d507,True,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,fimbrin/plastin,fimbrin 1
4920,BioInfer.d507,True,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,fimbrin/plastin,AtFim1
4921,BioInfer.d507,False,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,actin,fimbrin 1
4922,BioInfer.d507,False,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,actin,AtFim1
4923,BioInfer.d507,False,"Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].",BioInfer.d507.s0,fimbrin 1,AtFim1
4924,BioInfer.d509,True,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,beta-catenin,actin
4925,BioInfer.d509,True,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,beta-catenin,actin
4926,BioInfer.d509,True,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,beta-catenin,alpha-catenin
4927,BioInfer.d509,True,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,actin,alpha-catenin
4928,BioInfer.d509,False,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,actin,actin
4929,BioInfer.d509,False,Recombinant human beta-catenin can simultaneously bind to the alpha-catenin/actin complex but does not bind actin directly.,BioInfer.d509.s0,actin,alpha-catenin
4930,BioInfer.d510,True,Recruitment of a myosin heavy chain kinase to actin-rich protrusions in Dictyostelium.,BioInfer.d510.s0,actin,myosin heavy chain kinase
4931,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,plakoglobin,alpha-catenin
4932,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,plakoglobin,beta-catenin
4933,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,plakoglobin,E-cadherin
4934,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,alpha-catenin,beta-catenin
4935,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,alpha-catenin,E-cadherin
4936,BioInfer.d512,False,"Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).",BioInfer.d512.s0,beta-catenin,E-cadherin
4937,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha- catenin,alpha-catenin
4938,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha- catenin,beta-catenin
4939,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha- catenin,E-cadherin
4940,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha- catenin,E-cadherin
4941,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha-catenin,beta-catenin
4942,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha-catenin,E-cadherin
4943,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,alpha-catenin,E-cadherin
4944,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,beta-catenin,E-cadherin
4945,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,beta-catenin,E-cadherin
4946,BioInfer.d514,False,"Reduced expression of E-cadherin and alpha-catenin, as well as mutations in the E-cadherin gene, have been found in various carcinomas, whereas mutations in the alpha- and beta-catenin genes have been described only in carcinoma cell lines.",BioInfer.d514.s0,E-cadherin,E-cadherin
4947,BioInfer.d515,False,Regulation of myosin heavy chain and actin isogenes during cardiac growth and hypertrophy.,BioInfer.d515.s0,myosin heavy chain,actin
4948,BioInfer.d517,False,Removal of one nonhomologous DNA end during gene conversion by a RAD1- and MSH2-independent pathway.,BioInfer.d517.s0,RAD1,MSH2
4949,BioInfer.d519,True,Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.,BioInfer.d519.s0,MSH2,MSH6
4950,BioInfer.d519,True,Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.,BioInfer.d519.s0,MSH2,MSH3
4951,BioInfer.d519,False,Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.,BioInfer.d519.s0,MSH6,MSH3
4952,BioInfer.d519,True,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH2
4953,BioInfer.d519,True,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH2,MSH3
4954,BioInfer.d519,True,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH2
4955,BioInfer.d519,True,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH2,MSH3
4956,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH6
4957,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH3
4958,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH2
4959,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH3
4960,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH2,MSH6
4961,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH2,MSH2
4962,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH2,MSH3
4963,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH3
4964,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH6,MSH3
4965,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH3,MSH2
4966,BioInfer.d519,False,Results from epistasis analyses indicate that MSH2 functions in mismatch repair in conjunction with MSH3 or MSH6 and that MSH3 and MSH6 constitute alternate pathways of MSH2-dependent mismatch repair.,BioInfer.d519.s1,MSH3,MSH3
4967,BioInfer.d520,True,Requirement of yeast fimbrin for actin organization and morphogenesis in vivo.,BioInfer.d520.s0,actin,fimbrin
4968,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,myosin heavy chain,myosin
4969,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,myosin heavy chain,actin
4970,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,myosin heavy chain,regulatory light chain
4971,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,myosin,actin
4972,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,myosin,regulatory light chain
4973,BioInfer.d521,False,"Resonance energy transfer determination of the following distances, using a hybrid myosin: those between Cys-55 on the Mercenaria regulatory light chain, SH-1 on the Aequipecten myosin heavy chain, and Cys-374 of actin.",BioInfer.d521.s0,actin,regulatory light chain
4974,BioInfer.d522,True,Reversible binding of actin to gelsolin and profilin in human platelet extracts.,BioInfer.d522.s0,profilin,actin
4975,BioInfer.d522,True,Reversible binding of actin to gelsolin and profilin in human platelet extracts.,BioInfer.d522.s0,actin,gelsolin
4976,BioInfer.d522,False,Reversible binding of actin to gelsolin and profilin in human platelet extracts.,BioInfer.d522.s0,profilin,gelsolin
4977,BioInfer.d522,True,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,actin,profilin
4978,BioInfer.d522,True,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,actin,gelsolin
4979,BioInfer.d522,False,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,actin,gelsolin
4980,BioInfer.d522,False,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,profilin,gelsolin
4981,BioInfer.d522,False,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,profilin,gelsolin
4982,BioInfer.d522,False,"Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).",BioInfer.d522.s1,gelsolin,gelsolin
4983,BioInfer.d522,True,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,Thrombin,actin
4984,BioInfer.d522,True,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,Thrombin,platelet profilin
4985,BioInfer.d522,True,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,Thrombin,platelet gelsolin
4986,BioInfer.d522,True,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,actin,platelet profilin
4987,BioInfer.d522,True,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,actin,platelet gelsolin
4988,BioInfer.d522,False,"Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.",BioInfer.d522.s2,platelet profilin,platelet gelsolin
4989,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,TNF,RIPc
4990,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,FADD,RIPc
4991,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,FADD,TRADD
4992,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,RIPc,MORT1
4993,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,RIPc,TRADD
4994,BioInfer.d523,True,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,MORT1,TRADD
4995,BioInfer.d523,False,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,TNF,FADD
4996,BioInfer.d523,False,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,TNF,MORT1
4997,BioInfer.d523,False,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,TNF,TRADD
4998,BioInfer.d523,False,"RIPc, one of the cleavage products, enhanced interaction between TRADD and FADD/MORT1 and increased cells' sensitivity to TNF.",BioInfer.d523.s0,FADD,MORT1
4999,BioInfer.d526,True,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,PAC2,CIN1
5000,BioInfer.d526,True,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,PAC2,CIN 4
5001,BioInfer.d526,True,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,PAC2,CIN 2
5002,BioInfer.d526,False,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,CIN1,CIN 4
5003,BioInfer.d526,False,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,CIN1,CIN 2
5004,BioInfer.d526,False,"Saccharomyces cerevisiae PAC2 functions with CIN1, 2 and 4 in a pathway leading to normal microtubule stability.",BioInfer.d526.s0,CIN 4,CIN 2
5005,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,spectrin,actin
5006,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,spectrin,tubulin
5007,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,spectrin,myosin heavy chain
5008,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,actin,tubulin
5009,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,actin,myosin heavy chain
5010,BioInfer.d528,False,"SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).",BioInfer.d528.s0,tubulin,myosin heavy chain
5011,BioInfer.d529,True,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,smooth muscle myosin heavy chain
5012,BioInfer.d529,True,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,smooth muscle myosin heavy chain,SM1
5013,BioInfer.d529,True,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,smooth muscle myosin heavy chain,SMemb
5014,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,alpha-SMA
5015,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,alpha-smooth muscle actin
5016,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,SM1
5017,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,desmin
5018,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM2,SMemb
5019,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-SMA,smooth muscle myosin heavy chain
5020,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-SMA,alpha-smooth muscle actin
5021,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-SMA,SM1
5022,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-SMA,desmin
5023,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-SMA,SMemb
5024,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,smooth muscle myosin heavy chain,alpha-smooth muscle actin
5025,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,smooth muscle myosin heavy chain,desmin
5026,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-smooth muscle actin,SM1
5027,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-smooth muscle actin,desmin
5028,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,alpha-smooth muscle actin,SMemb
5029,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM1,desmin
5030,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,SM1,SMemb
5031,BioInfer.d529,False,"Semiserial sections were subjected to immunohistochemical staining with antibodies to alpha-smooth muscle actin (alpha-SMA), desmin and smooth muscle myosin heavy chain isoforms: SM1, SM2 and SMemb.",BioInfer.d529.s0,desmin,SMemb
5032,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,nucleocapsid protein,P
5033,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,nucleocapsid protein,phosphoprotein
5034,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,nucleocapsid protein,P
5035,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,P,phosphoprotein
5036,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,P,P
5037,BioInfer.d530,False,"Sequence analysis of the genes encoding the nucleocapsid protein and phosphoprotein (P) of phocid distemper virus, and editing of the P gene transcript.",BioInfer.d530.s0,phosphoprotein,P
5038,BioInfer.d532,True,"Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).",BioInfer.d532.s0,CBP,CREB
5039,BioInfer.d532,True,"Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).",BioInfer.d532.s0,CREB,CREB binding protein
5040,BioInfer.d532,False,"Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).",BioInfer.d532.s0,CBP,CREB binding protein
5041,BioInfer.d533,True,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,cofilin
5042,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,actin-binding protein
5043,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,type IV collagen
5044,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,profilin
5045,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,embryonic alpha-tubulin
5046,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,hnRNP
5047,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,embryonic beta-tubulin
5048,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,cofilin
5049,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,PIMT
5050,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,ferritin heavy chain,protein L-isoaspartyl methyltransferase
5051,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,type IV collagen
5052,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,profilin
5053,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,embryonic alpha-tubulin
5054,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,hnRNP
5055,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,embryonic beta-tubulin
5056,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,PIMT
5057,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,actin-binding protein,protein L-isoaspartyl methyltransferase
5058,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,profilin
5059,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,embryonic alpha-tubulin
5060,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,hnRNP
5061,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,embryonic beta-tubulin
5062,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,cofilin
5063,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,PIMT
5064,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,type IV collagen,protein L-isoaspartyl methyltransferase
5065,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,embryonic alpha-tubulin
5066,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,hnRNP
5067,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,embryonic beta-tubulin
5068,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,cofilin
5069,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,PIMT
5070,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,profilin,protein L-isoaspartyl methyltransferase
5071,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic alpha-tubulin,hnRNP
5072,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic alpha-tubulin,embryonic beta-tubulin
5073,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic alpha-tubulin,cofilin
5074,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic alpha-tubulin,PIMT
5075,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic alpha-tubulin,protein L-isoaspartyl methyltransferase
5076,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,hnRNP,embryonic beta-tubulin
5077,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,hnRNP,cofilin
5078,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,hnRNP,PIMT
5079,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,hnRNP,protein L-isoaspartyl methyltransferase
5080,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic beta-tubulin,cofilin
5081,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic beta-tubulin,PIMT
5082,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,embryonic beta-tubulin,protein L-isoaspartyl methyltransferase
5083,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,cofilin,PIMT
5084,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,cofilin,protein L-isoaspartyl methyltransferase
5085,BioInfer.d533,False,"Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.",BioInfer.d533.s0,PIMT,protein L-isoaspartyl methyltransferase
5086,BioInfer.d534,True,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,cadherins,catenins
5087,BioInfer.d534,True,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,plakoglobin,catenins
5088,BioInfer.d534,True,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,catenins,alpha-catenin
5089,BioInfer.d534,True,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,catenins,beta-catenin
5090,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,cadherins,plakoglobin
5091,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,cadherins,alpha-catenin
5092,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,cadherins,beta-catenin
5093,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,plakoglobin,alpha-catenin
5094,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,plakoglobin,beta-catenin
5095,BioInfer.d534,False,"Several intracellular proteins termed catenins, including alpha-catenin, beta-catenin, and plakoglobin, are tightly associated with these cadherins and serve to link them to the cytoskeleton.",BioInfer.d534.s0,alpha-catenin,beta-catenin
5096,BioInfer.d535,True,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5097,BioInfer.d535,True,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,actin
5098,BioInfer.d535,True,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,profilins
5099,BioInfer.d535,True,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,profilin-I
5100,BioInfer.d535,True,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5101,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin
5102,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5103,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5104,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5105,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5106,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5107,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5108,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5109,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilins
5110,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilins
5111,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilin-I
5112,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilins
5113,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilin-I
5114,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,profilins
5115,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin,actin
5116,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5117,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5118,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5119,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5120,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5121,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5122,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5123,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,profilins
5124,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,profilin-I
5125,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,profilins
5126,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,profilin-I
5127,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,actin,actin
5128,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5129,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5130,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5131,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5132,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5133,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,profilins
5134,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,profilins
5135,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,actin
5136,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilin-I
5137,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,profilins
5138,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,profilins
5139,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilin-I,actin
5140,BioInfer.d535,False,"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.",BioInfer.d535.s0,profilins,actin
5141,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calbindin,fimbrin
5142,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calbindin,calmodulin
5143,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calbindin,actin
5144,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calbindin,tubulin
5145,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,fimbrin,calmodulin
5146,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,fimbrin,actin
5147,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,fimbrin,tubulin
5148,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calmodulin,actin
5149,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,calmodulin,tubulin
5150,BioInfer.d536,False,"Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.",BioInfer.d536.s0,actin,tubulin
5151,BioInfer.d537,True,Signaling pathways involved in dephosphorylation and localization of the actin-binding protein cofilin in stimulated human neutrophils.,BioInfer.d537.s0,actin-binding protein,cofilin
5152,BioInfer.d537,True,These findings suggest a role of cofilin in stimulus-dependent actin remodeling in motile neutrophils.,BioInfer.d537.s1,cofilin,actin
5153,BioInfer.d538,True,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,actin,fimbrin
5154,BioInfer.d538,True,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,actin,Sac6p
5155,BioInfer.d538,False,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,actin,actin
5156,BioInfer.d538,False,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,fimbrin,Sac6p
5157,BioInfer.d538,False,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,fimbrin,actin
5158,BioInfer.d538,False,"Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.",BioInfer.d538.s0,Sac6p,actin
5159,BioInfer.d539,True,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,GBD,SIR1
5160,BioInfer.d539,True,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,H4,histone
5161,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,GBD
5162,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,SIR1
5163,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,SIR3
5164,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,H4
5165,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,SIR2
5166,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR4,histone
5167,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,GBD,SIR3
5168,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,GBD,H4
5169,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,GBD,SIR2
5170,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,GBD,histone
5171,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR1,SIR3
5172,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR1,H4
5173,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR1,SIR2
5174,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR1,histone
5175,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR3,H4
5176,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR3,SIR2
5177,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR3,histone
5178,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,H4,SIR2
5179,BioInfer.d539,False,"Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.",BioInfer.d539.s0,SIR2,histone
5180,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,armadillo,cadherin
5181,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,armadillo,beta-catenin
5182,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,armadillo,alpha-catenin
5183,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,cadherin,beta-catenin
5184,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,cadherin,alpha-catenin
5185,BioInfer.d540,False,"Since alpha-catenin is required for cadherin-mediated adhesion, the armadillo repeat region alone probably cannot promote cell adhesion, making it unlikely that beta-catenin induces axis duplication by increasing cell adhesion.",BioInfer.d540.s0,beta-catenin,alpha-catenin
5186,BioInfer.d542,True,"Since RAD54 is a recombinational protein associated with RAD51, this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.",BioInfer.d542.s0,RAD51,RAD54
5187,BioInfer.d543,True,"Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.",BioInfer.d543.s0,actin,Single-headed myosin
5188,BioInfer.d543,True,"Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.",BioInfer.d543.s0,Single-headed myosin,myosin heavy chain
5189,BioInfer.d543,False,"Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.",BioInfer.d543.s0,actin,myosin heavy chain
5190,BioInfer.d544,False,Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles.,BioInfer.d544.s0,Smooth muscle alpha actin,Smooth muscle myosin heavy chain
5191,BioInfer.d545,True,Smooth muscle talin prepared from chicken gizzard binds to skeletal muscle actin in vitro.,BioInfer.d545.s0,Smooth muscle talin,skeletal muscle actin
5192,BioInfer.d546,True,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,myosin heavy chain
5193,BioInfer.d546,True,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM2,myosin heavy chain
5194,BioInfer.d546,True,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SMemb,myosin heavy chain
5195,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,alpha-smooth muscle actin
5196,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,caldesmon
5197,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,SM2
5198,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,SMemb
5199,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM1,SMemb
5200,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,alpha-smooth muscle actin,caldesmon
5201,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,alpha-smooth muscle actin,SM2
5202,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,alpha-smooth muscle actin,SMemb
5203,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,alpha-smooth muscle actin,SMemb
5204,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,alpha-smooth muscle actin,myosin heavy chain
5205,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,caldesmon,SM2
5206,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,caldesmon,SMemb
5207,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,caldesmon,SMemb
5208,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,caldesmon,myosin heavy chain
5209,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM2,SMemb
5210,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SM2,SMemb
5211,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SMemb,SMemb
5212,BioInfer.d546,False,"Specific antibodies to myosin heavy chain isoforms (SM1, SM2, SMemb), caldesmon, and alpha-smooth muscle actin and cDNAs for SMemb were used.",BioInfer.d546.s0,SMemb,myosin heavy chain
5213,BioInfer.d547,True,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,P,nucleocapsid protein
5214,BioInfer.d547,True,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,P,N
5215,BioInfer.d547,True,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,phosphoprotein,nucleocapsid protein
5216,BioInfer.d547,True,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,phosphoprotein,N
5217,BioInfer.d547,False,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,P,phosphoprotein
5218,BioInfer.d547,False,"Specific interaction between the nucleocapsid protein (N) and the phosphoprotein (P) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.",BioInfer.d547.s0,nucleocapsid protein,N
5219,BioInfer.d549,False,Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes RAD51 and RAD54 but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-/-) cells.,BioInfer.d549.s0,RAD51,RAD54
5220,BioInfer.d550,True,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,N-cadherin,plakoglobin
5221,BioInfer.d550,True,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,alpha-catenin,plakoglobin
5222,BioInfer.d550,True,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,beta-catenin,plakoglobin
5223,BioInfer.d550,False,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,N-cadherin,alpha-catenin
5224,BioInfer.d550,False,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,N-cadherin,beta-catenin
5225,BioInfer.d550,False,"Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.",BioInfer.d550.s0,alpha-catenin,beta-catenin
5226,BioInfer.d551,False,Structural studies on the ribbon-to-helix transition in profilin: actin crystals.,BioInfer.d551.s0,profilin,actin
5227,BioInfer.d552,True,Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.,BioInfer.d552.s0,cadherins,alpha-catenin
5228,BioInfer.d552,True,Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.,BioInfer.d552.s0,cadherins,plakoglobin
5229,BioInfer.d552,False,Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.,BioInfer.d552.s0,alpha-catenin,plakoglobin
5230,BioInfer.d553,True,Studies on the interaction between actin and cofilin purified by a new method.,BioInfer.d553.s0,actin,cofilin
5231,BioInfer.d554,True,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,profilin,actin
5232,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,cap-,profilin
5233,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,cap-,actin
5234,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,cap-,profilins
5235,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,cap-,profilins
5236,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,profilin,profilins
5237,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,profilin,profilins
5238,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,actin,profilins
5239,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,actin,profilins
5240,BioInfer.d554,False,"Study of mutated yeast profilins and profilins from Acanthamoeba suggests that the ability of profilin to suppress cap- cells is dependent upon a property other than, or in addition to, its ability to bind actin.",BioInfer.d554.s0,profilins,profilins
5241,BioInfer.d556,True,Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.,BioInfer.d556.s0,proliferating cell nuclear antigen,p57KIP2
5242,BioInfer.d556,True,Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.,BioInfer.d556.s0,p57KIP2,cyclin-dependent kinase inhibitor
5243,BioInfer.d556,False,Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.,BioInfer.d556.s0,proliferating cell nuclear antigen,cyclin-dependent kinase inhibitor
5244,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,skeletal muscle actin
5245,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,Myf5
5246,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,MRF4
5247,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,MyoD1
5248,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,myosin light chain 2
5249,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin heavy chain,myogenin
5250,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,skeletal muscle actin,Myf5
5251,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,skeletal muscle actin,MRF4
5252,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,skeletal muscle actin,MyoD1
5253,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,skeletal muscle actin,myosin light chain 2
5254,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,skeletal muscle actin,myogenin
5255,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,Myf5,MRF4
5256,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,Myf5,MyoD1
5257,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,Myf5,myosin light chain 2
5258,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,Myf5,myogenin
5259,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,MRF4,MyoD1
5260,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,MRF4,myosin light chain 2
5261,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,MRF4,myogenin
5262,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,MyoD1,myosin light chain 2
5263,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,MyoD1,myogenin
5264,BioInfer.d557,False,"Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.",BioInfer.d557.s0,myosin light chain 2,myogenin
5265,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,talin,alpha-Sm actin
5266,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,talin,beta1-integrin
5267,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,talin,vinculin
5268,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,alpha-Sm actin,beta1-integrin
5269,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,alpha-Sm actin,vinculin
5270,BioInfer.d558,False,"alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.",BioInfer.d558.s1,beta1-integrin,vinculin
5271,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,actin,TESK1
5272,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,actin,Testicular protein kinase 1
5273,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,TESK1,serine/threonine kinase
5274,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,TESK1,cofilin
5275,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,Testicular protein kinase 1,serine/threonine kinase
5276,BioInfer.d559,True,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,Testicular protein kinase 1,cofilin
5277,BioInfer.d559,False,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,actin,serine/threonine kinase
5278,BioInfer.d559,False,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,actin,cofilin
5279,BioInfer.d559,False,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,TESK1,Testicular protein kinase 1
5280,BioInfer.d559,False,Testicular protein kinase 1 (TESK1) is a serine/threonine kinase highly expressed in testicular germ cells and has the potential to phosphorylate cofilin and induce actin cytoskeletal reorganization.,BioInfer.d559.s0,serine/threonine kinase,cofilin
5281,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,phosphoprotein
5282,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,fusion protein
5283,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,small hydrophobic protein
5284,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,nucleocapsid protein
5285,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,large protein
5286,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,M
5287,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,HN
5288,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,NP
5289,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,matrix protein
5290,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,haemagglutinin-neuraminidase protein
5291,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,P
5292,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,SH
5293,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,F
5294,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,V protein,L
5295,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,fusion protein
5296,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,small hydrophobic protein
5297,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,nucleocapsid protein
5298,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,large protein
5299,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,M
5300,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,HN
5301,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,NP
5302,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,matrix protein
5303,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,haemagglutinin-neuraminidase protein
5304,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,P
5305,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,SH
5306,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,F
5307,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,phosphoprotein,L
5308,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,small hydrophobic protein
5309,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,nucleocapsid protein
5310,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,large protein
5311,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,M
5312,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,HN
5313,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,NP
5314,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,matrix protein
5315,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,haemagglutinin-neuraminidase protein
5316,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,P
5317,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,SH
5318,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,F
5319,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,fusion protein,L
5320,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,nucleocapsid protein
5321,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,large protein
5322,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,M
5323,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,HN
5324,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,NP
5325,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,matrix protein
5326,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,haemagglutinin-neuraminidase protein
5327,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,P
5328,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,SH
5329,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,F
5330,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,small hydrophobic protein,L
5331,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,large protein
5332,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,M
5333,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,HN
5334,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,NP
5335,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,matrix protein
5336,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,haemagglutinin-neuraminidase protein
5337,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,P
5338,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,SH
5339,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,F
5340,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,nucleocapsid protein,L
5341,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,M
5342,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,HN
5343,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,NP
5344,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,matrix protein
5345,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,haemagglutinin-neuraminidase protein
5346,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,P
5347,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,SH
5348,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,F
5349,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,large protein,L
5350,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,HN
5351,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,NP
5352,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,matrix protein
5353,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,haemagglutinin-neuraminidase protein
5354,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,P
5355,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,SH
5356,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,F
5357,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,M,L
5358,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,NP
5359,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,matrix protein
5360,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,haemagglutinin-neuraminidase protein
5361,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,P
5362,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,SH
5363,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,F
5364,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,HN,L
5365,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,matrix protein
5366,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,haemagglutinin-neuraminidase protein
5367,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,P
5368,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,SH
5369,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,F
5370,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,NP,L
5371,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,matrix protein,haemagglutinin-neuraminidase protein
5372,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,matrix protein,P
5373,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,matrix protein,SH
5374,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,matrix protein,F
5375,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,matrix protein,L
5376,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,haemagglutinin-neuraminidase protein,P
5377,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,haemagglutinin-neuraminidase protein,SH
5378,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,haemagglutinin-neuraminidase protein,F
5379,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,haemagglutinin-neuraminidase protein,L
5380,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,P,SH
5381,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,P,F
5382,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,P,L
5383,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,SH,F
5384,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,SH,L
5385,BioInfer.d560,False,"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.",BioInfer.d560.s0,F,L
5386,BioInfer.d561,True,"The actin-binding protein profilin was isolated from Tetrahymena thermophila by affinity chromatography, and the peptide sequence was determined for part of the protein.",BioInfer.d561.s0,actin-binding protein,profilin
5387,BioInfer.d562,True,The actin bundle formation induced by overexpression of cofilin is accompanied with an increase in cell motility of Dictyostelium cells. 4.,BioInfer.d562.s0,actin,cofilin
5388,BioInfer.d563,True,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,actin,talin
5389,BioInfer.d563,True,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,talin,integrins
5390,BioInfer.d563,True,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,talin,vinculin
5391,BioInfer.d563,True,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,talin,actin
5392,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,actin,integrins
5393,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,actin,vinculin
5394,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,actin,actin
5395,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,integrins,vinculin
5396,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,integrins,actin
5397,BioInfer.d563,False,"The actin cytoskeleton-associated protein talin binds to integrins, vinculin, and actin.",BioInfer.d563.s0,vinculin,actin
5398,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,plakoglobin
5399,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,alpha-catenin
5400,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,actin
5401,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,beta-catenin,E-cadherin
5402,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,beta-catenin,alpha-catenin
5403,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,beta-catenin,actin
5404,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,alpha-catenin
5405,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,actin
5406,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,plakoglobin,alpha-catenin
5407,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,plakoglobin,actin
5408,BioInfer.d564,True,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,alpha-catenin,actin
5409,BioInfer.d564,False,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,beta-catenin
5410,BioInfer.d564,False,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,E-cadherin
5411,BioInfer.d564,False,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,beta-catenin,plakoglobin
5412,BioInfer.d564,False,The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.,BioInfer.d564.s0,E-cadherin,plakoglobin
5413,BioInfer.d566,True,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,profilin,WIP
5414,BioInfer.d566,True,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,actin,WIP
5415,BioInfer.d566,True,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,WIP,verprolin
5416,BioInfer.d566,False,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,profilin,actin
5417,BioInfer.d566,False,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,profilin,verprolin
5418,BioInfer.d566,False,The ability of WIP to replace verprolin is dependent on its WH2 actin binding domain and a putative profilin binding domain.,BioInfer.d566.s0,actin,verprolin
5419,BioInfer.d566,True,"Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.",BioInfer.d566.s1,verprolin,actin
5420,BioInfer.d566,True,"Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.",BioInfer.d566.s1,actin,WIP
5421,BioInfer.d566,False,"Thus, like verprolin, WIP functions in yeast to link the polarity development pathway and the actin cytoskeleton to generate cytoskeletal asymmetry.",BioInfer.d566.s1,verprolin,WIP
5422,BioInfer.d567,True,The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.,BioInfer.d567.s0,CBP,CREB
5423,BioInfer.d567,True,The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.,BioInfer.d567.s0,CBP,c-Jun
5424,BioInfer.d567,False,The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.,BioInfer.d567.s0,CREB,c-Jun
5425,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,c-Raf-1-BxB,ER
5426,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,c-Raf-1-BxB,cyclin D1
5427,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,c-Raf-1-BxB,p27Kip1
5428,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,ER,cyclin D1
5429,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,ER,p27Kip1
5430,BioInfer.d568,True,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,cyclin-dependent kinase inhibitor,p27Kip1
5431,BioInfer.d568,False,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,c-Raf-1-BxB,cyclin-dependent kinase inhibitor
5432,BioInfer.d568,False,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,ER,cyclin-dependent kinase inhibitor
5433,BioInfer.d568,False,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,cyclin D1,cyclin-dependent kinase inhibitor
5434,BioInfer.d568,False,The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.,BioInfer.d568.s0,cyclin D1,p27Kip1
5435,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,smoothelin,desmin
5436,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,smoothelin,SM myosin heavy chain
5437,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,smoothelin,alpha-SM actin
5438,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,desmin,SM myosin heavy chain
5439,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,desmin,alpha-SM actin
5440,BioInfer.d569,False,"The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.",BioInfer.d569.s0,SM myosin heavy chain,alpha-SM actin
5441,BioInfer.d571,True,"The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.",BioInfer.d571.s0,vinculin,actin
5442,BioInfer.d571,True,"The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.",BioInfer.d571.s0,talin,actin
5443,BioInfer.d571,False,"The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.",BioInfer.d571.s0,vinculin,talin
5444,BioInfer.d573,True,"The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and profilin (5 microM), the barbed ends being capped.",BioInfer.d573.s0,profilin,actin
5445,BioInfer.d573,True,"The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and profilin (5 microM), the barbed ends being capped.",BioInfer.d573.s0,actin,T beta 4Xen
5446,BioInfer.d573,False,"The amount of unassembled actin (12 microM) is accounted for by the sequestering functions of T beta 4Xen (20 microM) and profilin (5 microM), the barbed ends being capped.",BioInfer.d573.s0,profilin,T beta 4Xen
5447,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,F
5448,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,nucleocapsid proteins
5449,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,P
5450,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,N
5451,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,H proteins
5452,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,fusion proteins
5453,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,matrix proteins
5454,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,M,phosphoprotein proteins
5455,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,nucleocapsid proteins
5456,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,P
5457,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,N
5458,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,H proteins
5459,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,fusion proteins
5460,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,matrix proteins
5461,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,F,phosphoprotein proteins
5462,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,P
5463,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,N
5464,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,H proteins
5465,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,fusion proteins
5466,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,matrix proteins
5467,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,nucleocapsid proteins,phosphoprotein proteins
5468,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,P,N
5469,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,P,H proteins
5470,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,P,fusion proteins
5471,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,P,matrix proteins
5472,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,P,phosphoprotein proteins
5473,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,N,H proteins
5474,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,N,fusion proteins
5475,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,N,matrix proteins
5476,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,N,phosphoprotein proteins
5477,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,H proteins,fusion proteins
5478,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,H proteins,matrix proteins
5479,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,H proteins,phosphoprotein proteins
5480,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,fusion proteins,matrix proteins
5481,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,fusion proteins,phosphoprotein proteins
5482,BioInfer.d574,False,"The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.",BioInfer.d574.s0,matrix proteins,phosphoprotein proteins
5483,BioInfer.d575,True,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,beta-catenin
5484,BioInfer.d575,True,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,alpha-catenin,beta-catenin
5485,BioInfer.d575,True,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,beta-catenin
5486,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,alpha-catenin
5487,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,APC
5488,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,beta-catenin
5489,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,alpha-catenin,APC
5490,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,alpha-catenin,beta-catenin
5491,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,APC,beta-catenin
5492,BioInfer.d575,False,"The APC binding site on beta-catenin may be discontinuous since neither the carboxyl- nor amino-terminal halves of beta-catenin will independently associate with APC, although the amino-terminal half independently binds alpha-catenin.",BioInfer.d575.s0,beta-catenin,beta-catenin
5493,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,E-cadherin,APC
5494,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,E-cadherin,plakoglobin
5495,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,E-cadherin,alpha-catenin
5496,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,E-cadherin,beta-catenin
5497,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,APC,plakoglobin
5498,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,APC,alpha-catenin
5499,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,APC,beta-catenin
5500,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,plakoglobin,alpha-catenin
5501,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,plakoglobin,beta-catenin
5502,BioInfer.d575,True,"The APC protein and E-cadherin form similar but independent complexes with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d575.s1,alpha-catenin,beta-catenin
5503,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,beta-catenin,alpha-catenin
5504,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,beta-catenin,plakoglobin
5505,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,beta-catenin,cadherin
5506,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,beta-catenin,APC
5507,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,beta-catenin,catenin
5508,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,alpha-catenin,plakoglobin
5509,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,alpha-catenin,cadherin
5510,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,alpha-catenin,APC
5511,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,alpha-catenin,catenin
5512,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,plakoglobin,cadherin
5513,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,plakoglobin,APC
5514,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,plakoglobin,catenin
5515,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,cadherin,APC
5516,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,cadherin,catenin
5517,BioInfer.d575,True,"Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.",BioInfer.d575.s2,APC,catenin
5518,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,p14
5519,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,Arp2
5520,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,Arp 3
5521,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,p35
5522,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,Arp3
5523,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,p40
5524,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,p19
5525,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,Arp2
5526,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,Arp2
5527,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,Arp 3
5528,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,p35
5529,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,Arp3
5530,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,p40
5531,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,p19
5532,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,Arp2
5533,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,Arp 3
5534,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,p35
5535,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,Arp3
5536,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,p40
5537,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,p19
5538,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,Arp2
5539,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,p35
5540,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,Arp3
5541,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,p40
5542,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,p19
5543,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,Arp2
5544,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,Arp3
5545,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,p40
5546,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,p19
5547,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,Arp2
5548,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp3,p40
5549,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp3,actin
5550,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp3,p19
5551,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp3,Arp2
5552,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p40,p19
5553,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p40,Arp2
5554,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,actin,Arp2
5555,BioInfer.d576,True,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p19,Arp2
5556,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,actin
5557,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p18,profilin
5558,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,actin
5559,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p14,profilin
5560,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,actin
5561,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp2,profilin
5562,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,actin
5563,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp 3,profilin
5564,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,actin
5565,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p35,profilin
5566,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,Arp3,profilin
5567,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p40,actin
5568,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,p40,profilin
5569,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,actin,profilin
5570,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,actin,p19
5571,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,profilin,p19
5572,BioInfer.d576,False,"The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).",BioInfer.d576.s0,profilin,Arp2
5573,BioInfer.d577,True,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,profilin
5574,BioInfer.d577,True,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,profilin,Arp 3
5575,BioInfer.d577,True,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,profilin,Arp2
5576,BioInfer.d577,True,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Arp 3,Arp2
5577,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,Scar
5578,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,Arp 3
5579,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,Scar
5580,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,Scar
5581,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,actin,Arp2
5582,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,profilin,Scar
5583,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,profilin,Scar
5584,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,profilin,Scar
5585,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Arp 3
5586,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Scar
5587,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Scar
5588,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Arp2
5589,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Arp 3,Scar
5590,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Arp 3,Scar
5591,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Scar
5592,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Arp2
5593,BioInfer.d577,False,"The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.",BioInfer.d577.s0,Scar,Arp2
5594,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,Pol
5595,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,UL42
5596,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,UL52
5597,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,UL8
5598,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,UL9
5599,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,SSB,UL5
5600,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,Pol,UL42
5601,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,Pol,UL52
5602,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,Pol,UL8
5603,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,Pol,UL9
5604,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,Pol,UL5
5605,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL42,UL52
5606,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL42,UL8
5607,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL42,UL9
5608,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL42,UL5
5609,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL52,UL8
5610,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL52,UL9
5611,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL52,UL5
5612,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL8,UL9
5613,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL8,UL5
5614,BioInfer.d579,False,"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.",BioInfer.d579.s0,UL9,UL5
5615,BioInfer.d580,True,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,UL52,UL8
5616,BioInfer.d580,True,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,UL52,UL5
5617,BioInfer.d580,True,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,helicase-primase,UL8
5618,BioInfer.d580,True,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,UL8,UL5
5619,BioInfer.d580,False,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,UL52,helicase-primase
5620,BioInfer.d580,False,The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.,BioInfer.d580.s0,helicase-primase,UL5
5621,BioInfer.d580,True,"The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.",BioInfer.d580.s1,UL52,UL8
5622,BioInfer.d580,True,"The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.",BioInfer.d580.s1,UL52,UL5
5623,BioInfer.d580,True,"The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.",BioInfer.d580.s1,UL8,UL5
5624,BioInfer.d581,True,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,CD26,CD26
5625,BioInfer.d581,True,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,CD26,dipeptidyl peptidase IV
5626,BioInfer.d581,False,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,adenosine deaminase,CD26
5627,BioInfer.d581,False,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,adenosine deaminase,CD26
5628,BioInfer.d581,False,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,adenosine deaminase,dipeptidyl peptidase IV
5629,BioInfer.d581,False,The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.,BioInfer.d581.s0,CD26,dipeptidyl peptidase IV
5630,BioInfer.d583,True,"The binding surfaces for segment 1 and profilin are different, although they peripherally overlap on actin.",BioInfer.d583.s0,actin,profilin
5631,BioInfer.d583,True,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,actin,DNase I
5632,BioInfer.d583,True,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,actin,profilin
5633,BioInfer.d583,True,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,actin,gelsolin
5634,BioInfer.d583,False,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,DNase I,profilin
5635,BioInfer.d583,False,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,DNase I,gelsolin
5636,BioInfer.d583,False,"This review describes three structures of actin complexed with different monomer-binding proteins, namely with DNase I, gelsolin segment 1, and profilin.",BioInfer.d583.s1,profilin,gelsolin
5637,BioInfer.d584,True,The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.,BioInfer.d584.s0,myosin heavy chain,actin
5638,BioInfer.d584,True,The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.,BioInfer.d584.s0,MHC,actin
5639,BioInfer.d584,False,The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.,BioInfer.d584.s0,myosin heavy chain,MHC
5640,BioInfer.d586,False,The RAD54 and RAD51 genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.,BioInfer.d586.s0,RAD54,RAD51
5641,BioInfer.d587,True,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,actin,Arp 3
5642,BioInfer.d587,True,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,actin,Arp2
5643,BioInfer.d587,True,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,actin,Wiskott-Aldrich syndrome protein
5644,BioInfer.d587,True,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,verprolin,Wiskott-Aldrich syndrome protein
5645,BioInfer.d587,True,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,Arp 3,Arp2
5646,BioInfer.d587,False,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,actin,verprolin
5647,BioInfer.d587,False,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,verprolin,Arp 3
5648,BioInfer.d587,False,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,verprolin,Arp2
5649,BioInfer.d587,False,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,Arp 3,Wiskott-Aldrich syndrome protein
5650,BioInfer.d587,False,The verprolin-like central (vc) region of Wiskott-Aldrich syndrome protein induces Arp2/3 complex-dependent actin nucleation.,BioInfer.d587.s0,Arp2,Wiskott-Aldrich syndrome protein
5651,BioInfer.d588,True,"The C374S mutation had the most pronounced effect; it reduced the polymerizability of the actin, abolished its binding to profilin, and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.",BioInfer.d588.s0,actin,profilin
5652,BioInfer.d590,True,The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.,BioInfer.d590.s0,actin,myosin heavy chain
5653,BioInfer.d590,True,The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.,BioInfer.d590.s0,actin,cardiac myosin heavy chain
5654,BioInfer.d590,True,The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.,BioInfer.d590.s0,myosin heavy chain,cardiac myosin heavy chain
5655,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,vinculin,fibronectin receptor
5656,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,vinculin,actin
5657,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,vinculin,talin
5658,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,fibronectin receptor,actin
5659,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,fibronectin receptor,talin
5660,BioInfer.d591,False,"The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the fibronectin receptor, talin, vinculin and actin.",BioInfer.d591.s0,actin,talin
5661,BioInfer.d592,True,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,CREB-binding protein,CBP
5662,BioInfer.d592,True,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,CBP,E1A
5663,BioInfer.d592,True,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,p300,E1A
5664,BioInfer.d592,False,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,CREB-binding protein,p300
5665,BioInfer.d592,False,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,CREB-binding protein,E1A
5666,BioInfer.d592,False,The cellular transcription co-activators p300 and the CREB-binding protein CBP are cellular targets for transformation by the E1A proteins of non-oncogenic adenovirus 5 (Ad5).,BioInfer.d592.s0,CBP,p300
5667,BioInfer.d595,True,The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).,BioInfer.d595.s0,beta-catenin,E-cadherin
5668,BioInfer.d595,True,The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).,BioInfer.d595.s0,beta-catenin,alpha-catenin
5669,BioInfer.d595,False,The common denominator is impaired beta-catenin association with either E-cadherin (PaTuII) or alpha-catenin (BxPc3 and T3M4).,BioInfer.d595.s0,E-cadherin,alpha-catenin
5670,BioInfer.d596,True,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,E-CD,plakoglobin
5671,BioInfer.d596,True,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,E-CD,beta-catenin
5672,BioInfer.d596,True,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,E-CD,alpha-catenin
5673,BioInfer.d596,False,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,plakoglobin,beta-catenin
5674,BioInfer.d596,False,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,plakoglobin,alpha-catenin
5675,BioInfer.d596,False,"The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d596.s0,beta-catenin,alpha-catenin
5676,BioInfer.d597,False,"The concentration of beta-catenin was constant during the follicular phase, whereas the content of alpha-catenin decreased in granulosa cells after treatment with diethylstilboestrol or hCG.",BioInfer.d597.s0,alpha-catenin,beta-catenin
5677,BioInfer.d597,False,alpha- and beta-catenin were present in most ovarian cells at all stages of folliculogenesis.,BioInfer.d597.s1,beta-catenin,alpha- catenin
5678,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2B
5679,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5680,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5681,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5682,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5683,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5684,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2B
5685,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5686,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5687,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5688,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5689,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5690,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5691,BioInfer.d599,True,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2B
5692,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5693,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histones
5694,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5695,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5696,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5697,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histones
5698,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5699,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5700,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5701,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5702,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5703,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5704,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2B
5705,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5706,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histones
5707,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5708,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5709,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5710,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5711,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histones
5712,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5713,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5714,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5715,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5716,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5717,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5718,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5719,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5720,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5721,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5722,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2B
5723,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histone
5724,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,histones
5725,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5726,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5727,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5728,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5729,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5730,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5731,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5732,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5733,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histones
5734,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5735,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5736,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5737,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5738,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5739,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5740,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5741,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5742,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5743,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histone
5744,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histones
5745,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5746,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5747,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5748,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5749,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5750,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5751,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5752,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5753,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,histone
5754,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,histones
5755,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H4
5756,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H4
5757,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H3
5758,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H4
5759,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H2A
5760,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H3
5761,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H2B
5762,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H2A
5763,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H3
5764,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,histones
5765,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5766,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5767,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H4
5768,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5769,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5770,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2B
5771,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H2A
5772,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histone,H3
5773,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5774,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5775,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H4
5776,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H2A
5777,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,histones,H3
5778,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H4
5779,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5780,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H4
5781,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5782,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5783,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2B
5784,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5785,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5786,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5787,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H4
5788,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5789,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5790,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2B
5791,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5792,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5793,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H4
5794,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H2A
5795,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H3
5796,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H2B
5797,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H2A
5798,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H3
5799,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5800,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5801,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2B
5802,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H2A
5803,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H4,H3
5804,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2A,H3
5805,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2A,H2B
5806,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2A,H2A
5807,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2A,H3
5808,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H2B
5809,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H2A
5810,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H3,H3
5811,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H2A
5812,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2B,H3
5813,BioInfer.d599,False,"The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.",BioInfer.d599.s0,H2A,H3
5814,BioInfer.d602,True,"The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.",BioInfer.d602.s0,ORC4,ORC5
5815,BioInfer.d602,True,"The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.",BioInfer.d602.s0,ORC4,ORC3
5816,BioInfer.d602,True,"The C-terminal region of ORC3 was, however, necessary to bring ORC4 and ORC5 into the core complex.",BioInfer.d602.s0,ORC5,ORC3
5817,BioInfer.d603,True,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,alpha-catenin,E-cadherin
5818,BioInfer.d603,True,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,plakoglobin,E-cadherin
5819,BioInfer.d603,True,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,E-cadherin,beta-catenin
5820,BioInfer.d603,True,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,E-cadherin,gamma-catenin
5821,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,alpha-catenin,plakoglobin
5822,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,alpha-catenin,E-cadherin
5823,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,alpha-catenin,gamma-catenin
5824,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,alpha-catenin,beta-catenin
5825,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,plakoglobin,E-cadherin
5826,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,plakoglobin,gamma-catenin
5827,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,plakoglobin,beta-catenin
5828,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,E-cadherin,E-cadherin
5829,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,E-cadherin,gamma-catenin
5830,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,E-cadherin,beta-catenin
5831,BioInfer.d603,False,"The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.",BioInfer.d603.s0,gamma-catenin,beta-catenin
5832,BioInfer.d603,True,alpha- and beta-catenin assemble into a 1:1 heterodimeric complex.,BioInfer.d603.s1,beta-catenin,alpha- catenin
5833,BioInfer.d604,True,The deduced peptide sequence contained a nuclear localization signal and a putative actin-binding sequence as reported in NM-type cofilin.,BioInfer.d604.s0,NM-type cofilin,actin
5834,BioInfer.d605,True,"The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.",BioInfer.d605.s0,actin,profilin
5835,BioInfer.d605,False,"The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.",BioInfer.d605.s0,actin,GAF/PAS
5836,BioInfer.d605,False,"The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.",BioInfer.d605.s0,GAF/PAS,profilin
5837,BioInfer.d606,True,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,E1A,p300
5838,BioInfer.d606,True,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,K03H1.10,CBP
5839,BioInfer.d606,True,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,p300,CBP
5840,BioInfer.d606,True,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,R10E11.1,CBP
5841,BioInfer.d606,True,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,CREB,CBP
5842,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,E1A,K03H1.10
5843,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,E1A,R10E11.1
5844,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,E1A,CREB
5845,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,E1A,CBP
5846,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,K03H1.10,p300
5847,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,K03H1.10,R10E11.1
5848,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,K03H1.10,CREB
5849,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,p300,R10E11.1
5850,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,p300,CREB
5851,BioInfer.d606,False,"The domains in CBP that are involved in CREB binding and transcriptional activation are highly related to the adenoviral E1A-associated cellular protein p300 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, R10E11.1 and K03H1.10 (refs 4 and 5, respectively), whose functions are unknown.",BioInfer.d606.s0,R10E11.1,CREB
5852,BioInfer.d607,True,"The drastic effects of the exogenous cofilin on actin assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).",BioInfer.d607.s0,actin,cofilin
5853,BioInfer.d607,True,"The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that cofilin is deeply involved in the regulation of actin assembly in developing skeletal muscle.",BioInfer.d607.s1,actin,cofilin
5854,BioInfer.d608,True,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,alpha-catenin,E-cadherin
5855,BioInfer.d608,True,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,beta-catenin,E-cadherin
5856,BioInfer.d608,False,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,alpha-catenin,beta-catenin
5857,BioInfer.d608,False,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,alpha-catenin,TPA
5858,BioInfer.d608,False,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,beta-catenin,TPA
5859,BioInfer.d608,False,The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.,BioInfer.d608.s0,TPA,E-cadherin
5860,BioInfer.d609,True,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,laminin,myosin heavy chain
5861,BioInfer.d609,True,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,laminin,MHC
5862,BioInfer.d609,True,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,laminin,alpha-skeletal actin
5863,BioInfer.d609,False,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,myosin heavy chain,MHC
5864,BioInfer.d609,False,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,myosin heavy chain,alpha-skeletal actin
5865,BioInfer.d609,False,The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.,BioInfer.d609.s0,MHC,alpha-skeletal actin
5866,BioInfer.d610,False,"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting myosin heavy chain, actin and tropomyosin.",BioInfer.d610.s0,actin,tropomyosin
5867,BioInfer.d610,False,"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting myosin heavy chain, actin and tropomyosin.",BioInfer.d610.s0,actin,myosin heavy chain
5868,BioInfer.d610,False,"The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting myosin heavy chain, actin and tropomyosin.",BioInfer.d610.s0,tropomyosin,myosin heavy chain
5869,BioInfer.d611,True,The existence of this pathway helps to explain some of the effects of LIM kinase and cofilin in the control of actin dynamics.,BioInfer.d611.s0,LIM kinase,actin
5870,BioInfer.d611,True,The existence of this pathway helps to explain some of the effects of LIM kinase and cofilin in the control of actin dynamics.,BioInfer.d611.s0,cofilin,actin
5871,BioInfer.d611,False,The existence of this pathway helps to explain some of the effects of LIM kinase and cofilin in the control of actin dynamics.,BioInfer.d611.s0,LIM kinase,cofilin
5872,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,APC,beta-catenin
5873,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,APC,alpha-catenin
5874,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,APC,APC
5875,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,beta-catenin,alpha-catenin
5876,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,beta-catenin,APC
5877,BioInfer.d612,False,"The expression of APC, alpha-catenin and beta-catenin also was decreased in HT29 cells, with a translocation of APC into the nucleus.",BioInfer.d612.s0,alpha-catenin,APC
5878,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,M1
5879,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,muscarinic receptor
5880,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,muscarinic receptors
5881,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,IL-2
5882,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,muscarinic receptor
5883,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,extracellular signal regulated protein kinase
5884,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,MAPK
5885,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,AP-1
5886,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,p38
5887,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,mitogen-activated protein kinase
5888,BioInfer.d613,True,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,p38
5889,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,muscarinic receptors
5890,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,c-Jun N-terminal kinase
5891,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,IL-2
5892,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,muscarinic receptor
5893,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,MAPK
5894,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,extracellular signal regulated protein kinase
5895,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,MAPK
5896,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,AP-1
5897,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,p38
5898,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,mitogen-activated protein kinase
5899,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,c-Jun N-terminal kinase
5900,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,IL-2
5901,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,muscarinic receptor
5902,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,muscarinic receptor
5903,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,MAPK
5904,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,extracellular signal regulated protein kinase
5905,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,MAPK
5906,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,AP-1
5907,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,p38
5908,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,M1,mitogen-activated protein kinase
5909,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,c-Jun N-terminal kinase
5910,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,IL-2
5911,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,muscarinic receptor
5912,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,muscarinic receptor
5913,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,MAPK
5914,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,extracellular signal regulated protein kinase
5915,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,MAPK
5916,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,AP-1
5917,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,p38
5918,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptors,mitogen-activated protein kinase
5919,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,muscarinic receptor
5920,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,muscarinic receptor
5921,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,MAPK
5922,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,extracellular signal regulated protein kinase
5923,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,MAPK
5924,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,AP-1
5925,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,p38
5926,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,c-Jun N-terminal kinase,mitogen-activated protein kinase
5927,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,muscarinic receptor
5928,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,IL-2,MAPK
5929,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,muscarinic receptor
5930,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,MAPK
5931,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,extracellular signal regulated protein kinase
5932,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,MAPK
5933,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,AP-1
5934,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,p38
5935,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,mitogen-activated protein kinase
5936,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,MAPK
5937,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,extracellular signal regulated protein kinase
5938,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,MAPK
5939,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,AP-1
5940,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,p38
5941,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,muscarinic receptor,mitogen-activated protein kinase
5942,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,extracellular signal regulated protein kinase
5943,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,MAPK
5944,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,AP-1
5945,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,mitogen-activated protein kinase
5946,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,extracellular signal regulated protein kinase,MAPK
5947,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,extracellular signal regulated protein kinase,AP-1
5948,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,extracellular signal regulated protein kinase,p38
5949,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,extracellular signal regulated protein kinase,mitogen-activated protein kinase
5950,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,AP-1
5951,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,p38
5952,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,MAPK,mitogen-activated protein kinase
5953,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,AP-1,p38
5954,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,AP-1,mitogen-activated protein kinase
5955,BioInfer.d613,False,"The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.",BioInfer.d613.s0,p38,mitogen-activated protein kinase
5956,BioInfer.d615,False,"The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.",BioInfer.d615.s0,CBP,CBP
5957,BioInfer.d615,False,"The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.",BioInfer.d615.s0,CBP,CREB binding protein
5958,BioInfer.d615,False,"The gene for the human CREB binding protein, the transcriptional coactivator CBP, is included in the RT1 cosmid, and mutations in CBP have recently been identified in nondeleted RTS patients.",BioInfer.d615.s0,CBP,CREB binding protein
5959,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,5S rRNA
5960,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,18S rRNA
5961,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,profilins Ia
5962,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,myosins IC
5963,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,actin I
5964,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,profilins II
5965,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,myosins II
5966,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,profilins I b
5967,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,myosins IB
5968,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5.8S rRNA,calmodulin
5969,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,18S rRNA
5970,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,profilins Ia
5971,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,myosins IC
5972,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,actin I
5973,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,profilins II
5974,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,myosins II
5975,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,profilins I b
5976,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,myosins IB
5977,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,5S rRNA,calmodulin
5978,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,profilins Ia
5979,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,myosins IC
5980,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,actin I
5981,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,profilins II
5982,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,myosins II
5983,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,profilins I b
5984,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,myosins IB
5985,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,18S rRNA,calmodulin
5986,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,myosins IC
5987,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,actin I
5988,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,profilins II
5989,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,myosins II
5990,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,profilins I b
5991,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,myosins IB
5992,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins Ia,calmodulin
5993,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,actin I
5994,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,profilins II
5995,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,myosins II
5996,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,profilins I b
5997,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,myosins IB
5998,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IC,calmodulin
5999,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,actin I,profilins II
6000,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,actin I,myosins II
6001,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,actin I,profilins I b
6002,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,actin I,myosins IB
6003,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,actin I,calmodulin
6004,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins II,myosins II
6005,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins II,profilins I b
6006,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins II,myosins IB
6007,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins II,calmodulin
6008,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins II,profilins I b
6009,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins II,myosins IB
6010,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins II,calmodulin
6011,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins I b,myosins IB
6012,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,profilins I b,calmodulin
6013,BioInfer.d616,False,"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia/b and II, myosins IB, IC and II, and calmodulin.",BioInfer.d616.s0,myosins IB,calmodulin
6014,BioInfer.d617,True,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,integrins,talin
6015,BioInfer.d617,True,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,integrins,actin
6016,BioInfer.d617,True,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,talin,integrin
6017,BioInfer.d617,True,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,talin,actin
6018,BioInfer.d617,False,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,integrins,integrin
6019,BioInfer.d617,False,The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.,BioInfer.d617.s0,integrin,actin
6020,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,UL5,helicase-primase
6021,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,UL5,UL8
6022,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,UL5,UL52
6023,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,helicase-primase,UL8
6024,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,helicase-primase,UL52
6025,BioInfer.d618,True,"The herpes simplex virus helicase-primase complex, a heterotrimer of the UL5, UL8, and UL52 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).",BioInfer.d618.s0,UL8,UL52
6026,BioInfer.d620,True,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,UL8,DNA helicase-primase
6027,BioInfer.d620,True,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,UL52,DNA helicase-primase
6028,BioInfer.d620,True,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,DNA helicase-primase,UL5
6029,BioInfer.d620,False,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,UL8,UL52
6030,BioInfer.d620,False,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,UL8,UL5
6031,BioInfer.d620,False,"The herpes simplex virus type-1 DNA helicase-primase is a heterotrimer encoded by the UL5, UL8, and UL52 genes.",BioInfer.d620.s0,UL52,UL5
6032,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,UL5,primosome
6033,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,UL5,UL8
6034,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,UL5,UL52
6035,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,primosome,UL8
6036,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,primosome,UL52
6037,BioInfer.d621,True,"The Herpes simplex virus type 1 primosome consists of three subunits that are the products of the UL5, UL8, and UL52 genes.",BioInfer.d621.s0,UL8,UL52
6038,BioInfer.d622,True,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL8,DNA helicase-primase
6039,BioInfer.d622,True,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL5,DNA helicase-primase
6040,BioInfer.d622,True,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL52,DNA helicase-primase
6041,BioInfer.d622,False,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL8,UL5
6042,BioInfer.d622,False,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL8,UL52
6043,BioInfer.d622,False,"The herpes simplex virus type-1 UL5, UL8, and UL52 genes encode an essential heterotrimeric DNA helicase-primase that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.",BioInfer.d622.s0,UL5,UL52
6044,BioInfer.d623,True,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,actin,profilin
6045,BioInfer.d623,False,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,profilin,profilin
6046,BioInfer.d623,False,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,profilin,actin
6047,BioInfer.d623,False,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,profilin,profilin
6048,BioInfer.d623,False,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,profilin,actin
6049,BioInfer.d623,False,The higher affinity of vaccinia profilin for polyphosphoinositides (Kd = 0.2-8.5 microM) than for actin or poly(L-proline) and the concentration of vaccinia profilin expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia profilin binds preferentially to PIP and PIP2 in vivo.,BioInfer.d623.s0,profilin,profilin
6050,BioInfer.d623,True,"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.",BioInfer.d623.s1,profilin,actin
6051,BioInfer.d623,False,"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.",BioInfer.d623.s1,profilin,profilins
6052,BioInfer.d623,False,"We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate profilins, purified the recombinant viral profilin, and characterized its interactions with actin and polyphosphoinositides.",BioInfer.d623.s1,profilins,actin
6053,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD5,RAD51
6054,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD5,RAD52
6055,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD5,rad18
6056,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD5,RAD1
6057,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD5,rad5
6058,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD51,RAD52
6059,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD51,rad18
6060,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD51,RAD1
6061,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD51,rad5
6062,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD52,rad18
6063,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD52,RAD1
6064,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD52,rad5
6065,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,rad18,RAD1
6066,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,rad18,rad5
6067,BioInfer.d624,False,"The high recombination levels seen in rad5 and rad18 mutants is dependent on the RAD1, RAD51, RAD52, and RAD5 genes.",BioInfer.d624.s0,RAD1,rad5
6068,BioInfer.d625,True,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,p27kip1
6069,BioInfer.d625,True,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p16ink4a,cyclin dependent kinase inhibitor
6070,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,p53
6071,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,p16ink4a
6072,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,cyclin dependent kinase inhibitor
6073,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,cyclin D1
6074,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p27kip1,p53
6075,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p27kip1,p16ink4a
6076,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p27kip1,cyclin dependent kinase inhibitor
6077,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p27kip1,cyclin D1
6078,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p53,p16ink4a
6079,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p53,cyclin dependent kinase inhibitor
6080,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p53,cyclin D1
6081,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,p16ink4a,cyclin D1
6082,BioInfer.d625,False,"The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of cyclin D1, the cyclin dependent kinase inhibitor p16ink4a and of p53 and decreased expression of the cyclin dependent kinase inhibitor p27kip1.",BioInfer.d625.s0,cyclin dependent kinase inhibitor,cyclin D1
6083,BioInfer.d627,True,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,collagens,vimentin
6084,BioInfer.d627,True,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,collagens,actin
6085,BioInfer.d627,True,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,collagens,vinculin
6086,BioInfer.d627,True,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,collagens,talin
6087,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,vimentin,actin
6088,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,vimentin,vinculin
6089,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,vimentin,talin
6090,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,actin,vinculin
6091,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,actin,talin
6092,BioInfer.d627,False,"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.",BioInfer.d627.s0,vinculin,talin
6093,BioInfer.d628,True,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,cyclin-dependent kinase inhibitor,kip1
6094,BioInfer.d628,True,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,cyclin-dependent kinase inhibitor,p27
6095,BioInfer.d628,False,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,cyclin-dependent kinase inhibitor,cyclin D1
6096,BioInfer.d628,False,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,cyclin D1,kip1
6097,BioInfer.d628,False,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,cyclin D1,p27
6098,BioInfer.d628,False,The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the cyclin-dependent kinase inhibitor p27(kip1) but a striking inhibition of the expression of cyclin D1.,BioInfer.d628.s0,kip1,p27
6099,BioInfer.d629,True,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,nucleocapsid protein,P
6100,BioInfer.d629,True,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,nucleocapsid protein,phosphoprotein protein
6101,BioInfer.d629,True,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,N,P
6102,BioInfer.d629,True,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,N,phosphoprotein protein
6103,BioInfer.d629,False,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,nucleocapsid protein,N
6104,BioInfer.d629,False,The interaction between the human respiratory syncytial virus phosphoprotein (P) and nucleocapsid (N) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.,BioInfer.d629.s0,P,phosphoprotein protein
6105,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,phosphoprotein
6106,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,P
6107,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,N,phosphoprotein
6108,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,N,P
6109,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,nucleocapsid proteins,phosphoprotein
6110,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,nucleocapsid proteins,P
6111,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,phosphoprotein,L
6112,BioInfer.d631,True,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,P,L
6113,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,N
6114,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,nucleocapsid proteins
6115,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,CAT
6116,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,large polymerase proteins,L
6117,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,N,nucleocapsid proteins
6118,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,N,CAT
6119,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,N,L
6120,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,nucleocapsid proteins,CAT
6121,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,nucleocapsid proteins,L
6122,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,phosphoprotein,P
6123,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,phosphoprotein,CAT
6124,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,P,CAT
6125,BioInfer.d631,False,The interaction of bovine respiratory syncytial virus (BRSV) phosphoprotein (P) with nucleocapsid (N) and large polymerase (L) proteins was investigated using an intracellular BRSV-CAT minigenome replication system.,BioInfer.d631.s0,CAT,L
6126,BioInfer.d632,True,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,actin,actobindin
6127,BioInfer.d632,True,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,actin,thymosin beta 4
6128,BioInfer.d632,True,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,actin,profilin
6129,BioInfer.d632,False,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,actobindin,thymosin beta 4
6130,BioInfer.d632,False,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,actobindin,profilin
6131,BioInfer.d632,False,"The interactions of actin with thymosin beta 4, actobindin and profilin are compared.",BioInfer.d632.s0,thymosin beta 4,profilin
6132,BioInfer.d633,True,The intracellular molecules calmodulin and profilin actively regulate actin-based motility and participate in the signaling pathways used to steer growth cones.,BioInfer.d633.s0,profilin,actin
6133,BioInfer.d633,True,The intracellular molecules calmodulin and profilin actively regulate actin-based motility and participate in the signaling pathways used to steer growth cones.,BioInfer.d633.s0,calmodulin,actin
6134,BioInfer.d633,False,The intracellular molecules calmodulin and profilin actively regulate actin-based motility and participate in the signaling pathways used to steer growth cones.,BioInfer.d633.s0,profilin,calmodulin
6135,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,TRAIL-R1
6136,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,TRAIL receptors 2
6137,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,TRAIL receptors 1
6138,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,TRAIL-R2
6139,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,TRAIL-R1
6140,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,TRAIL receptors 2
6141,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,TRAIL receptors 1
6142,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,TRAIL-R2
6143,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,TRAIL-R1
6144,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,TRAIL receptors 2
6145,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,TRAIL receptors 1
6146,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,TRAIL-R2
6147,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,TRAIL-R1
6148,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,TRAIL receptors 2
6149,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,TRAIL receptors 1
6150,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,TRAIL-R2
6151,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL-R1,caspases -10
6152,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL-R1,caspases-8
6153,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases -10,TRAIL receptors 2
6154,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases -10,TRAIL receptors 1
6155,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases -10,TRAIL-R2
6156,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases-8,TRAIL receptors 2
6157,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases-8,TRAIL receptors 1
6158,BioInfer.d634,True,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases-8,TRAIL-R2
6159,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,FADD
6160,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,TRADD
6161,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,MORT1
6162,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,caspases -10
6163,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,RIP,caspases-8
6164,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,TRADD
6165,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,MORT1
6166,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,caspases -10
6167,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,FADD,caspases-8
6168,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,MORT1
6169,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,caspases -10
6170,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRADD,caspases-8
6171,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,caspases -10
6172,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,MORT1,caspases-8
6173,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL-R1,TRAIL receptors 2
6174,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL-R1,TRAIL receptors 1
6175,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL-R1,TRAIL-R2
6176,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,caspases -10,caspases-8
6177,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL receptors 2,TRAIL receptors 1
6178,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL receptors 2,TRAIL-R2
6179,BioInfer.d634,False,"The involvement of the death adaptor proteins FADD/MORT1, TRADD, and RIP and the apoptosis-initiating caspases-8 and -10 in death signaling by the two death-inducing TRAIL receptors 1 and 2 (TRAIL-R1 and TRAIL-R2) are controversial.",BioInfer.d634.s0,TRAIL receptors 1,TRAIL-R2
6180,BioInfer.d635,True,"Their abilities to store lipids and express desmin intermediate filaments, alpha-smooth muscle actin, and smooth muscle myosin heavy chain in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.",BioInfer.d635.s0,smooth muscle myosin heavy chain,desmin
6181,BioInfer.d635,True,"Their abilities to store lipids and express desmin intermediate filaments, alpha-smooth muscle actin, and smooth muscle myosin heavy chain in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.",BioInfer.d635.s0,smooth muscle myosin heavy chain,alpha-smooth muscle actin
6182,BioInfer.d635,True,"Their abilities to store lipids and express desmin intermediate filaments, alpha-smooth muscle actin, and smooth muscle myosin heavy chain in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.",BioInfer.d635.s0,desmin,alpha-smooth muscle actin
6183,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,actin,brush border myosin-I
6184,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,actin,villin
6185,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,actin,fimbrin
6186,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,brush border myosin-I,villin
6187,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,brush border myosin-I,fimbrin
6188,BioInfer.d636,True,"The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: actin, villin, fimbrin and brush border myosin-I.",BioInfer.d636.s0,villin,fimbrin
6189,BioInfer.d637,True,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,AF-6,Rap1A
6190,BioInfer.d637,True,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,AF-6,profilin
6191,BioInfer.d637,True,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,Rap1A,GTPase
6192,BioInfer.d637,True,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,actin,profilin
6193,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,AF-6,actin
6194,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,AF-6,GTPase
6195,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,Rap1A,actin
6196,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,Rap1A,profilin
6197,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,actin,GTPase
6198,BioInfer.d637,False,The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin.,BioInfer.d637.s0,GTPase,profilin
6199,BioInfer.d637,True,"To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.",BioInfer.d637.s1,AF-6,profilin
6200,BioInfer.d637,True,"To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.",BioInfer.d637.s1,AF-6,actin
6201,BioInfer.d637,False,"To our knowledge, AF-6 is the only integral component in cell-cell junctions discovered thus far that interacts with profilin and thus could modulate actin modeling proximal to adhesion complexes.",BioInfer.d637.s1,profilin,actin
6202,BioInfer.d638,False,"The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.",BioInfer.d638.s0,actin,profilin
6203,BioInfer.d638,False,"The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.",BioInfer.d638.s0,actin,VASP
6204,BioInfer.d638,False,"The long repeats, which are interdigitated between the PRRs, increased the frequency with which actin-based motility occurred by a mechanism independent of the PRRs, VASP, and profilin.",BioInfer.d638.s0,profilin,VASP
6205,BioInfer.d638,True,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,profilin,ActA
6206,BioInfer.d638,True,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,ActA,actin
6207,BioInfer.d638,True,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,ActA,vasodilator-stimulated phosphoprotein
6208,BioInfer.d638,False,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,profilin,actin
6209,BioInfer.d638,False,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,profilin,vasodilator-stimulated phosphoprotein
6210,BioInfer.d638,False,"The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.",BioInfer.d638.s1,actin,vasodilator-stimulated phosphoprotein
6211,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,CDKI,p27
6212,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,cyclin-dependent kinase 2,p27
6213,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,cyclin-dependent kinase 2,Cdk2
6214,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,cyclin-dependent kinase 2,cyclin E
6215,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,p27,Cdk2
6216,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,p27,cyclin-dependent kinase inhibitor
6217,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,p27,cyclin E
6218,BioInfer.d639,True,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,Cdk2,cyclin E
6219,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,CDKI,cyclin-dependent kinase 2
6220,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,CDKI,Cdk2
6221,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,CDKI,cyclin-dependent kinase inhibitor
6222,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,CDKI,cyclin E
6223,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,cyclin-dependent kinase 2,cyclin-dependent kinase inhibitor
6224,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,Cdk2,cyclin-dependent kinase inhibitor
6225,BioInfer.d639,False,"The main inhibitory action of p27, a cyclin-dependent kinase inhibitor (CDKI), arises from its binding with the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex that results in G(1)-S arrest.",BioInfer.d639.s0,cyclin-dependent kinase inhibitor,cyclin E
6226,BioInfer.d640,False,"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.",BioInfer.d640.s0,alpha-catenin,E-CD
6227,BioInfer.d640,False,"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.",BioInfer.d640.s0,alpha-catenin,beta-catenin
6228,BioInfer.d640,False,"The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for E-CD; 86 per cent for alpha-catenin; 91 per cent for beta-catenin) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.",BioInfer.d640.s0,E-CD,beta-catenin
6229,BioInfer.d641,True,"The majority of the aromatic residues in profilin are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with actin.",BioInfer.d641.s0,profilin,actin
6230,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,villin,calmodulin
6231,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,villin,fimbrin
6232,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,villin,actin
6233,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,calmodulin,fimbrin
6234,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,calmodulin,actin
6235,BioInfer.d644,True,"The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, villin (95,000 daltons), fimbrin (68,000 daltons), actin (43,000 daltons), and calmodulin (17,000 daltons).",BioInfer.d644.s0,fimbrin,actin
6236,BioInfer.d645,True,"The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.",BioInfer.d645.s0,actin-binding protein,profilin
6237,BioInfer.d645,True,"The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.",BioInfer.d645.s0,actin,profilin
6238,BioInfer.d645,False,"The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.",BioInfer.d645.s0,actin-binding protein,actin
6239,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,gamma-catenin,alpha-catenin
6240,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,gamma-catenin,beta-catenin
6241,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,gamma-catenin,E-cadherin
6242,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,alpha-catenin,beta-catenin
6243,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,alpha-catenin,E-cadherin
6244,BioInfer.d646,False,"The most significant finding was the re-expression of E-cadherin, alpha-catenin, and beta-catenin, and increased down-regulation of gamma-catenin, in metastatic lesions.",BioInfer.d646.s0,beta-catenin,E-cadherin
6245,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,histone
6246,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H4
6247,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,acetylase
6248,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,acetylase(s)
6249,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,histone
6250,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,histone
6251,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase,H4
6252,BioInfer.d647,True,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase(s),H4
6253,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,histone
6254,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,H3
6255,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,H3
6256,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,acetylase
6257,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,acetylase(s)
6258,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,histone
6259,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,H4
6260,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,histone
6261,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6262,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H3
6263,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H3
6264,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,acetylase
6265,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,acetylase(s)
6266,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6267,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6268,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H3
6269,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H3
6270,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,acetylase
6271,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,acetylase(s)
6272,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6273,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H4
6274,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6275,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,H3
6276,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,histone
6277,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,H4
6278,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,acetylase
6279,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,acetylase(s)
6280,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,H4
6281,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H3,histone
6282,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase,acetylase(s)
6283,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase,histone
6284,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase,histone
6285,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase(s),histone
6286,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,acetylase(s),histone
6287,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,H4
6288,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,histone,histone
6289,BioInfer.d647,False,"The most striking difference was in the relative preference for acetylation of histone H4 versus acetylation of histone H3: with the purified acetylase, histone H4 in nucleosomes was acetylated to a much greater extent than was histone H3, whereas the reverse preference was found with the endogenous acetylase(s).",BioInfer.d647.s0,H4,histone
6290,BioInfer.d648,True,The multifunctional protein profilin is one of the most abundant proteins in the cytoplasm and is thought to regulate actin assembly and the phosphoinositide signaling pathway.,BioInfer.d648.s0,profilin,actin
6291,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,myosin heavy chain
6292,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,calmodulin
6293,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,myosin regulatory light chain
6294,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,myosin light chain kinase
6295,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,tropomyosin
6296,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,troponin I
6297,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,actin
6298,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,muscle LIM
6299,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,calponin
6300,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,SH3-binding glutamate-rich protein
6301,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calcium vector protein,creatine kinase
6302,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,calmodulin
6303,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,myosin regulatory light chain
6304,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,myosin light chain kinase
6305,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,tropomyosin
6306,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,troponin I
6307,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,actin
6308,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,muscle LIM
6309,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,calponin
6310,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,SH3-binding glutamate-rich protein
6311,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin heavy chain,creatine kinase
6312,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,myosin regulatory light chain
6313,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,myosin light chain kinase
6314,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,tropomyosin
6315,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,troponin I
6316,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,actin
6317,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,muscle LIM
6318,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,calponin
6319,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,SH3-binding glutamate-rich protein
6320,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calmodulin,creatine kinase
6321,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,myosin light chain kinase
6322,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,tropomyosin
6323,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,troponin I
6324,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,actin
6325,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,muscle LIM
6326,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,calponin
6327,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,SH3-binding glutamate-rich protein
6328,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin regulatory light chain,creatine kinase
6329,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,tropomyosin
6330,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,troponin I
6331,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,actin
6332,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,muscle LIM
6333,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,calponin
6334,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,SH3-binding glutamate-rich protein
6335,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,myosin light chain kinase,creatine kinase
6336,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,troponin I
6337,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,actin
6338,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,muscle LIM
6339,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,calponin
6340,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,SH3-binding glutamate-rich protein
6341,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,tropomyosin,creatine kinase
6342,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,troponin I,actin
6343,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,troponin I,muscle LIM
6344,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,troponin I,calponin
6345,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,troponin I,SH3-binding glutamate-rich protein
6346,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,troponin I,creatine kinase
6347,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,actin,muscle LIM
6348,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,actin,calponin
6349,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,actin,SH3-binding glutamate-rich protein
6350,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,actin,creatine kinase
6351,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,muscle LIM,calponin
6352,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,muscle LIM,SH3-binding glutamate-rich protein
6353,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,muscle LIM,creatine kinase
6354,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calponin,SH3-binding glutamate-rich protein
6355,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,calponin,creatine kinase
6356,BioInfer.d649,False,"The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.",BioInfer.d649.s0,SH3-binding glutamate-rich protein,creatine kinase
6357,BioInfer.d650,True,"The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.",BioInfer.d650.s0,profilin,actin
6358,BioInfer.d650,False,"The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.",BioInfer.d650.s0,profilin,actin
6359,BioInfer.d650,False,"The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.",BioInfer.d650.s0,actin,actin
6360,BioInfer.d650,True,The role of profilin in actin polymerization and nucleotide exchange.,BioInfer.d650.s1,actin,profilin
6361,BioInfer.d650,False,"With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).",BioInfer.d650.s2,profilins,actin
6362,BioInfer.d650,False,"With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).",BioInfer.d650.s2,profilins,actin
6363,BioInfer.d650,False,"With profilins, whose sequestering activity was low, the concentration of free actin monomers observed at steady-state of polymerization [Afree], was close to that seen with actin alone ([Acc], critical concentration of polymerization).",BioInfer.d650.s2,actin,actin
6364,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,S-100
6365,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,vimentin
6366,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,alpha-smooth muscle actin
6367,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,Factor-XIIIa
6368,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,desmin
6369,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,CD34
6370,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,high molecular weight caldesmon
6371,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,calponin
6372,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,collagen type IV
6373,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,smooth muscle myosin heavy chain,laminin
6374,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,vimentin
6375,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,alpha-smooth muscle actin
6376,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,Factor-XIIIa
6377,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,desmin
6378,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,CD34
6379,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,high molecular weight caldesmon
6380,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,calponin
6381,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,collagen type IV
6382,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,S-100,laminin
6383,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,alpha-smooth muscle actin
6384,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,Factor-XIIIa
6385,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,desmin
6386,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,CD34
6387,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,high molecular weight caldesmon
6388,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,calponin
6389,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,collagen type IV
6390,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,vimentin,laminin
6391,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,Factor-XIIIa
6392,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,desmin
6393,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,CD34
6394,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,high molecular weight caldesmon
6395,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,calponin
6396,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,collagen type IV
6397,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,alpha-smooth muscle actin,laminin
6398,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,desmin
6399,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,CD34
6400,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,high molecular weight caldesmon
6401,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,calponin
6402,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,collagen type IV
6403,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,Factor-XIIIa,laminin
6404,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,desmin,CD34
6405,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,desmin,high molecular weight caldesmon
6406,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,desmin,calponin
6407,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,desmin,collagen type IV
6408,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,desmin,laminin
6409,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,CD34,high molecular weight caldesmon
6410,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,CD34,calponin
6411,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,CD34,collagen type IV
6412,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,CD34,laminin
6413,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,high molecular weight caldesmon,calponin
6414,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,high molecular weight caldesmon,collagen type IV
6415,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,high molecular weight caldesmon,laminin
6416,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,calponin,collagen type IV
6417,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,calponin,laminin
6418,BioInfer.d651,False,"The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.",BioInfer.d651.s0,collagen type IV,laminin
6419,BioInfer.d652,True,The N-terminal talin polypeptide eventually disrupted actin stress fibres whereas the C-terminal polypeptide was without effect.,BioInfer.d652.s0,talin,actin
6420,BioInfer.d652,True,The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.,BioInfer.d652.s1,actin,talin
6421,BioInfer.d652,True,The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.,BioInfer.d652.s1,talin,vinculin
6422,BioInfer.d652,False,The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.,BioInfer.d652.s1,actin,vinculin
6423,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,P
6424,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,L
6425,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,L
6426,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,M
6427,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,fusion protein
6428,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,P
6429,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,N
6430,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,F
6431,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,nucleocapsid protein
6432,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,matrix protein
6433,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,phosphoprotein protein
6434,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,large protein
6435,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,M
6436,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,N
6437,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,L
6438,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,L
6439,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,M
6440,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,fusion protein
6441,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,P
6442,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,N
6443,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,F
6444,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,nucleocapsid protein
6445,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,matrix protein
6446,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,phosphoprotein protein
6447,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,large protein
6448,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,M
6449,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,N
6450,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,L
6451,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,M
6452,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,fusion protein
6453,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,P
6454,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,N
6455,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,F
6456,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,nucleocapsid protein
6457,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,matrix protein
6458,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,phosphoprotein protein
6459,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,large protein
6460,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,M
6461,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,N
6462,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,M
6463,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,fusion protein
6464,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,P
6465,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,N
6466,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,F
6467,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,nucleocapsid protein
6468,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,matrix protein
6469,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,phosphoprotein protein
6470,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,large protein
6471,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,M
6472,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,L,N
6473,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,fusion protein
6474,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,P
6475,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,N
6476,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,F
6477,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,nucleocapsid protein
6478,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,matrix protein
6479,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,phosphoprotein protein
6480,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,large protein
6481,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,M
6482,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,N
6483,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,P
6484,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,N
6485,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,F
6486,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,nucleocapsid protein
6487,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,matrix protein
6488,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,phosphoprotein protein
6489,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,large protein
6490,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,M
6491,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,fusion protein,N
6492,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,N
6493,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,F
6494,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,nucleocapsid protein
6495,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,matrix protein
6496,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,phosphoprotein protein
6497,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,large protein
6498,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,M
6499,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,P,N
6500,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,F
6501,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,nucleocapsid protein
6502,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,matrix protein
6503,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,phosphoprotein protein
6504,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,large protein
6505,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,M
6506,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,N,N
6507,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,nucleocapsid protein
6508,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,matrix protein
6509,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,phosphoprotein protein
6510,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,large protein
6511,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,M
6512,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,F,N
6513,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,nucleocapsid protein,matrix protein
6514,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,nucleocapsid protein,phosphoprotein protein
6515,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,nucleocapsid protein,large protein
6516,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,nucleocapsid protein,M
6517,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,nucleocapsid protein,N
6518,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,matrix protein,phosphoprotein protein
6519,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,matrix protein,large protein
6520,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,matrix protein,M
6521,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,matrix protein,N
6522,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,phosphoprotein protein,large protein
6523,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,phosphoprotein protein,M
6524,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,phosphoprotein protein,N
6525,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,large protein,M
6526,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,large protein,N
6527,BioInfer.d653,False,"The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.",BioInfer.d653.s0,M,N
6528,BioInfer.d654,False,"The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.",BioInfer.d654.s0,beta-catenin,alpha-catenin
6529,BioInfer.d654,False,"The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.",BioInfer.d654.s0,beta-catenin,plakoglobin
6530,BioInfer.d654,False,"The observed in vivo expression patterns of alpha-catenin, beta-catenin, and plakoglobin suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.",BioInfer.d654.s0,alpha-catenin,plakoglobin
6531,BioInfer.d654,False,"This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.",BioInfer.d654.s1,alpha-catenin,gamma-catenin
6532,BioInfer.d654,False,"This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.",BioInfer.d654.s1,alpha-catenin,beta-catenin
6533,BioInfer.d654,False,"This study details the expression patterns of alpha-catenin, beta-catenin, and gamma-catenin, during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.",BioInfer.d654.s1,gamma-catenin,beta-catenin
6534,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,beta-catenin,plakoglobin
6535,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,beta-catenin,alpha-catenin
6536,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,beta-catenin,E-cadherin
6537,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,plakoglobin,alpha-catenin
6538,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,plakoglobin,E-cadherin
6539,BioInfer.d656,True,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,alpha-catenin,E-cadherin
6540,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,beta-catenin,p120cas
6541,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,beta-catenin,protein tyrosine kinase
6542,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,plakoglobin,p120cas
6543,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,plakoglobin,protein tyrosine kinase
6544,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,alpha-catenin,p120cas
6545,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,alpha-catenin,protein tyrosine kinase
6546,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,E-cadherin,p120cas
6547,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,E-cadherin,protein tyrosine kinase
6548,BioInfer.d656,False,"The p120cas gene encodes a protein tyrosine kinase substrate that associates with the cell-cell adhesion protein complex containing E-cadherin and its cytoplasmic cofactors alpha-catenin, beta-catenin, and plakoglobin.",BioInfer.d656.s0,p120cas,protein tyrosine kinase
6549,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,cdk2
6550,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,p27
6551,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin A,cdk2
6552,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin A,p27
6553,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin D,cdk4
6554,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin D,p27
6555,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk2,p27
6556,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk4,p27
6557,BioInfer.d657,True,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk2,p27
6558,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,cyclin A
6559,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,cyclin D
6560,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,cdk2
6561,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin E,cdk4
6562,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin A,cyclin D
6563,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin A,cdk4
6564,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin A,cdk2
6565,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin D,cdk2
6566,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cyclin D,cdk2
6567,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk2,cdk4
6568,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk2,cdk2
6569,BioInfer.d657,False,"p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.",BioInfer.d657.s0,cdk4,cdk2
6570,BioInfer.d658,True,"The phosphoprotein was identified as cofilin, an actin-binding protein, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).",BioInfer.d658.s0,actin-binding protein,cofilin
6571,BioInfer.d659,True,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,protein kinase C alpha,AP-1
6572,BioInfer.d659,True,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,c-Jun N-terminal kinase,AP-1
6573,BioInfer.d659,True,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,polycystic kidney disease 1,AP-1
6574,BioInfer.d659,False,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,protein kinase C alpha,c-Jun N-terminal kinase
6575,BioInfer.d659,False,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,protein kinase C alpha,polycystic kidney disease 1
6576,BioInfer.d659,False,The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.,BioInfer.d659.s0,c-Jun N-terminal kinase,polycystic kidney disease 1
6577,BioInfer.d662,False,The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.,BioInfer.d662.s0,myosin heavy chain,MHC
6578,BioInfer.d662,False,The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.,BioInfer.d662.s0,myosin heavy chain,actin
6579,BioInfer.d662,False,The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.,BioInfer.d662.s0,MHC,actin
6580,BioInfer.d663,True,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin-dependent kinase inhibitor,Kip1
6581,BioInfer.d663,True,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin-dependent kinase inhibitor,p27
6582,BioInfer.d663,True,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,Kip1,insulin
6583,BioInfer.d663,True,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin E,insulin
6584,BioInfer.d663,True,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,insulin,p27
6585,BioInfer.d663,False,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin-dependent kinase inhibitor,cyclin E
6586,BioInfer.d663,False,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin-dependent kinase inhibitor,insulin
6587,BioInfer.d663,False,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,Kip1,cyclin E
6588,BioInfer.d663,False,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,Kip1,p27
6589,BioInfer.d663,False,The potentiating effect of insulin appears to involve increases in the expression of cyclin E and decreases in the expression of the cyclin-dependent kinase inhibitor p27(Kip1).,BioInfer.d663.s0,cyclin E,p27
6590,BioInfer.d665,False,"The presence, in varying quantities, of myosin heavy chain and actin isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.",BioInfer.d665.s0,actin,myosin heavy chain
6591,BioInfer.d666,False,The present study was designed to determine if cholesterol feeding results in alterations in the isoforms of actin and/or myosin heavy chain in gallbladder smooth muscle.,BioInfer.d666.s0,myosin heavy chain,actin
6592,BioInfer.d667,False,The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.,BioInfer.d667.s0,actin,MHC
6593,BioInfer.d667,False,The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.,BioInfer.d667.s0,actin,myosin heavy chain
6594,BioInfer.d667,False,The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.,BioInfer.d667.s0,MHC,myosin heavy chain
6595,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,phosphorylatable myosin light chain,myosin heavy chain
6596,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,phosphorylatable myosin light chain,actin
6597,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,phosphorylatable myosin light chain,myosin light chain
6598,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,myosin heavy chain,actin
6599,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,myosin heavy chain,myosin light chain
6600,BioInfer.d668,False,"The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.",BioInfer.d668.s0,actin,myosin light chain
6601,BioInfer.d669,False,"The product of UL38 has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of UL18.",BioInfer.d669.s0,UL38,UL18
6602,BioInfer.d670,False,The products of the yeast mismatch repair genes MSH2 and MSH3 participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.,BioInfer.d670.s0,MSH2,MSH3
6603,BioInfer.d670,False,These results suggest that MSH2 and MSH3 can function differentially to control homeologous exchanges.,BioInfer.d670.s1,MSH2,MSH3
6604,BioInfer.d671,False,The prominent 125 A transverse stripping pattern characteristic of the actin cross-bridges in a bundle is also absent in hair borders suggesting fimbrin as the component that gives rise to the transverse stripes.,BioInfer.d671.s0,actin,fimbrin
6605,BioInfer.d672,True,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,P
6606,BioInfer.d672,True,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,phosphoprotein
6607,BioInfer.d672,True,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,4a
6608,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,G
6609,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,L
6610,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,4b
6611,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,M
6612,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,N
6613,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,4a
6614,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,G
6615,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,L
6616,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,N
6617,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,M
6618,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,transcriptase
6619,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,glycoprotein
6620,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,nucleocapsid protein
6621,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,phosphoprotein
6622,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,4a
6623,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,matrix protein
6624,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,L
6625,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,4b
6626,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,M
6627,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,N
6628,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,4a
6629,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,G
6630,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,L
6631,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,N
6632,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,P
6633,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,M
6634,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,transcriptase
6635,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,glycoprotein
6636,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,nucleocapsid protein
6637,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,phosphoprotein
6638,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,4a
6639,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,matrix protein
6640,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,4b
6641,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,M
6642,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,N
6643,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,4a
6644,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,G
6645,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,L
6646,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,N
6647,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,P
6648,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,M
6649,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,transcriptase
6650,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,glycoprotein
6651,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,nucleocapsid protein
6652,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,phosphoprotein
6653,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,4a
6654,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,matrix protein
6655,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,M
6656,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,N
6657,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,4a
6658,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,G
6659,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,L
6660,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,N
6661,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,P
6662,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,M
6663,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,transcriptase
6664,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,glycoprotein
6665,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,nucleocapsid protein
6666,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,phosphoprotein
6667,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,4a
6668,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4b,matrix protein
6669,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,N
6670,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,4a
6671,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,G
6672,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,L
6673,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,N
6674,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,P
6675,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,M
6676,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,transcriptase
6677,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,glycoprotein
6678,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,nucleocapsid protein
6679,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,phosphoprotein
6680,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,4a
6681,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,matrix protein
6682,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,4a
6683,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,G
6684,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,L
6685,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,N
6686,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,P
6687,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,M
6688,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,transcriptase
6689,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,glycoprotein
6690,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,nucleocapsid protein
6691,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,phosphoprotein
6692,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,4a
6693,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,matrix protein
6694,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,G
6695,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,L
6696,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,N
6697,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,P
6698,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,M
6699,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,transcriptase
6700,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,glycoprotein
6701,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,nucleocapsid protein
6702,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,phosphoprotein
6703,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,4a
6704,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,matrix protein
6705,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,L
6706,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,N
6707,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,P
6708,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,M
6709,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,transcriptase
6710,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,glycoprotein
6711,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,nucleocapsid protein
6712,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,phosphoprotein
6713,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,4a
6714,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,G,matrix protein
6715,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,N
6716,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,P
6717,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,M
6718,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,transcriptase
6719,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,glycoprotein
6720,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,nucleocapsid protein
6721,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,phosphoprotein
6722,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,4a
6723,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,L,matrix protein
6724,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,P
6725,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,M
6726,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,transcriptase
6727,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,glycoprotein
6728,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,nucleocapsid protein
6729,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,phosphoprotein
6730,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,4a
6731,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,N,matrix protein
6732,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,M
6733,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,transcriptase
6734,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,glycoprotein
6735,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,nucleocapsid protein
6736,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,P,matrix protein
6737,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,transcriptase
6738,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,glycoprotein
6739,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,nucleocapsid protein
6740,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,phosphoprotein
6741,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,4a
6742,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,M,matrix protein
6743,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,transcriptase,glycoprotein
6744,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,transcriptase,nucleocapsid protein
6745,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,transcriptase,phosphoprotein
6746,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,transcriptase,4a
6747,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,transcriptase,matrix protein
6748,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,glycoprotein,nucleocapsid protein
6749,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,glycoprotein,phosphoprotein
6750,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,glycoprotein,4a
6751,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,glycoprotein,matrix protein
6752,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,nucleocapsid protein,phosphoprotein
6753,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,nucleocapsid protein,4a
6754,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,nucleocapsid protein,matrix protein
6755,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,phosphoprotein,4a
6756,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,phosphoprotein,matrix protein
6757,BioInfer.d672,False,"The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.",BioInfer.d672.s0,4a,matrix protein
6758,BioInfer.d673,True,The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.,BioInfer.d673.s0,actin,profilin
6759,BioInfer.d673,True,The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.,BioInfer.d673.s0,profilin,actin
6760,BioInfer.d673,False,The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.,BioInfer.d673.s0,actin,actin
6761,BioInfer.d674,True,"The protein has the two conserved domains identified as actin and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the cofilin family.",BioInfer.d674.s0,cofilin,actin
6762,BioInfer.d675,True,"The proteins encoded by MRS5 and MRS11, which display 35%, sequence identity are both located in the mitochondrial intermembrane space.",BioInfer.d675.s0,MRS5,MRS11
6763,BioInfer.d676,False,The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.,BioInfer.d676.s0,actin,profilins
6764,BioInfer.d676,False,The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.,BioInfer.d676.s0,actin,profilins
6765,BioInfer.d676,False,The proximity of the semi-conserved actin-binding site and the binding pocket characteristic of plant profilins suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant profilins thought to be responsible for type I allergies.,BioInfer.d676.s0,profilins,profilins
6766,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC5,XRCC1
6767,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC5,RAD52
6768,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC5,XRCC3
6769,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC5,RAD51
6770,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC1,RAD52
6771,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC1,XRCC3
6772,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC1,RAD51
6773,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,RAD52,XRCC3
6774,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,RAD52,RAD51
6775,BioInfer.d678,False,"The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes (XRCC1, XRCC3, XRCC5, RAD51, RAD52).",BioInfer.d678.s0,XRCC3,RAD51
6776,BioInfer.d680,True,"There are only 14 non-conservative substitutions in the two myosin heavy chains, three of which are located in the secondary actin-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.",BioInfer.d680.s0,myosin heavy chains,actin
6777,BioInfer.d682,True,"The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.",BioInfer.d682.s0,skeletal actin,profilin
6778,BioInfer.d682,False,"The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.",BioInfer.d682.s0,skeletal actin,actin
6779,BioInfer.d682,False,"The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.",BioInfer.d682.s0,actin,profilin
6780,BioInfer.d683,True,The recombinant material is similar to authentic human platelet profilin based on the measured Kd for rabbit skeletal muscle actin.,BioInfer.d683.s0,skeletal muscle actin,platelet profilin
6781,BioInfer.d685,True,The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.,BioInfer.d685.s0,beta-catenin,alpha-catenin
6782,BioInfer.d685,True,The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.,BioInfer.d685.s0,alpha-catenin,actin
6783,BioInfer.d685,False,The resulting beta-catenin product is unable to bind alpha-catenin that is responsible for actin filament binding and organization.,BioInfer.d685.s0,beta-catenin,actin
6784,BioInfer.d686,True,The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.,BioInfer.d686.s0,cofilin,actin
6785,BioInfer.d686,False,The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.,BioInfer.d686.s0,cofilin,cofilin
6786,BioInfer.d686,False,The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.,BioInfer.d686.s0,cofilin,actin
6787,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,plakoglobin
6788,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6789,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,beta-catenin
6790,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,cadherin
6791,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,vinculin,plakoglobin
6792,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,vinculin,beta-catenin
6793,BioInfer.d688,True,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,plakoglobin,beta-catenin
6794,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,LEF-1
6795,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,alpha-catenin
6796,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6797,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,vinculin
6798,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,plakoglobin
6799,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,cadherin
6800,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6801,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6802,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,alpha-catenin
6803,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6804,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,vinculin
6805,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,cadherin
6806,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,LEF-1,beta-catenin
6807,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,vinculin
6808,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,plakoglobin
6809,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,cadherin
6810,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,beta-catenin
6811,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,alpha-catenin,beta-catenin
6812,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,vinculin
6813,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,plakoglobin
6814,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,beta-catenin
6815,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,beta-catenin
6816,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,vinculin,cadherin
6817,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,vinculin,beta-catenin
6818,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,plakoglobin,cadherin
6819,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,plakoglobin,beta-catenin
6820,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,cadherin,beta-catenin
6821,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,cadherin,beta-catenin
6822,BioInfer.d688,False,"The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.",BioInfer.d688.s0,beta-catenin,beta-catenin
6823,BioInfer.d692,True,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp54+,RAD54
6824,BioInfer.d692,True,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD51,rhp51+
6825,BioInfer.d692,True,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rad22+,RAD52
6826,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp54+,RAD51
6827,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp54+,rad22+
6828,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp54+,rhp51+
6829,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp54+,RAD52
6830,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD54,RAD51
6831,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD54,rad22+
6832,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD54,rhp51+
6833,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD54,RAD52
6834,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD51,rad22+
6835,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,RAD51,RAD52
6836,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rad22+,rhp51+
6837,BioInfer.d692,False,"The Schizosaccharomyces pombe rhp51+, rad22+ and rhp54+ genes are homologous to RAD51, RAD52 and RAD54 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.",BioInfer.d692.s0,rhp51+,RAD52
6838,BioInfer.d693,False,"These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.",BioInfer.d693.s0,beta-catenin,alpha-catenin
6839,BioInfer.d693,False,"These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.",BioInfer.d693.s0,beta-catenin,N-cadherin
6840,BioInfer.d693,False,"These cells have both alpha-catenin and beta-catenin, display unusual expression of N-cadherin, and have the typical fibroblastic phenotype of transformed cells.",BioInfer.d693.s0,alpha-catenin,N-cadherin
6841,BioInfer.d694,True,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,class II myosins,myosin II
6842,BioInfer.d694,True,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,class II myosins,myosin heavy chains
6843,BioInfer.d694,True,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,myosin II,actin
6844,BioInfer.d694,True,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,myosin II,MgATPase
6845,BioInfer.d694,True,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,myosin II,myosin heavy chains
6846,BioInfer.d694,False,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,class II myosins,actin
6847,BioInfer.d694,False,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,class II myosins,MgATPase
6848,BioInfer.d694,False,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,actin,MgATPase
6849,BioInfer.d694,False,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,actin,myosin heavy chains
6850,BioInfer.d694,False,"These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.",BioInfer.d694.s0,MgATPase,myosin heavy chains
6851,BioInfer.d695,True,These data suggest that nuclear profilin can mediate a stimulus-response action on the actin cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.,BioInfer.d695.s0,actin,profilin
6852,BioInfer.d696,False,"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.",BioInfer.d696.s0,tropomyosin,myosin heavy chain
6853,BioInfer.d696,False,"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.",BioInfer.d696.s0,tropomyosin,actin
6854,BioInfer.d696,False,"These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of myosin heavy chain, actin and tropomyosin.",BioInfer.d696.s0,myosin heavy chain,actin
6855,BioInfer.d697,False,These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of RAD51 and RAD52.,BioInfer.d697.s0,RAD51,RAD52
6856,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL5,UL9
6857,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL5,UL8
6858,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL5,UL52
6859,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL5,UL42
6860,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL9,UL8
6861,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL9,UL52
6862,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL9,UL42
6863,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL8,UL52
6864,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL8,UL42
6865,BioInfer.d699,False,"These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.",BioInfer.d699.s0,UL52,UL42
6866,BioInfer.d700,False,"These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.",BioInfer.d700.s0,profilin,actin depolymerizing factor
6867,BioInfer.d700,False,"These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.",BioInfer.d700.s0,profilin,lactic dehydrogenase
6868,BioInfer.d700,False,"These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.",BioInfer.d700.s0,actin depolymerizing factor,lactic dehydrogenase
6869,BioInfer.d701,True,"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.",BioInfer.d701.s0,actin,myosin heavy chain
6870,BioInfer.d701,False,"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.",BioInfer.d701.s0,skeletal actin,actin
6871,BioInfer.d701,False,"These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.",BioInfer.d701.s0,skeletal actin,myosin heavy chain
6872,BioInfer.d702,True,"These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.",BioInfer.d702.s0,PFY1,profilin
6873,BioInfer.d702,True,"These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.",BioInfer.d702.s0,actin-binding protein,profilin
6874,BioInfer.d702,False,"These phenotypes are similar to those of the mutant of PFY1, which encodes profilin, an actin-binding protein.",BioInfer.d702.s0,PFY1,actin-binding protein
6875,BioInfer.d704,True,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,Arp2,actin
6876,BioInfer.d704,True,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,Arp2,Arp 3
6877,BioInfer.d704,True,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,actin,Arp 3
6878,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,verprolin,Arp2
6879,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,verprolin,actin
6880,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,verprolin,cofilin
6881,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,verprolin,Arp 3
6882,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,Arp2,cofilin
6883,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,actin,cofilin
6884,BioInfer.d704,False,"These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.",BioInfer.d704.s0,cofilin,Arp 3
6885,BioInfer.d705,True,The sequence of the inhibitory region is similar to that of a beta-hairpin region of the actin-binding protein profilin.,BioInfer.d705.s0,actin-binding protein,profilin
6886,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,cell adhesion proteins
6887,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,HMP-2
6888,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,alpha-catenin
6889,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,classical cadherin
6890,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,Armadillo
6891,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,alpha-catenin,HMP-1
6892,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,classical cadherin,HMR-1
6893,BioInfer.d706,True,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,HMP-2,Armadillo
6894,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,alpha-catenin
6895,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,classical cadherin
6896,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,HMR-1
6897,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,Armadillo
6898,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,beta-catenin,HMP-1
6899,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,HMP-2
6900,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,HMR-1
6901,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,cell adhesion proteins,HMP-1
6902,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,alpha-catenin,classical cadherin
6903,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,alpha-catenin,HMP-2
6904,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,alpha-catenin,HMR-1
6905,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,alpha-catenin,Armadillo
6906,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,classical cadherin,HMP-2
6907,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,classical cadherin,Armadillo
6908,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,classical cadherin,HMP-1
6909,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,HMP-2,HMR-1
6910,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,HMP-2,HMP-1
6911,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,HMR-1,Armadillo
6912,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,HMR-1,HMP-1
6913,BioInfer.d706,False,"The sequences of the predicted HMP-1, HMP-2, and HMR-1 proteins are related to the cell adhesion proteins alpha-catenin, beta-catenin/Armadillo, and classical cadherin, respectively.",BioInfer.d706.s0,Armadillo,HMP-1
6914,BioInfer.d707,True,"These regions also interact with the physiologically relevant ligands of profilin, actin and proline-rich peptides.",BioInfer.d707.s0,actin,profilin
6915,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,cofilin
6916,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,actin
6917,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,ROCK
6918,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,cofilin
6919,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,actin
6920,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,cofilin,actin
6921,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,cofilin,ROCK
6922,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,actin,Rho
6923,BioInfer.d709,True,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,actin,ROCK
6924,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,LIM-kinase
6925,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,Rho
6926,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,Rho
6927,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,LIM-kinase,ROCK
6928,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,cofilin,Rho
6929,BioInfer.d709,False,These results indicate that phosphorylation of LIM-kinase by ROCK and consequently increased phosphorylation of cofilin by LIM-kinase contribute to Rho-induced reorganization of the actin cytoskeleton.,BioInfer.d709.s0,Rho,ROCK
6930,BioInfer.d710,True,These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.,BioInfer.d710.s0,cofilin,actin
6931,BioInfer.d710,True,These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.,BioInfer.d710.s0,ADF,actin
6932,BioInfer.d710,False,These results show that cofilin/ADF is an important regulator of actin-based cell motility during Drosophila development.,BioInfer.d710.s0,cofilin,ADF
6933,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,actin-binding proteins
6934,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin-binding proteins,PI kinases
6935,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin-binding proteins,PKC
6936,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin-binding proteins,PIP kinases
6937,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin-binding proteins,actin
6938,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin-binding proteins,gelsolin
6939,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PI kinases,PKC
6940,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PI kinases,actin
6941,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PKC,PIP kinases
6942,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PKC,actin
6943,BioInfer.d711,True,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PIP kinases,actin
6944,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,PI kinases
6945,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,PKC
6946,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,PIP kinases
6947,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,actin
6948,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,profilin,gelsolin
6949,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PI kinases,PIP kinases
6950,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PI kinases,gelsolin
6951,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PKC,gelsolin
6952,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,PIP kinases,gelsolin
6953,BioInfer.d711,False,"These results suggest that activation of PKC precedes the activation of PI and PIP kinases and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of actin in RBL cells, possibly through the interaction of the polyphosphoinositides with actin-binding proteins such as gelsolin and profilin.",BioInfer.d711.s0,actin,gelsolin
6954,BioInfer.d712,True,These results suggest that profilin may be involved in the pathogenesis of glomerulonephritis by reorganizing actin cytoskeleton.,BioInfer.d712.s0,profilin,actin
6955,BioInfer.d713,True,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,ROCK,LIMK2
6956,BioInfer.d713,True,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,LIMK2,cofilin/ADF
6957,BioInfer.d713,True,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,LIMK2,actin
6958,BioInfer.d713,True,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,LIMK2,Rho
6959,BioInfer.d713,True,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,cofilin/ADF,actin
6960,BioInfer.d713,False,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,ROCK,cofilin/ADF
6961,BioInfer.d713,False,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,ROCK,actin
6962,BioInfer.d713,False,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,ROCK,Rho
6963,BioInfer.d713,False,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,cofilin/ADF,Rho
6964,BioInfer.d713,False,"These results suggest that LIMK2 functions downstream of the Rho-ROCK signalling pathway and plays a role in reorganization of actin filaments and membrane structures, by phosphorylating cofilin/ADF proteins.",BioInfer.d713.s0,actin,Rho
6965,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK2,cofilin
6966,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK2,ADF
6967,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK2,cofilin
6968,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK2,actin-depolymerizing factor
6969,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,cofilin,LIMK1
6970,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK1,ADF
6971,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK1,cofilin
6972,BioInfer.d713,True,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK1,actin-depolymerizing factor
6973,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,LIMK2,LIMK1
6974,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,cofilin,ADF
6975,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,cofilin,cofilin
6976,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,cofilin,actin-depolymerizing factor
6977,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,ADF,cofilin
6978,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,ADF,actin-depolymerizing factor
6979,BioInfer.d713,False,We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.,BioInfer.d713.s1,cofilin,actin-depolymerizing factor
6980,BioInfer.d714,True,"These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.",BioInfer.d714.s0,cofilin,actin
6981,BioInfer.d714,False,"These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.",BioInfer.d714.s0,actin,cofilin
6982,BioInfer.d714,False,"These results suggest that the heptapeptide sequence is specific for the interaction with actin and, therefore, may constitute part of the actin-binding domain of cofilin.",BioInfer.d714.s0,actin,actin
6983,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TRADD,TNF-alpha
6984,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TRADD,TNFR1
6985,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TNF-alpha,FLICE
6986,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TNF-alpha,FADD
6987,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,FLICE,TNFR1
6988,BioInfer.d715,True,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,FADD,TNFR1
6989,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TRADD,FLICE
6990,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TRADD,FADD
6991,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TRADD,TNF
6992,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TNF-alpha,TNF
6993,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TNF-alpha,TNFR1
6994,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,FLICE,FADD
6995,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,FLICE,TNF
6996,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,FADD,TNF
6997,BioInfer.d715,False,"These results suggest that TNF-alpha can cause apoptosis in pancreatic beta cells through TNFR1-linked apoptotic factors, TRADD, FADD, and FLICE, and TNF-induced ceramide production may be involved in the pathways.",BioInfer.d715.s0,TNF,TNFR1
6998,BioInfer.d716,True,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,actin-binding protein,cofilin
6999,BioInfer.d716,True,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,cofilin,PP1
7000,BioInfer.d716,True,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,cofilin,PP2A
7001,BioInfer.d716,True,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,PP1,serine phosphatases
7002,BioInfer.d716,True,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,PP2A,serine phosphatases
7003,BioInfer.d716,False,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,actin-binding protein,PP1
7004,BioInfer.d716,False,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,actin-binding protein,PP2A
7005,BioInfer.d716,False,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,actin-binding protein,serine phosphatases
7006,BioInfer.d716,False,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,cofilin,serine phosphatases
7007,BioInfer.d716,False,The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes.,BioInfer.d716.s0,PP1,PP2A
7008,BioInfer.d718,True,"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.",BioInfer.d718.s0,cofilin,actin
7009,BioInfer.d718,False,"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.",BioInfer.d718.s0,cofilin,cofilin
7010,BioInfer.d718,False,"These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive actin-depolymerizing protein, cofilin, by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for cofilin.",BioInfer.d718.s0,cofilin,actin
7011,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,F0
7012,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,fusion proteins
7013,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,non-structural proteins
7014,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,matrix proteins
7015,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,HN
7016,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,large proteins
7017,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,nucleocapsid proteins
7018,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,haemagglutinin neuraminidase proteins
7019,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,phosphoprotein proteins
7020,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,P
7021,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,V
7022,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,N
7023,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,L,M
7024,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,fusion proteins
7025,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,non-structural proteins
7026,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,matrix proteins
7027,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,HN
7028,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,large proteins
7029,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,nucleocapsid proteins
7030,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,haemagglutinin neuraminidase proteins
7031,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,phosphoprotein proteins
7032,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,P
7033,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,V
7034,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,N
7035,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,F0,M
7036,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,non-structural proteins
7037,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,matrix proteins
7038,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,HN
7039,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,large proteins
7040,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,nucleocapsid proteins
7041,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,haemagglutinin neuraminidase proteins
7042,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,phosphoprotein proteins
7043,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,P
7044,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,V
7045,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,N
7046,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,fusion proteins,M
7047,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,matrix proteins
7048,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,HN
7049,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,large proteins
7050,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,nucleocapsid proteins
7051,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,haemagglutinin neuraminidase proteins
7052,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,phosphoprotein proteins
7053,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,P
7054,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,V
7055,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,N
7056,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,non-structural proteins,M
7057,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,HN
7058,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,large proteins
7059,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,nucleocapsid proteins
7060,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,haemagglutinin neuraminidase proteins
7061,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,phosphoprotein proteins
7062,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,P
7063,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,V
7064,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,N
7065,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,matrix proteins,M
7066,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,large proteins
7067,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,nucleocapsid proteins
7068,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,haemagglutinin neuraminidase proteins
7069,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,phosphoprotein proteins
7070,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,P
7071,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,V
7072,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,N
7073,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,HN,M
7074,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,nucleocapsid proteins
7075,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,haemagglutinin neuraminidase proteins
7076,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,phosphoprotein proteins
7077,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,P
7078,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,V
7079,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,N
7080,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,large proteins,M
7081,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,haemagglutinin neuraminidase proteins
7082,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,phosphoprotein proteins
7083,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,P
7084,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,V
7085,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,N
7086,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,nucleocapsid proteins,M
7087,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,haemagglutinin neuraminidase proteins,phosphoprotein proteins
7088,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,haemagglutinin neuraminidase proteins,P
7089,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,haemagglutinin neuraminidase proteins,V
7090,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,haemagglutinin neuraminidase proteins,N
7091,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,haemagglutinin neuraminidase proteins,M
7092,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,phosphoprotein proteins,P
7093,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,phosphoprotein proteins,V
7094,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,phosphoprotein proteins,N
7095,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,phosphoprotein proteins,M
7096,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,P,V
7097,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,P,N
7098,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,P,M
7099,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,V,N
7100,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,V,M
7101,BioInfer.d721,False,"The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.",BioInfer.d721.s0,N,M
7102,BioInfer.d722,True,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,verprolin,Myo5p
7103,BioInfer.d722,True,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,Myo5p,type I myosin
7104,BioInfer.d722,True,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,Myo5p,Src
7105,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,verprolin,type I myosin
7106,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,verprolin,actin
7107,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,verprolin,Src
7108,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,Myo5p,actin
7109,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,type I myosin,actin
7110,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,type I myosin,Src
7111,BioInfer.d722,False,"The Src homology domain 3 (SH3) of a yeast type I myosin, Myo5p, binds to verprolin and is required for targeting to sites of actin polarization.",BioInfer.d722.s0,actin,Src
7112,BioInfer.d723,True,The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.,BioInfer.d723.s0,actin,gelsolin
7113,BioInfer.d723,True,The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.,BioInfer.d723.s0,actin,cofilin
7114,BioInfer.d723,True,The structural homology between cofilin and gelsolin segment-1 binding to actin was confirmed experimentally by two types of competitive binding assays.,BioInfer.d723.s0,gelsolin,cofilin
7115,BioInfer.d724,True,The structure of an actin-crosslinking domain from human fimbrin.,BioInfer.d724.s0,fimbrin,actin
7116,BioInfer.d725,True,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,syntaxin,Ykt6pN
7117,BioInfer.d725,True,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,actin,profilin
7118,BioInfer.d725,True,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,Ykt6pN,profilin
7119,BioInfer.d725,False,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,syntaxin,actin
7120,BioInfer.d725,False,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,syntaxin,profilin
7121,BioInfer.d725,False,"The structure of Ykt6pN differed entirely from that of syntaxin and resembled the overall fold of the actin regulatory protein, profilin.",BioInfer.d725.s0,actin,Ykt6pN
7122,BioInfer.d726,True,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,actin,fimbrin
7123,BioInfer.d726,True,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,fimbrin,actin
7124,BioInfer.d726,False,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,actin,fimbrin
7125,BioInfer.d726,False,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,actin,actin
7126,BioInfer.d726,False,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,fimbrin,fimbrin
7127,BioInfer.d726,False,"The Tetrahymena fimbrin has two actin-binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena fimbrin probably cross-links actin filaments in a Ca(2+)- insensitive manner during cytokinesis.",BioInfer.d726.s0,fimbrin,actin
7128,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,RAIDD
7129,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,TNFR1
7130,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,Fas
7131,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,tumor necrosis factor receptor 1
7132,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,RIP kinase
7133,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TRADD,FADD
7134,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RAIDD,TNFR1
7135,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RAIDD,Fas
7136,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RAIDD,tumor necrosis factor receptor 1
7137,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RAIDD,RIP kinase
7138,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RAIDD,FADD
7139,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TNFR1,RIP kinase
7140,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TNFR1,FADD
7141,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,Fas,RIP kinase
7142,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,Fas,FADD
7143,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,tumor necrosis factor receptor 1,RIP kinase
7144,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,tumor necrosis factor receptor 1,FADD
7145,BioInfer.d727,True,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,RIP kinase,FADD
7146,BioInfer.d727,False,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TNFR1,Fas
7147,BioInfer.d727,False,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,TNFR1,tumor necrosis factor receptor 1
7148,BioInfer.d727,False,"The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].",BioInfer.d727.s0,Fas,tumor necrosis factor receptor 1
7149,BioInfer.d728,True,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,beta myosin
7150,BioInfer.d728,True,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,alpha Myosin
7151,BioInfer.d728,True,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,actin
7152,BioInfer.d728,True,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,cardiac myosin heavy chain alpha,cardiac myosin heavy chain beta
7153,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,alpha myosin
7154,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,beta myosin
7155,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,cardiac myosin heavy chain alpha
7156,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,ATPase,cardiac myosin heavy chain beta
7157,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,alpha Myosin
7158,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,alpha myosin
7159,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,beta myosin
7160,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,cardiac myosin heavy chain alpha
7161,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,actin
7162,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,cardiac myosin heavy chain beta
7163,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha Myosin,alpha myosin
7164,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha Myosin,beta myosin
7165,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha Myosin,cardiac myosin heavy chain alpha
7166,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha Myosin,actin
7167,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha Myosin,cardiac myosin heavy chain beta
7168,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha myosin,beta myosin
7169,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha myosin,cardiac myosin heavy chain alpha
7170,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha myosin,actin
7171,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,alpha myosin,cardiac myosin heavy chain beta
7172,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,cardiac myosin heavy chain alpha
7173,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,actin
7174,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,beta myosin,cardiac myosin heavy chain beta
7175,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,cardiac myosin heavy chain alpha,actin
7176,BioInfer.d728,False,"The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.",BioInfer.d728.s0,actin,cardiac myosin heavy chain beta
7177,BioInfer.d729,True,"The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.",BioInfer.d729.s0,cofilin,destrin
7178,BioInfer.d729,True,"The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.",BioInfer.d729.s0,cofilin,actin
7179,BioInfer.d729,True,"The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.",BioInfer.d729.s0,destrin,actin
7180,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,talin
7181,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,vinculin
7182,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,vinculin
7183,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,fibronectin
7184,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,laminin
7185,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,fibronectin
7186,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,gelatin
7187,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,fibronectin
7188,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,beta1 integrin
7189,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,paxillin
7190,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,laminin
7191,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,actin,vinculin
7192,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,vinculin
7193,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,vinculin
7194,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,fibronectin
7195,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,laminin
7196,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,fibronectin
7197,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,gelatin
7198,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,fibronectin
7199,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,beta1 integrin
7200,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,paxillin
7201,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,laminin
7202,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,talin,vinculin
7203,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,vinculin
7204,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7205,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,laminin
7206,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7207,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,gelatin
7208,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7209,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,beta1 integrin
7210,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,paxillin
7211,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,laminin
7212,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,vinculin
7213,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7214,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,laminin
7215,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7216,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,gelatin
7217,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,fibronectin
7218,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,beta1 integrin
7219,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,paxillin
7220,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,laminin
7221,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,vinculin,vinculin
7222,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,laminin
7223,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,fibronectin
7224,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,gelatin
7225,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,fibronectin
7226,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,beta1 integrin
7227,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,paxillin
7228,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,laminin
7229,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,vinculin
7230,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,fibronectin
7231,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,gelatin
7232,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,fibronectin
7233,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,beta1 integrin
7234,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,paxillin
7235,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,laminin
7236,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,vinculin
7237,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,gelatin
7238,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,fibronectin
7239,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,beta1 integrin
7240,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,paxillin
7241,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,laminin
7242,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,vinculin
7243,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,gelatin,fibronectin
7244,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,gelatin,beta1 integrin
7245,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,gelatin,paxillin
7246,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,gelatin,laminin
7247,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,gelatin,vinculin
7248,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,beta1 integrin
7249,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,paxillin
7250,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,laminin
7251,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,fibronectin,vinculin
7252,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,beta1 integrin,paxillin
7253,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,beta1 integrin,laminin
7254,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,beta1 integrin,vinculin
7255,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,paxillin,laminin
7256,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,paxillin,vinculin
7257,BioInfer.d730,False,"The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.",BioInfer.d730.s0,laminin,vinculin
7258,BioInfer.d731,True,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,E3L,PKR
7259,BioInfer.d731,True,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,protein kinase,PKR
7260,BioInfer.d731,True,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,pE3,PKR
7261,BioInfer.d731,True,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,interferon,PKR
7262,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,E3L,protein kinase
7263,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,E3L,pE3
7264,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,E3L,interferon
7265,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,protein kinase,pE3
7266,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,protein kinase,interferon
7267,BioInfer.d731,False,"The vaccinia virus E3L gene product, pE3, is a dsRNA binding protein that prevents activation of the interferon-induced, dsRNA-activated protein kinase, PKR.",BioInfer.d731.s0,pE3,interferon
7268,BioInfer.d732,True,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,nucleocapsid protein,phosphoprotein
7269,BioInfer.d732,True,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,nucleocapsid protein,P
7270,BioInfer.d732,True,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,phosphoprotein,N
7271,BioInfer.d732,True,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,P,N
7272,BioInfer.d732,False,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,nucleocapsid protein,N
7273,BioInfer.d732,False,The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) phosphoprotein (P) and nucleocapsid protein (N).,BioInfer.d732.s0,phosphoprotein,P
7274,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD52,RAD50
7275,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD52,RAD51
7276,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD52,CAN1
7277,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD50,RAD51
7278,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD50,CAN1
7279,BioInfer.d733,False,"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and RAD52 for viability.",BioInfer.d733.s0,RAD51,CAN1
7280,BioInfer.d734,True,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,integrin,rac-1 GAP
7281,BioInfer.d734,True,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,talin,rac-1 GAP
7282,BioInfer.d734,True,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,vinculin,rac-1 GAP
7283,BioInfer.d734,True,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,rac-1 GAP,actin
7284,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,integrin,talin
7285,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,integrin,vinculin
7286,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,integrin,fibronectin
7287,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,integrin,actin
7288,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,talin,vinculin
7289,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,talin,fibronectin
7290,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,talin,actin
7291,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,vinculin,fibronectin
7292,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,vinculin,actin
7293,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,fibronectin,rac-1 GAP
7294,BioInfer.d734,False,"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.",BioInfer.d734.s0,fibronectin,actin
7295,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,RIP,Fas
7296,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,RIP,FADD-DN
7297,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,RIP,TRADD
7298,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD,death receptors
7299,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,Fas,FADD-DN
7300,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,Fas,TRADD
7301,BioInfer.d735,True,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD-DN,TRADD
7302,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,RIP,FADD
7303,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,RIP,death receptors
7304,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD,Fas
7305,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD,FADD-DN
7306,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD,TRADD
7307,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,Fas,death receptors
7308,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,FADD-DN,death receptors
7309,BioInfer.d735,False,"This activity is independent of FADD-DN's ability to bind to three known interacting proteins, Fas, TRADD or RIP suggesting that it is distinct from FADD's functions at activated death receptors.",BioInfer.d735.s0,death receptors,TRADD
7310,BioInfer.d736,True,This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.,BioInfer.d736.s0,actin,actin-binding protein
7311,BioInfer.d736,False,This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.,BioInfer.d736.s0,actin-binding protein,actin
7312,BioInfer.d736,False,This approach is based on the assumption that an actin mutation that specifically impairs the interaction with an actin-binding protein will cause a phenotype similar to a null mutation in the gene that encodes the actin-binding protein.,BioInfer.d736.s0,actin-binding protein,actin-binding protein
7313,BioInfer.d736,True,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,fimbrin
7314,BioInfer.d736,True,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,fimbrin
7315,BioInfer.d736,False,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,actin
7316,BioInfer.d736,False,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,actin
7317,BioInfer.d736,False,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,actin
7318,BioInfer.d736,False,"21 actin mutations were analyzed in budding yeast, and specific regions of actin subdomain 1 were implicated in the interaction with fimbrin, an actin filament-bundling protein.",BioInfer.d736.s1,actin,fimbrin
7319,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,sgs1,srs2
7320,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,sgs1,RAD52
7321,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,sgs1,RAD57
7322,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,sgs1,RAD51
7323,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,srs2,RAD52
7324,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,srs2,RAD57
7325,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,srs2,RAD51
7326,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,RAD52,RAD57
7327,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,RAD52,RAD51
7328,BioInfer.d737,False,"This arrest can be suppressed by mutations in RAD51, RAD52, and RAD57, suggesting that the cell cycle defect in sgs1 srs2 mutants results from inappropriate homologous recombination.",BioInfer.d737.s0,RAD57,RAD51
7329,BioInfer.d739,True,"This filament growth is driven by a large storage pool of actin bound to the sequestering protein, profilin.",BioInfer.d739.s0,actin,profilin
7330,BioInfer.d740,True,This is consistent with cofilin activation being required for actin reorganization during exocytosis.,BioInfer.d740.s0,cofilin,actin
7331,BioInfer.d741,True,"This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.",BioInfer.d741.s0,actin,profilin
7332,BioInfer.d741,False,"This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.",BioInfer.d741.s0,actin,profilin
7333,BioInfer.d741,False,"This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.",BioInfer.d741.s0,profilin,profilin
7334,BioInfer.d742,True,This novel mutation was predicted to disrupt the binding of beta-catenin to alpha-catenin and may be related to the diffuse type morphology.,BioInfer.d742.s0,alpha-catenin,beta-catenin
7335,BioInfer.d746,True,This shows that structural changes in the poly(L-proline)-binding region of profilin can affect the distantly located actin-binding site.,BioInfer.d746.s0,actin,profilin
7336,BioInfer.d747,True,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin,cortexillin I
7337,BioInfer.d747,True,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin,cortexillin II
7338,BioInfer.d747,True,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin,actin
7339,BioInfer.d747,True,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,talin,actin
7340,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin,talin
7341,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin,actin
7342,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin I,talin
7343,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin I,cortexillin II
7344,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin I,actin
7345,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin I,actin
7346,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,talin,cortexillin II
7347,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,talin,actin
7348,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin II,actin
7349,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,cortexillin II,actin
7350,BioInfer.d747,False,"This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.",BioInfer.d747.s0,actin,actin
7351,BioInfer.d749,True,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,gelsolin,actin
7352,BioInfer.d749,True,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin-binding protein,actin
7353,BioInfer.d749,True,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin,profilin
7354,BioInfer.d749,True,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin,profilin
7355,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,gelsolin,actin-binding protein
7356,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,gelsolin,actin
7357,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,gelsolin,profilin
7358,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin-binding protein,actin
7359,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin-binding protein,profilin
7360,BioInfer.d749,False,"Three actin-associated proteins, actin-binding protein, gelsolin, and profilin, influence gelation, solation, and polymerization, respectively, of actin in vitro.",BioInfer.d749.s0,actin,actin
7361,BioInfer.d750,True,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,Armadillo,beta-catenin
7362,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,E-cadherin,Armadillo
7363,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,E-cadherin,alpha-catenin
7364,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,E-cadherin,beta-catenin
7365,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,E-cadherin,DE-cadherin
7366,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,Armadillo,alpha-catenin
7367,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,Armadillo,DE-cadherin
7368,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,alpha-catenin,beta-catenin
7369,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,alpha-catenin,DE-cadherin
7370,BioInfer.d750,False,"Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.",BioInfer.d750.s0,beta-catenin,DE-cadherin
7371,BioInfer.d751,True,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,fimbrin,actin
7372,BioInfer.d751,False,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,fimbrin,actin
7373,BioInfer.d751,False,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,fimbrin,fimbrin
7374,BioInfer.d751,False,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,actin,actin
7375,BioInfer.d751,False,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,actin,fimbrin
7376,BioInfer.d751,False,"Thus, actin was found in association with fimbrin in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in actin, did not reveal fimbrin.",BioInfer.d751.s0,actin,fimbrin
7377,BioInfer.d752,False,"Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.",BioInfer.d752.s0,alpha-catenin,beta-catenin
7378,BioInfer.d752,False,"Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.",BioInfer.d752.s0,alpha-catenin,E-cadherin
7379,BioInfer.d752,False,"Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.",BioInfer.d752.s0,beta-catenin,E-cadherin
7380,BioInfer.d755,True,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,actin,mHip1R
7381,BioInfer.d755,True,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,Sla2p,mHip1R
7382,BioInfer.d755,True,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,talin,mHip1R
7383,BioInfer.d755,False,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,actin,Sla2p
7384,BioInfer.d755,False,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,actin,talin
7385,BioInfer.d755,False,"Thus, mHip1R contains an NH(2)-terminal domain homologous to that implicated in Sla2p's endocytic function, three predicted coiled-coils, a leucine zipper, and a talin-like actin-binding domain at the COOH terminus.",BioInfer.d755.s0,Sla2p,talin
7386,BioInfer.d756,True,"Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.",BioInfer.d756.s0,actin,profilin
7387,BioInfer.d756,True,"Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.",BioInfer.d756.s0,actin,profilin
7388,BioInfer.d756,False,"Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.",BioInfer.d756.s0,actin,actin
7389,BioInfer.d757,True,"Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.",BioInfer.d757.s0,actin,cofilin
7390,BioInfer.d757,False,"Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.",BioInfer.d757.s0,actin,cofilin
7391,BioInfer.d757,False,"Thus, the actin-binding dodecapeptide sequence of cofilin may constitute a multifunctional domain in cofilin.",BioInfer.d757.s0,cofilin,cofilin
7392,BioInfer.d757,True,"We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of cofilin is a potent inhibitor of actin polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).",BioInfer.d757.s1,cofilin,actin
7393,BioInfer.d758,False,"TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.",BioInfer.d758.s0,TNF,myosin heavy chain
7394,BioInfer.d758,False,"TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.",BioInfer.d758.s0,TNF,alpha-skeletal actin
7395,BioInfer.d758,False,"TNF also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as alpha-skeletal actin and myosin heavy chain.",BioInfer.d758.s0,myosin heavy chain,alpha-skeletal actin
7396,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,DNA polymerase,major DNA-binding protein
7397,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,DNA polymerase,UL8
7398,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,DNA polymerase,UL5
7399,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,DNA polymerase,UL52
7400,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,DNA polymerase,UL42
7401,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,major DNA-binding protein,UL8
7402,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,major DNA-binding protein,UL5
7403,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,major DNA-binding protein,UL52
7404,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,major DNA-binding protein,UL42
7405,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL8,UL5
7406,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL8,UL52
7407,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL8,UL42
7408,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL5,UL52
7409,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL5,UL42
7410,BioInfer.d760,False,"To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).",BioInfer.d760.s0,UL52,UL42
7411,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,IgA,alpha-smooth muscle actin
7412,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,IgA,nonmuscle-type myosin heavy chain
7413,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,IgA,alpha-SM actin
7414,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,IgA,SMemb
7415,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,alpha-smooth muscle actin,nonmuscle-type myosin heavy chain
7416,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,alpha-smooth muscle actin,alpha-SM actin
7417,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,alpha-smooth muscle actin,SMemb
7418,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,nonmuscle-type myosin heavy chain,alpha-SM actin
7419,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,nonmuscle-type myosin heavy chain,SMemb
7420,BioInfer.d761,False,"To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of nonmuscle-type myosin heavy chain, SMemb, and alpha-smooth muscle actin (alpha-SM actin) in IgA nephropathy.",BioInfer.d761.s0,alpha-SM actin,SMemb
7421,BioInfer.d762,False,"To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.",BioInfer.d762.s0,alpha-catenin,beta-catenin
7422,BioInfer.d762,False,"To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.",BioInfer.d762.s0,alpha-catenin,E-cadherin
7423,BioInfer.d762,False,"To check its applicability, well characterized, commercially available antibodies (against E-cadherin, alpha-catenin, and beta-catenin) were used on sections of human small intestine.",BioInfer.d762.s0,beta-catenin,E-cadherin
7424,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,CD44,polymerase
7425,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,CD44,alpha-catenin
7426,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,CD44,cell adhesion molecules
7427,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,CD44,E-cadherin
7428,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,CD44,beta-catenin
7429,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,polymerase,alpha-catenin
7430,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,polymerase,cell adhesion molecules
7431,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,polymerase,E-cadherin
7432,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,polymerase,beta-catenin
7433,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,alpha-catenin,cell adhesion molecules
7434,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,alpha-catenin,E-cadherin
7435,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,alpha-catenin,beta-catenin
7436,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,cell adhesion molecules,E-cadherin
7437,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,cell adhesion molecules,beta-catenin
7438,BioInfer.d763,False,"To clarify the relation between alteration of expression of cell adhesion molecules and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for E-cadherin, alpha-catenin, beta-catenin, and CD44, with additional reverse transcription-polymerase chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.",BioInfer.d763.s0,E-cadherin,beta-catenin
7439,BioInfer.d764,True,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,HHF35,muscle actin
7440,BioInfer.d764,True,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,CGA7,muscle actin
7441,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,HHF35,SM1
7442,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,HHF35,SMC myosin heavy chain
7443,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,HHF35,SM2
7444,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,HHF35,CGA7
7445,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM1,SMC myosin heavy chain
7446,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM1,SM2
7447,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM1,CGA7
7448,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM1,muscle actin
7449,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SMC myosin heavy chain,SM2
7450,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SMC myosin heavy chain,CGA7
7451,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SMC myosin heavy chain,muscle actin
7452,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM2,CGA7
7453,BioInfer.d764,False,"To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.",BioInfer.d764.s0,SM2,muscle actin
7454,BioInfer.d765,True,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,CKIs
7455,BioInfer.d765,True,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,cyclin-dependent kinase inhibitors
7456,BioInfer.d765,True,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,CKIs,p57
7457,BioInfer.d765,True,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin-dependent kinase inhibitors,p57
7458,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,cyclin D1
7459,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,cyclin A
7460,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,cyclin B1
7461,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,p27,p57
7462,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,CKIs,cyclin-dependent kinase inhibitors
7463,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,CKIs,cyclin D1
7464,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,CKIs,cyclin A
7465,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,CKIs,cyclin B1
7466,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin-dependent kinase inhibitors,cyclin D1
7467,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin-dependent kinase inhibitors,cyclin A
7468,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin-dependent kinase inhibitors,cyclin B1
7469,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin D1,cyclin A
7470,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin D1,cyclin B1
7471,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin D1,p57
7472,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin A,cyclin B1
7473,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin A,p57
7474,BioInfer.d765,False,"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.",BioInfer.d765.s0,cyclin B1,p57
7475,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,myosin light chain 2,actin
7476,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,myosin light chain 2,myosin light chain 1
7477,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,myosin light chain 2,myosin heavy chain
7478,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,actin,myosin light chain 1
7479,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,actin,myosin heavy chain
7480,BioInfer.d766,False,"To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.",BioInfer.d766.s0,myosin light chain 1,myosin heavy chain
7481,BioInfer.d767,False,"To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for myosin heavy chain and actin.",BioInfer.d767.s0,myosin heavy chain,actin
7482,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,TGFbeta,clusterin
7483,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,TGFbeta,AP-1
7484,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,TGFbeta,AP-1
7485,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,TGFbeta,protein kinase C
7486,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,clusterin,AP-1
7487,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,clusterin,AP-1
7488,BioInfer.d768,True,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,AP-1,AP-1
7489,BioInfer.d768,False,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,clusterin,protein kinase C
7490,BioInfer.d768,False,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,AP-1,protein kinase C
7491,BioInfer.d768,False,"Together these results indicate that TGFbeta regulates clusterin gene expression through an AP-1 site and its cognate transcription factor AP-1, and requires the involvement of protein kinase C.",BioInfer.d768.s0,AP-1,protein kinase C
7492,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL5,UL9
7493,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL5,UL8
7494,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL5,UL52
7495,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL9,UL8
7496,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL9,UL52
7497,BioInfer.d769,False,"To improve our ability to study these proteins, we have expressed UL5, UL8, UL9, and UL52 in insect cells by using the baculovirus expression system.",BioInfer.d769.s0,UL8,UL52
7498,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL52,UL8
7499,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL52,UL9
7500,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL52,UL5
7501,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL8,UL9
7502,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL8,UL5
7503,BioInfer.d769,False,"Various immunological assays suggest that four of these proteins (UL5, UL8, UL9, and UL52) are made in infected cells in very low abundance relative to the other three.",BioInfer.d769.s1,UL9,UL5
7504,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,TNFalpha
7505,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,TNFalpha
7506,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,TNFalpha
7507,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,FAF
7508,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,TNFR1
7509,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,DR3
7510,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,Fas
7511,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,p55
7512,BioInfer.d772,True,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFalpha,RIP
7513,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,TRADD
7514,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,FADD
7515,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,FAF
7516,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,TNFR1
7517,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,DR3
7518,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,Fas
7519,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,p55
7520,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FLICE,RIP
7521,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,FADD
7522,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,FAF
7523,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,TNFR1
7524,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,DR3
7525,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,Fas
7526,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,p55
7527,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TRADD,RIP
7528,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,FAF
7529,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,TNFR1
7530,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,DR3
7531,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,Fas
7532,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,p55
7533,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FADD,RIP
7534,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FAF,TNFR1
7535,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FAF,DR3
7536,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FAF,Fas
7537,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FAF,p55
7538,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,FAF,RIP
7539,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFR1,DR3
7540,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFR1,Fas
7541,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFR1,p55
7542,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,TNFR1,RIP
7543,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,DR3,Fas
7544,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,DR3,p55
7545,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,DR3,RIP
7546,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,Fas,p55
7547,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,Fas,RIP
7548,BioInfer.d772,False,"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.",BioInfer.d772.s0,p55,RIP
7549,BioInfer.d773,True,"Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, GAL4, and a negative regulatory protein, GAL80.",BioInfer.d773.s0,GAL4,GAL80
7550,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,beta-catenin,alpha-catenin
7551,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,beta-catenin,cadherin
7552,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,beta-catenin,E-cadherin
7553,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,alpha-catenin,cadherin
7554,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,alpha-catenin,E-cadherin
7555,BioInfer.d774,False,Transfection of alpha-catenin-deficient colon carcinoma cells recruited E-cadherin and beta-catenin to cell-cell contacts and functional cadherin-mediated cell-cell adhesion was restored in this way.,BioInfer.d774.s0,cadherin,E-cadherin
7556,BioInfer.d776,False,"Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.",BioInfer.d776.s0,beta catenin,gamma catenin
7557,BioInfer.d776,False,"Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.",BioInfer.d776.s0,beta catenin,alpha catenin
7558,BioInfer.d776,False,"Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.",BioInfer.d776.s0,gamma catenin,alpha catenin
7559,BioInfer.d777,True,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK1,extracellular signal-regulated protein kinases
7560,BioInfer.d777,True,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK2,extracellular signal-regulated protein kinases
7561,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK1,ERK2
7562,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK1,AP-1
7563,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK1,c-jun
7564,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK1,c-fos
7565,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK2,AP-1
7566,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK2,c-jun
7567,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,ERK2,c-fos
7568,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,AP-1,c-jun
7569,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,AP-1,c-fos
7570,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,AP-1,extracellular signal-regulated protein kinases
7571,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,c-jun,c-fos
7572,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,c-jun,extracellular signal-regulated protein kinases
7573,BioInfer.d777,False,"Treatment with HNE resulted in activation of extracellular signal-regulated protein kinases ERK1 and ERK2, induction of c-fos and c-jun protein expression, and an increase in transcription factor AP-1 DNA binding activity.",BioInfer.d777.s0,c-fos,extracellular signal-regulated protein kinases
7574,BioInfer.d779,True,"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.",BioInfer.d779.s0,actin-depolymerizing factor,cofilin
7575,BioInfer.d779,True,"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.",BioInfer.d779.s0,ADF,cofilin
7576,BioInfer.d779,False,"Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.",BioInfer.d779.s0,actin-depolymerizing factor,ADF
7577,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,myosin,ABP
7578,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,myosin,actin-binding protein
7579,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,myosin,talin
7580,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,myosin,actin
7581,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,ABP,actin-binding protein
7582,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,ABP,talin
7583,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,ABP,actin
7584,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,actin-binding protein,talin
7585,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,actin-binding protein,actin
7586,BioInfer.d781,False,"Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.",BioInfer.d781.s0,talin,actin
7587,BioInfer.d782,True,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,profilin,actin-binding proteins
7588,BioInfer.d782,True,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,tropomyosin,actin-binding proteins
7589,BioInfer.d782,True,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,Cdc42p,GFP
7590,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,profilin,tropomyosin
7591,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,profilin,Cdc42p
7592,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,profilin,actin
7593,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,profilin,GFP
7594,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,tropomyosin,Cdc42p
7595,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,tropomyosin,actin
7596,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,tropomyosin,GFP
7597,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,Cdc42p,actin
7598,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,Cdc42p,actin-binding proteins
7599,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,actin,GFP
7600,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,actin,actin-binding proteins
7601,BioInfer.d782,False,"Unexpectedly, treatment with the actin-depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the actin-binding proteins tropomyosin and profilin also did not exhibit medial GFP-Cdc42p staining.",BioInfer.d782.s0,GFP,actin-binding proteins
7602,BioInfer.d783,True,"Unlike fimbrin, L-plastin's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.",BioInfer.d783.s0,L-plastin,actin
7603,BioInfer.d783,True,"Unlike fimbrin, L-plastin's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.",BioInfer.d783.s0,fimbrin,actin
7604,BioInfer.d783,False,"Unlike fimbrin, L-plastin's actin-bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.",BioInfer.d783.s0,L-plastin,fimbrin
7605,BioInfer.d784,True,Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.,BioInfer.d784.s0,VASP,actin
7606,BioInfer.d784,True,Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.,BioInfer.d784.s0,VASP,profilin
7607,BioInfer.d784,True,Unmasking of this site serves as a molecular switch that initiates assembly of an actin-based motility complex containing VASP and profilin.,BioInfer.d784.s0,actin,profilin
7608,BioInfer.d786,True,"Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of skeletal myosin heavy chain, we recently demonstrated that this segment is an actin binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].",BioInfer.d786.s0,skeletal myosin heavy chain,actin
7609,BioInfer.d787,True,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,ATPase,myosin II
7610,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,ATPase
7611,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,myosin II
7612,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,MHCK
7613,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,myosin II heavy-chain kinase
7614,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,myosin heavy chains
7615,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,actin
7616,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,ATPase,MHCK
7617,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,ATPase,myosin II heavy-chain kinase
7618,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,ATPase,myosin heavy chains
7619,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,ATPase,actin
7620,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II,MHCK
7621,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II,myosin II heavy-chain kinase
7622,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II,myosin heavy chains
7623,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II,actin
7624,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,myosin II heavy-chain kinase
7625,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,myosin heavy chains
7626,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,MHCK,actin
7627,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II heavy-chain kinase,myosin heavy chains
7628,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin II heavy-chain kinase,actin
7629,BioInfer.d787,False,"Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.",BioInfer.d787.s0,myosin heavy chains,actin
7630,BioInfer.d788,True,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,utrophin,fimbrin
7631,BioInfer.d788,True,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,utrophin,actin
7632,BioInfer.d788,True,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,utrophin,actin
7633,BioInfer.d788,True,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,fimbrin,actin
7634,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,utrophin,actin
7635,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,fimbrin,actin
7636,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,fimbrin,actin
7637,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,actin,actin
7638,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,actin,actin
7639,BioInfer.d788,False,"Using the known three-dimensional structure of the homologous actin-binding domain of fimbrin, these results have enabled us to determine the likely orientation of the utrophin actin-binding domain with respect to the actin filament.",BioInfer.d788.s0,actin,actin
7640,BioInfer.d789,True,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,profilin,actin
7641,BioInfer.d789,True,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,actin,AtFim1
7642,BioInfer.d789,True,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,actin,ZmPRO5
7643,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,profilin,AtFim1
7644,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,profilin,ZmPRO5
7645,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,profilin,actin
7646,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,actin,actin
7647,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,AtFim1,ZmPRO5
7648,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,AtFim1,actin
7649,BioInfer.d789,False,"Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.",BioInfer.d789.s0,ZmPRO5,actin
7650,BioInfer.d790,True,"Using these methods, we confirm previous reports that intact talin induces cross-linking as well as filament shortening on actin networks.",BioInfer.d790.s0,talin,actin
7651,BioInfer.d791,True,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,VE-cadherin,alpha-catenin
7652,BioInfer.d791,True,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,VE-cadherin,beta-catenin
7653,BioInfer.d791,True,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,actin,alpha-catenin
7654,BioInfer.d791,True,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,Vascular endothelial cadherin,alpha-catenin
7655,BioInfer.d791,True,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,Vascular endothelial cadherin,beta-catenin
7656,BioInfer.d791,False,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,VE-cadherin,actin
7657,BioInfer.d791,False,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,VE-cadherin,Vascular endothelial cadherin
7658,BioInfer.d791,False,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,actin,Vascular endothelial cadherin
7659,BioInfer.d791,False,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,actin,beta-catenin
7660,BioInfer.d791,False,"Vascular endothelial cadherin (VE-cadherin) clusters were co-localized with beta-catenin, an important signal transduction ligand, and with alpha-catenin, which is thought to link the complex to the peri-junctional actin.",BioInfer.d791.s0,alpha-catenin,beta-catenin
7661,BioInfer.d792,True,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,profilin,VASP
7662,BioInfer.d792,True,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,profilin,actin
7663,BioInfer.d792,True,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,profilin,actin
7664,BioInfer.d792,False,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,VASP,actin
7665,BioInfer.d792,False,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,VASP,actin
7666,BioInfer.d792,False,"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates actin filament assembly.",BioInfer.d792.s0,actin,actin
7667,BioInfer.d793,True,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,actin,fimbrin
7668,BioInfer.d793,True,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,actin,Villin
7669,BioInfer.d793,True,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,fimbrin,actin-binding proteins
7670,BioInfer.d793,True,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,Villin,actin-binding proteins
7671,BioInfer.d793,False,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,actin,actin-binding proteins
7672,BioInfer.d793,False,Villin and fimbrin are two actin-binding proteins that bundle actin filaments in the intestine and kidney brush border epithelium.,BioInfer.d793.s0,fimbrin,Villin
7673,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,WASp
7674,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,WASp
7675,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,WASp
7676,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,Rho GTPase
7677,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,actin
7678,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,WASp
7679,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,actin
7680,BioInfer.d795,True,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,actin
7681,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,cofilin
7682,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,CDC42Hs
7683,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,CDC42Hs
7684,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,WASp
7685,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,actin
7686,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,actin
7687,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,verprolin,Rho GTPase
7688,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,CDC42Hs
7689,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,CDC42Hs
7690,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,WASp
7691,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,actin
7692,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,actin
7693,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,cofilin,Rho GTPase
7694,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,CDC42Hs
7695,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,WASp
7696,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,actin
7697,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,actin
7698,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,CDC42Hs
7699,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,WASp
7700,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,actin
7701,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,Rho GTPase
7702,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,actin
7703,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,CDC42Hs,Rho GTPase
7704,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,actin
7705,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,WASp,Rho GTPase
7706,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,actin,actin
7707,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,actin,Rho GTPase
7708,BioInfer.d795,False,"WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.",BioInfer.d795.s0,actin,Rho GTPase
7709,BioInfer.d796,True,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD51,rhp51
7710,BioInfer.d796,True,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD54,rhp54
7711,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD51,RAD54
7712,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD51,rhp54
7713,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD51,rad3
7714,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD54,rhp51
7715,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,RAD54,rad3
7716,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,rhp51,rhp54
7717,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,rhp51,rad3
7718,BioInfer.d796,False,"We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant rad3-d and two recombination mutants defective in rhp51 and rhp54 (homologues of S.cerevisiae RAD51 and RAD54, respectively) are not affected.",BioInfer.d796.s0,rhp54,rad3
7719,BioInfer.d797,True,We believe that this complex may mediate the cortical functions of profilin at actin patches in S. pombe.,BioInfer.d797.s0,profilin,actin
7720,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL5,UL9
7721,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL5,UL8
7722,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL5,UL52
7723,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL9,UL8
7724,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL9,UL52
7725,BioInfer.d799,False,"We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes (UL5, UL8, UL9 and UL52) in the absence of any of the other proteins required for viral DNA synthesis.",BioInfer.d799.s0,UL8,UL52
7726,BioInfer.d800,True,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,p120
7727,BioInfer.d800,True,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,alpha-catenin
7728,BioInfer.d800,True,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,vinculin
7729,BioInfer.d800,True,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,beta-catenin
7730,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,pancadherin
7731,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,p120
7732,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,alpha-catenin
7733,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,vinculin
7734,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,N-cadherin
7735,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,beta-catenin
7736,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,actin,cadherin-11
7737,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,N-cadherin
7738,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,pancadherin,cadherin-11
7739,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,p120,alpha-catenin
7740,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,p120,vinculin
7741,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,p120,N-cadherin
7742,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,p120,beta-catenin
7743,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,p120,cadherin-11
7744,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,alpha-catenin,vinculin
7745,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,alpha-catenin,N-cadherin
7746,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,alpha-catenin,beta-catenin
7747,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,alpha-catenin,cadherin-11
7748,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,vinculin,N-cadherin
7749,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,vinculin,beta-catenin
7750,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,vinculin,cadherin-11
7751,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,N-cadherin,beta-catenin
7752,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,N-cadherin,cadherin-11
7753,BioInfer.d800,False,"We describe the localization of cadherin-11 and N-cadherin along the cell margins of mouse osteoblast-like cells, the colocalization of ""pancadherin"" with alpha-catenin, beta-catenin, p120, and vinculin, and the association of these complexes with the actin microfilaments.",BioInfer.d800.s0,beta-catenin,cadherin-11
7754,BioInfer.d801,False,"We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.",BioInfer.d801.s0,actin,myosin heavy chain
7755,BioInfer.d801,False,"We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.",BioInfer.d801.s0,actin,MHC
7756,BioInfer.d801,False,"We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.",BioInfer.d801.s0,myosin heavy chain,MHC
7757,BioInfer.d802,True,We examined whether levels of alpha-smooth-muscle actin or proliferating cell nuclear antigen correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.,BioInfer.d802.s0,proliferating cell nuclear antigen,myosin heavy-chain
7758,BioInfer.d802,True,We examined whether levels of alpha-smooth-muscle actin or proliferating cell nuclear antigen correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.,BioInfer.d802.s0,alpha-smooth-muscle actin,myosin heavy-chain
7759,BioInfer.d802,False,We examined whether levels of alpha-smooth-muscle actin or proliferating cell nuclear antigen correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.,BioInfer.d802.s0,proliferating cell nuclear antigen,alpha-smooth-muscle actin
7760,BioInfer.d803,True,We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.,BioInfer.d803.s0,cofilin,actin
7761,BioInfer.d803,True,We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.,BioInfer.d803.s0,profilin,actin
7762,BioInfer.d803,False,We find that profilin and cofilin regulate actin-filament formation throughout the cell cortex.,BioInfer.d803.s0,cofilin,profilin
7763,BioInfer.d804,True,We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.,BioInfer.d804.s0,profilin,actin
7764,BioInfer.d804,True,We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.,BioInfer.d804.s0,actin,Cdc42
7765,BioInfer.d804,False,We find that profilin contributes in several ways to Cdc42-induced nucleation of actin filaments in high speed supernatant of lysed neutrophils.,BioInfer.d804.s0,profilin,Cdc42
7766,BioInfer.d805,False,"We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.",BioInfer.d805.s0,beta-catenin,alpha-catenin
7767,BioInfer.d805,False,"We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.",BioInfer.d805.s0,beta-catenin,plakoglobin
7768,BioInfer.d805,False,"We found normal levels of alpha-catenin and beta-catenin in BT549 and HS578t cells; however, low levels of plakoglobin were expressed in these cells compared to those found in weakly invasive MCF-7 cells.",BioInfer.d805.s0,alpha-catenin,plakoglobin
7769,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,alpha-catenin,plakoglobin
7770,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,alpha-catenin,beta-catenin
7771,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,alpha-catenin,E-cadherin
7772,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,plakoglobin,beta-catenin
7773,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,plakoglobin,E-cadherin
7774,BioInfer.d807,False,"We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas.",BioInfer.d807.s0,beta-catenin,E-cadherin
7775,BioInfer.d809,True,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,actin,profilin
7776,BioInfer.d809,True,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,actin,tropomyosin
7777,BioInfer.d809,True,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,profilin,actin-binding proteins
7778,BioInfer.d809,True,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,actin-binding proteins,tropomyosin
7779,BioInfer.d809,False,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,actin,actin-binding proteins
7780,BioInfer.d809,False,"We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.",BioInfer.d809.s0,profilin,tropomyosin
7781,BioInfer.d809,True,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,profilin,actin
7782,BioInfer.d809,True,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,profilin,actin
7783,BioInfer.d809,True,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,profilin,skeletal muscle actin
7784,BioInfer.d809,False,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,actin,actin
7785,BioInfer.d809,False,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,actin,skeletal muscle actin
7786,BioInfer.d809,False,"Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.",BioInfer.d809.s1,actin,skeletal muscle actin
7787,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,cofilin,COF1
7788,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,cofilin,actin-binding protein
7789,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,cofilin,Cof
7790,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,COF1,Cof
7791,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,Cof,actin-binding protein
7792,BioInfer.d810,True,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,Cof,Cof
7793,BioInfer.d810,False,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,cofilin,Cof
7794,BioInfer.d810,False,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,COF1,actin-binding protein
7795,BioInfer.d810,False,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,COF1,Cof
7796,BioInfer.d810,False,We have cloned a Saccharomyces cerevisiae gene (COF1) encoding a low-M(r) actin-binding protein of 143 amino acid (aa) residues (yeast cofilin; Cof); its aa sequence is 35% identical to porcine Cof.,BioInfer.d810.s0,actin-binding protein,Cof
7797,BioInfer.d812,True,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,p27kip,cyclin-dependent kinase inhibitor
7798,BioInfer.d812,True,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,cyclin E,G1 cyclin
7799,BioInfer.d812,False,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,p27kip,cyclin E
7800,BioInfer.d812,False,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,p27kip,G1 cyclin
7801,BioInfer.d812,False,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,cyclin E,cyclin-dependent kinase inhibitor
7802,BioInfer.d812,False,"We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.",BioInfer.d812.s0,G1 cyclin,cyclin-dependent kinase inhibitor
7803,BioInfer.d813,True,"We have found that cofilin, a 21-kDa actin-binding protein, is a component of these rods.",BioInfer.d813.s0,cofilin,actin-binding protein
7804,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,Bnr1p
7805,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,Bni1p
7806,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,profilin
7807,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,Bnr1p
7808,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,small GTP-binding proteins
7809,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,Bni1p
7810,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bnr1p,small GTP-binding proteins
7811,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bnr1p,profilin
7812,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bnr1p,FH proteins
7813,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,small GTP-binding proteins,Bni1p
7814,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bni1p,profilin
7815,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bni1p,FH proteins
7816,BioInfer.d814,True,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,profilin,actin-binding protein
7817,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,Rho
7818,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,small GTP-binding proteins
7819,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,actin-binding protein
7820,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin,FH proteins
7821,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,profilin
7822,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,actin-binding protein
7823,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Rho,FH proteins
7824,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bnr1p,Bni1p
7825,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bnr1p,actin-binding protein
7826,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,small GTP-binding proteins,profilin
7827,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,small GTP-binding proteins,actin-binding protein
7828,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,small GTP-binding proteins,FH proteins
7829,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,Bni1p,actin-binding protein
7830,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,profilin,FH proteins
7831,BioInfer.d814,False,"We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.",BioInfer.d814.s0,actin-binding protein,FH proteins
7832,BioInfer.d815,True,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,nuclear basic proteins,H4
7833,BioInfer.d815,True,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,nuclear basic proteins,SP2
7834,BioInfer.d815,True,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,nuclear basic proteins,H3
7835,BioInfer.d815,True,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,H3
7836,BioInfer.d815,True,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,H4
7837,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,nuclear basic proteins,histone
7838,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,nuclear basic proteins,histone
7839,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,histone
7840,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,H4
7841,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,SP2
7842,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,SP2
7843,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,histone,H3
7844,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,H4,SP2
7845,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,H4,H3
7846,BioInfer.d815,False,"We have shown that these proteins are indeed nuclear basic proteins: the 14 kd is the histone H4, the 19 kd is the histone H3, and the 25 kd is the sperm-specific protein SP2.",BioInfer.d815.s0,SP2,H3
7847,BioInfer.d817,True,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,actin,cofilin
7848,BioInfer.d817,True,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,actin,profilin
7849,BioInfer.d817,True,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,actin,actin depolymerizing factor
7850,BioInfer.d817,False,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,cofilin,profilin
7851,BioInfer.d817,False,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,cofilin,actin depolymerizing factor
7852,BioInfer.d817,False,"We previously showed that actin is transported in an unassembled form with its associated proteins actin depolymerizing factor, cofilin, and profilin.",BioInfer.d817.s0,profilin,actin depolymerizing factor
7853,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,villin,tropomyosin
7854,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,calmodulin,actin
7855,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,calmodulin,tropomyosin
7856,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,fimbrin,tropomyosin
7857,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,actin,tropomyosin
7858,BioInfer.d819,True,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,tropomyosin,actin
7859,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,villin,calmodulin
7860,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,villin,fimbrin
7861,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,villin,actin
7862,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,villin,actin
7863,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,calmodulin,fimbrin
7864,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,calmodulin,actin
7865,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,fimbrin,actin
7866,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,fimbrin,actin
7867,BioInfer.d819,False,"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.",BioInfer.d819.s0,actin,actin
7868,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,UL29
7869,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,UL8
7870,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,UL5
7871,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,Rep68
7872,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,UL52
7873,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL30,UL42
7874,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL29,UL8
7875,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL29,UL5
7876,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL29,Rep68
7877,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL29,UL52
7878,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL29,UL42
7879,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL8,UL5
7880,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL8,Rep68
7881,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL8,UL52
7882,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL8,UL42
7883,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL5,Rep68
7884,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL5,UL52
7885,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL5,UL42
7886,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,Rep68,UL52
7887,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,Rep68,UL42
7888,BioInfer.d821,False,"We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.",BioInfer.d821.s0,UL52,UL42
7889,BioInfer.d822,True,We speculate that fimbrin may help maintain the parallel growth of actin filaments within the stereocilia.,BioInfer.d822.s0,fimbrin,actin
7890,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,nucleosome
7891,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,histone
7892,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,nucleosome
7893,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,AH
7894,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,USF
7895,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,GAL4
7896,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,H4
7897,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,AH
7898,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,GAL4
7899,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,H4
7900,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,USF
7901,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,H4
7902,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,AH,GAL4
7903,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,AH,H4
7904,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,H4
7905,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,USF,H4
7906,BioInfer.d823,True,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,GAL4,H4
7907,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,H3,histone
7908,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,histone
7909,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,nucleosome
7910,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,histone
7911,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,USF
7912,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,nucleosome
7913,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,AH
7914,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,histone
7915,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,USF
7916,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,GAL4
7917,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,H4
7918,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,AH
7919,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,histone
7920,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,nucleosome,GAL4
7921,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,AH,histone
7922,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,AH,USF
7923,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,USF
7924,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,histone,GAL4
7925,BioInfer.d823,False,Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.,BioInfer.d823.s0,USF,GAL4
7926,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH2,MSH3
7927,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH2,MLH1
7928,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH2,BAX
7929,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH2,MSH6
7930,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH2,TGFbeta RII
7931,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH3,MLH1
7932,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH3,BAX
7933,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH3,MSH6
7934,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH3,TGFbeta RII
7935,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MLH1,BAX
7936,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MLH1,MSH6
7937,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MLH1,TGFbeta RII
7938,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,BAX,MSH6
7939,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,BAX,TGFbeta RII
7940,BioInfer.d827,False,"We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.",BioInfer.d827.s0,MSH6,TGFbeta RII
7941,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,mgt1
7942,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,MSH6
7943,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,PMS1
7944,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,MSH2
7945,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,MSH3
7946,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,methyltransferase,MLH1
7947,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,mgt1,MSH6
7948,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,mgt1,PMS1
7949,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,mgt1,MSH2
7950,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,mgt1,MSH3
7951,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,mgt1,MLH1
7952,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH6,PMS1
7953,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH6,MSH2
7954,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH6,MSH3
7955,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH6,MLH1
7956,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,PMS1,MSH2
7957,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,PMS1,MSH3
7958,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,PMS1,MLH1
7959,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH2,MSH3
7960,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH2,MLH1
7961,BioInfer.d828,False,"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.",BioInfer.d828.s0,MSH3,MLH1
7962,BioInfer.d829,False,"When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.",BioInfer.d829.s0,tropomyosin,actin
7963,BioInfer.d829,False,"When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.",BioInfer.d829.s0,tropomyosin,myosin heavy chain
7964,BioInfer.d829,False,"When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at myosin heavy chain, actin, and tropomyosin.",BioInfer.d829.s0,actin,myosin heavy chain
7965,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,ADF,cofilin
7966,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,ADF,actin
7967,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,ADF,actin
7968,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,cofilin,actin
7969,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,cofilin,actin
7970,BioInfer.d830,False,"When the actin monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of ADF and actin are down-regulated compared with cofilin and 19 other proteins selected at random.",BioInfer.d830.s0,actin,actin
7971,BioInfer.d831,True,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,WAF1,cyclin-dependent kinase inhibitor
7972,BioInfer.d831,True,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,p21,cyclin-dependent kinase inhibitor
7973,BioInfer.d831,True,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,cyclin-dependent kinase inhibitor,Cip1
7974,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,WAF1,p21
7975,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,WAF1,cyclin D1
7976,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,WAF1,Cip1
7977,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,p21,cyclin D1
7978,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,p21,Cip1
7979,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,cyclin D1,cyclin-dependent kinase inhibitor
7980,BioInfer.d831,False,"While levels of most of these proteins decrease, accumulation of cyclin D1 and the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 is observed.",BioInfer.d831.s0,cyclin D1,Cip1
7981,BioInfer.d832,True,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H3
7982,BioInfer.d832,True,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H1
7983,BioInfer.d832,True,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H4
7984,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,histone
7985,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,histone
7986,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H4
7987,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H1
7988,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,H3,histone
7989,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,H3,histone
7990,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,H3,H4
7991,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,H3,H1
7992,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,histone
7993,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H4
7994,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,histone,H1
7995,BioInfer.d832,False,"While poly(ADP-ribose) effectively competed with DNA for binding of histone H4, it equally competed with DNA for binding of histone H3 and only inefficiently competed with DNA for binding of histone H1.",BioInfer.d832.s0,H4,H1
7996,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,alpha-catenin
7997,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,paxillin
7998,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,talin
7999,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,plakoglobin
8000,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,alpha-actinin
8001,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,vinculin
8002,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,cadherins
8003,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,beta-catenin,integrins
8004,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,paxillin
8005,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,talin
8006,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,plakoglobin
8007,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,alpha-actinin
8008,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,vinculin
8009,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,cadherins
8010,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-catenin,integrins
8011,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,talin
8012,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,plakoglobin
8013,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,alpha-actinin
8014,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,vinculin
8015,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,cadherins
8016,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,paxillin,integrins
8017,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,talin,plakoglobin
8018,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,talin,alpha-actinin
8019,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,talin,vinculin
8020,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,talin,cadherins
8021,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,talin,integrins
8022,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,plakoglobin,alpha-actinin
8023,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,plakoglobin,vinculin
8024,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,plakoglobin,cadherins
8025,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,plakoglobin,integrins
8026,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-actinin,vinculin
8027,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-actinin,cadherins
8028,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,alpha-actinin,integrins
8029,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,vinculin,cadherins
8030,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,vinculin,integrins
8031,BioInfer.d833,True,"Within 1 hour of raising the concentration of calcium ions, integrins, cadherins, alpha-catenin, beta-catenin, plakoglobin, vinculin and alpha-actinin appeared to accumulate at cell-cell borders, whereas the focal contact proteins, paxillin and talin, did not.",BioInfer.d833.s0,cadherins,integrins
8032,BioInfer.d834,False,"Within the sieve-tube exudate, profilin was present in 15-fold molar excess to actin.",BioInfer.d834.s0,profilin,actin
8033,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD52,color vision red pigment
8034,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD52,RAD6
8035,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD52,RAD51
8036,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD52,RAD1
8037,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,color vision red pigment,RAD6
8038,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,color vision red pigment,RAD51
8039,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,color vision red pigment,RAD1
8040,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD6,RAD51
8041,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD6,RAD1
8042,BioInfer.d835,False,"YACs containing color vision red pigment gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the RAD1, RAD6, RAD51, or RAD52 loci.",BioInfer.d835.s0,RAD51,RAD1
